• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-Deoxy-D-Glucose (2DG)
      • Acacia Cyanophylla Flower
      • Acori Graminei Rhizoma
      • Aegle Marmelos Correa
      • Agaricus Blazei
      • Aged Garlic Extract
      • Aframomum Melegueta
      • Aloe Arborescens
      • Albizia
      • Alpinia Officinarum
      • Alternanthera Sessilis
      • American Ginseng
      • Amygdalin
      • Anacyclus Pyrethrum
      • Angelica Archangelica
      • Angelica Sinensis
      • Antrodia
      • Artichoke Leaf
      • Artocarpin
      • Ajuga Turkestanica
      • Ashwagandha
      • Aspalathin
      • Astragalus Complanatus
      • Avena Sativa
      • Bacopa Monnieri
      • Bavachin
      • Bee Pollen
      • Betulinic Acid
      • Boswellic Acid
      • Brevilin A
      • Campesterol
      • Casticin
      • Chrysin
      • Cinnamomum Zeylanicum
      • Citrullus Colocynthis
      • Citrus Reticulata Peel
      • Codonopsis
      • Costunolide
      • Cucurbitacin D
      • Daidzein
      • Decursin
      • Delphinidin
      • Digitalis Purprea (Digoxin)
      • Diosmin
      • Embelin
      • Gallic Acid
      • Glycitein
      • Glycyrrhizin
      • Hyperforin
      • Icariin
      • Isorhamnetin
      • Isoorientin
      • Isovitexin
      • Jaceosidin
      • Kaempferol
      • Kurarinone
      • Lemon balm
      • Licoricidin
      • Lipoic acid
      • Lupeol
      • Magnolol
      • Mulberry Leaf
      • Naringenin
      • Nobiletin
      • Oleacein
      • Oleanolic acid
      • Oridonin
      • Parthenolide
      • Phloroglucinol
      • Piceatannol
      • Pristimerin
      • Proanthocyanidins
      • Procyanidin B3
      • Pseudolaric acid b
      • Pterostilbene
      • Rutin
      • Solidago Virgaurea
      • Tangeretin
      • Taraxasterol
      • Trichostatin A
      • Wedelolactone
      • Wogonin
      • Yerba Mate
    • ABOUT
    • SCIENTIFIC STUDIES
      • ALLERGIES & CYTOKINES
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • AMPK
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • APOPTOSIS
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BMI-1
      • CARDIAC GLYCOSIDES
      • CENTENARIANS
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • EPIGENETIC MODIFIERS
      • FGF21
      • KLOTHO
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HMGB1
      • HSP90 INHIBITORS
      • HYPERINSULINEMIA
      • IKK
      • IL-6/STAT3
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INSULIN & AGING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LIFESPAN EXTENSION
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MSG (MONOSOSODIUM GLUTAMATE)
      • mTOR: THE RAPID AGING PATHWAY
      • NEUROINFLAMMATION
      • NMDA & ANXIETY & DEPRESSION
      • NOOTROPICS
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PPARY2
      • PREMATURE SENESCENCE
      • SASP & ADIPOSE TISSUE
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SIRT1 & LONGEVITY
      • SUGAR & AGING
      • STAT3
      • TELOMERE SHORTENING & PREMATURE AGING
    • HOME
    • FAQ
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    Oleacein
    February 19, 2020
    RULES FOR 30LBS IN 5 DAYS CHALLENGE
    February 19, 2020
    1. … -(5-methylpyridin-2-yl)− 1H-pyrazol-5-yl) pyrazolo [1, 5-a] pyrimidine-3-carboxamide as a new potential PET agent for imaging of IRAK4 enzyme in neuroinflammation
    2. … -1 gp120 and Methamphetamine-mediated Induction of Proinflammatory Cytokines/chemokines and Oxidative Stress in Astrocytes: Implications in neuroinflammation
    3. … -19 MRI at 21.1 T: enhanced spin–lattice relaxation of perfluoro-15-crown-5-ether and sensitivity as demonstrated in ex vivo murine neuroinflammation
    4. … -19 MRI sensitivity using a cryogenic radiofrequency probe: technical developments and ex vivo demonstration in a mouse model of neuroinflammation
    5. … -276: MAPKAP kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity: Relevance to neuroinflammation in a transgenic …
    6. … -activated receptor-γ agonist benefited propionic acid induced autism-like behavioral phenotypes in rats by attenuation of neuroinflammation and oxidative stress
    7. … -analytic studies of the glial cell marker TSPO in psychosis–a question of apples and pears?: A commentary on ‘neuroinflammation in schizophrenia: metaanalysis of …
    8. … -cinnamaldehyde, an essential oil in cinnamon powder, ameliorates cerebral ischemia-induced brain injury via inhibition of neuroinflammation through attenuation of …
    9. … -glu-PAL is neuroprotective in a chronic Parkinson’s disease mouse model and increases BNDF expression while reducing neuroinflammation and lipid peroxidation
    10. … -induced reward and striatal dopaminergic denervation without changing the expression of dopamine D1 and D2 receptors: implications for neuroinflammation
    11. … -low dose naloxone attenuates morphine tolerance in rats via attenuation of NMDA receptor neurotransmission and suppression of neuroinflammation in the spinal …
    12. … -rich ethanol extract from the leaves of Diospyros kaki attenuates cognitive deficits, amyloid-beta production, oxidative stress, and neuroinflammation in APP/PS1 …
    13. … -Tetrahydrocannabinol Suppresses Human Monocyte Activation and Monocyte-Mediated Astrocyte Inflammation: Implications for HIV-Associated neuroinflammation
    14. … ‐specific patterns of carboxyterminally truncated Aβ peptides 1–37/38/39 in addition to 1–40/42 in Alzheimer’s disease and in patients with chronic neuroinflammation
    15. … , an inhibitor of 5alpha-reductase enzyme, induces long-lasting effects on depressive-like behavior, hippocampal neurogenesis, neuroinflammation and gut microbiota …
    16. … , and Lonicera japonica Thunb. protect against cognitive dysfunction and energy and glucose dysregulation by reducing neuroinflammation and hippocampal insulin …
    17. … , based on the paper entitled” The inhibitory effect of manganese on acetylcholinesterase activity enhances oxidative stress and neuroinflammation in the brain” by …
    18. … , Ravikanth, ElBakoush, Abdelmeneim, Fiebich, Bernd L. and Olajide, Olumayokun A. Antimalarial drug artemether inhibits neuroinflammation in BV2 microglia …
    19. … , Renal, and Metabolic Diseases: Nutrient-sensing mechanisms in hypothalamic cell models: neuropeptide regulation and neuroinflammation in male-and …
    20. … (Cannabis sativa L.) seed phenylpropionamides composition and effects on memory dysfunction and biomarkers of neuroinflammation induced by lipopolysaccharide …
    21. … [(4‐methoxyphenyl)carbamoyl]amino}‐N‐{[1‐(5‐methoxypyridin‐2‐yl)cyclohexyl]methyl}propanamide: An Attempt to Visualize Brain Formyl Peptide Receptors in Mouse Models of neuroinflammation
    22. … [1,5-a]pyrimidines as Translocator Protein 18 kDa (TSPO) Ligands: Synthesis, in Vitro Biological Evaluation, [18F]-Labeling, and in Vivo neuroinflammation PET …
    23. … ]-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer’s disease
    24. … /maob inhibitor ory2001 prevents the development of the memory deficit in samp8 mice through induction of neuronal plasticity and reduction of neuroinflammation
    25. … 2 Deficiency in Microglia Inhibits Pro-inflammatory Mediator Release and Resultant Neurotoxicity RELEVANCE TO neuroinflammation IN A TRANSGENIC …
    26. … 25-methoxy hispidol A isolated from Poncirus trifoliate against bacteria-induced anxiety and depression by targeting neuroinflammation, oxidative stress and …
    27. … 3170 The TLR2/4 antagonist (+)-naltrexone blocks contextual long-term memory deficits in experimental autoimmune encephalitis and associated neuroinflammation …
    28. … a novel regulator of amphetamine-induced striatal gliosis and cognitive impairment: evidence for a stimulus-dependent regulation of neuroinflammation by midkine/M …
    29. … abrogate chronic restraint stress-induced behavioral deficits: implication of oxido-nitrosative, endoplasmic reticulum stress cascade, and neuroinflammation
    30. … acid produces antidepressant‐like effects in a chronic unpredictable stress model of depression via attenuation of neuroinflammation, oxido‐nitrosative stress, and …
    31. … ACTIVATION OF PROAPOPTOTIC KINASE PKCδ IN DOPAMINERGIC NEURONS BY TNFα DEATH RECEPTOR SIGNALING AND neuroinflammation
    32. … administration of neural stem cells after hypoxia–ischemia reduces sensorimotor deficits, cerebral lesion size, and neuroinflammation in neonatal mice
    33. … administration of the noradrenergic neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) modulates neuroinflammation and amyloid plaque …
    34. … after intracerebroventricular streptozotocin injection improves cognitive dysfunction in rats by modulating oxidative stress, cholinergic functions and neuroinflammation
    35. … against 72-h sleep deprivation induced anxiety like behavior: possible roles of oxidative stress, mitochondrial dysfunction and neuroinflammation
    36. … against intrahippocampal aβ-induced long-term memory dysfunction; upregulation of effective neurogenesis with the abrogated apoptosis and neuroinflammation
    37. … AJ, 2012. A hematopoietic contribution to microhemorrhage formation during antiviral CD8 T cell-initiated blood-brain barrier disruption. Journal of neuroinflammation …
    38. … Alterations Reveal Key Role of Prostaglandin Synthase and Cyclooxygenase 1 and 2 in Traumatic Brain Injury–Induced neuroinflammation in the Cerebral Cortex of …
    39. … an antidepressant effect in an unpredictable chronic mild stress model of depression in rats and is associated with the regulation of hippocampal neuroinflammation
    40. … analysis of laser capture microdissected white matter astrocytes and higher phenol sulfotransferase 1A1 expression during autoimmune neuroinflammation
    41. … and ameliorates tau hyperphosphorylation by limiting the self-perpetuating pathogenic cycle between NF-κB signaling, oxidative stress and neuroinflammation
    42. … and brain penetrant p38αMAPK inhibitor candidate for neurologic and neuropsychiatric disorders that attenuates neuroinflammation and cognitive dysfunction
    43. … and Cerebrovascular Physiology, Disease, and Signaling Mechanisms: Sex differences in depression-like behavior and neuroinflammation in rats post-MI …
    44. … and N‐acetylcysteine co‐administration markedly inhibit chronic ethanol intake and block relapse binge drinking: Role of neuroinflammation‐oxidative stress self …
    45. … and nitrosative stress biomarkers of depression symptoms in subjects with multiple sclerosis: increased peripheral inflammation but less acute neuroinflammation
    46. … and striatal dopaminergic denervation without changing the expression of dopamine D1 and D2 receptors: Implications for neuroinflammation/M. Vicente-Rodríguez …
    47. … antagonism attenuates the intermittent hypoxia-induced spatial deficits in a murine model of sleep apnea via inhibiting neuroinflammation and oxidative stress
    48. … Antiretroviral Restriction Factor Profiling Reveals the Evolutionary Imprint of the ex Vivo and in Vivo IFN-b Response in HTLV-1-Associated neuroinflammation.
    49. … antiretroviral restriction factor profiling reveals the evolutionary imprint of the ex Vivo and in vivo IFN-β response in HTLV-1-associated neuroinflammation
    50. … are expressed in the central nervous system during experimental autoimmune encephalomyelitis: implications for the maintenance of chronic neuroinflammation
    51. … attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer’s disease
    52. … based N-formyl peptide receptor 2 (FPR2) agonists with potential application for central nervous system disorders characterized by neuroinflammation
    53. … behaviors and reduces the activation of pro-inflammatory cytokines and the phosphorylation of glucocorticoid receptors at serine 246 induced by neuroinflammation
    54. … benzodiazepine receptor ligand [11C] DAA1106 can be used to image microglia in animal models of Parkinson’s disease and neuroinflammation in vivo using PET.
    55. … between the chemokine receptor CCR5 and microglia in neurological disorders: consequences of targeting CCR5 on neuroinflammation, neuronal death and …
    56. … binds to activated and infected brain macrophages in areas of synaptic degeneration: implications for PET imaging of neuroinflammation in lentiviral encephalitis
    57. … bioavailability curcumin: an anti-inflammatory and neurosupportive bioactive nutrient for neurodegenerative diseases characterized by chronic neuroinflammation
    58. … BioGlue injection in the fetal lamb: a novel model for creation of obstructive congenital hydrocephalus without additional chemically induced neuroinflammation
    59. … cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: relevance to oxidative stress and neuroinflammation in Parkinson’s disease
    60. … cells treated with crude Plasmodium berghei extracts acquire immune‐modulatory properties and suppress the development of autoimmune neuroinflammation
    61. … cerebral ischemia/reperfusion injury in streptozotocin-induced hyperglycemic rats via the inhibition of the cellular apoptosis pathway and neuroinflammation
    62. … changes in neuroinflammatory and arachidonic acid cascade markers with synaptic marker loss in rat lipopolysaccharide infusion model of neuroinflammation
    63. … changes in neuroinflammatory and arachidonic acid cascade markers with synaptic marker loss in rat lipopolysaccharide infusion model of neuroinflammation
    64. … compound Camellikaempferoside B decreases Aβ production, interferes with Aβ aggregation, and prohibits Aβ-mediated neurotoxicity and neuroinflammation
    65. … deficit in a pilocarpine-induced status epilepticus rat model via a decrease in the nuclear factor-κB activation and reduction in microglia neuroinflammation
    66. … deficit induced by energy-dense diet in a rat model of early-Alzheimer’s disease is associated to neurotoxic Aβ species and independent of neuroinflammation
    67. … deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage
    68. … derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer’s disease mouse model through modulation of neuroinflammation
    69. … effect of alendronate against intracerebroventricular streptozotocin induced alteration in neurobehavioral, neuroinflammation and biochemical parameters with …
    70. … EFFECT OF GINSENG AGAINST HALOPERIDOL-INDUCED COGNITIVE IMPAIRMENT, neuroinflammation AND BIOCHEMICAL ALTERATIONS IN …
    71. … effect of interleukin (IL)‐17 secreted by reactive astrocytes is emerged from a high‐level IL‐17‐containing environment during acute neuroinflammation
    72. … effect of mangiferin on early brain injury after subarachnoid hemorrhage by attenuating mitochondria-related apoptosis and neuroinflammation
    73. … effects of indomethacin-loaded nanocapsules against oxygen-glucose deprivation in organotypic hippocampal slice cultures: involvement of neuroinflammation
    74. … effects of intravenous administration of bone marrow stromal cells on sevoflurane-induced neuronal apoptosis and neuroinflammation in neonatal rats
    75. … effects of penta-acetyl geniposide in chronic unpredictable mild stress-induced depression rat model: Involvement of inhibiting neuroinflammation in prefrontal cortex …
    76. … environmental standard impairs neuronal behavior and represses glutamate receptor gene expression and memory-related kinase activation via neuroinflammation …
    77. … epoxide hydrolase and p38 kinase alleviating tau hyperphosphorylation and amyloid neurotoxicity for potential treatment of neuroinflammation in Alzheimer’s disease
    78. … Exacerbates Obesity-Induced Oxidative Stress, Neurovascular Dysfunction, Blood–Brain Barrier Disruption, neuroinflammation, Amyloidogenic Gene Expression …
    79. … exposure activates astroglial hemichannels and pannexons in the hippocampus of adolescent rats: effects on neuroinflammation and astrocyte arborization
    80. … express low levels of D oublecortin, but their proliferation is unaffected by 6‐OHDA‐induced nigral lesion or M inocycline‐mediated inhibition of neuroinflammation
    81. … extract improves learning and memory of chemically-induced aging mice through upregulating neurotrophins BDNF and FGF2 and sequestering neuroinflammation
    82. … extracts of se-enriched Auricularia auricular attenuates D-galactose-induced cognitive deficits, oxidative stress and neuroinflammation via suppressing RAGE/MAPK …
    83. … factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death
    84. … factor receptor-associated death domain mediated neuronal death contributes to the glial activation and subsequent neuroinflammation in Japanese encephalitis
    85. … fatty acid supplementation alleviates doxorubicin-induced depressive-like behaviors and neurotoxicity in rats: involvement of oxidative stress and neuroinflammation
    86. … FGF10 activate neuronal FGFR2/PI3K/Akt signaling and inhibit microglia/macrophages TLR4/NF-κ B-dependent neuroinflammation to improve functional …
    87. … fluid level of Nogo receptor 1 antagonist lateral olfactory tract usher substance (LOTUS) correlates inversely with the extent of neuroinflammation
    88. … GINSENG AGAINST CHRONIC UNPREDICTABLE STRESS-INDUCED COGNITIVE IMPAIRMENT, neuroinflammation, AND BIOCHEMICAL ALTERATIONS
    89. … GLIA SHARE CHARACTERISTICS WITH ANTIGEN PRESENTING CELLS AND MAY ALTER SERUM CHEMOKINE LEVELS DURING neuroinflammation
    90. … growth factor (PDGF)-BB-mediated induction of monocyte chemoattractant protein 1 in human astrocytes: implications for HIV-associated neuroinflammation
    91. … GSK3β-dependent Aβ and p-tau proteins and cognitive loss in young rats: Reduced HB-EGF signaling and downstream neuroinflammation as critical regulators
    92. … high-fat diet-induced obese gerbils but rather elicits neuronal death through increase of abnormal mTOR activation-mediated oxidative stress and neuroinflammation
    93. … hybrid with metal-chelating property ameliorates Cu (II)-induced spatial learning and memory deficits via preventing neuroinflammation and oxido-nitrosative stress in …
    94. … hydrogen sulfide releasing compounds ATB-346 and diallyl trisulfide attenuate streptozotocin-induced cognitive impairment, neuroinflammation, and oxidative stress …
    95. … hyperglycaemia-induced neuronal injury in experimental models of diabetic neuropathy: effects on mitochondrial biogenesis, autophagy and neuroinflammation
    96. … hyperglycaemia-induced neuronal injury in experimental models of diabetic neuropathy: effects on mitochondrial biogenesis, autophagy and neuroinflammation
    97. … identify a new natural-based polyphenol, counteracting Aβ oligomerization in vitro and Aβ oligomer-mediated memory impairment and neuroinflammation in an acute …
    98. … IL-1RA-PEP fusion protein with enhanced brain penetration ameliorates cerebral ischemia-reperfusion injury by inhibition of oxidative stress and neuroinflammation
    99. … immune modulator for the treatment of secondary progressive multiple sclerosis acts directly within the CNS to induce Type I IFN and suppress neuroinflammation (P5 …
    100. … improved Alzheimer disease–like symptoms by potentiating hippocampal insulin signaling and decreasing neuroinflammation and norepinephrine degradation in …
    101. … in molecular biology and proteomics adapted to in vivo peptide phage display define active protein domains as biomarkers in multiple sclerosis neuroinflammation
    102. … in Non-Obese Gerbils, but Results in Neuronal Death in Obese Gerbils by Increasing Abnormal mTOR Activation-Mediated Oxidative Stress and neuroinflammation
    103. … in rats causes long-lasting impairments in impulse control that are differentially sensitive to pharmacotherapeutics and associated with chronic neuroinflammation
    104. … in the acute stage of traumatic brain injury attenuates brain trauma-induced depression-like behavior in rats by reducing neuroinflammation in the hippocampus
    105. … induces human monocytic cell toxicity toward neuronal cells: exploring a possible link between obesity-related metabolic impairments and neuroinflammation
    106. … Inhibition Prevents the Adult Excitatory-Inhibitory Imbalance Induced by the Reciprocal Interaction Between neuroinflammation and Oxidative Stress During …
    107. … inhibitory factor deficiency modulates the immune response and limits autoimmune demyelination: a new role for neurotrophic cytokines in neuroinflammation
    108. … injury‐induced neuronal damage in the somatosensory cortex causes formation of rod‐shaped microglia that promote astrogliosis and persistent neuroinflammation
    109. … investigation of therapeutic mechanisms of exercise in Parkinson’s disease: effects on dopamine release, ventral striatal activity and neuroinflammation
    110. … Levels of Binge Alcohol Reduce Calcium-independent Phospholipase A2 (iPLA2) Levels in Rat Brain: An Unrecognized Initial Sign of neuroinflammation
    111. … lipopolysaccharide-induced cognition impairment and amyloidogenesis by modulating brain-derived neurotropic factor, neuroinflammation and oxido-nitrosative …
    112. … long-term neuroinflammatory responses in a rat encephalopathy model as assessed by multi-parametric MRI: implications for aging-associated neuroinflammation
    113. … Maternal Immune Activation in the Aetiology of Schizophrenia: Establishing a Rat Model with a Focus on Cognitive Symptomology and neuroinflammation.
    114. … Mechanism by which 4-Nonylphenol Accelerates Alzheimer’s Pathogenesis and Induces both Tau-amyloid Mediated Toxicity and neuroinflammation (P1. 9-084)
    115. … Mechanisms in the Neuroprotective Effect of Centella asiatica Against Sleep Deprivation Induced Anxiety Like Behaviour, Oxidative Damage and neuroinflammation
    116. … mechanisms of bone marrow-derived mesenchymal stem cells in the regulation of microglia-mediated neuroinflammation after subarachnoid hemorrhage
    117. … microfluidically supported in vitro model of an endothelial barrier combined with cortical spheroids simulates effects of neuroinflammation in neocortex development
    118. … Modulation of Immune and Central Nervous System Homeostasis: The Role of Diet in Development of neuroinflammation and Neurological Disease
    119. … object discrimination, but not spatial, memory: evidence for selective disruption of specific hippocampus-dependent memory functions during acute neuroinflammation
    120. … odorifera suppresses lipopolysaccharide-induced mouse BV2 microglial cell activation, which protects mouse hippocampal HT22 cells death from neuroinflammation …
    121. … of astrocytic connexin-43, hemichannels, and gap junctions in oxygen-glucose deprivation/reperfusion injury induced neuroinflammation and the possible …
    122. … of cannabinoids, Δ9-tetrahydrocannabinol and cannabidiol, ameliorates experimental multiple sclerosis by suppressing neuroinflammation through regulation of …
    123. … of cerebral dopamine neurotrophic factor transducted BMSCs in contusion spinal cord injury of rats: promotion of nerve regeneration by alleviating neuroinflammation
    124. … of Cnestis ferruginea vahl ex DC (Connaraceae) root extract on kainic acid-induced temporal lobe epilepsy in mice: Role of oxidative stress and neuroinflammation
    125. … of Drug Reward and Reinforcement: Implications of TLR4 Dependent Cocaine and Methamphetamine Induced neuroinflammation on Reward, Relapse …
    126. … of in vivo binding properties of the 18-kDa translocator protein (TSPO) ligands [18F]PBR102 and [18F]PBR111 in a model of excitotoxin-induced neuroinflammation
    127. … of lycopene attenuates lipopolysaccharide-induced amyloidogenesis and cognitive impairments via mediating neuroinflammation and oxidative stress
    128. … of Melanocortin 1 Receptor Attenuates Early Brain Injury in a Rat Model of Subarachnoid Hemorrhage viathe Suppression of neuroinflammation through AMPK/TBK1 …
    129. … of mid-regional proenkephalin A and N-terminal protachykinin A immune reactivity in cerebrospinal fluid of patients with dementia and acute neuroinflammation
    130. … of Neutrophil Gelatinase-Associated Lipocalin Concentration in Canine Cerebrospinal Fluid and Serum and Its Involvement in neuroinflammation
    131. … of peripheral M1 macrophages reverses motor deficits in MPTP-treated mouse by suppressing neuroinflammation and dopaminergic neurodegeneration
    132. … of pro-inflammatory cytokines and the phosphorylation of p38 in the habenula and reverses depressive-like behaviors induced by neuroinflammation
    133. … of salvianolic acid B against cerebral ischemic injury in rats via the CD40/NF-κB pathway associated with suppression of platelets activation and neuroinflammation
    134. … of Th17 cells in the nervous system compartment in multiple sclerosis and experimental autoimmune encephalomyelitis: one possible link between neuroinflammation …
    135. … of the injured sciatic nerve of mice carrying the Wld (S) mutant gene: identification of genes involved in neuroprotection, neuroinflammation, and nerve regeneration
    136. … of β2–adrenoceptor attenuates sepsis–induced hippocampus–dependent cognitive impairments by reversing neuroinflammation and synaptic abnormalities
    137. … of cerebral dopamine neurotrophic factor transducted BMSCs in contusion spinal cord injury of rats: promotion of nerve regeneration by alleviating neuroinflammation
    138. … of Cnestis ferruginea vahl ex DC (Connaraceae) root extract on kainic acid-induced temporal lobe epilepsy in mice: Role of oxidative stress and neuroinflammation
    139. … of Drug Reward and Reinforcement: Implications of TLR4 Dependent Cocaine and Methamphetamine Induced neuroinflammation on Reward, Relapse …
    140. … of in vivo binding properties of the 18-kDa translocator protein (TSPO) ligands [18F]PBR102 and [18F]PBR111 in a model of excitotoxin-induced neuroinflammation
    141. … of lycopene attenuates lipopolysaccharide-induced amyloidogenesis and cognitive impairments via mediating neuroinflammation and oxidative stress
    142. … omega-3 and 6 polyunsaturated fatty acid profile, attenuates glial activation and regulates BDNF function in a rodent model of neuroinflammation induced by central …
    143. … OXIDANT EFFECT OF N-METHANESULFONYLPYRAZOLINYL SUBSTITUTED HETEROSTEROIDS IN AN LPS-INDUCED neuroinflammation MODEL OF MICE
    144. … p53 inactivators pifithrin-μ and pifithrin-α mitigate TBI-induced neuronal damage through regulation of oxidative stress, neuroinflammation, autophagy and mitophagy
    145. … PEPTIDE RECEPTOR 2 (FPR2) AGONISTS WITH NEUROPROTECTIVE PROPERTIES IN MODELS OF neuroinflammation RELATED TO ALZHEIMER’S …
    146. … phospholipase A2 and n− 3 polyunsaturated fatty acid docosahexaenoic acid in prostanoid production in brain: perspectives for protection in neuroinflammation
    147. … platelet activation and inhibits thrombin-induced calcium influx: possible role of copaxone in targeting platelets during autoimmune neuroinflammation
    148. … Polymorphism for Translocator Protein 18 Kda Affects both in Vitro and in Vivo Radioligand Binding in Human Brain to this Putative Biomarker of neuroinflammation
    149. … post-stroke cognitive impairments via inhibition of peri-infarct astroglial and microglial/macrophage P2 purinoceptors-mediated neuroinflammation and …
    150. … pretreated mesenchymal stem cell culture ameliorates mouse lipopolysaccharide-induced cerebral neuroinflammation-histological and immunohistochemical …
    151. … Proenkephalin A and N-terminal Protachykinin A are decreased in the cerebrospinal fluid of patients with dementia disorders and acute neuroinflammation
    152. … profile. Impaired function of the CO2, AQP1, and AQP4 gas channels may cause hypoxia and thus enhance neuroinflammation in autistic individuals
    153. … profiling of cortical gene expression in Alzheimer’s disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation
    154. … proliferator-activated receptor-α, ameliorates lipopolysaccharide-induced depressive-like behaviors by preventing neuroinflammation and oxido-nitrosative stress in …
    155. … protected against microglial‐mediated neurotoxicity in SH‐SY5Y and BV2 cocultured cells from LPS–induced neuroinflammation and death by inhibiting MAPK, NF …
    156. … radiotracer 2-(7-butyl-2-(4-(2-([18F] fluoroethoxy) phenyl)-5-methylpyrazolo [1, 5-a] pyrimidin-3-yl)-N, N-diethylacetamide in a preclinical model of neuroinflammation
    157. … regulates the differentiation of CD11b+ Ly-6Chigh monocytes and permeability of blood–brain barrier to galvanize the immune privileged CNS to neuroinflammation
    158. … regulation of ecto-5′-nucleotidase/CD73 and A2AR-mediated adenosine signaling at neurovascular unit: a link between acute and chronic neuroinflammation
    159. … regulation of the major histocompatibility complex class I in the Cns: functional implications for brain aging and sexually dimorphic differences in neuroinflammation
    160. … relapsing experimental allergic encephalomyelitis (CREAE) in plasminogen activator inhibitor‐1 knockout mice: the effect of fibrinolysis during neuroinflammation
    161. … Reticulum Calcium ATPase 1 est induite dans la Maladie d’Alzheimer, promeut le métabolisme amyloïdogène de l’APP et provoque la neuroinflammation.
    162. … Reveals Susceptibilities to Spatial Memory Deficits, Decreased Dopamine Marker Expression and Increased neuroinflammation in the Hippocampus of Male …
    163. … reverses depressive-like behaviors and restores the suppressed FGF2-ERK1/2 signaling and the impaired hippocampal neurogenesis induced by neuroinflammation
    164. … reverses type 2 diabetes-induced cognitive deficits via attenuation of oxidative/nitrosative stress and NF-κB-mediated neuroinflammation in rat hippocampus
    165. … signalling pathway by American ginseng attenuates chronic unpredictable stress-induced cognitive impairment, neuroinflammation, and biochemical alterations
    166. … similar pathogenesis with neurodegenerative diseases: Endosome‐autophagosome‐lysosome pathway dysfunction and microglia‐mediated neuroinflammation
    167. … soluble HLA-E correlates with disease activity in patients with multiple sclerosis and may cooperate with soluble HLA-G in the resolution of neuroinflammation
    168. … SPLENIC AND PERIPHERAL BLOOD IMMUNE CELL POPULATIONS AND MAY CONTRIBUTE TO neuroinflammation AND NEURODEGENERATION IN …
    169. … stem cells alleviate the early brain injury of subarachnoid hemorrhage partly by suppression of Notch1-dependent neuroinflammation: involvement of Botch
    170. … stromal cells modulate peripheral stress-induced innate immune activation indirectly limiting the emergence of neuroinflammation-driven depressive and anxiety-like …
    171. … sulfate affords neuroprotection in an eclampsia-like model induced in pregnant rats by ameliorating brain edema and neuroinflammation: Immune and inflammatory …
    172. … SYSTEM AND MOTOR IMPAIRMENT IN CRITICAL ILLNESS: Experimental Abdominal Sepsis Induces Persistent neuroinflammation And Microglial Activation
    173. … targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation
    174. … Tetrahydroxystilbene-2-O-β-d-glucoside prevention of lipopolysaccharide-induced depressive-like behaviors in mice involves neuroinflammation and oxido-nitrosative …
    175. … thaliana extracts optimized for polyphenols production as potential therapeutics for the APOE-modulated neuroinflammation characteristic of Alzheimer’s …
    176. … the Cognitive Impairment and Depression-Like Behaviors in a Cuprizone Mouse Model by Alleviating Demyelination and neuroinflammation in the Brain
    177. … to As-, Cd-, and Pb-mixture induces Aβ, amyloidogenic APP processing and cognitive impairments via oxidative stress-dependent neuroinflammation in young rats
    178. … tolerance alleviates the intracranial lipopolysaccharide injection-induced neuroinflammation and protects the dopaminergic neurons from neuroinflammation …
    179. … traumatic brain injury in mice promotes functional improvement and acute neuron survival but has little effect on neurogenesis, glial responses or neuroinflammation
    180. … virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation
    181. … Vital M, Sato MDO Adam GP (2016) Depression in Parkinson’s Disease is Associated with a Serotoninergic System Change Secondary to neuroinflammation
    182. ” Effects of exercise on adolescent and adult hypothalamic and hippocampal neuroinflammation“: Corrigendum.
    183. (-)-Phenserine Ameliorates Contusion Volume, neuroinflammation, and Behavioral Impairments Induced by Traumatic Brain Injury in Mice
    184. (-)-Phenserine and the prevention of pre-programmed cell death and neuroinflammation in mild traumatic brain injury and Alzheimer’s disease challenged mice
    185. (+)-Sesamin attenuates chronic unpredictable mild stress-induced depressive-like behaviors and memory deficits via suppression of neuroinflammation
    186. (−)-Epicatechin Mitigates Oxidative Stress, neuroinflammation and Hyperphosphorylation of TAU in Hippocampus of Senile Mice
    187. (−)-β-Caryophyllene, a CB2 receptor-selective phytocannabinoid, suppresses motor paralysis and neuroinflammation in a murine model of multiple sclerosis
    188. (161) Peripheral gene expression changes in the chronic constriction injury (CCI) rat model at the sciatic nerve following administration of neuroinflammation-targeted …
    189. (329) PARP inhibition attenuates neuroinflammation and oxidative stress in chronic constriction injury induced peripheral neuropathy
    190. [11C] PK11195 PET IMAGING REVEALS neuroinflammation IN DEMENTIA WITH LEWY BODIES IS NEGATIVELY ASSOCIATED WITH DISEASE SEVERITY …
    191. [11C] PK11195-PET to assess neuroinflammation in multiple sclerosis (MS) patients undergoing an anti-inflammatory therapy
    192. [11C] PK11195-PET to image neuroinflammation in focal epilepsy
    193. [11C] SSR180575: Preliminary evaluation in rodent models of neuroinflammation
    194. [11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson’s disease?
    195. [11C]DAC-PET for Noninvasively Monitoring neuroinflammation and Immunosuppressive Therapy Efficacy in Rat Experimental Autoimmune Encephalomyelitis …
    196. [11C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification …
    197. [11C]PBR28 PET Imaging is Sensitive to neuroinflammation in the Aged Rat
    198. [18F] DBT10 as alpha7-nAChR ligand to image stroke-associated neuroinflammation by PET
    199. [18F] FEBMP: positron emission tomography imaging of TSPO in a model of neuroinflammation in rats, and in vitro autoradiograms of the human brain
    200. [18F]DPA-714 PET Imaging Reveals Global neuroinflammation in Zika Virus-Infected Mice
    201. [18F]DPA-714, a potent PET-based radioligand targeted for translocator protein (18kDa) imaging in neuroinflammation: radiolabeling and in vitro evaluation
    202. [18F]DPA‐C5yne, a novel fluorine‐18‐labelled analogue of DPA‐714: radiosynthesis and preliminary evaluation as a radiotracer for imaging neuroinflammation with …
    203. [18F]Fluoromethyl-PBR28 as a Potential Radiotracer for TSPO: Preclinical Comparison with [11C]PBR28 in a Rat Model of neuroinflammation
    204. [53-OR]: Magnesium sulfate (MgSO4) increases seizure threshold via reduced neuroinflammation in a rat model of preeclampsia
    205. # 7-The Role of RNF216/TRIAD3 in neuroinflammation Through Interactions with Toll-Like-Receptors
    206. 0071 Topic: S25-Symposium 27: The role of neuroinflammation and infection in bipolar disorder and schizophrenia Therapeutic Trials of Minocycline, Ondansetron …
    207. 1-Methylnicotinamide attenuates lipopolysaccharide-induced cognitive deficits via targeting neuroinflammation and neuronal apoptosis
    208. 1-Trichloromethyl-1, 2, 3, 4-tetrahydro-beta-carboline (TaClo) Induces the Apoptosis of Dopaminergic Neurons via Oxidative Stress and neuroinflammation
    209. 112. Infiltrating monocytes contribute to neuroinflammation in obese mice with latent herpes simplex virus-1
    210. 117. Imipramine attenuates neuroinflammation and reverses stress-induced social avoidance
    211. 117.1 TSPO in Microglia Activation and “neuroinflammation”: Are We Ready to Go Beyond Metaphors?
    212. 117.4 Pet Imaging of neuroinflammation in Schizophrenia
    213. 11C-DPA-713 versus 18F-GE-180: a preclinical comparison of translocator protein 18 kDa PET tracers to visualize acute and chronic neuroinflammation in a mouse …
    214. 11C-DPA-713 versus 18F-GE-180: A preclinical comparison of TSPO-PET tracers to visualize acute and chronic neuroinflammation in a mouse model of ischemic …
    215. 11C-DPA-713: a novel peripheral benzodiazepine receptor PET ligand for in vivo imaging of neuroinflammation
    216. 11C-PK11195 PET for the in vivo evaluation of neuroinflammation in the rat brain after cortical spreading depression
    217. 12: Evidence for the crucial role of estrogen signaling with preterm labor and perinatal neuroinflammation
    218. 12/15 lipoxygenase inhibition suppresses neuroinflammation in a thrombotic permanent cerebral ischemia model
    219. 123. Evaluating the role of neuroinflammation in head and neck cancer-related symptoms
    220. 129. Blockade of L-type voltage dependent calcium channels or ryanodine receptors during chronic neuroinflammation improves spatial memory and reduces …
    221. neuroinflammation&ots=aCTFZjyh_I&sig=OTPft26v4uDCpQNiy_KuGU4t9Ec”>15 Natural Vitamin E Tocotrienol against neuroinflammation and Oxidative Stress
    222. 151. neuroinflammation: An animal model of fatigue induced through interleukin-1 beta
    223. 159 Mitigating Microglial-Mediated neuroinflammation: The Sur1-Trpm4 Channel Regulates Calcium-Sensitive Induction of iNOS.
    224. 16: MECHANISMS OF NANOPARTICLE UPTAKE IN neuroinflammation INDUCED PEDIATRIC BRAIN INJURY
    225. 16. Methylene blue infusion for treatment of traumatic brain injury-associated neuroinflammation and depressive-like behavior
    226. 17 BETA ESTRADIOL AMELIORATES neuroinflammation DRIVEN NEUROPATHIC PAIN IN CHRONIC CONSTRICTION INJURY-INDUCED PERIPHERAL …
    227. 17-Ethynyl-androst-5-ene-3, 7, 17-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and neuroinflammation in a Murine MPTP Model of Parkinson’s …
    228. 17a-Ethynyl-androst-5-ene-3ß, 7ß, 17ß-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and neuroinflammation in a Murine MPTP Model of …
    229. 17α-Ethynyl-androst-5-ene-3β, 7β, 17β-triol (HE3286) Is neuroprotective and reduces motor impairment and neuroinflammation in a murine MPTP Model of …
    230. neuroinflammation_IN_A_SWINE_MODEL_OF.153.aspx”>186: neuroinflammation IN A SWINE MODEL OF PEDIATRIC CARDIAC ARREST
    231. 18F-DPA-714 PET imaging for detecting neuroinflammation in rats with chronic hepatic encephalopathy
    232. 18F-FEAnGA for PET of β-glucuronidase activity in neuroinflammation
    233. 18F-PBR111 PET Imaging in Healthy Controls and Schizophrenia: Test–Retest Reproducibility and Quantification of neuroinflammation
    234. 18F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis
    235. 194: IRF8 regulates autophagy and activates microglia to exacerbate neuroinflammation
    236. 1H NMR-Based Metabolomics of Clinacanthus nutans Leaves Extracts in Correlation with Their Anti-neuroinflammation Towards LPS-Induced BV2 Cells
    237. 2-Deoxy-d-glucose attenuates sevoflurane-induced neuroinflammation through nuclear factor-kappa B pathway in vitro
    238. 2‐AG limits Theiler’s virus induced acute neuroinflammation by modulating microglia and promoting MDSCs
    239. 200. neuroinflammation in Individuals at Clinical High Risk for Psychosis: A PET Study With [(18) F]-FEPPA
    240. 2163 Molecular imaging of cardiac and neuroinflammation early after myocardial infarction and in progressive heart failure
    241. 2283: Brain thermometry to detect neuroinflammation in traumatic brain injury
    242. 24. Tumor progression increases neuroinflammation, fatigue and depressive-like behavior without altering muscle function
    243. 241 Tnf-α Induction of Infant Murine Brain Inflammation Via Ikk/Nf Kappa B Signalling: A Potential Model for Paediatric neuroinflammation
    244. 249 Serial 11C-methionine PET detects involvement of astroglia in neuroinflammation following acute myocardial infarction
    245. 27. neuroinflammation mediates the delayed behavioral effects of microembolism
    246. 270: Maternal MgSo4 paradoxically increases fetal brain cytokines associated with neuroinflammation: suggestion for focused Mg use
    247. 28. Early-life viral infection causes neuroinflammation, cognitive deficits, and changes in neurogenesis in the neonatal piglet
    248. 3, 4-DAA, an orally active synthetic tryptophan catabolite, treats established autoimmune neuroinflammation
    249. 3, 6′‐dithiothalidomide improves experimental stroke outcome by suppressing neuroinflammation
    250. 40. NEW INSIGHTS ON THE ROLE OF neuroinflammation IN SCHIZOPHRENIA PATHOPHYSIOLOGY FROM POST MORTEM AND ANIMAL STUDIES
    251. 40.4 LOW-DOSE RISPERIDONE TREATMENT IN ADOLESCENCE PREVENTS THE DEVELOPMENT OF neuroinflammation IN THE MATERNAL …
    252. 43: Distinct dictation of Japanese encephalitis virus-induced neuroinflammation and lethality via triggering TLR3 and TLR4 signal pathways
    253. 4Aβ1-15-derived monoclonal antibody reduces more Aβ burdens and neuroinflammation than homologous vaccine in APP/PS1 mice
    254. 5-lipoxygenase inhibitor zileuton attenuates neuroinflammation and brain damage via modulating ERK1/2 signaling pathway in rats of cerebral ischemia
    255. 5-Lipoxygenase-Activating Protein Inhibitors: Promising Drugs for Treating Acute and Chronic neuroinflammation Following Brain Injury
    256. 573. Evidence of both Systemic Inflammation and neuroinflammation in Patients with Chronic Widespread Pain
    257. 5LO GENETIC DELETION ATTENUATES neuroinflammation IN A P301S MOUSE MODEL OF TAUOAPTHY
    258. 6 neuroinflammation
    259. 6-Gingerol attenuates LPS-induced neuroinflammation and cognitive impairment partially via suppressing astrocyte overactivation
    260. 6-O-angeloylplenolin exerts neuroprotection against lipopolysaccharide-induced neuroinflammation in vitro and in vivo
    261. 6-O-galloylpaeoniflorin attenuates cerebral ischemia reperfusion-induced neuroinflammation and oxidative stress via PI3K/Akt/Nrf2 activation
    262. 6-Shogaol, a ginger product, modulates neuroinflammation: a new approach to neuroprotection
    263. 6-Shogaol, an active compound of ginger, protects dopaminergic neurons in Parkinson’s disease models via anti-neuroinflammation
    264. 6-Shogaol, an active constituent of ginger, attenuates neuroinflammation and cognitive deficits in animal models of dementia
    265. 6‐Mer hyaluronan oligosaccharides modulate neuroinflammation and α‐synuclein expression in neuron‐like SH‐SY5Y cells
    266. 6. Crosstalk between mitochondrial dysfunction and neuroinflammation in TBI
    267. 670 Male Vs Female: Structural Susceptibility to neuroinflammation.
    268. 7-Deoxy-trans-dihydronarciclasine Isolated from Lycoris chejuensis Inhibits neuroinflammation in Experimental Models
    269. 7-Fluoro-1, 3-diphenylisoquinoline reverses motor and non-motor symptoms induced by MPTP in mice: role of striatal neuroinflammation
    270. 7-O-Esters of taxifolin with pronounced and overadditive effects in neuroprotection, anti-neuroinflammation, and amelioration of short-term memory …
    271. 7‐methoxyflavanone alleviates neuroinflammation in lipopolysaccharide‐stimulated microglial cells by inhibiting TLR4/MyD88/MAPK signalling and activating the Nrf2 …
    272. 778: BBB DISRUPTION AFTER CORTICAL IMPACT: A ROLE FOR FIBRIN IN POST-TBI neuroinflammation?
    273. 9: The role of Nur77 in perinatal neuroinflammation in a preterm labor mouse model
    274. A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer’s disease
    275. A blazing landscape: neuroinflammation shapes brain metastasis
    276. A BRAVE NEURO WORLD: UNCOVERING THE ROLE OF RON RECEPTOR TYROSINE KINASE IN neuroinflammation.
    277. A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis
    278. A Central Role for neuroinflammation in Vascular Clearance of Amyloid-Beta
    279. A changing perspective on the role of neuroinflammation in Alzheimer’s disease
    280. A chemical proteomic atlas of brain serine hydrolases identifies cell type-specific pathways regulating neuroinflammation
    281. A combination of resveratrol and curcumin is effective against aluminum chloride-induced neuroinflammation in rats
    282. A commensal bacterial product elicits and modulates migratory capacity of CD39+ CD4 T regulatory subsets in the suppression of neuroinflammation
    283. A common (GT) n repeat polymorphism in the heme oxygenase-1 promoter associates with neuroinflammation and cognitive impairment in HIV infection (S29. 002)
    284. A comparison of neurodegeneration linked with neuroinflammation in different brain areas of rats after intracerebroventricular colchicine injection
    285. A comparison of neuroinflammation to implanted microelectrodes in rat and mouse models
    286. A comparison of the high‐affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)‐PK11195 in rat models of neuroinflammation: implications for PET …
    287. A constraint kinetic modeling approach to quantify [11C] DPA-713 specific binding for PET imaging of neuroinflammation
    288. A decade of research on TLR2 discovering its pivotal role in glial activation and neuroinflammation in neurodegenerative diseases
    289. A Dual Investigation of Questions in Drug Addiction: Exploring the Role of neuroinflammation in Opioid Withdrawal and A Novel Measure of Reward-Seeking …
    290. A dual role for apolipoprotein E in neuroinflammation
    291. A Facile Radiolabeling of [18F]FDPA via Spirocyclic Iodonium Ylides: Preliminary PET Imaging Studies in Preclinical Models of neuroinflammation
    292. A FAS LYMPHOPROLIFERATIVE PHENOTYPE REVEALS NON-APOPTOTIC FAS SIGNALING IN HTLV-1-ASSOCIATED neuroinflammation
    293. A fashi lymphoproliferative phenotype reveals non-apoptotic fas signaling in HTLV-1-associated neuroinflammation
    294. neuroinflammation/”>A Focus on the Effect of L-Theanine on Improving Depression and Cognition in C57BL/J Male Mice Subjected for Chronic Stress Induced neuroinflammation
    295. A genetic and neurochemical analysis of dopamine regulation in drosophila melanogaster of human neurodegenerative disorders and neuroinflammation
    296. A genetically engineered thermally responsive sustained release curcumin depot to treat neuroinflammation
    297. A lack of ovarian function increases neuroinflammation in aged mice
    298. A lincRNA-p21/miR-181 family feedback loop regulates microglial activation during systemic LPS-and MPTP-induced neuroinflammation
    299. A Logic Model of Neuronal-Glial Interaction Suggests Altered Homeostatic Regulation in the Perpetuation of neuroinflammation
    300. A Malva parviflora´ s fraction prevents the deleterious effects resulting from neuroinflammation
    301. A mathematical model of neuroinflammation in severe clinical traumatic brain injury
    302. A mechanistic link between glia and neuronal excitability in acute neuroinflammation
    303. A method for personalized brain mapping of neuroinflammation using 11C-DPA-713 PET
    304. A model of systemic inflammation to study neuroinflammation
    305. neuroinflammation_in_Ovine_Batten_Disease/links/57fc2e5b08ae329c3d498181/A-Molecular-Dissection-of-neuroinflammation-in-Ovine-Batten-Disease.pdf”>A Molecular Dissection of neuroinflammation in Ovine Batten
    306. A mouse model for juvenile, lateral fluid percussion brain injury reveals sex-dependent differences in neuroinflammation and functional recovery
    307. A Multi-Approach Investigation to Evaluate Compounds that Mitigate neuroinflammation.
    308. A Multifunctional Chemical Agent as an Attenuator of Amyloid and Tau Burden and neuroinflammation in Alzheimer’s Disease
    309. A natural variant of the T cell receptor-signaling molecule Vav1 reduces both effector T cell functions and susceptibility to neuroinflammation
    310. A Naturally Occurring Polymorphism in the HIV-1 Tat Basic Domain Inhibits Uptake by Bystander Cells and Leads to Reduced neuroinflammation
    311. A neuroinflammation Inhibitor, Hypoxylon xanthone A, from Soil Fungus Hypoxylon sp.
    312. A new avenue for treating Parkinson’s disease targeted at aggrephagy modulation and neuroinflammation: Insights from in vitro and animal studies
    313. A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury
    314. A new mouse model of prostaglandin J2 (PGJ2) induced neuroinflammation and parkinsonism: Validation using μPET and C-11 labeled radiotracers
    315. A new road to neuroinflammation in Parkinson’s disease?
    316. A new therapeutic target for Alzheimer’s disease: effects of palmitoylethanolamide with luteolin association on neuroinflammation pathway (845.10)
    317. A nitric oxide-donating flurbiprofen derivative reduces neuroinflammation without interacting with galantamine in the rat
    318. A Novel and Selective p38 Mitogen-Activated Protein Kinase Inhibitor Attenuates LPS-Induced neuroinflammation in BV2 Microglia and a Mouse Model
    319. A novel animal model for neuroinflammation and white matter degeneration
    320. A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice
    321. A NOVEL CANNABINOID RECEPTOR 1 ANTAGONIST ALLEVIATES METABOLIC DISORDER AND neuroinflammation IN THE MODELS OF ALZHEIMER’S …
    322. A novel immunosuppressor,(5R)-5-hydroxytriptolide, alleviates movement disorder and neuroinflammation in a 6-OHDA hemiparkinsonian rat model
    323. A Novel Marker for neuroinflammation in Diabetic Neuropathy (P03. 195)
    324. A novel perspective on the ApoM-S1P axis, highlighting the metabolism of ApoM and its role in liver fibrosis and neuroinflammation
    325. A novel PET radioligand,[11C] PS13, successfully images COX-1, a potential biomarker for neuroinflammation.
    326. A novel role for earthworm peptide Lumbricusin as a regulator of neuroinflammation
    327. A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation
    328. A novel targeted local analgesia platform to mitigate neuroinflammation and promote neuroregeneration
    329. A NOVEL THERAPEUTIC (NTRX-07) TARGETING neuroinflammation IN ALZHEIMER’S DISEASE IS UNDERGOING PHASE I TRIALS
    330. A novel treatment of neuroinflammation against low back pain by soluble fullerol nanoparticles
    331. A pilot study of high‐dose intravenous immunoglobulin 5% for autism: Impact on autism spectrum and markers of neuroinflammation
    332. A Pivotal Role for Thiamine Deficiency in the Expression of neuroinflammation Markers in Models of Alcohol‐Related Brain Damage
    333. A potential mechanistic role for neuroinflammation in reward processing impairments in autism spectrum disorder
    334. A potential role for the PD1/PD-L1 pathway in the neuroinflammation of Alzheimer’s disease
    335. A Preliminary Model for the Protective Role of the Endocannabinoid 2-Arachydonylglycerol in neuroinflammation
    336. A prenylated xanthone, cudratricusxanthone A, isolated from Cudrania tricuspidata inhibits lipopolysaccharide-induced neuroinflammation through inhibition of NF-κB …
    337. A Primary Neural Cell Culture Model for neuroinflammation
    338. A promising I-123 labeled radioligand for imaging neuroinflammation response by assessment P2X7 receptor expression
    339. A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis
    340. A research update on the potential roles of aquaporin 4 in neuroinflammation
    341. A review of postoperative cognitive dysfunction and neuroinflammation associated with cardiac surgery and anaesthesia
    342. A review of spinal and peripheral neuromodulation and neuroinflammation: lessons learned thus far and future prospects of biotype development
    343. A Role for CRH and HPA Activation in the Regulation of Plasticity Signaling, neuroinflammation and Emotional/Mnesic Behavior Following Global Cerebral …
    344. A role for cyclooxygenase-1 in β-amyloid-induced neuroinflammation
    345. A role for hypertension in CAA, neuroinflammation and neuropathology In Alzheimer’s?
    346. A role for neuronal NF-κB in suppressing neuroinflammation and promoting neuroprotection in the CNS
    347. A role for the non-receptor tyrosine kinase Abl2/Arg in experimental neuroinflammation
    348. A silver lining of neuroinflammation: beneficial effects on myelination
    349. A single dose of trichloroethylene given during development does not substantially alter markers of neuroinflammation in brains of adult mice
    350. A Single Lipopolysaccharide (LPS) Injection to the Rat Brain Induces neuroinflammation Two Months After Treatment
    351. A small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammation
    352. A sterile animal model for neuroinflammation?
    353. A strategy to passively reduce neuroinflammation surrounding devices implanted chronically in brain tissue by manipulating device surface permeability
    354. A study of the effects of chronic neuroinflammation on cognition and behaviour in the GFAP-IL6 transgenic mouse and investigation of the flavonoid apigenin as a …
    355. A Study of the Endogenous Control of neuroinflammation, A Leading Cause of Morbidity from Traumatic Brain Injury
    356. A study on neuroinflammation and NMDA receptor function in STZ (ICV) induced memory impaired rats
    357. A survey from 2012 of evidence for the role of neuroinflammation in neurotoxin animal models of Parkinson’s disease and potential molecular targets
    358. A Systematic review of positron emission tomography of tau, amyloid beta, and neuroinflammation in chronic traumatic encephalopathy: the evidence to date
    359. A TELOscopic view of neuroinflammation
    360. A thin-skull window technique for chronic two-photon in vivo imaging of murine microglia in models of neuroinflammation
    361. A Tip leads cytotoxic T cells to the crime scene in neuroinflammation
    362. A trifluoromethyl analogue of celecoxib exerts beneficial effects in neuroinflammation
    363. A Zika Virus Primary Isolate Induces neuroinflammation, Compromises the Blood-Brain Barrier, and Upregulates CXCL12 in Adult Macaques
    364. A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis
    365. A16 Endoplasmic reticulum stress: an initiator of neuroinflammation in Huntington’s disease?
    366. A20 critically controls microglia activation and inhibits inflammasome-dependent neuroinflammation
    367. A31 The development of translational biomarkers of neuroinflammation in a mouse model of huntington’s disease
    368. AAV-mediated gene delivery attenuates neuroinflammation in feline Sandhoff disease
    369. AAV9-mediated expression of a non-self protein in nonhuman primate central nervous system triggers widespread neuroinflammation driven by antigen …
    370. AB0050 Irf8 Promotes TH17 Differentiation via Activation of Integrin-Mediated Tgfbeta Signaling in neuroinflammation
    371. ABCA1 influences neuroinflammation and neuronal death
    372. Aberrant NF-kappaB expression in autism spectrum condition: a mechanism for neuroinflammation
    373. Ablation of the pro-inflammatory master regulator miR-155 does not mitigate neuroinflammation or neurodegeneration in a vertebrate model of Gaucher’s disease
    374. Ablation of the transcription factors E2F1-2 limits neuroinflammation and associated neurological deficits after contusive spinal cord injury
    375. Abnormal increase of neuronal precursor cells and exacerbated neuroinflammation in the corpus callosum in murine model of systemic lupus erythematosus
    376. Absence of galectin-3 attenuates neuroinflammation improving functional recovery after spinal cord injury
    377. Absence of the cellular prion protein exacerbates and prolongs neuroinflammation in experimental autoimmune encephalomyelitis
    378. Abstract OT2-05-03: Does minocycline mitigate chemotherapy induced neuroinflammation? A phase II randomized placebo controlled study
    379. Abstract P2-11-04: Chemotherapy Induces neuroinflammation and Cognitive Deficits in Female Mice
    380. Abstract TMP35: CD200-CD200R1 Inhibitory Signaling Attenuates neuroinflammation and Reduces Behavioral Deficits Following Ischemic Stroke
    381. Abstract TP102: Modulation of neuroinflammation by Haptoglobin Reduces Oxidative Stress and Improves ICH Outcomes
    382. Abstract TP141: Mesenchymal Stem Cell Derived Exosomes as a Modulator of neuroinflammation Following Cortical Injury
    383. Abstract TP226: Aging and Smoking Exacerbates Post-Stroke Complement Driven neuroinflammation
    384. Abstract TP279: Brain-Derived Microparticles Mediate neuroinflammation After Stroke
    385. Abstract TP317: Chemokine Production by Microglia Mediates Blood-Derived Monocytes Trafficking in neuroinflammation
    386. Abstract TP337: Microglial Activation and neuroinflammation Are Mediated by Over-Activation of Cofilin After Intracerebral Hemorrhage
    387. Abstract W P250: Food Restriction Ameliorates neuroinflammation and Provides Protection in a Mouse Model of Ischemic Stroke
    388. Abstract W P369: Inhibitory Effect of FTY720 on neuroinflammation in Cerebral Ischemia-reperfusion
    389. Abstract WMP37: Neurovascular Protection by Telmisartan Via Reducing neuroinflammation in SHR-SR Brain After Ischemic Stroke
    390. Abstract WMP73: Discerning How Vascular Inflammation Modulates neuroinflammation Using Novel Vascular Brain Organ-On-A-Chip: Proof-of-Concept Study
    391. Abstract WMP79: Phosphatidylserine-containing Liposomes Pretreatment Attenuates neuroinflammation in a Rat Model of Surgical Brain Injury
    392. Abstract WP142: Targeting VCAM1 to Reduce Acute and Chronic neuroinflammation After Stroke
    393. Abstract WP159: FPS-ZM1 Alleviates neuroinflammation in Focal Cerebral Ischemia Rats via Blocking the RAGE/DIAPH1/NF-kappa B Pathway
    394. Abstract WP418: Mineralocorticoid Receptor Signaling is Associated With neuroinflammation and Changes in Cognitive Function in Angiotensin II-Induced …
    395. Abstract# 1704 Cardiac surgery causes more extended neuroinflammation and cognitive dysfunction compared to abdominal surgery in rats
    396. Abstract# 1736 The role of endothelial IL-1R1 in anxiogenic neuroinflammation
    397. Abstract# 1831 Repeated social defeat stress-induced neuroinflammation contributes to later fear sensitization and impaired extinction recall of fear conditioning in …
    398. Abstract# 3081 Impaired cognition and fatigue; the role of sleep and neuroinflammation for non-specific symptoms in allergy
    399. Abstract# 3113 The role of estrogen in tumor-induced cognitive performance and neuroinflammation
    400. Abstract# 3114 neuroinflammation and chemotherapy-related fatigue
    401. Abstract# 3175 Mycobacterium vaccae immunization protects aged rats from surgery-elicited neuroinflammation and cognitive dysfunction
    402. Abstract# 3182 neuroinflammation and hypertension iteract in the pathogenesis of white matter hyperintensity in subjects with mild cognitive impairment
    403. Acacetin attenuates neuroinflammation via regulation the response to LPS stimuli in vitro and in vivo
    404. Acacetin protects dopaminergic cells against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced neuroinflammation in vitro and in vivo
    405. Accelerated accumulation of retinal α-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson’s …
    406. Accelerated neurodegeneration and neuroinflammation in transgenic mice expressing P301L tau mutant and tau-tubulin kinase 1
    407. Accelerated neurodegeneration and phenotypic switch of neuroinflammation in transgenic mice expressing P301L tau-mutant and tau-tubulin kinase 1
    408. Accessible method for the development of novel sterol analogues with dipeptide-like side chains that act as neuroinflammation inhibitors
    409. Accessing neuroinflammation sites: Monocyte/neutrophil-mediated drug delivery for cerebral ischemia
    410. Accumulation of class switched IgD− IgM− memory B cells in the cerebrospinal fluid during neuroinflammation
    411. Accumulation of quinolinic acid with neuroinflammation: does it mean excitotoxicity?
    412. Accuracy of hippocampal network activity is disrupted by neuroinflammation: rescue by memantine
    413. Acetate supplementation attenuates lipopolysaccharide‐induced neuroinflammation
    414. Acetate supplementation modulates brain adenosine metabolizing enzymes and adenosine A2Areceptor levels in rats subjected to neuroinflammation
    415. Acetate supplementation modulates brain histone acetylation and decreases interleukin-1β expression in a rat model of neuroinflammation
    416. Acetate, an Ethanol Metabolite Increases neuroinflammation and Neuronal Death: Implications in Ethanol Neurodegeneration
    417. Acetylcholinesterase inhibitors and cholinergic modulation in Myasthenia Gravis and neuroinflammation
    418. Acetylcholinesterase inhibitors reduce neuroinflammation and-degeneration in the cortex and hippocampus of a surgery stress rat model
    419. Acetylcholinesterase-Inhibitoren reduzieren die neuroinflammation und-degeneration im Cortex und Hippocampus in einem Operations-Stressmodell der adulten …
    420. Acetylpuerarin inhibits oxygen‑glucose deprivation‑induced neuroinflammation of rat primary astrocytes via the suppression of HIF‑1 signaling
    421. Achyranthes bidentata polypeptide k suppresses neuroinflammation in BV2 microglia through Nrf2-dependent mechanism
    422. Acid-sensing ion channels as potential therapeutic targets in neurodegeneration and neuroinflammation
    423. Acorus gramineus inhibits microglia mediated neuroinflammation and prevents neurotoxicity in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced mouse …
    424. Acrolein Scavenger Hydralazine Prevents Streptozotocin‐Induced Painful Diabetic Neuropathy and Spinal neuroinflammation in Rats
    425. Actin filament reorganization in astrocyte networks is a key functional step in neuroinflammation resulting in persistent pain: novel findings on network restoration
    426. Activated microglia targeting dendrimer–minocycline conjugate as therapeutics for neuroinflammation
    427. Activation of adenosine monophosphate–activated protein kinase suppresses neuroinflammation and ameliorates bone cancer paininvolvement of inhibition …
    428. Activation of dopamine D2 receptor suppresses neuroinflammation through αB-crystalline by inhibition of NF-κB nuclear translocation in experimental ICH mice model
    429. Activation of glial α7 nAChR promotes neurogenesis by suppressing Aβ-mediated neuroinflammation in Alzheimer’s disease
    430. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1140-6″>Activation of melanocortin receptor 4 with RO27-3225 attenuates neuroinflammation through AMPK/JNK/p38 MAPK pathway after intracerebral hemorrhage in …
    431. Activation of Melanocortin-4 Receptor by a Synthetic Agonist Inhibits Ethanolinduced neuroinflammation in Rats
    432. Activation of Melanocortin-4 Receptor Inhibits Both neuroinflammation Induced by Early Exposure to Ethanol and Subsequent Voluntary Alcohol Intake in …
    433. Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease
    434. Activation of microglial poly (ADP-ribose)-polymerase-1 by cholesterol breakdown products during neuroinflammation: a link between demyelination and neuronal …
    435. Activation of nicotinic acetylcholine receptors on bone marrow-derived cells relieves neuropathic pain accompanied by peripheral neuroinflammation
    436. Activation of P2X7 receptors in peritoneal and meningeal mast cells detected by uptake of organic dyes: possible purinergic triggers of neuroinflammation in …
    437. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses
    438. Activation of the G Protein-Coupled Estrogen Receptor (GPER) Increases Neurogenesis and Ameliorates neuroinflammation in the Hippocampus of Male …
    439. Activation of the STING-dependent type I interferon response reduces microglial reactivity and neuroinflammation
    440. Acupuncture Resolves Persistent Pain and neuroinflammation in a Mouse Model of Chronic Overlapping Pain Conditions
    441. Acupuncture suppresses stress-induced neuroinflammation in the rat hypothalamus
    442. Acute Alcohol Intoxication is Associated With Sustained neuroinflammation Without Exacerbation of Early Neurobehavioral Outcomes Post Traumatic Brain Injury
    443. Acute alcohol intoxication prolongs neuroinflammation without exacerbating neurobehavioral dysfunction following mild traumatic brain injury
    444. Acute and long-term effects of haloperidol on surgery-induced neuroinflammation and cognitive deficits in aged rats
    445. Acute CSF interleukin-6 trajectories after TBI: associations with neuroinflammation, polytrauma, and outcome
    446. Acute drivers of neuroinflammation in traumatic brain injury
    447. Acute effects of a selective cannabinoid-2 receptor agonist on neuroinflammation in a model of traumatic brain injury
    448. Acute inhalation of combustion smoke triggers neuroinflammation and persistent anxiety-like behavior in the mouse
    449. Acute Kahweol Treatment Attenuates Traumatic Brain Injury neuroinflammation and Functional Deficits
    450. Acute neuroinflammation and glial reactivity to rebuild neural circuits: Unraveling the role of inflammatory mediators during zebrafish optic nerve regeneration
    451. Acute neuroinflammation and neurogenesis: a role for microglial COX-1
    452. Acute neuroinflammation elicited by TLR-3 systemic activation combined with early life stress induces working memory impairments in male adolescent mice
    453. Acute neuroinflammation exacerbates excitotoxicity in rat hippocampus in vivo
    454. Acute neuroinflammation impairs context discrimination memory and disrupts pattern separation processes in hippocampus
    455. Acute neuroinflammation in a clinically relevant focal cortical ischemic stroke model in rat: longitudinal positron emission tomography and immunofluorescent tracking
    456. Acute neuroinflammation in Lewis rats—a model for acute multiple sclerosis relapses
    457. Acute neuroinflammation induces AIS structural plasticity in a NOX2-dependent manner
    458. Acute neuroinflammation mediates optic nerve regeneration in adult zebrafish
    459. Acute neuroinflammation promotes cell responses to 1800 MHz GSM electromagnetic fields in the rat cerebral cortex
    460. Acute neuroinflammation provokes intracellular acidification in mouse hippocampus
    461. Acute nicotine treatment attenuates lipopolysaccharide-induced cognitive dysfunction by increasing BDNF expression and inhibiting neuroinflammation in the rat …
    462. Acute postoperative pain exacerbates neuroinflammation and related delirium-like cognitive dysfunction in rats
    463. Acute social defeat-induced neuroinflammation in the vmPFC of Syrian hamsters via microglial activation
    464. Acute, chronic, and nonclassical neuroinflammation: Definitions in a changing scientific environment
    465. Acyl ghrelin improves cognition, synaptic plasticity deficits and neuroinflammation following amyloid β (Aβ1‐40) administration in mice
    466. Adalimumab improves cognitive impairment, exerts neuroprotective effects and attenuates neuroinflammation in an Aβ1-40-injected mouse model of Alzheimer’s …
    467. ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia–reperfusion injury
    468. Adaptive brain shut-down counteracts neuroinflammation in the near-term ovine fetus
    469. Adenosine 2A receptor: a crucial neuromodulator with bidirectional effect in neuroinflammation and brain injury
    470. Adenosine A2A receptor involves in neuroinflammation-mediated cognitive decline through activating microglia under acute hypobaric hypoxia
    471. Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction
    472. Adenosine Receptors and neuroinflammation
    473. Adenosine Receptors Modulate Acute Injury and neuroinflammation in Brain Ischemia
    474. Adipocyte cannabinoid CB1 receptor deficiency alleviates high fat diet-induced memory deficit, depressive-like behavior, neuroinflammation and impairment in adult …
    475. Adiponectin levels in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients: possible influence on neuroinflammation?
    476. AdipoRon Attenuates neuroinflammation After Intracerebral Hemorrhage Through AdipoR1-AMPK Pathway
    477. Adipose mesenchymal stem cell transplantation alleviates spinal cord injury-induced neuroinflammation partly by suppressing the Jagged1/Notch pathway
    478. Adjudin protects against cerebral ischemia reperfusion injury by inhibition of neuroinflammation and blood-brain barrier disruption
    479. Adolescent traumatic brain injury induces chronic mesolimbic neuroinflammation with concurrent enhancement in the rewarding effects of cocaine in mice during …
    480. neuroinflammation-and-neurodegeneration-in-parki”>Adrenergic Receptors as Pharmacological Targets for neuroinflammation and Neurodegeneration in Parkinson’s Disease
    481. Adult Mice Exposed to Aerosalized Alternaria Exhibit neuroinflammation in the Brainstem but not Rest of Brain
    482. Adult neural stem cells for the treatment of neuroinflammation: Fondazione Centro San Raffaele del Monte Tabor: WO2007015173
    483. Adult neurogenesis, neuroinflammation and therapeutic potential of adult neural stem cells
    484. ADVANCING THERAPEUTICS FOR neuroinflammation IN ALZHEIMER’S DISEASE: CLINICAL DEVELOPMENT CONSIDERATIONS
    485. Agathisflavone isolated from Anacardium occidentale suppresses SIRT1‐mediated neuroinflammation in BV2 microglia and neurotoxicity in APPSwe‐transfected SH …
    486. Age and neuroinflammation: a lifetime of psychoneuroimmune consequences
    487. Age and neuroinflammation: a lifetime of psychoneuroimmune consequences
    488. Age exacerbates surgery-induced cognitive impairment and neuroinflammation in Sprague-Dawley rats: the role of IL-4
    489. Age related macular degeneration and drusen: neuroinflammation in the retina
    490. Age-dependent neuroinflammation and cognitive decline in a novel Ala152Thr-Tau transgenic mouse model of PSP and AD
    491. AGE-DEPENDENT NEUROPROTECTIVE EFFECTS OF CLUSTERIN IN THE SETTING OF neuroinflammation
    492. AGE-NORMED DIFFUSION BASIS SPECTRUM IMAGING (DBSI) CELL RATIOS TO ASSESS neuroinflammation IN ALZHEIMER’S DISEASE CLINICAL TRIALS
    493. Age-related changes in neuroinflammation and prepulse inhibition in offspring of rats treated with Poly I: C in early gestation
    494. Age-related cognitive impairment is associated with long-term neuroinflammation and oxidative stress in a mouse model of episodic systemic inflammation
    495. Age-related differences in secondary neuroinflammation and amyloid-β deposition in a rat sepsis model
    496. Age-related neuroinflammation and changes in AKT-GSK-3β and WNT/β-CATENIN signaling in rat hippocampus
    497. Age-specific susceptibility to neuroinflammation during post-natal development
    498. Age‐dependent release of high‐mobility group box protein‐1 and cellular neuroinflammation after traumatic brain injury in mice
    499. Aged Mice Lacking Fatty Acid Amide Hydrolase Show Reduced neuroinflammation, Senescence, and Cognitive Impairment
    500. Ageing and recurrent episodes of neuroinflammation promote progressive experimental autoimmune encephalomyelitis in Biozzi ABH mice
    501. Ageing, neuroinflammation and neurodegeneration
    502. Aging alters Hv1‐mediated microglial polarization and enhances neuroinflammation after peripheral surgery
    503. Aging and Parkinson’s Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis
    504. Aging differentially affects the loss of neuronal dendritic spine, neuroinflammation and memory impairment at rats after surgery
    505. Aging modulates microglia phenotypes in neuroinflammation of MPTP-PD mice
    506. Aging, Immunity, and neuroinflammation: The Modulatory Potential of Nutrition
    507. Aging, neurogenesis and neuroinflammation in hearing loss and protection
    508. neuroinflammation&ots=Y6qNt5Oc4C&sig=7Evx-84l3x4IzaV8IXiapicy_ew”>Aging, neuroinflammation, and Behavior
    509. AGK2 Alleviates Lipopolysaccharide Induced neuroinflammation through Regulation of Mitogen-Activated Protein Kinase Phosphatase-1
    510. Agmatine Produces Antidepressant Effect via Modulation of neuroinflammation in Chronic Unpredictable Mild Stress Model of Rats: Implication in Inflammatory …
    511. Agomelatine could prevent brain and cerebellum injury against LPS-induced neuroinflammation in rats
    512. Agonism of peroxisome proliferator receptor-gamma may have therapeutic potential for neuroinflammation and Parkinson’s disease
    513. Air pollution & the brain: subchronic diesel exhaust exposure causes neuroinflammation and elevates early markers of neurodegenerative disease
    514. Air pollution, a rising environmental risk factor for cognition, neuroinflammation and neurodegeneration: the clinical impact on children and beyond
    515. Air pollution: mechanisms of neuroinflammation and CNS disease
    516. Akkermansia muciniphila ameliorates depressive symptoms in irritable bowel syndrome via improving neuroinflammation
    517. AKR1B1 upregulation contributes to neuroinflammation and astrocytes proliferation by regulating the energy metabolism in rat spinal cord injury
    518. Alarm or curse? The pain of neuroinflammation
    519. ALCAM regulates BBB integrity and neuroinflammation
    520. ALCAM: cell adhesion molecule or tight junction? The characterization of its role in the context of neuroinflammation
    521. Alcohol abuse enhances neuroinflammation and impairs immune responses in an animal model of human immunodeficiency virus-1 encephalitis
    522. Alcohol and Alzheimer’s Disease—Does Alcohol Dependence Contribute to Beta-Amyloid Deposition, neuroinflammation and Neurodegeneration in Alzheimer’s …
    523. Alcohol brain damage and neuroinflammation: Is there a connection?
    524. Alcohol exposure after mild focal traumatic brain injury impairs neurological recovery and exacerbates localized neuroinflammation
    525. Alcohol shifts gut microbial networks and ameliorates a murine model of neuroinflammation in a sex-specific pattern
    526. Alcohol-Induced neuroinflammation in an Animal Model of FASD and Neuroprotection by Anti-Inflammatory Agents
    527. Alcohol‐induced IL‐1β in the brain is mediated by NLRP3/ASC inflammasome activation that amplifies neuroinflammation
    528. Alcohol, Phospholipase A2-associated neuroinflammation, and ω3 Docosahexaenoic Acid Protection
    529. Aldehyde dehydrogenase 2 activity and aldehydic load contribute to neuroinflammation and Alzheimer’s disease related pathology
    530. Alginate-derived oligosaccharide inhibits neuroinflammation and promotes microglial phagocytosis of β-amyloid
    531. All trans retinoic acid attenuates markers of neuroinflammation in rat brain by modulation of SIRT1 and NFκB
    532. All-trans retinoic acid (ATRA) prevents lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment in aged rats
    533. All-Trans-Retinoic Acid Augments the Histopathological Outcome of neuroinflammation and Neurodegeneration in Lupus-Prone MRL/lpr Mice
    534. Alleviation of symptoms of Alzheimer’s disease by diminishing Aβ neurotoxicity and neuroinflammation
    535. Allopregnanolone and neuroinflammation: a focus on multiple sclerosis
    536. Allyl sulfide counteracts 1-bromopropane-induced neurotoxicity by inhibiting neuroinflammation and oxidative stress
    537. Allyl-isothiocynate (AITC) ameliorates LPS induced NF-κB mediated neuroinflammation
    538. Alpha-1 antitrypsin attenuates M1 microglia-mediated neuroinflammation in retinal degeneration
    539. Alpha-chymotrypcin ameliorates neuroinflammation and apoptosis characterizing Alzheimer’s disease-induced in ovarictomized rats
    540. Alpha-lipoic acid attenuates acute neuroinflammation and long-term cognitive impairment after polymicrobial sepsis
    541. Alpha-synuclein stimulation of astrocytes: potential role for neuroinflammation and neuroprotection
    542. Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease
    543. Alpha-tocopherol quinine ameliorates spatial memory deficits by reducing beta-amyloid oligomers, neuroinflammation and oxidative stress in transgenic mice with …
    544. Alpha‐7 nicotinic acetylcholine receptor agonist treatment reduces neuroinflammation, oxidative stress, and brain injury in mice with ischemic stroke and bone fracture
    545. Alteration in nuclear factor-kappaB pathway and functionality of estrogen via receptors promote neuroinflammation in frontal cortex after 1-Methyl-4-Phenyl-1 …
    546. Alteration of Blood Brain Barrier during Cuprizone-Induced neuroinflammation using multi-tracers with PET:[68Ga] EDTA,[11C](R) PK11195, and [11C] DPA713
    547. Alteration of nuclear factor-kappaB pathway promote neuroinflammation depending on the functions of estrogen receptors in substantia nigra after 1-methyl-4-phenyl …
    548. ALTERATIONS IN DNA METHYLATION CONTRIBUTE TO neuroinflammation IN ALZHEIMER’S DISEASE
    549. Alterations in frontal white matter neurochemistry and microstructure in schizophrenia: implications for neuroinflammation
    550. Alterations in immune cells and mediators in the brain: it’s not always neuroinflammation!
    551. Alterations in striatal microRNA-mRNA networks contribute to neuroinflammation in multiple system atrophy
    552. Alterations in the endocannabinoid syste m as a link between unbalanced energy homeostasis, neuroinflammation, and neurological and neuropsychiatric disorders
    553. Alterations in tight junction protein and IgG permeability accompany leukocyte extravasation across the choroid plexus during neuroinflammation
    554. Altered amyloid metabolism in neuroinflammation
    555. Altered filamin A enables amyloid beta-induced tau hyperphosphorylation and neuroinflammation in Alzheimer’s disease
    556. Altered function of neuronal L-type calcium channels in ageing and neuroinflammation: Implications in age-related synaptic dysfunction and cognitive decline
    557. Altered gut microbiome in a mouse model of Gulf War Illness causes neuroinflammation and intestinal injury via leaky gut and TLR4 activation
    558. Altered neuroinflammation and behavior after traumatic brain injury in a mouse model of Alzheimer’s disease
    559. neuroinflammation_and_behavior_following_traumatic_brain_injury_in_a_mouse_model_of_Alzheimer’s_disease/links/561804e108ae044edbad0917/Altered-neuroinflammation-and-behavior-following-traumatic-brain-injury-in-a-mouse-model-of-Alzheimers-disease.pdf”>Altered neuroinflammation and behavior following traumatic brain injury in a mouse model of Alzheimer’s disease
    560. Altered Social Behavior and neuroinflammation in a Mouse Model of Pten Mislocalization
    561. Alternate Activation of Microglia as a Protective Adaptation against Chronic neuroinflammation in Young Rats
    562. Aluminum chloride induces neuroinflammation, loss of neuronal dendritic spine and cognition impairment in developing rat
    563. Alzheimer disease and neuroinflammation
    564. Alzheimer’s disease, neuroinflammation and the influence of different combinations of nutrients
    565. Alzheimer’s disease: recent concepts on the relation of mitochondrial disturbances, excitotoxicity, neuroinflammation, and kynurenines
    566. neuroinflammation_IN_RATS/links/5bf5ed91299bf1124fe4cffb/AMELIORATION-EFFECT-OF-Clinacanthus-nutans-ON-LPS-INDUCED-neuroinflammation-IN-RATS.pdf”>Amelioration effect of Clinacanthus nutans on LPS-induced neuroinflammation in rats
    567. Amelioration of age associated neuroinflammation on long term bacosides treatment
    568. Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoprotein
    569. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-10-36″>Amelioration of autoimmune neuroinflammation by the fusion molecule Fn14· TRAIL
    570. Amelioration of diabetes-induced cognitive deficits by GSK-3β inhibition is attributed to modulation of neurotransmitters and neuroinflammation
    571. Amelioration of neuroinflammation and apoptosis characterizing Alzheimer’s disease by natural products’
    572. neuroinflammation_and_Oxidative_Damage_in_Rats/links/5badada192851ca9ed2b8f7f/Ameliorative-Potential-of-Euphorbia-hirta-Linn-Extract-against-Lipopolysaccharide-Induced-neuroinflammation-and-Oxidative-Damage-in-Rats.pdf”>Ameliorative Potential of Euphorbia hirta (Linn.) Extract against Lipopolysaccharide Induced-neuroinflammation and Oxidative Damage in Rats
    573. Aminochrome decreases NGF, GDNF and induces neuroinflammation in organotypic midbrain slice cultures
    574. Aminopyridazines attenuate hippocampus-dependent behavioral deficits induced by human β-amyloid in a murine model of neuroinflammation
    575. Amitriptyline and bromazepam in the treatment of vibratory angioedema: which role for neuroinflammation?
    576. Amitriptyline suppresses neuroinflammation and up-regulates glutamate transporters in morphine-tolerant rats
    577. neuroinflammation_and.854.aspx”>Amitriptyline suppresses neuroinflammation and up-regulates glutamate transporters in morphine-tolerant rats: A-921
    578. Amitriptyline suppresses neuroinflammation-dependent interleukin-10-p38 mitogen-activated protein kinase-heme oxygenase-1 signaling pathway in chronic …
    579. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1216-3″>Ammoxetine attenuates diabetic neuropathic pain through inhibiting microglial activation and neuroinflammation in the spinal cord
    580. Ampelopsin improves cognitive impairment in Alzheimer’s disease and involvement of neuroinflammation and oxidative stress in the hippocampus.
    581. Amphetamine-Induced Sensitization of Hypertension and Lamina Terminalis neuroinflammation
    582. AMPK activation: Role in the signaling pathways of neuroinflammation and neurodegeneration
    583. AMPK and SIRT1 activation contribute to inhibition of neuroinflammation by thymoquinone in BV2 microglia
    584. Amylin treatment reduces neuroinflammation and ameliorates abnormal patterns of gene expression in the cerebral cortex of an Alzheimer’s disease mouse model
    585. Amyloid burden, neuroinflammation, and links to cognitive decline after ischemic stroke
    586. Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation
    587. Amyloid peptide induced neuroinflammation increases the P2X7R expression in microglial cells impacting to their functionality
    588. Amyloid-associated proteins, neuroinflammation and neurofibrillary degeneration in Alzheimer’s disease and cerebral prion amyloidosis
    589. Amyloid‐β neurotoxicity in organotypic culture is attenuated by melatonin: involvement of GSK‐3β, tau and neuroinflammation
    590. Amyotrophic lateral sclerosis and multiple sclerosis associated neuroinflammation: nationwide epidemiological studies on etiology, comorbidities, and treatment
    591. Amyotrophic Lateral Sclerosis, neuroinflammation, and Cromolyn
    592. An altered blood–brain barrier contributes to brain iron accumulation and neuroinflammation in the 6-OHDA rat model of Parkinson’s disease
    593. An alternative path to reduce neuroinflammation
    594. An apoE-derived mimic peptide, COG1410, alleviates early brain injury via reducing apoptosis and neuroinflammation in a mouse model of subarachnoid hemorrhage
    595. An aqueous extract of herbal medicine ALWPs enhances cognitive performance and inhibits LPS-induced neuroinflammation via FAK/NF-κB signaling …
    596. An eighteen-month helicobacter infection does not induce amyloid plaques or neuroinflammation in brains of wild type C57BL/6J mice
    597. An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation
    598. An Evaluation of GABAB Receptors on Modulating neuroinflammation in a Non-Transgenic Animal Model of Alzheimer’s Disease
    599. An in vitro experimental model of neuroinflammation: the induction of interleukin‐6 in murine astrocytes infected with Theiler’s murine encephalomyelitis virus, and its …
    600. An integrative approach to neuroinflammation in psychiatric disorders and neuropathic pain
    601. An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling
    602. AN ISOFORM-SPECIFIC ROLE OF FYNT IN ALZHEIMER’S DISEASE AND ITS RELEVANCE IN neuroinflammation
    603. An open-label trial of JAK 1/2 blockade in progressive IFIH1-associated neuroinflammation
    604. Analysis of Aβ and neuroinflammation as a function of brain region and disease progression in the TgCRND8 brain
    605. Analysis of the pain and neuroinflammation after rats with neuropathic pain receive immunoglobulin intervention
    606. Anandamide, acting via CB2 receptors, alleviates LPS-induced neuroinflammation in rat primary microglial cultures
    607. neuroinflammation&ots=RMtS0vhQRl&sig=tmC2_3dV1QU1T0wJHKqMIKEK6wY”>and Their Receptors in neuroinflammation
    608. Andalucin from Artemisia lannta suppresses the neuroinflammation via the promotion of Nrf2-mediated HO-1 levels by blocking the p65–p300 interaction in LPS …
    609. Andrographolide ameliorates intracerebral hemorrhage induced secondary brain injury by inhibiting neuroinflammation induction
    610. Andrographolide does not protect against neuroinflammation in a Parkinsonism model: Focus on tumor necrosis factor alpha
    611. Andrographolide enhances hippocampal BDNF signaling and suppresses neuronal apoptosis, astroglial activation, neuroinflammation, and spatial memory deficits in …
    612. Andrographolide Reduces neuroinflammation and Oxidative Stress in Aged Octodon degus
    613. Anesthesia, surgery and neuroinflammation
    614. Anesthetic immunomodulation of the neuroinflammation in postoperative cognitive dysfunction
    615. Anesthetic modulation of neuroinflammation in Alzheimer’s disease
    616. Aneurysmal subarachnoid hemorrhage and neuroinflammation: a comprehensive review
    617. Angelicae Gigantis Radix Regulates LPS-Induced neuroinflammation in BV2 Microglia by Inhibiting NF-κB and MAPK Activity and Inducing Nrf-2 Activity
    618. Angiotensin II type 1a receptors in the subfornical organ modulate neuroinflammation in the hypothalamic paraventricular nucleus in heart failure rats
    619. Angiotensin II-Induced neuroinflammation Contributes to Sympathetic Overactivity in Hypertensive Rats.
    620. Angiotensin receptor blockade modulates NFκB and STAT3 signaling and inhibits glial activation and neuroinflammation better than angiotensin-converting enzyme …
    621. Angiotensin receptor blocker, losartan ameliorates neuroinflammation and behavioral consequences of lipopolysaccharide injection
    622. Angiotensin type 1 receptor antagonists protect against alpha-synuclein-induced neuroinflammation and dopaminergic neuron death
    623. Angiotensin type 2 receptors: role in aging and neuroinflammation in the substantia nigra
    624. Angiotensin-converting enzyme inhibitor suppresses Type I interferon responses, decreases neuroinflammation and improves depression-like behavior in MRL/lpr …
    625. neuroinflammation&ots=EyPHIMHAMi&sig=wbCgeRHRmnM7Wpc7zM55o8tXisI”>Animal model of Parkinson disease: neuroinflammation and apoptosis in the 6-hydroxydopamine-induced model
    626. Animal models of neuroinflammation secondary to acute insults originated outside the brain
    627. Annexin A1 attenuates neuroinflammation through FPR2/p38/COX‐2 pathway after intracerebral hemorrhage in male mice
    628. Annexin A1 Bioactive Peptide Promotes Resolution of neuroinflammation in an Experimental Model of Exsanguinating Cardiac Arrest Treated by Emergency …
    629. Annexin A2 Deficiency Exacerbates neuroinflammation and Long-Term Neurological Deficits after Traumatic Brain Injury in Mice
    630. Announcement of Special Issues for 2019: Stress and neuroinflammation
    631. Annual research review: the neuroinflammation hypothesis for stress and psychopathology in children–developmental psychoneuroimmunology
    632. Antagonist of the neurokinin-1 receptor curbs neuroinflammation in ex vivo and in vitro models of Lyme neuroborreliosis
    633. Antarctic krill oil diet protects against lipopolysaccharide-induced oxidative stress, neuroinflammation and cognitive impairment
    634. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0752-y”>Anthocyanins abrogate glutamate-induced AMPK activation, oxidative stress, neuroinflammation, and neurodegeneration in postnatal rat brain
    635. Anthocyanins attenuate neuroinflammation through the suppression of MLK3 activation in a mouse model of perioperative neurocognitive disorders
    636. Anthocyanins control neuroinflammation and consequent memory dysfunction in mice exposed to lipopolysaccharide
    637. Anthocyanins from Lycium ruthenicum Murr. Ameliorated d-Galactose-Induced Memory Impairment, Oxidative Stress, and neuroinflammation in Adult Rats
    638. Anthocyanins protect against LPS-induced oxidative stress-mediated neuroinflammation and neurodegeneration in the adult mouse cortex
    639. Anthocyanins reversed D-galactose-induced oxidative stress and neuroinflammation mediated cognitive impairment in adult rats
    640. Anti-allodynic effects of obtusifolin and gluco-obtusifolin against inflammatory and neuropathic pain: Possible mechanism for neuroinflammation
    641. neuroinflammation/”>Anti-inflammatory activity of hydroxytyrosol inhibition of cytokine production in a Parkinson’s model system of neuroinflammation
    642. Anti-Inflammatory and neuroprotective effect of apigenin: Studies in the GFAP-IL6 mouse model of chronic neuroinflammation
    643. Anti-inflammatory effect of afatinib (an EGFR-TKI) on OGD-induced neuroinflammation
    644. Anti-inflammatory Effect of AZD6244 on Acrolein-Induced neuroinflammation
    645. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1361-8″>Anti-inflammatory effects induced by pharmaceutical substances on inflammatory active brain astrocytes—promising treatment of neuroinflammation
    646. Anti-inflammatory Effects of ,-Dihydroxyeudesm-4(15)-ene Isolated from Myrrh on LPS-induced neuroinflammation in BV2 cells
    647. Anti-inflammatory mechanism of Isodon japonicas (Burm) Hara on lipopolysaccharide-induced neuroinflammation
    648. Anti-inflammatory mechanism of lonchocarpine in LPS-or poly (I: C)-induced neuroinflammation
    649. Anti-inflammatory role of microsomal prostaglandin E synthase-1 in a model of neuroinflammation
    650. Anti-inflammatory therapy with simvastatin improves neuroinflammation and CNS function in a mouse model of metachromatic leukodystrophy
    651. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-9-197″>Anti-inflammatory/anti-amyloidogenic effects of plasmalogens in lipopolysaccharide-induced neuroinflammation in adult mice
    652. Anti-Malarial Drug Artemisinin Extenuates Amyloidogenesis and neuroinflammation in APPswe/PS1dE9 Transgenic Mice Via Inhibition of NF-κB and NLRP3 …
    653. Anti-neuroinflammation activity of acetylpuerarin mediated by a PKC-δ-dependent caspase signaling pathway: in vivo and in vitro studies
    654. Anti-neuroinflammation ameliorates systemic inflammation-induced mitochondrial DNA impairment in the nucleus of the solitary tract and cardiovascular reflex …
    655. Anti-neuroinflammation effect of ginsenoside Rbl in a rat model of Alzheimer disease
    656. Anti-neuroinflammatory effects of DPTP, a novel synthetic clovamide derivative in in vitro and in vivo model of neuroinflammation
    657. Anti-neuroinflammatory effects of Quercetin-3-O-glucuronide isolated from the leaf of Vitis labruscana on LPS-induced neuroinflammation in BV2 cells
    658. Anti-NMDAR encephalitis: demonstration of neuroinflammation and the effect of immunotherapy
    659. Antidepressant activity of crocin-I is associated with amelioration of neuroinflammation and attenuates oxidative damage induced by corticosterone in mice
    660. Antidepressant activity of ω-3 polyunsaturated fatty acids in ovariectomized rats: role of neuroinflammation and microglial polarization
    661. neuroinflammation_in_the_Prefrontal_Cortex_and_Hippocampus/links/5dce4e244585156b351386f0/Antidepressant-and-Anxiolytic-Effect-of-Echium-amoenum-in-Restraint-Stress-Model-The-Role-of-neuroinflammation-in-the-Prefrontal-Cortex-and-Hippocampus.pdf”>Antidepressant and Anxiolytic Effect of Echium amoenum in Restraint Stress Model: The Role of neuroinflammation in the Prefrontal Cortex and Hippocampus
    662. Antidepressant effect of Xingnao Jieyu decoction mediated by alleviating neuroinflammation in a rat model of post-stroke depression
    663. Antidepressant-like activity of Myelophil via attenuation of microglial-mediated neuroinflammation in mice undergoing unpredictable chronic mild stress
    664. Antidepressant-like effect of a new selenium-containing compound is accompanied by a reduction of neuroinflammation and oxidative stress in lipopolysaccharide …
    665. Antidepressant-Like Effect of Bauhinia blakeana Dunn in a neuroinflammation Model in Mice
    666. Antidepressant-like effect of zileuton is accompanied by hippocampal neuroinflammation reduction and CREB/BDNF upregulation in lipopolysaccharide-challenged …
    667. Antidepressants and neuroinflammation: can antidepressants calm glial rage down?
    668. Antigen-independent pathogenic and protective immunity in chronic neuroinflammation
    669. Antihypertensive effects of ACE2 in the paraventricular nucleus: a consequence of reduced neuroinflammation?
    670. Antimalarial drug artemether inhibits neuroinflammation in BV2 microglia through Nrf2-dependent mechanisms
    671. Antimalarial Drug Artemisinin Extenuates Amyloidogenesis and neuroinflammation in APP swe/PS 1dE9 Transgenic Mice via Inhibition of Nuclear Factor‐κ B and …
    672. Antioxidant treatment limits neuroinflammation in experimental glaucoma
    673. Antiparkinson and antioxidant effect of pyridylpyrazolinyl substituted heterosteroids in LPS induced neuroinflammation model of neurodegenerative disorders
    674. Antiviral drug ganciclovir is a potent inhibitor of microglial proliferation and neuroinflammation
    675. Anxiety, neuroinflammation, cholinergic and GABAergic abnormalities are early markers of Gulf War illness in a mouse model of the disease
    676. Anxiolytic effects of polydatin through the blockade of neuroinflammation in a chronic pain mouse model
    677. Anxiolytic properties of compounds that counteract oxidative stress, neuroinflammation, and glutamatergic dysfunction: a review
    678. Anxiolytic-like effects of the ethanol extract of Magnolia obovata leaves through its effects on GABA-benzodiazepine receptor and neuroinflammation
    679. Apelin attenuates depressive-like behavior and neuroinflammation in rats co-treated with chronic stress and lipopolysaccharide
    680. Apelin-13 suppresses neuroinflammation against cognitive deficit in a streptozotocin-induced rat model of Alzheimer’s disease through activation of BDNF-TrkB …
    681. Apigenin attenuates isoflurane-induced cognitive dysfunction via epigenetic regulation and neuroinflammation in aged rats
    682. Apigetrin from Scutellaria baicalensis Georgi Inhibits neuroinflammation in BV-2 Microglia and Exerts Neuroprotective Effect in HT22 Hippocampal Cells
    683. APOE ISOFORMS DIFFERENTIALLY REGULATE ALZHEIMER’S neuroinflammation
    684. APOE‐modulated Aβ‐induced neuroinflammation in Alzheimer’s disease: current landscape, novel data, and future perspective
    685. Apolipoprotein E alters the association of neuroinflammation with Alzheimer’s disease
    686. Apolipoprotein E Deficiency Aggravates Neuronal Injury by Enhancing neuroinflammation via the JNK/c-Jun Pathway in the Early Phase of Experimental …
    687. Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer’s disease
    688. Apoptosis inhibition can be threatening in Aβ-induced neuroinflammation, through promoting cell proliferation
    689. APP intracellular domain impairs adult neurogenesis in transgenic mice by inducing neuroinflammation
    690. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0755-8″>Appearance of claudin-5+ leukocytes in the central nervous system during neuroinflammation: a novel role for endothelial-derived extracellular vesicles
    691. Application of europium-doped very small iron oxide nanoparticles to visualize neuroinflammation with MRI and fluorescence microscopy
    692. Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer’s disease and mild cognitive impairment
    693. Applying clustering coefficient to the pattern of international author collaboration in neuroimmunology and neuroinflammation
    694. Apurinic/apyrimidinic endonuclease 1 is a key modulator of aluminum-induced neuroinflammation
    695. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-9-279″>Aquaporin 4: a player in cerebral edema and neuroinflammation
    696. Aquaporin-4 mediates communication between astrocyte and microglia: Implications of neuroinflammation in experimental Parkinson’s disease
    697. Aqueous extract of Dendropanax morbiferus leaves effectively alleviated neuroinflammation and behavioral impediments in MPTP-induced Parkinson’s mouse model
    698. Arctigenin protects focal cerebral ischemia-reperfusion rats through inhibiting neuroinflammation
    699. Are the emergence of affective disturbances in neuropathic pain states contingent on supraspinal neuroinflammation?
    700. Are we ready for successful clinical targeting of neuroinflammation?: major challenges and how to overcome them
    701. neuroinflammation“>Area Postrema Syndrome Secondary to Lupus neuroinflammation
    702. Arginase 1+ microglia reduce Aβ plaque deposition during IL-1β-dependent neuroinflammation
    703. Arginase 2 Deficiency Promotes neuroinflammation and Pain Behaviors Following Nerve Injury in Mice
    704. ARMD 84 AIDS Kaposi’s sarcoma 488 neuroinflammation (M) 12 vitamin E (L) 376
    705. Aromatase and neuroinflammation in rat focal brain ischemia
    706. Aromatic‐turmerone attenuates LPS‐induced neuroinflammation and consequent memory impairment by targeting TLR4‐dependent signaling pathway
    707. Artemisinin B improves learning and memory impairment in AD dementia mice by suppressing neuroinflammation
    708. Arterial input function combined with PET to follow longitudinally neuroinflammation in rats
    709. Asiatic acid attenuates methamphetamine-induced neuroinflammation and neurotoxicity through blocking of NF-kB/STAT3/ERK and mitochondria-mediated …
    710. Asiatic Acid Protects Dopaminergic Neurons from neuroinflammation by Suppressing Mitochondrial ROS Production
    711. Asiatic acid suppresses neuroinflammation in BV2 microglia via modulation of the Sirt1/NF-κB signaling pathway
    712. Assessing neuroinflammation in Obese Individuals Using Diffusion Basis Spectrum Imaging (DBSI)
    713. neuroinflammation&ots=ye2X25E4M4&sig=gDP9amn0dmnrs9IaoyvFwEiUJa0″>Assessing the influence of neuroinflammation on neurogenesis: in vitro models using neural stem cells and microglia as valuable research tools
    714. Assessment of blood-brain barrier integrity and neuroinflammation in preeclampsia
    715. Assessment of neuroinflammation and microglial activation in Alzheimer’s disease with radiolabelled PK11195 and single photon emission computed tomography
    716. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0700-x”>Assessment of neuroinflammation in a mouse model of obesity and β-amyloidosis using PET
    717. Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study
    718. neuroinflammation&ots=lE8867kRDT&sig=wu3qzZI_LuaZcTGZpNJgIorwgso”>Assessment of neuroinflammation in transferred EAE via a translocator protein ligand
    719. Assessment of translocator protein density, as marker of neuroinflammation, in major depressive disorder: a pilot, multicenter, comparative, controlled, brain …
    720. Association between Hippocampal Shape, neuroinflammation, and Cognitive Decline in Alzheimer’s Disease
    721. Association Between Vaccines and neuroinflammation—Reply
    722. Association Between Vaccines and neuroinflammation: Time, Risks, and Benefits
    723. Association of antibodies against myelin and neuronal antigens with neuroinflammation in systemic lupus erythematosus
    724. Association of high-fat diet with neuroinflammation, anxiety-like defensive behavioral responses, and altered thermoregulatory responses in male rats
    725. Association of long-term atorvastatin with escalated stroke-induced neuroinflammation in rats
    726. Association of serum bilirubin and uric acid levels changes during neuroinflammation in patients with initial and relapsed demyelination attacks
    727. AST-120 reduces neuroinflammation induced by indoxyl sulfate in glial cells
    728. Astaxanthin ameliorates lipopolysaccharide-induced neuroinflammation, oxidative stress and memory dysfunction through inactivation of the signal …
    729. Astaxanthin attenuates neuroinflammation contributed to the neuropathic pain and motor dysfunction following compression spinal cord injury
    730. Astaxanthin offers neuroprotection and reduces neuroinflammation in experimental subarachnoid hemorrhage
    731. Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson’s disease …
    732. Astragaloside IV ameliorates neuroinflammation-induced depressive-like behaviors in mice via the PPARγ/NF-κB/NLRP3 inflammasome axis
    733. neuroinflammation_and_Cognitive_Impairment_in_Rats/links/5a870988aca272017e5aad15/Astragaloside-IV-Protects-Against-Ab1-42-induced-Oxidative-Stress-neuroinflammation-and-Cognitive-Impairment-in-Rats.pdf”>Astragaloside Ⅳ Protects Against Aβ1-42-induced Oxidative Stress, neuroinflammation and Cognitive Impairment in Rats.
    734. Astragalus membranaceus-polysaccharides ameliorates obesity, hepatic steatosis, neuroinflammation and cognition impairment without affecting amyloid deposition …
    735. Astrocyte and macrophage regulation of YKL‐40 expression and cellular response in neuroinflammation
    736. Astrocyte elevated gene-1 is a novel modulator of HIV-1-associated neuroinflammation via regulation of nuclear factor-κB signaling and excitatory amino acid …
    737. Astrocyte gene expression during neuroinflammation: βC/EBPregulates TIMP-1 and other inflammation genes
    738. Astrocyte neuropathology in autism: role of neuroinflammation & glutamatergic signalling
    739. Astrocyte-and endothelial-targeted CCL2 conditional knockout mice: critical tools for studying the pathogenesis of neuroinflammation
    740. Astrocyte-derived CCL2 participates in surgery-induced cognitive dysfunction and neuroinflammation via evoking microglia activation
    741. Astrocyte-derived retinoic acid: a novel regulator of blood–brain barrier function during neuroinflammation in multiple sclerosis
    742. Astrocyte-specific IKK2 activation in mice is sufficient to induce neuroinflammation but does not increase susceptibility to MPTP
    743. Astrocyte‐T cell crosstalk regulates region‐specific neuroinflammation
    744. Astrocyte, reactive astrocytes and self-regulative apoptosis in the neuroinflammation
    745. Astrocyte/microglia cocultures as a model to study neuroinflammation
    746. Astrocytes and neuroinflammation in Alzheimer’s disease
    747. Astrocytes in neuroinflammation and Neuronal Disorders: Shifting the Focus from Neurons
    748. Astrocytes: integrative regulators of neuroinflammation in stroke and other neurological diseases
    749. Astrocytes: key regulators of neuroinflammation
    750. Astrocytic CCAAT/Enhancer-binding protein delta contributes to reactive oxygen species formation in neuroinflammation
    751. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1436-1″>Astrocytic ceramide as possible indicator of neuroinflammation
    752. Astrocytic orosomucoid-2 modulates microglial activation and neuroinflammation
    753. Astrocytic transforming growth factor‐beta signaling reduces subacute neuroinflammation after stroke in mice
    754. Astroglial Connexin 43 Deficiency Protects against LPS-Induced neuroinflammation: A TSPO Brain µPET Study with [18F] FEPPA
    755. Astroglial control of neuroinflammation: TLR3-mediated dsRNA-sensing pathways are in the focus
    756. At the interface of the immune system and the nervous system: how neuroinflammation modulates the fate of neural progenitors in vivo
    757. Atorvastatin Attenuates Cognitive Deficits and neuroinflammation Induced by Aβ1–42 Involving Modulation of TLR4/TRAF6/NF-κB Pathway
    758. Atorvastatin pretreatment attenuates kainic acid-induced hippocampal neuronal death via regulation of lipocalin-2-associated neuroinflammation
    759. Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative 2 stress following amyloid-β1–40 administration in mice: Evidence for …
    760. Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β1–40 administration in mice: Evidence for dissociation …
    761. Atorvastatin prevents neuroinflammation in chronic constriction injury rats through nuclear NFκB downregulation in the dorsal root ganglion and spinal cord
    762. Atp13a2 Deficiency Aggravates Astrocyte‐Mediated neuroinflammation via NLRP3 Inflammasome Activation
    763. Atractylenolide III ameliorates cerebral ischemic injury and neuroinflammation associated with inhibiting JAK2/STAT3/Drp1-dependent mitochondrial fission in …
    764. Atractylodis rhizoma alba attenuates neuroinflammation in BV2 microglia upon LPS stimulation by inducing HO-1 activity and inhibiting NF-κB and MAPK
    765. Atsttrin reduces lipopolysaccharide-induced neuroinflammation by inhibiting the nuclear factor kappa B signaling pathway
    766. Attenuated neurological deficit, cell death and lesion volume in Fas-mutant mice is associated with altered neuroinflammation following traumatic brain injury
    767. Attenuated SIV causes persisting neuroinflammation in the absence of a chronic viral load and neurotoxic antiretroviral therapy
    768. Attenuation of aluminum chloride-induced neuroinflammation and caspase activation through the AKT/GSK-3β pathway by hesperidin in wistar rats
    769. Attenuation of chronic neuroinflammation by a nitric oxide‐releasing derivative of the antioxidant ferulic acid
    770. Attenuation of Ischemic Stroke-Caused Brain Injury by a Monoamine Oxidase Inhibitor Involves Improved Proteostasis and Reduced neuroinflammation
    771. Attenuation of neuroinflammation and Alzheimer’s disease pathology by liver x receptors
    772. Attenuation of neuroinflammation by dexmedetomidine is associated with activation of a cholinergic anti-inflammatory pathway in a rat tibial fracture model
    773. Attenuation of neuroinflammation reverses Adriamycin-induced cognitive impairments
    774. Attenuation of oxidative stress, neuroinflammation, and apoptosis by curcumin prevents cognitive deficits in rats postnatally exposed to ethanol
    775. Attenuation of β-amyloid-induced neuroinflammation by KHG21834 in vivo
    776. Attractylone attenuates sepsis‐associated encephalopathy and cognitive dysfunction by inhibiting microglial activation and neuroinflammation
    777. Aucubin alleviates seizures activity in Li-Pilocarpine-Induced epileptic mice: involvement of inhibition of neuroinflammation and regulation of neurotransmission
    778. Auricular vagus nerve stimulation protects against postoperative cognitive dysfunction by attenuating neuroinflammation and neurodegeneration in aged rats
    779. Author Correction: Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammation
    780. Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease
    781. Author Correction: T-bet-dependent NKp46+ innate lymphoid cells regulate the onset of TH17-induced neuroinflammation.
    782. Autism spectrum disorders may be due to cerebral toxoplasmosis associated with chronic neuroinflammation causing persistent hypercytokinemia that resulted in an …
    783. Autoantibodies recognizing native MOG are closely associated with active demyelination but not with neuroinflammation in chronic EAE
    784. Autoantibody-mediated neuroinflammation: pathogenesis of neuropsychiatric systemic lupus erythematosus in the NZM88 murine model
    785. Autoimmunity, neuroinflammation, pathogen load: a decisive crosstalk in neuropsychiatric SLE
    786. Automated Production of [18F] FEPPA as a neuroinflammation Imaging Agent
    787. Autophagy and NLRP3 inflammasome crosstalk in neuroinflammation in aged bovine brains
    788. Autophagy itself and/or its anti-neuroinflammation action in hippocampus attenuates postoperative cognitive decline in aged rats undergoing splenectomy
    789. Autophagy Modulators and neuroinflammation
    790. AVE0991, a nonpeptide analogue of Ang-(1-7), attenuates aging-related neuroinflammation
    791. Axl activation attenuates neuroinflammation by inhibiting the TLR/TRAF/NF-κB pathway after MCAO in rats
    792. Axon Guidance Molecules Guiding neuroinflammation
    793. Axonal Injury, neuroinflammation and Amyloid Pathology after Traumatic Brain Injury: Making Connections to Neurodegeneration (I12-1.007)
    794. Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes
    795. Axonal regeneration and neuroinflammation: roles for the translocator protein 18 kDa
    796. Axonally derived matrilin-2 induces proinflammatory responses that exacerbate autoimmune neuroinflammation
    797. Aza‐CGP37157‐lipoic hybrids designed as novel Nrf2‐inducers and antioxidants exert neuroprotection against oxidative stress and show neuroinflammation …
    798. B cell antigen presentation is sufficient to drive neuroinflammation in an animal model of multiple sclerosis
    799. B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation
    800. B2 receptor blockage prevents Aβ-induced cognitive impairment by neuroinflammation inhibition
    801. BACE inhibitor NB-360 reveals strong reduction of amyloid-β generation, robust blockade of amyloid deposition and lowering of neuroinflammation in APP transgenic …
    802. Bacille Calmette-Guérin (BCG) Vaccine in neuroinflammation
    803. BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy
    804. Baicalein administered in the subacute phase ameliorates ischemia-reperfusion-induced brain injury by reducing neuroinflammation and neuronal damage
    805. Baicalein attenuates the neuroinflammation in LPS-activated BV-2 microglial cells through suppression of pro-inflammatory cytokines, COX2/NF-κB expressions and …
    806. Baicalein promotes neuronal and behavioral recovery after intracerebral hemorrhage via suppressing apoptosis, oxidative stress and neuroinflammation
    807. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1474-8″>Baicalin ameliorates neuroinflammation-induced depressive-like behavior through inhibition of toll-like receptor 4 expression via the PI3K/AKT/FoxO1 …
    808. Baicalin attenuates lipopolysaccharide-induced neuroinflammation in cerebral cortex of mice via inhibiting nuclear factor kappa B (NF-κB) activation
    809. Baicalin mitigates cognitive impairment and protects neurons from microglia‐mediated neuroinflammation via suppressing NLRP 3 inflammasomes and TLR 4/NF‐κB …
    810. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1661-7″>BAP31 regulates IRAK1-dependent neuroinflammation in microglia
    811. Basic aspects of the immunology of neuroinflammation
    812. neuroinflammation&ots=JTiCdLlkSN&sig=dPR10XLDFD_DxI7GVmV6EQNLjMc”>Basic Aspects of the Immunology of neuroinflammation
    813. Basic concept of microglia biology and neuroinflammation in relation to psychiatry
    814. BDNF Alleviates neuroinflammation in the Hippocampus of Type 1 Diabetic Mice via Blocking the Aberrant HMGB1/RAGE/NF-κB Pathway
    815. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-020-1704-0″>BDNF promotes activation of astrocytes and microglia contributing to neuroinflammation and mechanical allodynia in cyclophosphamide-induced cystitis
    816. Bee pollen and propolis improve neuroinflammation and dysbiosis induced by propionic acid, a short chain fatty acid in a rodent model of autism
    817. Bee venom acupuncture reduces neuroinflammation modulating microglia/macrophage phenotype polarization in spinal cord injury compression model
    818. Bee venom ameliorates cognitive dysfunction caused by neuroinflammation in an animal model of vascular dementia
    819. Bee venom phospholipase A2 ameliorates amyloidogenesis and neuroinflammation through inhibition of signal transducer and activator of transcription-3 …
    820. Bee venom reduces neuroinflammation in the MPTP-induced model of Parkinson’s disease
    821. Behavioral and biochemical effects of GSM 900MHz in neuroinflammation and gestational inflammation models
    822. Behavioral and ultrastructural changes induced by chronic neuroinflammation in young rats
    823. Behavioural and neurological symptoms accompanied by cellular neuroinflammation in IL-10-deficient mice infected with Plasmodium chabaudi
    824. neuroinflammation.1.aspx”>Behavioural aspects of neuroinflammation
    825. Benefical effects of mediterranean diet in neuroinflammation and related diseases
    826. Beneficial effect of the flavonoid luteolin on neuroinflammation
    827. Beneficial effects of lycopene against haloperidol induced orofacial dyskinesia in rats: Possible neurotransmitters and neuroinflammation modulation
    828. Benzimidazole Containing Acetamide Derivatives Attenuate neuroinflammation and Oxidative Stress in Ethanol-Induced Neurodegeneration
    829. Benzodiazepine-refractory status epilepticus, neuroinflammation, and interneuron neurodegeneration after acute organophosphate intoxication
    830. Berberine alleviates postoperative cognitive dysfunction by suppressing neuroinflammation in aged mice
    831. Beta-amyloid oligomers acutely induce memory deficits in association to tlr4-mediated neuroinflammation
    832. Bexarotent attenuated CCI-induced spinal neuroinflammation and neuropathic pain by targeting MKP-1
    833. Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation
    834. Bibliometric Analysis of the Journal neuroinflammation
    835. Bicuculline reduces neuroinflammation in hippocampus and improves spatial learning and anxiety in hyperammonemic rats. Role of glutamate receptors
    836. Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammation
    837. Bidirectional relationship of mast cells-neurovascular unit communication in neuroinflammation and its involvement in POCD
    838. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by …
    839. Biglycan regulates neuroinflammation by promoting M1 microglial activation in early brain injury after experimental subarachnoid hemorrhage
    840. Bilberry anthocyanins improve neuroinflammation and cognitive dysfunction in APP/PSEN1 mice via the CD33/TREM2/TYROBP signaling pathway in microglia
    841. Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation
    842. Bile Acid Metabolism is Altered in Multiple Sclerosis and Supplementation Leads to Amelioration of neuroinflammation (S55. 002)
    843. Bile acid-mediated sphingosine-1-phosphate receptor 2 signaling promotes neuroinflammation during hepatic encephalopathy in mice
    844. Bioaccumulation and neuroinflammation of Gold Nanoparticles in the Central Nervous System
    845. Bioactive components from garlic on brain resiliency against neuroinflammation and neurodegeneration
    846. Bioactive phenols as potential neuroinflammation inhibitors from the leaves of Xanthoceras sorbifolia Bunge
    847. Bioavailable curcumin alleviates lipopolysaccharide-induced neuroinflammation and improves cognition in experimental animals
    848. Biochemical Aspects of neuroinflammation
    849. Biodistribution of fluorescently labeled PAMAM dendrimers in neonatal rabbits: effect of neuroinflammation
    850. Bioengineered 3D glial cell culture systems and applications for neurodegeneration and neuroinflammation
    851. Biology of neuroinflammation: A Common Denominator in Brain Pathologies
    852. Bioluminescence Imaging of neuroinflammation in a Mouse Model of Parkinson’s Disease
    853. neuroinflammation-transgenic-mice-after”>Bioluminescence Imaging of neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils
    854. Biomarkers For neuroinflammation And Satellite Glia Activation In Dry Eye Disease
    855. Biomaterials and glia: Progress on designs to modulate neuroinflammation
    856. Black Ginseng Extract Prevents neuroinflammation and Enhances Learning Behavior in Mice
    857. neuroinflammation/links/573ed6f808ae298602e8de0c/Blockade-of-adenosine-A2A-receptor-confers-neuroprotection-against-retinal-ischemia-reperfusion-injury-through-the-control-of-neuroinflammation.pdf”>Blockade of adenosine A2A receptor confers neuroprotection against retinal ischemia-reperfusion injury through the control of neuroinflammation
    858. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0997-0″>Blocking ATP-sensitive potassium channel alleviates morphine tolerance by inhibiting HSP70-TLR4-NLRP3-mediated neuroinflammation
    859. Blocking endothelin-B receptors rescues retinal ganglion cells from optic nerve injury through suppression of neuroinflammation
    860. Blood brain barrier and neuroinflammation are critical targets of IGF-1-mediated neuroprotection in stroke for middle-aged female rats
    861. Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells
    862. Blood-brain barrier at the interface of air pollution-associated neurotoxicity and neuroinflammation
    863. Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults
    864. Blood-brain barrier disruption and neuroinflammation as pathophysiological mechanisms of the diffuse manifestations of neuropsychiatric systemic lupus …
    865. Blood-Brain Barrier Disruption During neuroinflammation
    866. Blood–brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation
    867. Blood–Brain Barrier Transporters and neuroinflammation: Partners in Neuroprotection and in Pathology
    868. Blueberries Improve neuroinflammation and Cognition differentially Depending on Individual Cognitive baseline Status
    869. Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease
    870. BML-111 Reduces neuroinflammation and Cognitive Impairment in Mice With Sepsis via the SIRT1/NF-κB Signaling Pathway
    871. Bombycis excrementum reduces amyloid-β oligomer-induced memory impairments, neurodegeneration, and neuroinflammation in mice
    872. Bone Marrow Chimeras to Study neuroinflammation
    873. Bone marrow mesenchymal stem cells regulate TGF‐β to adjust neuroinflammation in postoperative central inflammatory mice
    874. Bone morphogenetic proteins in multiple sclerosis: role in neuroinflammation
    875. Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke
    876. Botch protects neurons from ischemic insult by antagonizing Notch-mediated neuroinflammation
    877. Botulinum toxin type A ameliorates adjuvant-arthritis pain by inhibiting microglial activation-mediated neuroinflammation and intracellular molecular signaling
    878. Brain and peripheral atypical inflammatory mediators potentiate neuroinflammation and neurodegeneration
    879. Brain aromatase imaging in an acute neuroinflammation model using µPET and 11C-vorozole
    880. Brain barrier breakdown as a cause and consequence of neuroinflammation in sepsis
    881. Brain biopsy findings link major depressive disorder to neuroinflammation, oxidative stress, and neurovascular dysfunction: a case report
    882. Brain Consequences of Spinal Cord Injury with and without Neuropathic Pain: Translating Animal Models of neuroinflammation onto Human Neural Networks …
    883. Brain endothelial IL-1R1 mediates central IL-1 induced neuroinflammation and anxiety-like behavior
    884. Brain energy metabolism and neuroinflammation in ageing APP/PS1-21 mice using longitudinal 18F-FDG and 18F-DPA-714 PET imaging
    885. Brain injury associated with widely abused amphetamines: neuroinflammation, neurogenesis and blood-brain barrier
    886. Brain injury, neuroinflammation and Alzheimer’s disease
    887. Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system
    888. Brain Innate Immunity in the Regulation of neuroinflammation: Therapeutic Strategies by Modulating CD200-CD200R Interaction Involve the Cannabinoid System
    889. Brain interleukin-15 in neuroinflammation and behavior
    890. Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer’s disease
    891. Brain metabolites and peripheral biomarkers associated with neuroinflammation in complex regional pain syndrome using [11C]-(R)-PK11195 positron emission …
    892. Brain Oxidative markers in stress: possible new drug targets against neuroinflammation
    893. Brain pericytes as mediators of neuroinflammation
    894. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0946-y”>Brain ureido degenerative protein modifications are associated with neuroinflammation and proteinopathy in Alzheimer’s disease with cerebrovascular …
    895. Brain viral burden, neuroinflammation and neurodegeneration in HAART-treated HIV positive injecting drug users
    896. Brain-derived microparticles (BDMPs) contribute to neuroinflammation and Lactadherin reduces BDMP induced neuroinflammation and improves outcome after stroke
    897. Brain-derived microparticles activate microglia/macrophages and induce neuroinflammation
    898. Brain-derived neurotrophic factor in brain disorders: focus on neuroinflammation
    899. Brain-immune interactions and neuroinflammation after traumatic brain injury
    900. Brain‐derived neurotrophic factor fused with a collagen‐binding domain inhibits neuroinflammation and promotes neurological recovery of traumatic brain injury mice …
    901. Brazilian green propolis suppresses microglia-mediated neuroinflammation by inhibiting NF-kB activation
    902. Breaking peripheral immune tolerance to CNS antigens in neurodegenerative diseases: boosting autoimmunity to fight-off chronic neuroinflammation
    903. Broken or maladaptive? Altered trajectories in neuroinflammation and behavior after early life adversity
    904. Bushen-Yizhi Formula Alleviates neuroinflammation via Inhibiting NLRP3 Inflammasome Activation in a Mouse Model of Parkinson’s Disease
    905. Butyrate and dietary soluble fiber improve neuroinflammation associated with aging in mice
    906. BV-2 microglial cells used in a model of neuroinflammation
    907. C-reactive protein increases BBB permeability: implications for obesity and neuroinflammation
    908. C-type lectin receptors Mcl and Mincle control development of multiple sclerosis–like neuroinflammation
    909. C/EBPβ and C/EBPδ in neuroinflammation
    910. neuroinflammation_in_Alzheimer’s_Disease_The_Preventive_and_Therapeutic_Potential_of_Polyphenolic_Nutraceuticals/links/5b21b995458515270fc6e189/neuroinflammation-in-Alzheimers-Disease-The-Preventive-and-Therapeutic-Potential-of-Polyphenolic-Nutraceuticals.pdf”>C0550 neuroinflammation in Alzheimer’s Disease: The Preventive and Therapeutic Potential of Polyphenolic Nutraceuticals
    911. C5b-9 complement complex in autoimmune demyelination: dual role in neuroinflammation and neuroprotection
    912. C5b‐9 complement complex in autoimmune demyelination and multiple sclerosis: dual role in neuroinflammation and neuroprotection
    913. Caffeic acid attenuates lipopolysaccharide-induced sickness behaviour and neuroinflammation in mice
    914. Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma
    915. Caffeine and modafinil ameliorate the neuroinflammation and anxious behavior in rats during sleep deprivation by inhibiting the microglia activation
    916. Caffeine attenuates lipopolysaccharide-induced neuroinflammation
    917. Caffeine May Abrogate LPS-Induced Oxidative Stress and neuroinflammation by Regulating Nrf2/TLR4 in Adult Mouse Brains
    918. Caffeine modulates cadmium-induced oxidative stress, neuroinflammation, and cognitive impairments by regulating Nrf-2/HO-1 in vivo and in vitro
    919. neuroinflammation_and_cell_survival_in_retinal_ischemia/links/573ed73908ae9ace84132e62/Caffeine-modulates-retinal-neuroinflammation-and-cell-survival-in-retinal-ischemia”>Caffeine modulates retinal neuroinflammation and cell survival in retinal ischemia
    920. Caffeine prevents d-galactose-induced cognitive deficits, oxidative stress, neuroinflammation and neurodegeneration in the adult rat brain
    921. neuroinflammation%202018%20course%20directors.pdf”>Cajal course on neuroinflammation and how to study it Course directors
    922. neuroinflammation%202018_instructors.pdf”>Cajal course on neuroinflammation and how to study it Instructors
    923. Calcineurin and glial signaling: neuroinflammation and beyond
    924. Calcineurin/nuclear factor-κB signaling mediates isoflurane-induced hippocampal neuroinflammation and subsequent cognitive impairment in aged rats
    925. Calcium dysregulation and neuroinflammation: discrete and integrated mechanisms for age-related synaptic dysfunction
    926. Call for papers: Neurology: Neuroimmunology & neuroinflammation, a new Neurology journal
    927. neuroinflammation/links/5d8195c792851c22d5e09541/CaMKKb-Dependent-Activation-of-AMP-Activated-Protein-Kinase-Is-Critical-to-Suppressive-Effects-of-Hydrogen-Sulfide-on-neuroinflammation.pdf”>CaMKKb-Dependent Activation of AMP-Activated Protein Kinase Is Critical to Suppressive Effects of Hydrogen Sulfide on neuroinflammation
    928. CaMKKβ-dependent activation of AMP-activated protein kinase is critical to suppressive effects of hydrogen sulfide on neuroinflammation
    929. Can cocaine-induced neuroinflammation explain maladaptive cocaine-associated memories?
    930. Can GPCR, such as Kappa Opioid Receptor, be a Viable Therapeutic Target for Reducing or Preventing neuroinflammation
    931. Can neuroinflammation influence the development of autism spectrum disorders?
    932. Can studies of neuroinflammation in a TSPO genetic subgroup (HAB or MAB) be applied to the entire AD cohort?
    933. Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention?
    934. Can the emerging field of immunometabolism provide insights into neuroinflammation?
    935. Caniferolide A, a Macrolide from Streptomyces caniferus, Attenuates neuroinflammation, Oxidative Stress, Amyloid-Beta, and Tau Pathology in Vitro
    936. Cannabidiol in vivo blunts β‐amyloid induced neuroinflammation by suppressing IL‐1β and iNOS expression
    937. Cannabidiol Reduces Ab-Induced neuroinflammation and Promotes Hippocampal
    938. Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement
    939. Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia
    940. Cannabinoid CB2 receptors in a mouse model of Aβ amyloidosis: immunohistochemical analysis and suitability as a PET biomarker of neuroinflammation
    941. Cannabinoid control of neuroinflammation related to multiple sclerosis
    942. Cannabinoid receptor 2 activation mitigates lipopolysaccharide-induced neuroinflammation and sickness behavior in mice
    943. Cannabinoid receptor 2 agonist reduces immune cell migration in neuroinflammation via inhibition of matrix metalloproteinase-9
    944. Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimer’s disease mouse model
    945. Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation
    946. Cannabinoid receptor-2 stimulation suppresses neuroinflammation by regulating microglial M1/M2 polarization through the cAMP/PKA pathway in an experimental …
    947. Cannabinoid type 2 (CB2) receptors activation protects against oxidative stress and neuroinflammation associated dopaminergic neurodegeneration in …
    948. Cannabinoids and innate immunity: taking a toll on neuroinflammation
    949. Cannabinoids and neuroinflammation
    950. Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis
    951. Cannabinoids for the treatment of neuroinflammation
    952. Cannabinoids in health and disease: Pharmacological potential in metabolic syndrome and neuroinflammation
    953. neuroinflammation-oxidative-stress-and-neuro-excitotoxicity-2153-2435-1000346.pdfK_b.pdf”>Cannabinoids in neuroinflammation, oxidative stress and neuro excitotoxicity
    954. Cannabis sativa L. constituents and their role in neuroinflammation
    955. Canonical Transient Receptor Potential Channel 3 Contributes to Febrile Seizure Inducing Neuronal Cell Death and neuroinflammation
    956. Canonical wnt signaling in dendritic cells regulates Th1/Th17 responses and suppresses autoimmune neuroinflammation
    957. CAP37: A Marker of neuroinflammation
    958. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1226-1″>Carbon monoxide-releasing molecule-3 protects against ischemic stroke by suppressing neuroinflammation and alleviating blood-brain barrier disruption
    959. Cardiotonic steroids as modulators of neuroinflammation
    960. Care Giving As a Chronic Psychosocial Distress: neuroinflammation Trajectory
    961. Caruifolin D from Artemisia absinthium L. inhibits neuroinflammation via reactive oxygen species-dependent c-jun N-terminal kinase and protein kinase c/NF-κB …
    962. Carvedilol abrogates hypoxia-induced oxidative stress and neuroinflammation in microglial BV2 cells
    963. Cas9 Ribonucleoprotein complex delivery: methods and applications for neuroinflammation
    964. Caspase inhibition in neuroinflammation induced by soluble β amyloid monomer, protects cells from abnormal survival and proliferation, via attenuation of NFқB …
    965. Caspase inhibitors may attenuate opioid-induced hyperalgesia and tolerance via inhibiting microglial activation and neuroinflammation
    966. Caspases playing in the field of neuroinflammation: old and new players
    967. Catechin supressed LPS-induced neuroinflammation in BV-2, C6 and NG108-15 cells by modulating CCL21 through PI3K-Akt
    968. Cathepsin C aggravates neuroinflammation involved in disturbances of behaviour and neurochemistry in acute and chronic stress-induced murine model of …
    969. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1398-3″>Cathepsin C promotes microglia M1 polarization and aggravates neuroinflammation via activation of Ca 2+-dependent PKC/p38MAPK/NF-κB pathway
    970. Cationic liposomes target sites of acute neuroinflammation in experimental autoimmune encephalomyelitis
    971. Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system
    972. Caveolin1 is required for Th1 cell infiltration, but not tight junction remodeling, at the blood-brain barrier in autoimmune neuroinflammation
    973. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0630-7″>CC motif chemokine ligand 20 regulates neuroinflammation following spinal cord injury via Th17 cell recruitment
    974. CCDC88B is a novel regulator of maturation and effector functions of T cells during pathological inflammationCCDC88B regulates neuroinflammation
    975. CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions
    976. CCL2 disrupts the adherens junction: implications for neuroinflammation
    977. CCR1 Activation Promotes neuroinflammation Through CCR1/TPR1/ERK1/2 Signaling Pathway After Intracerebral Hemorrhage in Mice
    978. CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward
    979. CD11chi Dendritic Cells Regulate Ly-6Chi Monocyte Differentiation to Preserve Immune-privileged CNS in Lethal neuroinflammation
    980. CD200 modulates spinal cord injury neuroinflammation and outcome through CD200R1
    981. CD200 negatively regulates β-amyloid-induced microglial activation and neuroinflammation in vivo and in vitro
    982. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1426-3″>CD200-CD200R1 inhibitory signaling prevents spontaneous bacterial infection and promotes resolution of neuroinflammation and recovery after stroke
    983. CD38 and CD157 Expression: Glial Control of Neurodegeneration and neuroinflammation
    984. CD38 regulation in activated astrocytes: Implications for neuroinflammation and HIV‐1 brain infection
    985. CD38/cyclic ADP-ribose regulates astrocyte calcium signaling: implications for neuroinflammation and HIV-1-associated dementia
    986. CD4+ NKG2D+ T cells exhibit enhanced migratory and encephalitogenic properties in neuroinflammation
    987. CD40-CD40 ligand pathway is a major component of acute neuroinflammation and contributes to long-term cognitive dysfunction after sepsis
    988. CD49d/CD29‐integrin controls the accumulation of plasmacytoid dendritic cells into the CNS during neuroinflammation
    989. CD99L2 deficiency inhibits leukocyte entry into the central nervous system and ameliorates neuroinflammation
    990. Cdk5/p25-induced cytosolic PLA2-mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration
    991. Celecoxib Prevents Cognitive Impairment and neuroinflammation
    992. Celecoxib prevents cognitive impairment and neuroinflammation in soluble amyloid β-treated rats
    993. Cell-Derived Microparticles/Exosomes in neuroinflammation
    994. Cell-selective gene ablation as a tool to resolve site-specific roles of CCL2 at the blood-brain barrier during neuroinflammation
    995. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-11-10″>Cell-selective knockout and 3D confocal image analysis reveals separate roles for astrocyte-and endothelial-derived CCL2 in neuroinflammation
    996. Cellular and Molecular Mechanisms of neuroinflammation in Epilepsy
    997. Cellular and molecular mediators of neuroinflammation in Alzheimer disease
    998. Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson’s disease
    999. Cellular aspect of neuroinflammation in Guillain-Barre syndrome: a key to a new therapeutic option?
    1000. Cellular components of neuroinflammation—an introduction
    1001. Cellular imaging at 1.5 T: detecting cells in neuroinflammation using active labeling with superparamagnetic iron oxide
    1002. cellular Inhibitor of Apoptosis Protein2–A critical regulator of neuroinflammation
    1003. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-6-38″>Cellular injury and neuroinflammation in children with chronic intractable epilepsy
    1004. Cellular markers of neuroinflammation and neurogenesis after ischemic brain injury in the long-term survival rat model
    1005. Cellular neuroinflammation in a lateral forceps compression model of spinal cord injury
    1006. Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
    1007. Central inhibition of interleukin-6 trans-signaling during peripheral infection reduced neuroinflammation and sickness in aged mice
    1008. Central intracrine DHEA synthesis in ageing-related neuroinflammation and neurodegeneration: therapeutic potential?
    1009. Central modulation of neuroinflammation by neuropeptides and energy-sensing hormones during obesity
    1010. Central nervous system parasitosis and neuroinflammation ameliorated by systemic IL-10 administration in trypanosoma brucei-infected mice
    1011. Central nervous system recruitment of effector memory CD8+ T lymphocytes during neuroinflammation is dependent on α4 integrin
    1012. neuroinflammation&ots=SxGI7SaigW&sig=ZfeE6F6mzkMZfO8QPrJmYqrTjBs”>Central Nervous System Resident Cells in neuroinflammation: A Brave New World
    1013. Central nervous system stromal cells control local CD8+ T cell responses during virus-induced neuroinflammation
    1014. Central neuroinflammation in Cerebral Ischemia: The Role of Glia
    1015. Cerebellum can serve as a pseudo-reference region in Alzheimer disease to detect neuroinflammation measured with PET radioligand binding to translocator protein
    1016. Cerebral dopamine neurotrophic factor protects microglia by combining with AKT and by regulating FoxO1/mTOR signaling during neuroinflammation
    1017. Cerebral FDG PET CT in pediatric neuroinflammation: an exploration in the application of statistical parametric mapping
    1018. Cerebral focal neuroinflammation after acute stroke: Preliminary study with 18F-DPA-714
    1019. Cerebral microglial activation in patients with hepatitis c: in vivo evidence of neuroinflammation
    1020. Cerebral microvascular amyloid β protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic …
    1021. Cerebral transcriptome analysis reveals age-dependent progression of neuroinflammation in P301S mutant tau transgenic male mice
    1022. Cerebral venous congestion promotes blood-brain barrier disruption and neuroinflammation, impairing cognitive function in mice
    1023. Cerebrolysin attenuates hyperalgesia, photophobia, and neuroinflammation in a nitroglycerin-induced migraine model in rats
    1024. Cerebrospinal Fluid Biomarkers of neuroinflammation and Axonal Degeneration in Patients with Multiple Sclerosis
    1025. Cerebrospinal Fluid Markers in neuroinflammation: The Paradigm of Optic Neuritis
    1026. Cerebrospinal fluid markers of extracellular matrix remodelling, synaptic plasticity and neuroinflammation before and after cranial radiotherapy
    1027. Cerebrospinal fluid markers of neuroinflammation in delirium: a role for interleukin-1β in delirium after hip fracture
    1028. Cerebrovascular remodeling and neuroinflammation is a late effect of radiation-induced brain injury in non-human primates
    1029. Cessation of anti-VLA-4 therapy in a focal rat model of multiple sclerosis causes an increase in neuroinflammation
    1030. cGMP signaling pathway in hepatic encephalopathy neuroinflammation and cognition
    1031. Changes in brain oxysterols at different stages of Alzheimer’s disease: Their involvement in neuroinflammation
    1032. Changes in the expression of genes related to neuroinflammation over the course of sporadic Alzheimer’s disease progression: CX3CL1, TREM2, and PPARγ
    1033. Characteristics and pharmacodynamics of severe neuroinflammation in a child with neurolupus
    1034. Characterization and modulation of immunoregulatory molecules in neuroinflammation
    1035. Characterization of 11C-GSK1482160 for targeting the P2X7 receptor as a biomarker for neuroinflammation
    1036. Characterization of a novel acetamidobenzoxazolone‐based PET ligand for translocator protein (18 kDa) imaging of neuroinflammation in the brain
    1037. Characterization of a rat model to study acute neuroinflammation on histopathological, biochemical and functional outcomes
    1038. Characterization of an in vivo model of neuroinflammation and evaluation of the anti-inflammatory and neuroprotective effects of curcumin as a potential lead …
    1039. Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammation
    1040. Characterization of MCAM contribution to neuroinflammation using a new murine knockout model
    1041. Characterization of natural killer cells in paired CSF and blood samples during neuroinflammation
    1042. Characterization of neuroinflammation and periphery-to-CNS inflammatory cross-talk in patients with disc herniation and degenerative disc disease
    1043. neuroinflammation_and_periphery-to-CNS_inflammatory_cross-talk_in_patients_with_lumbar_disc_herniation_LDH_and_degenerative_disc_disease_DDD/links/5baa7c1992851ca9ed25d4a3/IASP-World-Congress-2018-Characterization-of-neuroinflammation-and-periphery-to-CNS-inflammatory-cross-talk-in-patients-with-lumbar-disc-herniation-LDH-and-degenerative-disc-disease-DDD.pdf”>Characterization of neuroinflammation and periphery-to-CNS inflammatory cross-talk in patients with lumbar disc herniation (LDH) and degenerative disc …
    1044. Characterization of platelet–monocyte complexes in HIV-1–infected individuals: Possible role in HIV-associated neuroinflammation
    1045. Characterization of rTg4510 mice yields evidence of significant neuroinflammation
    1046. Characterization of the early neuroinflammation after spinal cord injury in mice
    1047. Characterization of the lipopolysaccharide induced model of Parkinson’s disease: Role of oxidative stress and neuroinflammation
    1048. Characterization of the Role of Nicotine and Delta 9-THC in Modulation of neuroinflammation
    1049. Characterizing newly repopulated microglia in the adult mouse: impacts on animal behavior, cell morphology, and neuroinflammation
    1050. Charcot‐Marie‐Tooth disease and neuroinflammation
    1051. Chemerin suppresses neuroinflammation and improves neurological recovery via CaMKK2/AMPK/Nrf2 pathway after germinal matrix hemorrhage in neonatal rats
    1052. Chemical Biology Probes for Extracellular Vesicles Facilitate Studies of neuroinflammation
    1053. Chemical Elements and Oxidative Status in neuroinflammation
    1054. Chemical genetics of neuroinflammation: natural and synthetic compounds as microglial inhibitors
    1055. Chemokine receptor CXCR2: physiology regulator and neuroinflammation controller?
    1056. Chemokine receptor expression and function in experimental autoimmune neuroinflammation
    1057. Chemokine receptors in neuroinflammation
    1058. Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning
    1059. Chemokines and chemokine receptors: multipurpose players in neuroinflammation
    1060. Chemokines and cytokines in neuroinflammation leading to neuropathic pain
    1061. Chemokines regulate the migration of neural progenitors to sites of neuroinflammation
    1062. Chemotherapy-induced neuroinflammation is associated with disrupted colonic and bacterial homeostasis in female mice
    1063. CHF5074 reduces biomarkers of neuroinflammation in patients with mild cognitive impairment: a 12-week, double-blind, placebo-controlled study
    1064. Chi3l3 induces oligodendrogenesis in an experimental model of autoimmune neuroinflammation
    1065. Childhood Autoimmune and neuroinflammation-Related Epilepsies
    1066. Chitinases, neuroinflammation and biomarkers in ALS
    1067. Cholinergic protection via α7 nicotinic acetylcholine receptors and PI3K-Akt pathway in LPS-induced neuroinflammation
    1068. Cholinergic system and neuroinflammation: implication in multiple sclerosis
    1069. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1149-x”>Chorioamnionitis, neuroinflammation, and injury: timing is key in the preterm ovine fetus
    1070. Chronic alcohol-induced liver injury correlates with memory deficits: Role for neuroinflammation
    1071. Chronic alcohol-induced microRNA-155 contributes to neuroinflammation in a TLR4-dependent manner in mice
    1072. Chronic behavioral stress exaggerates motor deficit and neuroinflammation in the MPTP mouse model of Parkinson’s disease
    1073. Chronic Binge Alcohol-Associated Differential Brain Region Modulation of Growth Factor Signaling Pathways and neuroinflammation in Simian Immunodeficiency …
    1074. neuroinflammation/links/5490183d0cf2d1800d863b7e/Adenosine-A2A-receptor-blockade-and-caffeine-modulate-retinal-neuroinflammation.pdf”>Chronic caffeine administration prevents retinal neuroinflammation and cell death in a rat retinal ischemia-reperfusion model
    1075. Chronic ethanol exposure combined with high fat diet up-regulates P2X7 receptors that parallels neuroinflammation and neuronal loss in C57BL/6J mice
    1076. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-9-130″>Chronic ethanol increases systemic TLR3 agonist-induced neuroinflammation and neurodegeneration
    1077. Chronic ethanol increases systemic TLR3 agonist-induced neuroinflammation and neurodegeneration
    1078. Chronic exercise ameliorates the neuroinflammation in mice carrying NSE/htau23
    1079. Chronic functional bowel syndrome enhances gut-brain axis dysfunction, neuroinflammation, cognitive impairment, and vulnerability to dementia
    1080. Chronic hM3Dq signaling in microglia ameliorates neuroinflammation in male mice
    1081. Chronic IL-1β-mediated neuroinflammation mitigates amyloid pathology in a mouse model of Alzheimer’s disease without inducing overt neurodegeneration
    1082. Chronic immobilisation stress ameliorates clinical score and neuroinflammation in a MOG-induced EAE in Dark Agouti rats: mechanisms implicated
    1083. Chronic intermittent hypoxia induces chronic low-grade neuroinflammation in the dorsal hippocampus of mice
    1084. Chronic Intermittent Hypoxia-Induced neuroinflammation Undermines Respiratory Motor Plasticity After Chronic Incomplete Cervical Spinal Cord Injury
    1085. Chronic intra-ocular pressure induces neuroinflammation in retina and cerebral structures in an ocular hypertensive rat model
    1086. Chronic intracerebral LPS as a model of neuroinflammation
    1087. Chronic lithium administration attenuates up‐regulated brain arachidonic acid metabolism in a rat model of neuroinflammation
    1088. Chronic minocycline treatment reduces the anxiety-like behaviors induced by repeated restraint stress through modulating neuroinflammation
    1089. Chronic neurodegeneration after traumatic brain injury: Alzheimer disease, chronic traumatic encephalopathy, or persistent neuroinflammation?
    1090. Chronic neuroinflammation and cognitive impairment following transient global cerebral ischemia: role of fractalkine/CX3CR1 signaling (877.1)
    1091. Chronic neuroinflammation impacts the recruitment of adult-born neurons into behaviorally relevant hippocampal networks
    1092. Chronic neuroinflammation in Alzheimer’s disease: new perspectives on animal models and promising candidate drugs
    1093. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer’s disease
    1094. Chronic neuroinflammation underlying pathogenesis of Alzheimer’s disease
    1095. Chronic neuroinflammation: Contribution of IL-1β to Prostaglandin Production and Alzheimer’s Disease Pathology
    1096. Chronic NMDA administration increases neuroinflammatory markers in rat frontal cortex: cross-talk between excitotoxicity and neuroinflammation
    1097. Chronic noise exposure acts cumulatively to exacerbate Alzheimer’s disease-like amyloid-β pathology and neuroinflammation in the rat hippocampus
    1098. Chronic Oral Palmitoylethanolamide Administration Rescues Cognitive Deficit and Reduces neuroinflammation, Oxidative Stress, and Glutamate Levels in A …
    1099. Chronic stress induces transient spinal neuroinflammation, triggering sensory hypersensitivity and long-lasting anxiety-induced hyperalgesia
    1100. Chronic systemic IL-1β exacerbates central neuroinflammation independently of the blood–brain barrier integrity
    1101. Chronic traumatic stress impairs memory in mice: potential roles of acetylcholine, neuroinflammation and corticotropin releasing factor expression in the hippocampus
    1102. Chronic treatment with combined chemotherapeutic agents affects hippocampal micromorphometry and function in mice, independently of neuroinflammation
    1103. Chronic viral neuroinflammation: speculation on underlying mechanisms
    1104. Chrysin restores MPTP induced neuroinflammation, oxidative stress and neurotrophic factors in an acute Parkinson’s disease mouse model
    1105. Ciproxifan improves cholinergic transmission, attenuates neuroinflammation and oxidative stress but does not reduce amyloid level in transgenic mice
    1106. Circadian clock protein Rev-erbα regulates neuroinflammation
    1107. Circadian control of pain and neuroinflammation
    1108. Circadian rhythms, neuroinflammation and Oxidative Stress in the Story of Parkinson’s Disease
    1109. Clarifying the Role of Microglia Versus Macrophages in Facilitating neuroinflammation Surrounding Intracortical Microelectrodes
    1110. CLEC5A regulates Japanese encephalitis virus-induced neuroinflammation and lethality
    1111. Clec7a is a Potential Target to Relieve Neuropathic Pain via Inhibiting neuroinflammation Activation Through Regulating TLR4 Expression
    1112. CLG from Hemp Seed Inhibits LPS-Stimulated neuroinflammation in BV2 Microglia by Regulating NF-κB and Nrf-2 Pathways
    1113. Clinical clues for autoimmunity and neuroinflammation in patients with autistic regression
    1114. Clinical Features and Outcomes of Patients with Status Epilepticus Caused by neuroinflammation (P2. 5-019)
    1115. Clk1 deficiency promotes neuroinflammation and subsequent dopaminergic cell death through regulation of microglial metabolic reprogramming
    1116. Clofibrate, a PPAR‐α agonist, abrogates sodium fluoride‐induced neuroinflammation, oxidative stress, and motor incoordination via modulation of GFAP/Iba‐1/anti …
    1117. CNI-1493 Attenuates neuroinflammation and Dopaminergic Neurodegeneration in the Acute MPTP Mouse Model of Parkinson’s Disease
    1118. CNS immune surveillance and neuroinflammation: endocannabinoids keep control
    1119. CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature
    1120. CNS TLR2 mediates innate neuroinflammation but not autoimmune pathogenesis and demyelination
    1121. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation
    1122. Cobalt (II) β-ketoaminato complexes as novel inhibitors of neuroinflammation
    1123. Cocaine mediated neuroinflammation: role of dysregulated autophagy in pericytes
    1124. Cocaine self‐administration is increased after frontal traumatic brain injury and associated with neuroinflammation
    1125. Cofilin Knockdown Attenuates Collagenase-Induced ICH Injury in Mice by Combating Oxidative stress and Modulating neuroinflammation
    1126. Cognitive deficits and neurotoxicity induced by synthetic cathinones: is there a role for neuroinflammation?
    1127. Cognitive deficits in experimental autoimmune encephalomyelitis: neuroinflammation and synaptic degeneration
    1128. Cognitive trajectory of patients in the recovery period after ischemic stroke: role of neuroinflammation and structural cerebral factors
    1129. Cold-inducible RNA-binding protein mediates neuroinflammation in cerebral ischemia
    1130. Combination fluconazole/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease
    1131. Combinations of ketamine and atropine are neuroprotective and reduce neuroinflammation after a toxic status epilepticus in mice
    1132. COMBINED ADMINISTRATION OF AN A2A RECEPTOR ANTAGONIST AND A 5-HT1A/1B RECEPTOR AGONIST REVERSES neuroinflammation IN THE 6 …
    1133. Combined analysis of the glia secretome and the CSF proteome: neuroinflammation and novel biomarkers
    1134. Combining ceftriaxone with doxycycline and daptomycin reduces mortality, neuroinflammation, brain damage, and hearing loss in infant rat pneumococcal meningitis
    1135. Commentary (Complement-Initiated neuroinflammation and Its Role in Early Stage Alzheimer’s Disease)
    1136. neuroinflammation-and-aberration-in-monoamine-levels-in-hypothalamus-are-associated-with-temperature.pdf”>Commentary: Heat stress-induced neuroinflammation and aber-ration in monoamine levels in hypothalamus are associated with temperature dysregulation
    1137. Commentary: Important considerations on bone morphogenetic protein-2 and neuroinflammation
    1138. Commentary: Low-Grade Non-Resolving neuroinflammation: Age Does Matter
    1139. Commentary: Mild endoplasmic reticulum stress ameliorates lpopolysaccharide-induced neuroinflammation and cognitive impairment via regulation of …
    1140. Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study
    1141. Communication between enteric neurons, glia, and nociceptors underlies the effects of tachykinins on neuroinflammation
    1142. Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation
    1143. Comparative evaluation of three TSPO PET radiotracers in a LPS-induced model of mild neuroinflammation in rats
    1144. Comparing amyloid-β deposition, neuroinflammation, glucose metabolism, and mitochondrial complex I activity in brain: a PET study in aged monkeys
    1145. Comparison of [18F] FEPPA and [11C] PBR28, novel peripheral benzodiazepine receptor ligands for PET, in a rat model of neuroinflammation
    1146. Comparison of humoral neuroinflammation and adhesion molecule expression in two models of experimental intracerebral hemorrhage
    1147. Comparison of the effect of three licorice varieties on cognitive improvement via an amelioration of neuroinflammation in lipopolysaccharide-induced mice
    1148. Complement activation in autoimmune demyelination: dual role in neuroinflammation and neuroprotection
    1149. Complement activation sustains neuroinflammation and deteriorates adult neurogenesis and spatial memory impairment in rat hippocampus following sleep …
    1150. Complement in neuroinflammation
    1151. Complement in neuroinflammation: Studies in Leprosy and Amyotrophic Lateral Sclerosis
    1152. Complement, neuroinflammation and neuronal degeneration in Alzheimer disease
    1153. Compounds acting on the renin-angiotensin-aldosterone system as potential regulators of autoimmune neuroinflammation
    1154. Comprehensive analysis of the lncRNA-associated ceRNA network identifies neuroinflammation biomarkers for Alzheimer’s disease
    1155. Conditional expression of human β-hexosaminidase in the neurons of Sandhoff disease rescues mice from neurodegeneration but not neuroinflammation
    1156. Connecting metainflammation and neuroinflammation through the PTN-MK-RPTPβ/ζ axis: Relevance in therapeutic development
    1157. Connection between systemic inflammation and neuroinflammation underlies neuroprotective mechanism of several phytochemicals in neurodegenerative diseases
    1158. Connexin43-and pannexin-based channels in neuroinflammation and cerebral neuropathies
    1159. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-9-15″>Constitutive activity of NF-kappa B in myeloid cells drives pathogenicity of monocytes and macrophages during autoimmune neuroinflammation
    1160. Construction and optimization of novel recombinant Adeno-Associated Virus rAAV2/5 for targeting microglia to regulate immune responses during neuroinflammation
    1161. Consuming a diet supplemented with resveratrol reduced infection-related neuroinflammation and deficits in working memory in aged mice
    1162. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-1019-y”>Contrasting effect of the latency-reversing agents bryostatin-1 and JQ1 on astrocyte-mediated neuroinflammation and brain neutrophil invasion
    1163. Contribution of C5aR1 to neuroinflammation and Neuronal Dysfunction in Alzheimer’s Disease
    1164. Contribution of Dietary Fat in neuroinflammation
    1165. Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases
    1166. Contribution of microglia‐mediated neuroinflammation to retinal degenerative diseases
    1167. Contribution of neuroinflammation and immunity to brain aging and the mitigating effects of physical and cognitive interventions
    1168. Contribution of neuroinflammation in burning mouth syndrome: indications from benzodiazepine use
    1169. Contribution of neuroinflammation to changes in [11C] flumazenil binding in the rat brain: evaluation of the inflamed pons as reference tissue
    1170. Contribution of neuroinflammation to changes in [11C] flumazenil binding in the rat brain: evaluation of the inflamed pons as reference tissue
    1171. Contribution of neuroinflammation to the development of Alzheimer’s disease-like pathology in OXYS rats
    1172. Contribution of neuroinflammation to the pathogenesis of cancer cachexia
    1173. Contribution of Receptors, Transcription Factors, and Genes in the Induction of neuroinflammation
    1174. Contribution of Schwann cells to remyelination in a naturally occurring canine model of CNS neuroinflammation
    1175. Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders
    1176. Control of neuroinflammation for Therapeutic Gain
    1177. Controlling the activation of the B v8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals
    1178. CONTROLLING THE ACTIVATION OF THE PROKINETICIN SYSTEM REDUCES neuroinflammation AND ABOLISHES PAIN HYPERSENSITIVITY IN …
    1179. Conventional DCs sample and present myelin antigens in the healthy CNS and allow parenchymal T cell entry to initiate neuroinflammation
    1180. Convergence between microglia and peripheral macrophages phenotype during development and neuroinflammation
    1181. Cordycepin (3′-deoxyadenosine) promotes remyelination via suppression of neuroinflammation in a cuprizone-induced mouse model of demyelination
    1182. Core-cross-linked nanoparticles reduce neuroinflammation and improve outcome in a mouse model of traumatic brain injury
    1183. Cornel iridoid glycoside exerts a neuroprotective effect on neuroinflammation in rats with brain injury by inhibiting NF-κB and STAT3
    1184. Correction to Discovery of N-Alkyl Catecholamides as Selective Phosphodiesterase-4 Inhibitors with Anti-neuroinflammation Potential Exhibiting Antidepressant-like …
    1185. Correction to In Vivo Imaging of Human neuroinflammation
    1186. Correction to: Cathepsin C Aggravates neuroinflammation Involved in Disturbances of Behaviour and Neurochemistry in Acute and Chronic Stress-Induced Murine …
    1187. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0979-2″>Correction to: the disruption of mitochondrial axonal transport is an early event in neuroinflammation
    1188. Correction to: TREM2 Attenuates Aβ1-42-Mediated neuroinflammation in BV-2 Cells by Downregulating TLR Signaling.
    1189. Correction: Acetylcholinesterase Inhibitors Reduce neuroinflammation and-Degeneration in the Cortex and Hippocampus of a Surgery Stress Rat Model
    1190. Correction: Derivation of Neural Stem Cells from Human Adult Peripheral CD34+ Cells for an Autologous Model of neuroinflammation
    1191. Correction: Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral …
    1192. Correction: Imatinib Ameliorates neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral …
    1193. Correction: P-Glycoprotein Acts as an Immunomodulator during neuroinflammation
    1194. Correction: Platelets Recognize Brain-Specific Glycolipid Structures, Respond to Neurovascular Damage and Promote neuroinflammation
    1195. Correction: Tau Overexpression Impacts a neuroinflammation Gene Expression Network Perturbed in Alzheimer’s Disease
    1196. Correlation of CSF and plasma antioxidative capacity in patients with different clinical phenotypes of neuroinflammation and clinical and radiological findings
    1197. Correlations between blood–brain barrier disruption and neuroinflammation in an experimental model of penetrating ballistic-like brain injury
    1198. Corrigendum to “Characterization of MCAM contribution to neuroinflammation using a new murine knockout model”[J. Neuroimmunol., 275 (1–2)(2014) 143]
    1199. Corrigendum to’Cordycepin (3′-deoxyadenosine) promotes remyelination via suppression of neuroinflammation in a cuprizone-induced mouse model of …
    1200. Corrigendum to” 6-Shogaol, an active constituent of ginger, attenuates neuroinflammation and cognitive deficits in animal models of dementia”[BBRC 449 (2014) 8-13] …
    1201. Corrigendum to” Anxiety, neuroinflammation, cholinergic and GABAergic abnormalities are early markers of Gulf War illness in a mouse model of the disease”[Brain …
    1202. Corrigendum to” Parkinson’s disease: Autoimmunity and neuroinflammation“[Autoimmun Rev 15 (10)(2016) 1005-1011].
    1203. Corrigendum to” Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder-A combined magnetic resonance imaging and positron emission …
    1204. Corrigendum to” α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a …
    1205. Corrigendum: neuroinflammation and Cytokines in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Critical Review of Research Methods
    1206. Corrigendum: Versatility of the complement system in neuroinflammation, neurodegeneration, and brain homeostasis
    1207. Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats
    1208. Cortical Neuron-Derived Exosomal MicroRNA-181c-3p Inhibits neuroinflammation by Downregulating CXCL1 in Astrocytes of a Rat Model with Ischemic Brain Injury
    1209. Corticosterone and pyridostigmine/DEET exposure attenuate peripheral cytokine expression: Supporting a dominant role for neuroinflammation in a mouse …
    1210. Corticosterone basal levels and vulnerability to LPS-induced neuroinflammation in the rat brain
    1211. Corticosterone potentiates DFP-induced neuroinflammation and affects high-order diffusion imaging in a rat model of Gulf War Illness
    1212. Could fever and neuroinflammation play a role in the neurobiology of autism? A subject worthy of more research
    1213. Could probiotics be used to mitigate neuroinflammation?
    1214. Could the Combination of Two Non-Psychotropic Cannabinoids Counteract neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol
    1215. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1375-2″>Counteracting neuroinflammation in experimental Parkinson’s disease favors recovery of function: effects of Er-NPCs administration
    1216. COX-1 ACTIVITY PRECEDES THE COX-2 INDUCTION IN Aβ INDUCED neuroinflammation
    1217. Cranial irradiation leads to acute and persistent neuroinflammation with delayed increases in T-cell infiltration and CD11c expression in C57BL/6 mouse brain
    1218. Crashing the computer: apoptosis vs. necroptosis in neuroinflammation
    1219. CREB is upregulated in hepatic encephalopathy and contributes to the neuroprotection against neuroinflammation
    1220. Critical function of myeloid SOCS3 is in limiting the neuroinflammation of EAE (147.21)
    1221. Critical role of P2X7 receptors in the neuroinflammation and cognitive dysfunction after surgery
    1222. Critical role of the Mac1/NOX2 pathway in mediating reactive microgliosis-generated chronic neuroinflammation and progressive neurodegeneration
    1223. Cross-talk between glia, neurons and mast cells in neuroinflammation associated with Parkinson’s disease
    1224. Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging
    1225. Crosstalk between neurokinin receptor signaling and neuroinflammation in neurological disorders
    1226. Crystallins and neuroinflammation: The glial side of the story
    1227. CSB6B prevents β-amyloid-associated neuroinflammation and cognitive impairments via inhibiting NF-κB and NLRP3 in microglia cells
    1228. CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
    1229. CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia
    1230. CSF biomarkers related to sleep, cognition and neuroinflammation in patients with Kleine Levin Syndrome
    1231. Cu II (atsm) Attenuates neuroinflammation
    1232. Cues Guiding Leukocyte Transendothelial Migration across the Blood-Brain Barrier in neuroinflammation: Endothelial Heterogeneity, Chemokines, and …
    1233. CuII (atsm) Attenuates neuroinflammation
    1234. Curcumin Alleviates Lipopolysaccharide (LPS)-Activated neuroinflammation via Modulation of miR-199b-5p/IκB Kinase β (IKKβ)/Nuclear Factor Kappa B (NF …
    1235. Curcumin alleviates lipopolysaccharide-induced neuroinflammation in fetal mouse brain
    1236. Curcumin alleviates lumbar radiculopathy by reducing neuroinflammation, oxidative stress and nociceptive factors
    1237. Curcumin ameliorates neuroinflammation, neurodegeneration, and memory deficits in p25 transgenic mouse model that bears hallmarks of Alzheimer’s disease
    1238. Curcumin and Apigenin–novel and promising therapeutics against chronic neuroinflammation in Alzheimer’s disease
    1239. Curcumin attenuates beta-amyloid-induced neuroinflammation via activation of peroxisome proliferator-activated receptor-gamma function in a rat model of …
    1240. Curcumin inhibits LPS-induced neuroinflammation by promoting microglial M2 polarization via TREM2/TLR4/NF-κB pathways in BV2 cells
    1241. Curcumin prevents acute neuroinflammation and long-term memory impairment induced by systemic lipopolysaccharide in mice
    1242. Curcumin protects axons from degeneration in the setting of local neuroinflammation
    1243. Curcumin reduces neuroinflammation stimulated by Aβ25-35 in primary rat microglial cells
    1244. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer’s disease
    1245. Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases
    1246. Current perspectives on the link between neuroinflammation and neurogenesis
    1247. Current preclinical studies on neuroinflammation and changes in blood–brain barrier integrity by MDMA and methamphetamine
    1248. Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities
    1249. Cutting Edge: IL-27 Attenuates Autoimmune neuroinflammation via Regulatory T Cell/Lag3–Dependent but IL-10–Independent Mechanisms In Vivo
    1250. Cx3cr1‐deficiency exacerbates alpha‐synuclein‐A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson’s disease
    1251. CX3CR1‐dependent recruitment of mature NK cells into the central nervous system contributes to control autoimmune neuroinflammation
    1252. CXCL12 in control of neuroinflammation
    1253. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1646-6″>CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease
    1254. CXCL12-γ expression is inhibited in neuroinflammation
    1255. CXCL12: role in neuroinflammation
    1256. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-11-103″>CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation
    1257. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-9-93″>CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation
    1258. CXCL5 signaling is a shared pathway of neuroinflammation and blood–brain barrier injury contributing to white matter injury in the immature brain
    1259. CXCL8 gene silencing promotes neuroglial cells activation while inhibiting neuroinflammation through the PI3K/Akt/NF‐κB‐signaling pathway in mice with ischemic …
    1260. CXCL9, CXCL10, CXCL11, and their receptor (CXCR3) in neuroinflammation and neurodegeneration.
    1261. CXCR2 is essential for cerebral endothelial activation and leukocyte recruitment during neuroinflammation
    1262. CXCR2 signaling regulates neuroinflammation in models of viral and autoimmune-induced neurodegenerative disease
    1263. CXCR3 promotes cerebellar inflammation but prevents ocular destruction in transgenic mice with a TH1-driven neuroinflammation
    1264. Cyanidin attenuates Aβ 25-35-induced neuroinflammation by suppressing NF-κB activity downstream of TLR4/NOX4 in human neuroblastoma cells
    1265. Cyclic AMP pathway suppress autoimmune neuroinflammation by inhibiting functions of encephalitogenic CD4 T cells and enhancing M2 macrophage …
    1266. Cyclic AMP pathway suppress autoimmune neuroinflammation by inhibiting functions of encephalitogenic CD4 T cells and enhancing M2 macrophage polarization at …
    1267. Cyclin dependent kinase‐11, neuroinflammation and Alzheimer’s disease: a review
    1268. Cyclooxygenase (COX)-1 activity precedes the COX-2 induction in Aβ-induced neuroinflammation
    1269. Cyclooxygenase and neuroinflammation in Parkinson’s disease neurodegeneration
    1270. Cyclooxygenase-1 is involved in the inhibition of hippocampal neurogenesis after lipopolysaccharide-induced neuroinflammation
    1271. Cyclooxygenase-1 null mice show reduced neuroinflammation in response to β-amyloid
    1272. Cyclooxygenase-2-dependent neuroinflammation and oxidative stress in rostral ventrolateral medulla contribute to neurogenic hypertension following chronic …
    1273. CysLT1R downregulation reverses intracerebroventricular streptozotocin-induced memory impairment via modulation of neuroinflammation in mice
    1274. Cystatin F involvement in adenosine A 2A receptor-mediated neuroinflammation in BV2 microglial cells
    1275. Cytochrome P4504f, a potential therapeutic target limiting neuroinflammation
    1276. Cytoglobin attenuates neuroinflammation in lipopolysaccharide-activated primary preoptic area cells via NFkB pathway inhibition
    1277. Cytokine adaptations to repeated ethanol exposure and the role of internal and external cues in ethanol-driven neuroinflammation
    1278. Cytokine Dynamics, Diagnosis and Treatment of neuroinflammation In Chronic Constriction Injury Rat Model
    1279. Cytokine networks in neuroinflammation
    1280. Cytokines and chemokines as biomarkers of ethanol-induced neuroinflammation and anxiety-related behavior: role of TLR4 and TLR2
    1281. Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain
    1282. Cytokines as mediators of neuroinflammation in experimental autoimmune encephalomyelitis
    1283. Cytokines in neuroinflammation and Alzheimer’s disease
    1284. Cytomegalovirus infection exacerbates autoimmune mediated neuroinflammation
    1285. Cytotoxicity of acute neuroinflammation induced by lipopolysaccharide can be attenuated by ginkgolide B
    1286. CZ2HF mitigates β-amyloid 25-35 fragment-induced learning and memory impairment through inhibition of neuroinflammation and apoptosis in rats
    1287. D-4F increases microRNA-124a and reduces neuroinflammation in diabetic stroke rats
    1288. D27 neuroinflammation and changes in serotonin metabolism in presymptomatic HD gene carriers: a dual tracer positron emission tomography (PET) study
    1289. Daily Administration of Ibuprofen Modifies neuroinflammation Gene Expression, but not Neuroplasticity Gene Expression in Traumatic Brain Injured Rats
    1290. Dampening neuroinflammation
    1291. Dangguishaoyao-san attenuates LPS-induced neuroinflammation via the TLRs/NF-κB signaling pathway
    1292. Danshensu ameliorates the cognitive decline in streptozotocin-induced diabetic mice by attenuating advanced glycation end product-mediated neuroinflammation
    1293. DARS2 protects against neuroinflammation and apoptotic neuronal loss, but is dispensable for myelin producing cells
    1294. Dcf1 deficiency attenuates the role of activated microglia during neuroinflammation
    1295. DE NOVO NAD+ SYNTHESIS RESCUES neuroinflammation AND ALZHEIMER’S DISEASE PHENOTYPES: MODULATING IMMUNE CELL RESPONSES AND …
    1296. Debate:“is increasing neuroinflammation beneficial for neural repair?”
    1297. DECIPHERING THE ROLE OF neuroinflammation IN THE EARLY EVENTS OF ALZHEIMER’S DISEASE
    1298. Decrease in adult neurogenesis and neuroinflammation are involved in spatial memory impairment in the streptozotocin-induced model of sporadic Alzheimer’s …
    1299. Decrease in neuroinflammation after immunisation with synthetic prion peptides in an animal model of scrapie
    1300. Decrease of miR-19b-3p in Brain Microvascular Endothelial Cells Attenuates Meningitic Escherichia coli-Induced neuroinflammation via TNFAIP3-Mediated NF-κB …
    1301. Decreased neuroinflammation and increased brain energy homeostasis following environmental enrichment after mild traumatic brain injury is associated …
    1302. Decreased neuroinflammation correlates to higher vagus nerve activity fluctuations in near-term ovine fetuses: a case for the afferent cholinergic anti …
    1303. Decreased neuronal CD200 expression in IL-4-deficient mice results in increased neuroinflammation in response to lipopolysaccharide
    1304. Decreasing oxidative stress and neuroinflammation with a multifunctional peptide rescues memory deficits in mice with Alzheimer disease
    1305. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1693-z”>Dectin-1/Syk signaling triggers neuroinflammation after ischemic stroke in mice
    1306. Deep brain stimulation does not enhance neuroinflammation in multiple system atrophy
    1307. Deep hypothermia therapy attenuates LPS-induced microglia neuroinflammation via the STAT3 pathway
    1308. Deep sequencing and miRNA profiles in alcohol-induced neuroinflammation and the TLR4 response in mice cerebral cortex
    1309. Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation
    1310. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-015-0238-3″>Deferoxamine attenuates lipopolysaccharide-induced neuroinflammation and memory impairment in mice
    1311. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0740-2″>Deferoxamine regulates neuroinflammation and iron homeostasis in a mouse model of postoperative cognitive dysfunction
    1312. Deferoxamine regulates neuroinflammation and oxidative stress in rats with diabetes-induced cognitive dysfunction
    1313. Deficiency of tenascin-C alleviates neuronal apoptosis and neuroinflammation after experimental subarachnoid hemorrhage in mice
    1314. Deficiency of tPA Exacerbates White Matter Damage, neuroinflammation, Glymphatic Dysfunction and Cognitive Dysfunction in Aging Mice
    1315. Deficiency of TREK-1 potassium channel exacerbates blood-brain barrier damage and neuroinflammation after intracerebral hemorrhage in mice
    1316. Deficiency of α1, 6-fucosyltransferase promotes neuroinflammation by increasing the sensitivity of glial cells to inflammatory mediators
    1317. Deficits in systemic biomarkers of neuroinflammation and growth factors promoting nerve regeneration in patients with type 2 diabetes and polyneuropathy
    1318. Defining “neuroinflammation” Lessons from MPTP‐and Methamphetamine‐Induced Neurotoxicity
    1319. Defining the contribution of neuroinflammation to Parkinson’s disease in humanized immune system mice
    1320. Defining the role of IL-23 in autoimmune neuroinflammation
    1321. Definition of a 1.06-Mb region linked to neuroinflammation in humans, rats and mice
    1322. Definition of genetic and pathogenic mechanisms regulating neuroinflammation
    1323. Degeneration and regeneration of the peripheral nervous system: from Augustus Waller’s observations to neuroinflammation
    1324. Degenerative joint diseases and neuroinflammation
    1325. Delayed mGluR5 activation limits neuroinflammation and neurodegeneration after traumatic brain injury
    1326. Deletion of CD38 suppresses glial activation and neuroinflammation in a mouse model of demyelination
    1327. Deletion of Chitinase-3-like 1 accelerates stroke development through enhancement of neuroinflammation by STAT6-dependent M2 microglial inactivation in …
    1328. Deletion of equilibrative nucleoside transporter-2 protects against lipopolysaccharide-induced neuroinflammation and blood-brain barrier dysfunction in mice
    1329. Deletion of monoglyceride lipase in astrocytes attenuates lipopolysaccharide-induced neuroinflammation
    1330. Deletion of μ-Opioid Receptor in Mice Alters the Development of Acute neuroinflammation
    1331. Deletion or inhibition of soluble epoxide hydrolase protects against brain damage and reduces microglia-mediated neuroinflammation in traumatic brain injury
    1332. Delineating neuroinflammation, parasite CNS invasion, and blood-brain barrier dysfunction in an experimental murine model of human African …
    1333. Demyelinating Diseases and neuroinflammation
    1334. Demyelination caused by the copper chelator cuprizone halts T cell mediated autoimmune neuroinflammation
    1335. Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model
    1336. Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration
    1337. Dendrimer-based targeted systemic therapies for neuroinflammation in CNS disorders
    1338. Dendrimer-Fluocinolone Acetonide Nanodevices Supress Retinal neuroinflammation and Are Neuroprotective in RCS Rats
    1339. Dendritic cells as therapeutic targets in neuroinflammation
    1340. Dendritic cells, CD4+ T cells, and α synuclein triangle fuels neuroinflammation in Parkinson’s disease (P3. 053)
    1341. Dental Pulp Stem Cell-Derived Factors Alleviate Subarachnoid Hemorrhage-Induced neuroinflammation and Ischemic Neurological Deficits
    1342. Department of neuroinflammation, Institute of Neurology, Queen Square, London, UK
    1343. Depression comorbid with hyperalgesia: Different roles of neuroinflammation induced by chronic stress and hypercortisolism
    1344. Depression-like behavior, hyperglycemia, oxidative stress, and neuroinflammation presented in diabetic mice are reversed by the administration of 1-methyl-3 …
    1345. Depression-like behaviors and heme oxygenase-1 are regulated by Lycopene in lipopolysaccharide-induced neuroinflammation
    1346. Derivation of neural stem cells from human adult peripheral CD34+ cells for an autologous model of neuroinflammation
    1347. Design of a Novel PAMAM-Based Nanomedicine with Sustained NAC Release for Treatment of neuroinflammation
    1348. Design of antioxidant nanotherapeutics for attenuation of atherogenesis and neuroinflammation
    1349. Design of dual inhibitors of ROCK-I and NOX2 as potential leads for the treatment of neuroinflammation associated with various neurological diseases including …
    1350. Design, synthesis and evaluation in an LPS rodent model of neuroinflammation of a novel 18F-labelled PET tracer targeting P2X7
    1351. Designing of multi-target-directed ligands against the enzymes associated with neuroinflammation: an in silico approach
    1352. Detecting neuroinflammation Following Traumatic Brain Injury: Novel Quantitative, Multianalyte Immunoassay Improves Detection
    1353. Detecting neuroinflammation in the brain following chronic alcohol exposure in rats: A comparison between in vivo and in vitro TSPO radioligand binding
    1354. Detecting neuroinflammation with molecular MRI
    1355. Detection of cytotoxic activation of microglia in a rat neuroinflammation model using a novel translocator protein ligand,[18F] FEPPA
    1356. Detection of microglial activation in an acute model of neuroinflammation using PET and radiotracers 11C-(R)-PK11195 and 18F-GE-180
    1357. Detection of microRNAs in microglia by real-time PCR in normal CNS and during neuroinflammation
    1358. Detection of neuroinflammation before selective neuronal loss appearance after mild focal ischemia using [18 F] DPA-714 imaging
    1359. Detection of neuroinflammation in a Rat Model of Subarachnoid Hemorrhage Using [18F]DPA-714 PET Imaging
    1360. neuroinflammation-through-the-retina-by-means-of-Raman/10.1117/12.921358.short”>Detection of neuroinflammation through the retina by means of Raman spectroscopy and multivariate analysis
    1361. Detection of Zika virus (ZIKV)-induced neuroinflammation in a murine infection model with translocator protein (TSPO) ligand 3H-PK11195
    1362. Determinants of CCL5-driven mononuclear cell migration across the blood–brain barrier. Implications for therapeutically modulating neuroinflammation
    1363. Determining the role of IL-4 induced neuroinflammation in microglial activity and amyloid-β using BV2 microglial cells and APP/PS1 transgenic mice
    1364. Detrimental effects of HMGB-1 require microglial-astroglial interaction: Implications for the status epilepticus-induced neuroinflammation
    1365. Developing a Novel In-Vitro neuroinflammation Model for Huntington’s Disease
    1366. Development and characterisation of a novel NF-κB reporter cell line for investigation of neuroinflammation
    1367. DEVELOPMENT AND ELUCIDATION OF MECHANISM OF ACTION OF NEW LEADS TO ATTENUATE neuroinflammation IN STROKE MODEL
    1368. Development and Validation of a Targeted Next-Generation Sequencing Gene Panel for Children With neuroinflammation
    1369. Development of a human innervated tissue engineered skin for the study of neuroinflammation
    1370. Development of a methodology for monitoring spinal neuroinflammation mechanisms in the neuropathic rat in vivo
    1371. Development of a novel method for quantification of sterols and oxysterols by UPLC-ESI-HRMS: application to a neuroinflammation rat model
    1372. Development of a positron emission tomography radiotracer for imaging elevated levels of superoxide in neuroinflammation
    1373. Development of an in vitro model of neuroinflammation for studying secondary injury mechanisms in traumatic brain injury
    1374. neuroinflammation&ots=49dOl9Tnx2&sig=idqcBO81Ceicm6IBtebMKuS_Hqs”>Development of brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer’s disease
    1375. Development of highly potent phosphodiesterase 4 inhibitors with anti-neuroinflammation potential: design, synthesis, and structure-activity relationship study of …
    1376. Development of Novel Quinoxaline-Based κ-Opioid Receptor Agonists for the Treatment of neuroinflammation
    1377. Development of PET neuroimaging methods for stroke and neuroinflammation
    1378. Development of rodent in vivo models: neuroinflammation and neurodegeneration relevant to Alzheimer’s disease
    1379. Developmental endothelial locus-1 is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination
    1380. Developmental neuroinflammation and schizophrenia
    1381. Dexamethasone sodium phosphate attenuates lipopolysaccharide-induced neuroinflammation in microglia BV2 cells
    1382. Dexmedetomidine Attenuates neuroinflammation In LPS-Stimulated BV2 Microglia Cells Through Upregulation Of miR-340
    1383. Dexmedetomidine Inhibits neuroinflammation by Altering Microglial M1/M2 Polarization Through MAPK/ERK Pathway
    1384. Dexmedetomidine mitigates microglia-mediated neuroinflammation through upregulation of programmed cell death protein 1 in a rat spinal cord injury model
    1385. Dexmedetomidine modulates neuroinflammation and improves outcome via alpha2-adrenergic receptor signaling after rat spinal cord injury
    1386. Dexmedetomidine pretreatment inhibits cerebral ischemia/reperfusion‑induced neuroinflammation via activation of AMPK
    1387. Dexmedetomidine reduces lipopolysaccharide induced neuroinflammation, sickness behavior, and anhedonia
    1388. Dexmedetomidine suppresses sevoflurane anesthesia-induced neuroinflammation through activation of the PI3K/Akt/mTOR pathway
    1389. Diabetes insipidus contributes to traumatic brain injury pathology via CD36 neuroinflammation
    1390. neuroinflammation/links/5851255208ae8f3738194d78/DIABETIC-NEUROPATHY-OXIDATIVE-STRESS-AND-neuroinflammation.pdf”>DIABETIC NEUROPATHY: OXIDATIVE STRESS AND neuroinflammation
    1391. Diagnostic approaches and outcomes in patients with neuroinflammation
    1392. Diammonium Glycyrrhizinate Attenuates Aβ1–42‐Induced neuroinflammation and Regulates MAPK and NF‐κB Pathways In Vitro and In Vivo
    1393. DICAM: A novel molecular effector in neuroinflammation
    1394. Didehydro-cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic mice
    1395. Diesel exhaust activates and primes microglia: air pollution, neuroinflammation, and regulation of dopaminergic neurotoxicity
    1396. Diet induced neuroinflammation and cognitive decline
    1397. Diet-induced cellular neuroinflammation in the hypothalamus: Mechanistic insights from investigation of neurons and microglia
    1398. Diet-Induced neuroinflammation: Microgliosis Due to Binge Eating
    1399. Diet-induced obesity and low testosterone increase neuroinflammation and impair neural function
    1400. Diet-induced obesity and low testosterone interact to increase neuroinflammation and reduce neuron survival
    1401. Diet-induced obesity prolongs neuroinflammation and recruits CCR2+ monocytes to the brain following herpes simplex virus (HSV)-1 latency in mice
    1402. Dietary Acetate Supplementation Attenuates neuroinflammation
    1403. Dietary and donepezil modulation of mTOR signaling and neuroinflammation in the brain
    1404. Dietary broccoli mildly improves neuroinflammation in aged mice but does not reduce lipopolysaccharide-induced sickness behavior
    1405. Dietary fructose-induced gut dysbiosis promotes mouse hippocampal neuroinflammation: a benefit of short-chain fatty acids
    1406. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-014-0156-9″>Dietary intervention rescues maternal obesity induced behavior deficits and neuroinflammation in offspring
    1407. Dietary inulin alters the gut microbiome, enhances systemic metabolism and reduces neuroinflammation in an APOE4 mouse model
    1408. Dietary magnesium and copper affect survival time and neuroinflammation in chronic wasting disease
    1409. Dietary Restriction and neuroinflammation: A Potential Mechanistic Link
    1410. Dietary Saturated Fatty Acids Promote Differentiation of Th1 and Th17 Cells And Aggravate neuroinflammation (P6. 149)
    1411. Dietary Spray-Dried Porcine Plasma Prevents Cognitive Decline in Senescent Mice and Reduces neuroinflammation and Oxidative Stress
    1412. Dietary Supplementation of the Antioxidant Curcumin Halts Systemic LPS-Induced neuroinflammation-Associated Neurodegeneration and Memory/Synaptic …
    1413. Dietary supplementation with α-tocopherol reduces neuroinflammation and neuronal degeneration in the rat brain after kainic acid-induced status epilepticus
    1414. Differences in statin associated neuroprotection corresponds with either decreased production of IL-1β or TNF-α in an in vitro model of neuroinflammation-induced …
    1415. Differential changes in Neuregulin-1 signaling in major brain regions in a lipopolysaccharide-induced neuroinflammation mouse model
    1416. Differential effects of blueberry polyphenols on age-associated neuroinflammation and cognition.
    1417. Differential effects of duration and age on the consequences of neuroinflammation in the hippocampus
    1418. Differential effects of propofol and dexmedetomidine on neuroinflammation induced by systemic endotoxin lipopolysaccharides in adult mice
    1419. Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson’s disease
    1420. Differential local connectivity and neuroinflammation profiles in the medial prefrontal cortex and hippocampus in the valproic acid rat model of autism
    1421. Differential modulation of glial cell mediated neuroinflammation in Plasmodium berghei ANKA infection by TGF β and IL 6
    1422. Differential role of interleukin-1β in neuroinflammation-induced impairment of spatial and nonspatial memory in hyperammonemic rats
    1423. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1545-x”>Differential transcriptional profiles identify microglial-and macrophage-specific gene markers expressed during virus-induced neuroinflammation
    1424. neuroinflammation-and-psychosis-associated-with-chromosome-deletion/2F5C7657FD3577B108B660EEAB6CFC76″>Differential treatment response, neuroinflammation, and psychosis associated with chromosome deletion
    1425. Differentiation and transmigration of CD4 T cells in neuroinflammation and autoimmunity
    1426. Digested raspberries polyphenols for brain health: attenuation of neuroinflammation
    1427. Dihydrolipoic acid protects against lipopolysaccharide-induced behavioral deficits and neuroinflammation via regulation of Nrf2/HO-1/NLRP3 signaling in rat
    1428. Dihydromyricetin exerts a rapid antidepressant-like effect in association with enhancement of BDNF expression and inhibition of neuroinflammation
    1429. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP 3 inflammasome activation in APP/PS 1 transgenic mice
    1430. Dihydromyricetin protects against cerebral ischemia/reperfusion injury via suppressing microglia-mediated neuroinflammation and activation of ERK1/2-CREB …
    1431. Dimethyl fumarate attenuates neuroinflammation and neurobehavioral deficits induced by experimental traumatic brain injury
    1432. Dimethyl fumarate limits neuroinflammation and oxidative stress and improves cognitive impairment after polymicrobial sepsis
    1433. Dimethyltryptamine (DMT): a biochemical Swiss Army knife in neuroinflammation and neuroprotection?
    1434. Diosmin reduces cerebral Aβ levels, tau hyperphosphorylation, neuroinflammation, and cognitive impairment in the 3xTg-AD mice
    1435. Direct Test for neuroinflammation with [11C] DAP-713-PET Scanning
    1436. Direct Test for neuroinflammation with [11C] DPA-713-PET Scanning
    1437. Discovery development of drugs for alzheimers disease neuroinflammation and elucidating their molecular mechanism of action
    1438. Discovery of 2‐(3, 4‐dialkoxyphenyl)‐2‐(substituted pyridazin‐3‐yl) acetonitriles as phosphodiesterase 4 inhibitors with anti‐neuroinflammation potential based on …
    1439. Discovery of coumarin Mannich base derivatives as multifunctional agents against monoamine oxidase B and neuroinflammation for the treatment of Parkinson’s …
    1440. Discovery of N-Alkyl Catecholamides as Selective Phosphodiesterase-4 Inhibitors with Anti-neuroinflammation Potential Exhibiting Antidepressant-like Effects at Non …
    1441. Discovery of trifluoromethyl glycol carbamates as potent and selective covalent monoacylglycerol lipase (MAGL) inhibitors for treatment of neuroinflammation
    1442. Disease-induced neuroinflammation and depression
    1443. Disruption of calcitonin gene-related peptide signaling accelerates muscle denervation and dampens cytotoxic neuroinflammation in SOD1 mutant mice
    1444. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-020-1709-8″>Disruption of Midkine gene reduces traumatic brain injury through the modulation of neuroinflammation
    1445. Dissecting the complex landscape of neuroinflammation at single-cell resolution
    1446. Dissociation of frontotemporal dementia–related deficits and neuroinflammation in progranulin haploinsufficient mice
    1447. Distinct adrenergic system changes and neuroinflammation in response to induced locus ceruleus degeneration in APP/PS1 transgenic mice
    1448. Distinct contributions of astrocytes and pericytes to neuroinflammation identified in a 3D human blood-brain barrier on a chip
    1449. Distinct contributions of hyperglycemia and high-fat feeding in metabolic syndrome-induced neuroinflammation
    1450. Distinct dictation of Japanese encephalitis virus-induced neuroinflammation and lethality via triggering TLR3 and TLR4 signal pathways
    1451. Distinct role of Glutaminyl Cyclases (QCs) in inflammation/neuroinflammation: First results from QC and isoQC knock out mice
    1452. Distribution of different isoforms of receptor protein tyrosine phosphatase γ (Ptprg-RPTP γ) in adult mouse brain: upregulation during neuroinflammation
    1453. Dithiolethione ACDT suppresses neuroinflammation and ameliorates disease severity in experimental autoimmune encephalomyelitis
    1454. Diverse action of lipoteichoic acid and lipopolysaccharide on neuroinflammation, blood-brain barrier disruption, and anxiety in mice
    1455. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia
    1456. Dl-3-n-butylphthalide exerts dopaminergic neuroprotection through inhibition of neuroinflammation
    1457. DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington’s mice (R6/2) reveals neuroinflammation and insulin associations
    1458. DNA Subtraction of In Vivo Selected Phage Repertoires for Efficient Peptide Pathology Biomarker Identification in neuroinflammation Multiple Sclerosis Model
    1459. Docosahexaenoic acid (DHA) in stroke, Alzheimer’s disease, and blinding retinal degenerations: coping with neuroinflammation and sustaining cell survival
    1460. Docosahexaenoic acid decreased neuroinflammation in rat pups after controlled cortical impact
    1461. Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer’s, and other neurodegenerative …
    1462. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0939-x”>Docosahexaenoic acid-containing choline phospholipid modulates LPS-induced neuroinflammation in vivo and in microglia in vitro
    1463. Doenjang, A Korean Traditional Fermented Soybean Paste, Ameliorates neuroinflammation and Neurodegeneration in Mice Fed a High-Fat Diet
    1464. Does Anticholinergic Activity Affect Neuropathology Implication of neuroinflammation in Alzheimer’s Disease
    1465. DOES MEDITERRANEAN DIET CONFER NEUROPROTECTION AGAINST neuroinflammation AND RELATED DISEASES? AN OVERVIEW
    1466. Does neuroinflammation drive the relationship between tau hyperphosphorylation and dementia development following traumatic brain injury?
    1467. Does neuroinflammation fan the flame in neurodegenerative diseases?
    1468. Does neuroinflammation induce systemic aging?
    1469. Does neuroinflammation sustain neurodegeneration in ALS?
    1470. Does neuroinflammation turn on the flame in Alzheimer’s disease? Focus on astrocytes
    1471. Does neuroinflammation turn on the flame in Alzheimer’s disease? Focus on astrocytes
    1472. Does neuroinflammation turn on the flame in Alzheimer’s disease? Focus on astrocytes
    1473. Does the interplay between aging and neuroinflammation modulate Alzheimer’s disease clinical phenotypes? A clinico-pathological perspective
    1474. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1652-8″>Dopamine receptor D3 signalling in astrocytes promotes neuroinflammation
    1475. Dopaminochrome induces neuroinflammation in the substantia nigra of Sprague Dawley rats
    1476. Dorsal raphe neuroinflammation promotes dramatic behavioral stress dysregulation
    1477. Double-negative T cells remarkably promote neuroinflammation after ischemic stroke
    1478. Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis
    1479. Downregulated nuclear factor E2-related factor 2 (Nrf2) aggravates cognitive impairments via neuroinflammation and synaptic plasticity in the senescence …
    1480. Doxycycline and meloxicam can treat neuroinflammation by increasing activity of antioxidant enzymes in rat brain.
    1481. Doxycycline counteracts neuroinflammation restoring memory in Alzheimer’s disease mouse models
    1482. Doxycycline for Alzheimer’s disease: fighting β-amyloid oligomers and neuroinflammation
    1483. Drug Abuse-Related neuroinflammation in Human Postmortem Brains: An Immunohistochemical Approach
    1484. Drug development for Alzheimer’s disease: microglia induced neuroinflammation as a target?
    1485. Drug-and cell-based therapies for targeting neuroinflammation in traumatic brain injury
    1486. Ds-HMGB1 and fr-HMGB induce depressive behavior through neuroinflammation in contrast to nonoxid-HMGB1
    1487. Dual bioactivity of resveratrol fatty alcohols: differentiation of neural stem cells and modulation of neuroinflammation
    1488. Dual effects of daily FTY720 on human astrocytes in vitro: relevance for neuroinflammation
    1489. Dual effects of human placenta-derived neural cells on neuroprotection and the inhibition of neuroinflammation in a Rodent model of Parkinson’s disease
    1490. Dual Inhibitors of ROCK I and NOX to Attenuate neuroinflammation in Neurological Disorders High Throughput Virtual and Biological screening
    1491. Dual lentivirus infection potentiates neuroinflammation and neurodegeneration: viral copassage enhances neurovirulence
    1492. Dual role of ALCAM in neuroinflammation and blood–brain barrier homeostasis
    1493. Dual role of vitamin C on the neuroinflammation mediated neurodegeneration and memory impairments in colchicine induced rat model of Alzheimer disease
    1494. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation
    1495. Dual Targeting of Amyloid-beta Clearance and neuroinflammation as a Novel Therapeutic Approach against Alzheimer’s Disease
    1496. Dual therapeutic effects of C-10068, a dextromethorphan derivative, against post-traumatic nonconvulsive seizures and neuroinflammation in a rat model of …
    1497. Dyad of CD40/CD40 ligand fosters neuroinflammation at the blood–brain barrier and is regulated via JNK signaling: implications for HIV-1 encephalitis
    1498. Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV α …
    1499. Dynamic cross-talk between microglia and peripheral monocytes underlies stress-induced neuroinflammation and behavioral consequences
    1500. Dynamic development of glucocorticoid resistance during autoimmune neuroinflammation
    1501. Dynamic visualization of neuroinflammation in multiple sclerosis animal model with animal positron emission tomography
    1502. Dynamically Monitor neuroinflammation in a Mouse Model of Mo/Hu APPswePS1dE9 Mice with [18F]-DPA714 PET Imaging
    1503. Dynamics of neuroinflammation in the macrosphere model of arterio-arterial embolic focal ischemia: an approximation to human stroke patterns
    1504. Dynamics of Regulatory T Cell-Mediated Control of Antigen Responses and Autoimmune neuroinflammation
    1505. Dysfunction of brain pericytes in chronic neuroinflammation
    1506. Dysfunction of neuronal calcium signalling in neuroinflammation and neurodegeneration
    1507. Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation
    1508. Dysregulation in myelination mediated by persistent neuroinflammation: possible mechanisms in chemotherapy-related cognitive impairment
    1509. Dysregulation of intestinal IL17 signaling & the microbiome exacerbate autoimmune neuroinflammation.
    1510. Dysregulation of neurogenesis by neuroinflammation: key differences in neurodevelopmental and neurological disorders
    1511. neuroinflammation&ots=hOgZ6fGRTT&sig=V1wDaPuMBEbX1NRMdvbDD4nT3LU”>e role of NO/cGMP signaling on neuroinflammation: a new therapeutic opportunity
    1512. Early activation of Egr-1 promotes neuroinflammation and dopaminergic neurodegeneration in an experimental model of Parkinson’s disease
    1513. Early detection of neuroinflammation in p25 inducible mouse model
    1514. Early electroacupuncture treatment ameliorates neuroinflammation in rats with traumatic brain injury
    1515. Early enteral feeding reduces sepsis response and neuroinflammation in a pig model of neonatal bloodstream infection
    1516. Early gene activation initiates neuroinflammation prior to VSV neuroinvasion: Impact on antiviral responses and sleep
    1517. Early hyperbaric oxygen treatment attenuates burn-induced neuroinflammation by inhibiting the galectin-3-dependent toll-like receptor-4 pathway in a rat model
    1518. Early immune response in MPTP-induced neuroinflammation in the mouse myenteric plexus and central nervous system
    1519. Early intervention with ABA prevents neuroinflammation and memory impairment in a triple transgenic mice model of Alzheimer´ s disease
    1520. Early life experience contributes to the developmental programming of depressive-like behaviour, neuroinflammation and oxidative stress
    1521. Early minocycline and late FK506 treatment improves survival and alleviates neuroinflammation, neurodegeneration, and behavioral deficits in prion-infected …
    1522. Early miR-155 upregulation contributes to neuroinflammation in Alzheimer’s disease triple transgenic mouse model
    1523. Early Treatment of Experimental Autoimmune Encephalomyelitis with Cannabidiol Suppresses Tc1 Cells and Reduces neuroinflammation
    1524. Early-onset subicular microvascular amyloid and neuroinflammation correlate with behavioral deficits in vasculotropic mutant amyloid β-protein precursor transgenic …
    1525. Eating as a motivated behavior: modulatory effect of high fat diets on energy homeostasis, reward processing and neuroinflammation
    1526. EBI2–Sensor for dihydroxycholesterol gradients in neuroinflammation
    1527. Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs
    1528. Edaravone abrogates LPS-induced behavioral anomalies, neuroinflammation and PARP-1
    1529. Editor’s Perspective:“Connecting the Dots” from Blood Brain Barrier Dysfunction to neuroinflammation and Alzheimer’s Disease
    1530. Effect of adenovirus-mediated overexpression of PTEN on brain oxidative damage and neuroinflammation in a rat kindling model of epilepsy
    1531. Effect of agmatine on impairment of hippocampal neurogenesis and neuroinflammation in streptozotocin-induced diabetes in rats
    1532. neuroinflammation_in_Albino_Rats/links/5e1da08ea6fdcc28e9c4c5dc/Effect-of-Annona-Squamosa-Ethanolic-and-Aqueous-Leave-Extracts-on-Aluminum-Chloride-Induced-neuroinflammation-in-Albino-Rats.pdf”>Effect of Annona Squamosa Ethanolic and Aqueous Leave Extracts on Aluminum Chloride-Induced neuroinflammation in Albino Rats
    1533. Effect of anti-dementia drugs on LPS induced neuroinflammation in mice
    1534. Effect of antidepressant treatment on plasma levels of neuroinflammation‐associated molecules in patients with somatic symptom disorder with predominant pain …
    1535. Effect of atorvastatin on behavioral alterations and neuroinflammation during epileptogenesis
    1536. Effect of Cafeteria Diet Induced Obesity on neuroinflammation in the Orbitofrontal Cortex
    1537. Effect of chronic stress in the onset of Parkinson’s disease: possible role of microglial cells in neuroinflammation
    1538. Effect of cigarette smoking on a marker for neuroinflammation: A [11 C] DAA1106 positron emission tomography study
    1539. Effect of Clostridium butyricum against Microglia‐Mediated neuroinflammation in Alzheimer’s Disease via Regulating Gut Microbiota and Metabolites Butyrate
    1540. Effect of dimethyl fumarate on neuroinflammation and apoptosis in pentylenetetrazol kindling model in rats
    1541. Effect of hesperidin on neurobehavioral, neuroinflammation, oxidative stress and lipid alteration in intracerebroventricular streptozotocin induced cognitive impairment …
    1542. Effect of IL-17A on lipopolysaccharide-induced neuroinflammation and fear conditioning test
    1543. Effect of interferon-β on neuroinflammation, brain injury and neurological outcome after experimental subarachnoid hemorrhage
    1544. Effect of Linguizhugan decoction on neuroinflammation and expression disorder of the amyloid β‑related transporters RAGE and LRP‑1 in a rat model of …
    1545. Effect of long-term administration of antiretroviral drugs (Tenofovir and Nevirapine) on neuroinflammation and neuroplasticity in mouse hippocampi
    1546. Effect of low-dose cyclophosphamide, ACTH, and IVIg combination immunotherapy on neuroinflammation in pediatric-onset OMS: a retrospective pilot study
    1547. EFFECT OF MANGOSTEEN EXTRACT ON neuroinflammation IN RAT MODEL OF ACUTE TRAUMATIC BRAIN INJURY
    1548. Effect of melatonin on neuroinflammation and acetylcholinesterase activity induced by LPS in rat brain
    1549. Effect of NAC treatment and physical activity on neuroinflammation in subchronic Parkinsonism; is physical activity essential?
    1550. Effect of NALP1 inflammasome and Lipoxin in methamphetamine-induced on neuroinflammation in rats
    1551. Effect of neuroinflammation on ABC transporters: possible contribution to refractory epilepsy
    1552. neuroinflammation%20on%20cognition.pdf”>Effect of neuroinflammation on cognition and potential mechanisms involved
    1553. Effect of neuroinflammation on Mitochondrial Quality Control Pathways in Parkinson’s Disease–Affected Neurons
    1554. Effect of neuroinflammation on synaptic organization and function in the developing brain: implications for neurodevelopmental and neurodegenerative …
    1555. Effect of Novel ERβ Agonist in Controlling neuroinflammation and Apoptosis in Cerebral Ischemia in Rat Model
    1556. Effect of Pluchea lanceolata bioactives in LPS-induced neuroinflammation in C6 rat glial cells
    1557. Effect of Q-VD-OPh on neurodegeneration and neuroinflammation of sarin-exposed mice (877.6)
    1558. Effect of simvastatin on neuroinflammation in microglial cells via mitogen-activated protein kinase and nuclear factor κB pathways
    1559. Effect of stress on neuroinflammation in the substantia nigra and striatum of LRRK2 (R1441G) mouse model for Parkinson’s disease
    1560. Effect of systemic inflammation on rat attentional function and neuroinflammation: Possible protective role for food restriction
    1561. Effect of the Broad-Spectrum Caspase Inhibitor Q-VD-OPh on Neurodegeneration and neuroinflammation of Sarin Exposed Mice
    1562. Effect of the Lipid Peroxidation Product 4-Hydroxynonenal on neuroinflammation in Microglial Cells: Protective Role of Quercetin and …
    1563. Effect of Toxoplasma gondii on altering dopaminelevels and neuroinflammation contributing to an increased risk of developingschizophrenia
    1564. Effect of TRPC6 knock-out on the mouse neuroinflammation induced by MPTP
    1565. Effect of valerenic acid on neuroinflammation in a MPTP-induced mouse model of Parkinson’s disease
    1566. neuroinflammation_in_Experimental_Spinal_Cord_Injury/links/5d08bbc5a6fdcc35c155f41a/Effect-of-Whartons-Jelly-Derived-Mesenchymal-Stem-Cells-on-the-Expression-of-NLRP3-Receptor-and-neuroinflammation-in-Experimental-Spinal-Cord-Injury.pdf”>Effect of Wharton’s Jelly Derived Mesenchymal Stem Cells on the Expression of NLRP3 Receptor and neuroinflammation in Experimental Spinal Cord Injury.
    1567. Effects of 900 MHz radiofrequency on corticosterone, emotional memory and neuroinflammation in middle-aged rats
    1568. Effects of a High-Fat Diet on neuroinflammation and Apoptosis in Acute Stage After Moderate Traumatic Brain Injury in Rats
    1569. Effects of a high-fat diet on the cerebrovasculature and neuroinflammation in an experimental model of Alzheimer’s disease
    1570. Effects of a standardized phenolic-enriched maple syrup extract on β-amyloid aggregation, neuroinflammation in microglial and neuronal cells, and β-amyloid induced …
    1571. Effects of active immunisation with myelin basic protein and myelin-derived altered peptide ligand on pain hypersensitivity and neuroinflammation
    1572. Effects of bexarotene on neuroinflammation in an ad mouse model
    1573. Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer’s disease
    1574. Effects of CDP-choline on macrophages and oligodendrocytes in neuroinflammation
    1575. Effects of chronic systemic treatment with peroxisome proliferator-activated receptor α activators on neuroinflammation induced by intracerebral injection of …
    1576. Effects of cigarette smoke on immunity, neuroinflammation and multiple sclerosis
    1577. Effects of Clinacanthus nutans leaf extract on lipopolysaccharide-induced neuroinflammation in rats: A behavioral and 1H NMR-based metabolomics study
    1578. Effects of curcumin on neuroinflammation in animal models and in patients with Alzheimer disease
    1579. Effects of curcumin on short-term spatial and recognition memory, adult neurogenesis and neuroinflammation in a streptozotocin-induced rat model of dementia of …
    1580. Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson’s …
    1581. Effects of estrogen on expression of P2X7 receptor and neuroinflammation after subarachnoid hemorrhage in rats
    1582. Effects of exercise on adolescent and adult hypothalamic and hippocampal neuroinflammation
    1583. Effects of glatiramer acetate in a spontaneous model of autoimmune neuroinflammation
    1584. EFFECTS OF GSK-3 INHIBITION ON LPS-INDUCED neuroinflammation AND IL-10 PRODUCTION IN MICROGLIA
    1585. Effects of human Adipose-derived Stem Cell and their secretome on neuropathic pain, neuroinflammation and peripheral cytokines in a preclinical model of diabetes
    1586. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-9-105″>Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer’s disease
    1587. neuroinflammation/E7FD461949EC62B6696A5898686D4AE5″>Effects of IDO1 and TDO2 inhibition on cognitive deficits and anxiety following LPS-induced neuroinflammation
    1588. Effects of intermittent alcohol exposure on emotion and cognition: a potential role for the endogenous cannabinoid system and neuroinflammation
    1589. Effects of leonurine on intracerebral haemorrhage by attenuation of perihematomal edema and neuroinflammation via the JNK pathway
    1590. Effects of levosimendan on hemodynamics, local cerebral blood flow, neuronal injury, and neuroinflammation after asphyctic cardiac arrest in rats
    1591. Effects of LPLI on microglial phagocytosis in LPS-induced neuroinflammation model
    1592. Effects of Macrophage Migration Inhibitory Factors'(MIF) Inhibition on Chronic neuroinflammation
    1593. Effects of Mild Traumatic Brain Injury on Ethanol Consumption and the Combined Effects on neuroinflammation, Cognition, and Behavior in Mice
    1594. Effects of nanoparticles on neuroinflammation in a mouse model of asthma
    1595. Effects of neuroinflammation on glia–glia gap junctional intercellular communication: a perspective
    1596. neuroinflammation_on_microcirculation.381.aspx”>Effects of neuroinflammation on microcirculation in the brain-Visualized by intravital microscopy: 7AP2–9
    1597. Effects of neuroinflammation on neural stem cells
    1598. Effects of neuroinflammation on the regenerative capacity of brain stem cells
    1599. Effects of neuroinflammation on vascular dysfunction in Alzheimer’s disease
    1600. Effects of Ocrelizumab on Neurofilament Light Chain and Other Biomarkers of neuroinflammation and Neurodegeneration in MS: OBOE Study Design (P6. 337)
    1601. Effects of oral dimethyl fumarate on intestinal immune regulation in autoimmune neuroinflammation (P1. 164)
    1602. Effects of oxytocin on fear memory and neuroinflammation in a rodent model of posttraumatic stress disorder
    1603. Effects of physical exercise on neuroinflammation, neuroplasticity, neurodegeneration, and behavior: what we can learn from animal models in clinical settings
    1604. Effects of prebiotic galacto-oligosaccharide on postoperative cognitive dysfunction and neuroinflammation through targeting of the gut-brain axis
    1605. Effects of Rhei Undulati Rhizoma on lipopolysaccharide‐induced neuroinflammation in vitro and in vivo
    1606. Effects of RO27-3225 on neurogenesis, PDGFRβ+ cells and neuroinflammation after cerebral infarction
    1607. Effects of S100B on serotonergic plasticity and neuroinflammation in the hippocampus in Down syndrome and Alzheimer’s disease: studies in an S100B …
    1608. Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to FTY720 during neuroinflammation
    1609. Effects of sucrose and high fructose corn syrup consumption on spatial memory function and hippocampal neuroinflammation in adolescent rats
    1610. Effects of syringic acid on chronic MPTP/probenecid induced motor dysfunction, dopaminergic markers expression and neuroinflammation in C57BL/6 mice
    1611. Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats …
    1612. Effects of the Saturated Fatty Acid Palmitate on neuroinflammation,ER Stress, and Pomc mRNA Expression in Hypothalamic mHypoA-POMC/GFPNeurons
    1613. EFFECTS OF TREATMENT WITH DOXYCYCLINE ON BEHAVIOR, neuroinflammation AND BRAIN PATHOLOGY IN THE RTG-4510 MOUSE MODEL
    1614. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1089-5″>Effects of umbilical cord blood cells, and subtypes, to reduce neuroinflammation following perinatal hypoxic-ischemic brain injury
    1615. Effects of α-lipoic acid on LPS-induced neuroinflammation and NLRP3 inflammasome activation through the regulation of BV-2 microglial cells activation
    1616. Efficacy of vitamin D in treating multiple sclerosis-like neuroinflammation depends on developmental stage
    1617. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0734-0?optIn=true”>EGFR transactivation contributes to neuroinflammation in Streptococcus suis meningitis
    1618. Electric stimulation of the vagus nerve reduced mouse neuroinflammation induced by lipopolysaccharide
    1619. Electro-acupuncture alleviates chronic unpredictable stress-induced depressive-and anxiety-like behavior and hippocampal neuroinflammation in rat model …
    1620. Electroacupunctre improves motor impairment via inhibition of microglia-mediated neuroinflammation in the sensorimotor cortex after ischemic stroke
    1621. Electroacupuncture alleviates postoperative cognitive dysfunction in aged rats by inhibiting hippocampal neuroinflammation activated via microglia/TLRs pathway
    1622. Electroacupuncture attenuated cerebral ischemic injury and neuroinflammation through α7nAChR-mediated inhibition of NLRP3 inflammasome in stroke rats
    1623. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1665-3″>Electroacupuncture attenuates cognition impairment via anti-neuroinflammation in an Alzheimer’s disease animal model
    1624. Electroacupuncture preconditioning and postconditioning inhibit apoptosis and neuroinflammation induced by spinal cord ischemia reperfusion injury through …
    1625. Electroacupuncture prevents cognitive impairment induced by lipopolysaccharide via inhibition of oxidative stress and neuroinflammation
    1626. Electroencephalography Findings in Autoimmune and neuroinflammation-Related Epilepsies
    1627. Elevated Brain MCP-1 Contributes to neuroinflammation in Hypertension
    1628. Elevated circulating TGFβ1 during acute liver failure activates TGFβR2 on cortical neurons and exacerbates neuroinflammation and hepatic encephalopathy …
    1629. Elevated microRNA-129-5p level ameliorates neuroinflammation and blood-spinal cord barrier damage after ischemia-reperfusion by inhibiting HMGB1 and …
    1630. Elevated Neuroglobin Lessens neuroinflammation and Alleviates Neurobehavioral Deficits Induced by Acute Inhalation of Combustion Smoke in the Mouse
    1631. Elevation of USP4 antagonizes oxygen glucose deprivation/reoxygenation-evoked microglia activation and neuroinflammation-mediated neurotoxicity via the …
    1632. Ellagic Acid Protects the Brain Against 6-Hydroxydopamine Induced neuroinflammation in a Rat Model of Parkinson’s
    1633. Ellagic acid protects the brain against 6-hydroxydopamine induced neuroinflammation in a rat model of Parkinson’s disease
    1634. Elucidating the link between the modifiable risk factors of Alzheimer’s disease and neuroinflammation
    1635. Elucidation of relevant neuroinflammation mechanisms using gene expression profiling in patients with amyotrophic lateral sclerosis
    1636. Emerging CSF biomarkers of neuroinflammation, neuronal injury and synaptic integrity in the ADNI cohort
    1637. Emerging PET radiotracers and targets for imaging of neuroinflammation in neurodegenerative diseases: outlook beyond TSPO
    1638. Emerging role of diet and microbiota interactions in neuroinflammation
    1639. neuroinflammation/F05306C0BDCE1C7D9A956B5A76DCAC7F”>Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation
    1640. Emerging roles of protein kinases in microglia-mediated neuroinflammation
    1641. Emerging targets in neuroinflammation-driven chronic pain
    1642. Endocannabinoid degradation inhibition improves neurobehavioral function, blood–brain barrier integrity, and neuroinflammation following mild traumatic brain injury
    1643. Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation
    1644. Endocannabinoid modulation of TLR4-induced neuroinflammation: implications for autism spectrum disorders
    1645. Endocannabinoid regulation of amyloid-induced neuroinflammation
    1646. Endocrine influence on neuroinflammation: the use of reporter systems
    1647. Endogenous hydrogen sulphide attenuates NLRP3 inflammasome-mediated neuroinflammation by suppressing the P2X7 receptor after intracerebral …
    1648. Endogenous sex steroids dampen neuroinflammation and improve outcome of traumatic brain injury in mice
    1649. Endoplasmic Reticulum Stress and neuroinflammation in the RVLM: A Novel Mechanism Related to Sympathoexcitation in Preserved Ejection Fraction Heart Failure
    1650. Endoplasmic Reticulum Stress Contributes to Nociception via neuroinflammation in a Murine Bone Cancer Pain Model.
    1651. Endoplasmic reticulum stress induction by an endogenous retrovirus glycoprotein during neuroinflammation: regulation by a free radical scavenger
    1652. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0987-2″>Endothelial α6β4 integrin protects during experimental autoimmune encephalomyelitis-induced neuroinflammation by maintaining vascular integrity and tight …
    1653. Endothelin and Endothelin Receptors in Retinal neuroinflammation
    1654. Endotoxin-and ATP-neutralizing activity of alkaline phosphatase as a strategy to limit neuroinflammation
    1655. Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation
    1656. Enhanced network activity despite clinical recovery in experimental neuroinflammation using two-photon calcium imaging
    1657. neuroinflammation_and_oxidative_stress.8.aspx”>Enhanced neuroinflammation and oxidative stress are associated with altered hippocampal neurogenesis in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine treated …
    1658. Enhanced neuroinflammation and pain hypersensitivity after peripheral nerve injury in rats expressing mutated superoxide dismutase 1
    1659. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0782-5″>Enhanced neuroinflammation mediated by DNA methylation of the glucocorticoid receptor triggers cognitive dysfunction after sevoflurane anesthesia in adult …
    1660. Enhanced neuroprotection of anthocyanin-loaded PEG-gold nanoparticles against Aβ1-42-induced neuroinflammation and neurodegeneration via the NF-KB/JNK …
    1661. Enhanced susceptibility of S‐100B transgenic mice to neuroinflammation and neuronal dysfunction induced by intracerebroventricular infusion of human β‐amyloid
    1662. Enlarged Perivascular Spaces Correlate With CSF Biomarkers for Abnormal Blood-brain Barrier Permeability and neuroinflammation in Patients With Vascular …
    1663. Enteric neuroinflammation Driven by Exposure to Pyridostigmine Bromide is a Possible Contributing Factor to Gulf War Illness
    1664. Environmental enrichment attenuates hippocampal neuroinflammation and improves cognitive function during influenza infection
    1665. Environmental enrichment potently prevents microglia-mediated neuroinflammation by human amyloid β-protein oligomers
    1666. Enzyme Selective Flim in Microglia: Studying the Role of NADPH Oxidase in Chronic neuroinflammation
    1667. Eomes-expressing T-helper cells as potential target of therapy in chronic neuroinflammation
    1668. Eomesodermin-expressing T-helper cells are essential for chronic neuroinflammation
    1669. Ephedra-Cinnamomi Attenuates Cerebral Ischemia-Induced neuroinflammation via TLR4/NF-κB Pathway
    1670. Epigenetic and pharmacological targeting of neuroinflammation as novel therapeutic interventions for epilepsy
    1671. Epigenetic modifications associated to neuroinflammation and neuropathic pain after neural trauma
    1672. Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration
    1673. Epigenetic regulation of neuroinflammation in the aged mouse brain
    1674. Epigenetics and the modulation of neuroinflammation
    1675. Epilepsy: neuroinflammation, neurodegeneration, and APOE genotype
    1676. Epstein–Barr virus-induced gene 3 negatively regulates neuroinflammation and T cell activation following coronavirus-induced encephalomyelitis
    1677. ER stress and neuroinflammation: connecting the unfolded protein response to JAK/STAT signaling (P5196)
    1678. ER stress: an initiator of neuroinflammation in Alzheimer’s disease?
    1679. Erigeron linifolius attenuates lipopolysachharide-induced depressive-like behavior in mice by impeding neuroinflammation, oxido-nitrosative stress, and …
    1680. Eriodictyol attenuates LPS-induced neuroinflammation, amyloidogenesis, and cognitive impairments via the inhibition of NF-κB in male C57BL/6J mice and BV2 …
    1681. Erratum to “Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults”[Alzheimer’s & Dementia 2018; 14: 1640-50.]
    1682. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0593-8″>Erratum to: A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury
    1683. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-015-0430-5″>Erratum to: A role for human brain pericytes in neuroinflammation
    1684. neuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-015-0321-9″>Erratum to: Insulin improves memory and reduces chronic neuroinflammation in the hippocampus of young but not aged brains
    1685. Erratum to: MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal …
    1686. Erratum to: Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat
    1687. Erratum: Corrigendum to “Parkinson’s disease: Autoimmunity and neuroinflammation”(Autoimmunity Reviews (2016) 15 (10)(1005–1011)(S1568997216301677) …
    1688. Erratum: Corrigendum: Toll-like receptor 2 and poly (ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE
    1689. Erratum: REAC technology modifies pathological neuroinflammation and motor behaviour in an Alzheimer’s disease mouse model
    1690. Erratum: USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammation
    1691. Eruca sativa seed extract: A novel natural product able to counteract neuroinflammation
    1692. Erythrocytes’ antioxidative capacity as a potential marker of oxidative stress intensity in neuroinflammation
    1693. Erythropoietin ameliorates neonatal hypoxia-ischemia-induced neurobehavioral deficits, neuroinflammation, and hippocampal injury in the juvenile rat
    1694. Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis
    1695. Erythropoietin and CCL3 antagonise their functional properties during neuroinflammation
    1696. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-10-156″>Erythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and …
    1697. Esculentoside A suppresses Aβ1–42-induced neuroinflammation by down-regulating MAPKs pathways in vivo
    1698. ESE1 is associated with neuronal apoptosis in lipopolysaccharide induced neuroinflammation
    1699. Essay: TNF in neuroinflammation; what can be learned from TNF research in non-neuronal autoimmune diseases
    1700. Estradiol inhibits astrocytic GFAP expression in an animal model of neuroinflammation.
    1701. Estradiol inhibits ongoing autoimmune neuroinflammation and NFκB-dependent CCL2 expression in reactive astrocytes
    1702. Estrogen and neuroinflammation
    1703. Estrogen deficiency exacerbates Aβ-induced memory impairment through enhancement of neuroinflammation, amyloidogenesis and NF-ĸB activation in …
    1704. Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration
    1705. Estrogen-dependent modulation of neuroinflammation in endometriosis
    1706. Estrogen, neuroinflammation and neuroprotection in Parkinson’s disease: glia dictates resistance versus vulnerability to neurodegeneration
    1707. Estrogen, neuroinflammation and neuroprotection in Parkinson’s disease: key role of neuron-glia crosstalk
    1708. neuroinflammation&ots=3lt36ZOC2i&sig=iTPAzZZ4WIFT5nywvWTRlFIdGbg”>Estrogenic Regulation of Glia and neuroinflammation
    1709. Estrogens, neuroinflammation, and neurodegeneration
    1710. Etanercept reduces neuroinflammation and lethality in mouse model of Japanese encephalitis
    1711. Etanercept restores the antinociceptive effect of morphine and suppresses spinal neuroinflammation in morphine-tolerant rats
    1712. Etazolate, an α-secretase activator, reduces neuroinflammation and offers persistent neuroprotection following traumatic brain injury in mice
    1713. Ethanol Exposure Induces Microglia Activation and neuroinflammation through TLR4 Activation and SENP6 Modulation in the Adolescent Rat Hippocampus
    1714. Ethanol extract of Bupleurum falcatum and saikosaponins inhibit neuroinflammation via inhibition of NF-κB
    1715. Ethanol extract of Scutellaria baicalensis Georgi prevents oxidative damage and neuroinflammation and memorial impairments in artificial senescense mice
    1716. Ethanol induced modulation of microglial P2X7 receptor expression and its role in neuroinflammation
    1717. Ethyl-acetate fraction of Trichilia catigua protects against oxidative stress and neuroinflammation after cerebral ischemia/reperfusion
    1718. Etidronate–zinc Complex Ameliorated Cognitive and Synaptic Plasticity Impairments in 2-Vessel Occlusion Model Rats by Reducing neuroinflammation
    1719. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0687-3″>Etifoxine improves sensorimotor deficits and reduces glial activation, neuronal degeneration, and neuroinflammation in a rat model of traumatic brain injury
    1720. Etiology is the key determinant of neuroinflammation in epilepsy: Elevation of cerebrospinal fluid cytokines and chemokines in febrile infection‐related epilepsy …
    1721. Euflammation attenuates peripheral inflammation-induced neuroinflammation and mitigates immune-to-brain signaling
    1722. Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis–osteopontin as a potential marker of clinical severity
    1723. Evaluating white matter changes and executive function in rat models of mediodorsal thalamic stroke and neuroinflammation
    1724. Evaluation of [11C]-DAA1106 for imaging and quantification of neuroinflammation in a rat model of herpes encephalitis
    1725. Evaluation of [123I]-CLINDE as a potent SPECT radiotracer to assess the degree of astroglia activation in cuprizone-induced neuroinflammation
    1726. Evaluation of [18F] DPA-716 in a rat model of neuroinflammation: Comparison with [11C] DPA-713 and [18F] DPA-714 radiotracer for the TSPO 18 kDa
    1727. Evaluation of [18F] PBR111 in a rat model of neuroinflammation: A new radiotracer for the TSPO 18 kDa (peripheral benzodiazepine receptor)
    1728. Evaluation of a novel positron emission tomographic radioligand to measure cyclooxygenase-2 in a model of neuroinflammation in rhesus macaque
    1729. Evaluation Of Anti-Inflammatory Nutraceuticals In Lps-Induced Mouse neuroinflammation Model: An Update.
    1730. Evaluation of Antiinflammatory Activity of 4′-О-Methylhonokiol Derivatives in a neuroinflammation Model
    1731. Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation
    1732. Evaluation of neuroinflammation in amyotrophic lateral sclerosis with 18F-DPA-714
    1733. Evaluation of neuroinflammation in experimental autoimmune encephalomyelitis (EAE) mice with animal PET and MRI
    1734. Evaluation of neuroinflammation in X-linked adrenoleukodystrophy
    1735. Evaluation of neuroprotective activity of carvacrol against neuroinflammation induced by chronic stress in mice
    1736. Evaluation of nigrostriatal neurodegeneration and neuroinflammation following repeated intranasal 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) …
    1737. Evaluation of Novel PET ligands for Imaging neuroinflammation
    1738. Evaluation of Some Medicinal Plant Extracts against neuroinflammation Characterizing Alzheimer’s Disease in Experimental Rat Model
    1739. Evaluation of the effects of chlorpyrifos combined with lipopolysaccharide stress on neuroinflammation and spatial memory in neonatal rats
    1740. Everolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures
    1741. Evidence for neuroinflammation after myocardial infarction in a mouse model
    1742. Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy
    1743. Evidence for neuroinflammation in Alzheimer’s disease
    1744. Evidence of both systemic inflammation and neuroinflammation in fibromyalgia patients, as assessed by a multiplex protein panel applied to the cerebrospinal …
    1745. Evidence of diffuse cerebellar neuroinflammation in multiple sclerosis by 11C-PBR28 MR-PET
    1746. Evidence of neuroinflammation in subgroups of schizophrenia and mood disorder patients: a semiquantitative postmortem study of CD3 and CD20 immunoreactive …
    1747. EVIDENCE OF neuroinflammation IN THE RETINA IN PRESYMPTOMATIC ALZHEIMER’S DISEASE
    1748. Evidence of the impact of systemic inflammation on neuroinflammation from a non-bacterial endotoxin animal model
    1749. Evidence that erythropoietin modulates neuroinflammation through differential action on neurons, astrocytes, and microglia
    1750. Exacerbation of autoimmune neuroinflammation by dietary sodium is genetically controlled and sex specific
    1751. Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system
    1752. Examining the Role of Gut Dysbiosis in neuroinflammation and Hypertension in a Model of Obstructive Sleep Apnea
    1753. Examining the role of neuroinflammation in major depression
    1754. Excess administration of miR-340-5p ameliorates spinal cord injury-induced neuroinflammation and apoptosis by modulating the P38-MAPK signaling pathway
    1755. Excitotoxicity, neuroinflammation and oxidant stress as molecular bases of epileptogenesis and epilepsy-derived neurodegeneration: The role of vitamin E
    1756. Exendin-4 attenuates pain-induced cognitive impairment by alleviating hippocampal neuroinflammation in a rat model of spinal nerve ligation
    1757. Exercise and neuroinflammation in health and disease
    1758. Exercise prevents enhanced postoperative neuroinflammation and cognitive decline and rectifies the gut microbiome in a rat model of metabolic syndrome
    1759. Exercise-induced modulation of neuroinflammation in models of Alzheimer’s disease
    1760. Exogenous melatonin restrains neuroinflammation in high fat diet induced diabetic rats through attenuating indoleamine 2, 3-dioxygenase 1 expression
    1761. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-11-68″>Exosomes as mediators of neuroinflammation
    1762. Exosomes as mediators of neuron-glia communication in neuroinflammation
    1763. Exosomes derived from umbilical cord mesenchymal stem cells reduce microglia-mediated neuroinflammation in perinatal brain injury
    1764. Exosomes Isolated From Human Umbilical Cord Mesenchymal Stem Cells Alleviate neuroinflammation and Reduce Amyloid-Beta Deposition by Modulating …
    1765. Experimental and clinical evidence for the protective role of progesterone in motoneuron degeneration and neuroinflammation
    1766. EXPERIMENTAL INTESTINAL DYSBIOSIS IN RATS INCREASES THE PERMEABILITY OF THE BLOOD-BRAIN BARRIER AND INDUCES neuroinflammation
    1767. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1481-9″>Experimental necrotizing enterocolitis induces neuroinflammation in the neonatal brain
    1768. Experimental neuroinflammation: a focus on mitochondria, oxygen and function
    1769. Experimental neuroinflammation: a study of hypoxia and protein translation
    1770. Experimental Pulmonary Hypertension Is Associated With neuroinflammation in the Spinal Cord
    1771. Exploration of Novel Ureidobenzothiazole Library Against neuroinflammation
    1772. Exploring COX-2 as a biomarker of microglia-dependent neuroinflammation
    1773. Exploring Glial Marker Activation and neuroinflammation in Schizophrenia: A multimodal Approach
    1774. Exploring neuroinflammation as a potential avenue to improve the clinical efficacy of opioids
    1775. Exploring the Effects of neuroinflammation on Microglial Cytoskeletal Proteins
    1776. Exploring the neuroprotective function of extracellular vesicles containing small heat-shock proteins (HSPB1 and HSPB8) upon neuroinflammation
    1777. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-015-0382-9″>Exposure of neonatal rats to alcohol has differential effects on neuroinflammation and neuronal survival in the cerebellum and hippocampus
    1778. Exposure to a polluted urban environment and to chronic low doses of lipopolysaccharides produces neuroinflammation in mice, and is ameliorated by dark chocolate
    1779. Exposure to formaldehyde and diisononyl phthalate exacerbate neuroinflammation through NF-κB activation in a mouse asthma model
    1780. Exposure to gestational diabetes mellitus induces neuroinflammation, derangement of hippocampal neurons, and cognitive changes in rat offspring
    1781. Exposure to inflammatory cytokines IL-1β and TNFα induces compromise and death of astrocytes; implications for chronic neuroinflammation
    1782. Exposure to Inhalational Anaesthetics Causes neuroinflammation
    1783. Exposure to nanoscale diesel exhaust particles: Oxidative stress, neuroinflammation, anxiety and depression on adult male mice
    1784. Exposure to nerve agents: from status epilepticus to neuroinflammation, brain damage, neurogenesis and epilepsy
    1785. Expression of Ccl11 associates with immune response modulation and protection against neuroinflammation in rats
    1786. Expression of CD300lf by microglia contributes to resistance to cerebral malaria by impeding the neuroinflammation
    1787. Expression of metallothionein-I,-II, and-III in Alzheimer disease and animal models of neuroinflammation
    1788. Expression profile of Japanese encephalitis virus induced neuroinflammation and its implication in disease severity
    1789. Extinguishing neuroinflammation
    1790. Extracellular HSP70, neuroinflammation and Protection Against Viral Virulence
    1791. Extracellular interactions of alpha-synuclein with astrocytes and microglia linked to neuroinflammation and spread in multiple system atrophy
    1792. Extracellular matrix-degrading metalloproteinases and neuroinflammation in stroke
    1793. Extracellular vesicles containing IL-4 modulate neuroinflammation in a mouse model of multiple sclerosis
    1794. Extracellular vesicles from mesenchymal stem cells reduce microglial-mediated neuroinflammation after cortical injury in aged Rhesus monkeys
    1795. Extract of Fructus Schisandrae chinensis Inhibits neuroinflammation Mediator Production from Microglia via NF-κ B and MAPK Pathways
    1796. Extracts from Dendropanax morbifera Leaves Have Modulatory Effects on neuroinflammation in Microglia
    1797. Extrapituitary prolactin promotes generation of Eomes-positive helper T cells mediating neuroinflammation
    1798. Ezetimibe Attenuates Oxidative Stress and neuroinflammation via the AMPK/Nrf2/TXNIP Pathway after MCAO in Rats
    1799. EZH2 regulates spinal neuroinflammation in rats with neuropathic pain
    1800. neuroinflammation.40.aspx”>F-002 CYCLOOXYGENASE-2-DEPENDENT neuroinflammation AND OXIDATIVE STRESS IN ROSTRAL VENTROLATERAL MEDULLA CONTRIBUTE TO …
    1801. F235. DIFFERENTIAL EFFECTS OF ANTIPSYCHOTICS ON neuroinflammation AND ENERGY SENSING IN A HYPOTHALAMIC CELL LINE
    1802. FAAH-mediated modulation of TLR3-induced neuroinflammation in the rat hippocampus
    1803. Facile synthesis of carbon-11-labeled sEH/PDE4 dual inhibitors as new potential PET agents for imaging of sEH/PDE4 enzymes in neuroinflammation
    1804. Fast direct neuronal signaling via the IL-4 receptor as therapeutic target in neuroinflammation
    1805. Fatal neuroinflammation in a case of multiple sclerosis with anti-natalizumab antibodies
    1806. Fatigue sensation following peripheral viral infection is triggered by neuroinflammation: who will answer these questions?
    1807. Fatty acid and lipid profiles in models of neuroinflammation and mood disorders: application of high field NMR, gas chromotography and liquid chromotography …
    1808. Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity
    1809. FEATURES OF neuroinflammation IN TRANSGENIC RAT EXPRESSING MISFOLDED TAU PROTEIN VARY WITH GENETIC BACKGROUND AND INFLUENCE …
    1810. Ferumoxytol nanoparticle uptake in brain during acute neuroinflammation is cell-specific
    1811. FGF21 Protects Dopaminergic Neurons in Parkinson’s Disease Models Via Repression of neuroinflammation
    1812. Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer’s disease
    1813. Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration
    1814. Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation
    1815. Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation
    1816. Fibroblast growth factor 2 modulates hippocampal microglia activation in a neuroinflammation induced model of depression
    1817. Fighting Chronic neuroinflammation by Boosting Autoimmunity: The Distinction Between Neurodegenerative Diseases and Multiple Sclerosis
    1818. Finding our way through the ‘neuroinflammation‘fog
    1819. Finding the’ubiquitous’ threads in infection and autoimmune neuroinflammation
    1820. Fine-mapping resolves Eae23 into two QTLs and implicates ZEB1 as a candidate gene regulating experimental neuroinflammation in rat
    1821. Fingolimod (FTY720) attenuates social deficits, learning and memory impairments, neuronal loss and neuroinflammation in the rat model of autism
    1822. Fingolimod (FTY720) inhibits neuroinflammation and attenuates spontaneous convulsions in lithium-pilocarpine induced status epilepticus in rat model
    1823. Fingolimod effects in neuroinflammation: Regulation of astroglial glutamate transporters?
    1824. Fingolimod up-regulates BDNF expression within the CNS and Down-regulates tissue pathology in a pre-clinical model of chronic neuroinflammation (P1. 159)
    1825. neuroinflammation_manuscript_docx/7819991/1″>Finnell et al LC-NE neuroinflammation manuscript. docx
    1826. Fisetin improves lead-induced neuroinflammation, apoptosis and synaptic dysfunction in mice associated with the AMPK/SIRT1 and autophagy pathway
    1827. Fisetin nanoparticles protect against PM2. 5 exposure-induced neuroinflammation by down-regulation of astrocytes activation related NF-κB signaling …
    1828. Fisetin protects against intracerebral hemorrhage-induced neuroinflammation in aged mice
    1829. Fish oil prevents lipopolysaccharide-induced depressive-like behavior by inhibiting neuroinflammation
    1830. Fish oil supplementation attenuates neuroinflammation and alleviates depressive-like behavior in rats submitted to repeated lipopolysaccharide
    1831. Fish oil–rich lipid emulsion modulates neuroinflammation and prevents long-term cognitive dysfunction after sepsis
    1832. FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an α-synuclein-based rat model for Parkinson’s disease
    1833. Flavonoid-Rich Ethanol Extract from the Leaves of Diospyros kaki Attenuates D-Galactose-Induced Oxidative Stress and neuroinflammation-Mediated Brain Aging in …
    1834. Flavonoids have modulatory effects on neuroinflammation in microglia
    1835. FLUID BIOMARKERS OF neuroinflammation
    1836. Fluoride induces neuroinflammation and alters Wnt signaling pathway in BV2 microglial cells
    1837. Fluoxetine attenuates neuroinflammation in early brain injury after subarachnoid hemorrhage: a possible role for the regulation of TLR4/MyD88/NF-κB …
    1838. FLZ attenuates learning and memory deficits via suppressing neuroinflammation induced by LPS in mice
    1839. Focusing on the Mitochondrial Expression of TSPO as a Marker and Promoter of neuroinflammation
    1840. Follistatin-like protein 1 suppressed pro-inflammatory cytokines expression during neuroinflammation induced by lipopolysaccharide
    1841. Forced Wakefulness Enhances neuroinflammation in Postoperative Mice
    1842. Formononetin Ameliorates Cognitive Disorder via PGC-1α Pathway in neuroinflammation Conditions in High-Fat Diet-Induced Mice
    1843. Formononetin inhibits neuroinflammation and increases estrogen receptor beta (ERβ) protein expression in BV2 microglia
    1844. Forsythiae fructus and its active component, arctigenin, provide neuroprotection by inhibiting neuroinflammation
    1845. Foxo3 controls CD4 T cells differentiation and severity to neuroinflammation (IRM15P. 604)
    1846. neuroinflammation-selective-agonists-with-synergistic-anti-oxidative-and-pro-resolving-effects”>Fpr2 and neuroinflammation: selective agonists with synergistic anti-oxidative and pro-resolving effects
    1847. Fractalkine Expression Is Suppressed During Hepatic Encephalopathy in Mice and Promotes neuroinflammation: 2495
    1848. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0674-8″>Fractalkine suppression during hepatic encephalopathy promotes neuroinflammation in mice
    1849. Fractionated whole brain radiation-induced behavioral changes in athymic nude mice is associated with sustained neuroinflammation and microglial M1-phenotype
    1850. Fragmented sleep enhances postoperative neuroinflammation but not cognitive dysfunction
    1851. Fragmented Sleep Enhances Postoperative neuroinflammation but Not Cognitive Dysfunction: Really?
    1852. neuroinflammation&ots=khsnwI4cF2&sig=-vfqXQzQvo-2tvxTzEjGNAo0Exs”>From adolescence to late aging: A comprehensive review of social behavior, alcohol, and neuroinflammation across the lifespan.
    1853. From classic aspects of the stress response to neuroinflammation and sickness: implications for individuals and offspring
    1854. From molecules to neural morphology: understanding neuroinflammation in autism spectrum condition
    1855. From systemic inflammation to neuroinflammation: the case of neurolupus
    1856. From the “little brain” gastrointestinal infection to the “big brain” neuroinflammation: a proposed fast axonal transport pathway involved in multiple sclerosis
    1857. Fructose-derived advanced glycation end products (AGEs) enhance neuroinflammation and alter immune function in the brain
    1858. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-015-0308-6″>FTY720 attenuates excitotoxicity and neuroinflammation
    1859. FTY720-Mitoxy reduces synucleinopathy and neuroinflammation, restores behavior and mitochondria function, and increases GDNF expression in Multiple …
    1860. Full Recovery From Cocaine-Induced Toxic Leukoencephalopathy: Emphasizing the Role of neuroinflammation and Brain Edema
    1861. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
    1862. Function of Protein Kinase CK2 in Innate Immune Cells in neuroinflammation
    1863. Functional aspects of redox control during neuroinflammation
    1864. Functional polarization of neuroglia: implications in neuroinflammation and neurological disorders
    1865. Functions and mechanisms of microglia/macrophages in neuroinflammation and neurogenesis after stroke
    1866. Funding free and universal access to Journal of neuroinflammation
    1867. Furanodien-6-one from Commiphora erythraea inhibits the NF-κB signalling and attenuates LPS-induced neuroinflammation
    1868. Future Perspectives: New Strategies for Antagonism of Excitotoxicity, Oxidative Stress and neuroinflammation in Neurodegenerative Diseases
    1869. G-CSF attenuates neuroinflammation and stabilizes the blood–brain barrier via the PI3K/Akt/GSK-3β signaling pathway following neonatal hypoxia-ischemia in rats
    1870. G2019s LRRK2 promotes mitochondrial fission and increases TNFα-mediated neuroinflammation responses
    1871. GABA transport and neuroinflammation are coupled in multiple sclerosis: regulation of the GABA transporter-2 by ganaxolone
    1872. GABAB receptor mediate hippocampal neuroinflammation in adolescent male and female mice after cold expose
    1873. GABAergic/glutamatergic imbalance relative to excessive neuroinflammation in autism spectrum disorders
    1874. Gabrb2 knockout mice displayed schizophrenia-like and comorbid phenotypes with GABAergic interneuron-astrocyte-microglia dysregulation and neuroinflammation
    1875. Gadofluorine M-enhanced MRI shows involvement of circumventricular organs in neuroinflammation
    1876. Gal-3 is a potential biomarker for spinal cord injury and Gal-3 deficiency attenuates neuroinflammation through ROS/TXNIP/NLRP3 signaling pathway
    1877. Galectin-1 reduces neuroinflammation via modulation of nitric oxide-arginase signaling in HIV-1 transfected microglia: a gold nanoparticle-Galectin-1 “Nanoplex” a …
    1878. Galectin-1 suppresses methamphetamine induced neuroinflammation in human brain microvascular endothelial cells: neuroprotective role in maintaining blood brain …
    1879. Galectins and neuroinflammation
    1880. Gallic Acid Attenuated LPS-Induced neuroinflammation: Protein Aggregation and Necroptosis
    1881. Gallic acid, a histone acetyltransferase inhibitor, suppresses β‐amyloid neurotoxicity by inhibiting microglial‐mediated neuroinflammation
    1882. Gamisoyo-San Ameliorates neuroinflammation in the Spinal Cord of hSOD1G93A Transgenic Mice
    1883. Gamma Visual Stimulation Induces a Neuroimmune Signaling Profile Distinct from Acute neuroinflammation
    1884. Gamma-linolenic acid ameliorates Aβ-induced neuroinflammation through NF-κB and MAPK signalling pathways
    1885. Garcinia kola seeds may prevent cognitive and motor dysfunctions in a type 1 diabetes mellitus rat model partly by mitigating neuroinflammation
    1886. Gasdermin D in peripheral myeloid cells drives neuroinflammation in experimental autoimmune encephalomyelitis
    1887. Gastrodin attenuates neuroinflammation in DOI‐induce Tourette syndrome in rats
    1888. Gastrodin inhibits neuroinflammation in rotenone-induced Parkinson’s disease model rats
    1889. Gastrodin protects retinal ganglion cells through inhibiting microglial-mediated neuroinflammation in an acute ocular hypertension model
    1890. Gatekeeper role of brain antigen‐presenting CD11c+ cells in neuroinflammation
    1891. Gender-specific brain regional variation of neurons, endogenous estrogen, neuroinflammation and glial cells during rotenone-induced mouse model of Parkinson’s …
    1892. Gene therapy with mesenchymal stem cells expressing IFN‐ß ameliorates neuroinflammation in experimental models of multiple sclerosis
    1893. General control non-derepressible 2 (GCN2) in T cells controls disease progression of autoimmune neuroinflammation
    1894. General physiology and pathophysiology of microglia during neuroinflammation
    1895. Generation of neuroinflammation in human African trypanosomiasis
    1896. Genetic and Immunological Regulation of neuroinflammation
    1897. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-7-64″>Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for …
    1898. Genetic background modulates outcome of therapeutic amyloid peptides in treatment of neuroinflammation
    1899. Genetic deletion of galectin-3 enhances neuroinflammation, affects microglial activation and contributes to sub-chronic injury in experimental neonatal focal stroke
    1900. Genetic knockout of myosin light chain kinase (MLCK210) prevents cerebral microhemorrhages and attenuates neuroinflammation in a mouse model of …
    1901. Genetic regulation of autoimmune neuroinflammation
    1902. Genetic regulation of autoimmunity in experimental neuroinflammation
    1903. Genetic regulation of neuroinflammation after infection and injury
    1904. Genetic suppression of IKK2/NF-κB in astrocytes inhibits neuroinflammation and reduces neuronal loss in the MPTP-Probenecid model of Parkinson’s disease
    1905. Genetic variability commonly affecting neurodegeneration and neuroinflammation
    1906. Genetically engineered resveratrol-enriched rice inhibits neuroinflammation in lipopolysaccharide-activated BV2 microglia via downregulating mitogen-activated …
    1907. Genetics of autoimmune neuroinflammation
    1908. Genetics of neuroinflammation in Alzheimer disease
    1909. Genetics of rat neuroinflammation
    1910. Geniposidic acid ameliorates spatial learning and memory deficits and alleviates neuroinflammation via inhibiting HMGB-1 and downregulating TLR4/2 signaling …
    1911. Genistein alleviates neuroinflammation and restores cognitive function in rat model of hepatic encephalopathy: underlying mechanisms
    1912. Gestational Diabetes Mellitus Induces neuroinflammation, Synaptic Reduction, Behavioural Changes, and Impaired Memory in the Offspring.
    1913. Gestational intermittent hypoxia increases susceptibility to neuroinflammation and alters respiratory motor control in neonatal rats
    1914. Gestational intermittent hypoxia induces neuroinflammation and impairs compensatory respiratory plasticity in adult offspring
    1915. Ghrelin attenuates neuroinflammation and demyelination in experimental autoimmune encephalomyelitis involving NLRP3 inflammasome signaling pathway and …
    1916. neuroinflammation/”>Ghrelin: Friend or Foe for neuroinflammation?
    1917. Ginger Extract Reduces Chronic Morphine-Induced neuroinflammation and Glial Activation in Nucleus Accumbens of Rats
    1918. Ginkgetin aglycone attenuates neuroinflammation and neuronal injury in the rats with ischemic stroke by modulating STAT3/JAK2/SIRT1
    1919. Ginkgo biloba L. extract protects against chronic cerebral hypoperfusion by modulating neuroinflammation and the cholinergic system
    1920. Ginsenoside Rb1 Attenuates Isoflurane/surgery-induced Cognitive Dysfunction via Inhibiting neuroinflammation and Oxidative Stress
    1921. Ginsenoside Rd attenuates neuroinflammation of dopaminergic cells in culture
    1922. Ginsenoside Re attenuates neuroinflammation in a symptomatic ALS animal model
    1923. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model
    1924. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein …
    1925. Ginsenoside Rg1 attenuates neuroinflammation following systemic lipopolysaccharide treatment in mice
    1926. Ginsenoside Rg1 prevents chemotherapy-induced cognitive impairment: associations with microglia-mediated cytokines, neuroinflammation, and neuroplasticity
    1927. Ginsenoside Rg18 suppresses lipopolysaccharide-induced neuroinflammation in BV2 microglia and amyloid-β-induced oxidative stress in SH-SY5Y neurons via …
    1928. Ginsenoside Rg3 and Rh2 protect trimethyltin‐induced neurotoxicity via prevention on neuronal apoptosis and neuroinflammation
    1929. Glia as a link between neuroinflammation and neuropathic pain
    1930. Glia maturation factor and mast cell-dependent expression of inflammatory mediators and proteinase activated receptor-2 in neuroinflammation
    1931. Glia maturation factor-β: a potential therapeutic target in neurodegeneration and neuroinflammation
    1932. Glia-mediated retinal neuroinflammation as a biomarker in Alzheimer’s disease
    1933. Glia-neuron sandwich cocultures: an in vitro approach to evaluate cell-to-cell communication in neuroinflammation and neurotoxicity
    1934. Glial activation and synaptic neurotoxicity in Alzheimer’s disease: a focus on neuroinflammation
    1935. neuroinflammation-how-they-cause-centralized-pain?page=0,1″>Glial cell activation and neuroinflammation: How they cause centralized pain
    1936. Glial cell diversity and methamphetamine-induced neuroinflammation in human cerebral organoids
    1937. Glial communication via gap junction in neuroinflammation
    1938. Glial epigenetics in neuroinflammation and neurodegeneration
    1939. Glibenclamide mitigates cognitive impairment and hippocampal neuroinflammation in rats with type 2 diabetes and sporadic Alzheimer-like disease
    1940. Glimepiride prevents paraquat‐induced Parkinsonism in mice: involvement of oxidative stress and neuroinflammation
    1941. Gliotoxin Aggravates Experimental Autoimmune Encephalomyelitis by Triggering neuroinflammation
    1942. Global and 3D spatial assessment of neuroinflammation in rodent models of multiple sclerosis
    1943. Global neuroinflammation patterns in experimental neonatal hydrocephalus
    1944. Glucagon-like peptide-1 suppresses neuroinflammation and improves neural structure
    1945. Glucagon‐like peptide‐1 protects synaptic and learning functions from neuroinflammation in rodents
    1946. Glucocorticoid induced leucine zipper in lipopolysaccharide induced neuroinflammation
    1947. Glucocorticoid induced leucine zipper is inversely related with neuroinflammation in the brain
    1948. GLUCOCORTICOID-INDUCED LEUCINE ZIPPER ANALOGS SUPPRESS neuroinflammation IN ALZHEIMER’S DISEASE
    1949. Glucocorticoids in the control of neuroinflammation
    1950. Glucose-dependent insulinotropic polypeptide ameliorates mild traumatic brain injury-induced cognitive and sensorimotor deficits and neuroinflammation in rats
    1951. Glutamate release from astrocytes in physiological conditions and in neurodegenerative disorders characterized by neuroinflammation
    1952. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1120-x”>Glutaminase 1 regulates the release of extracellular vesicles during neuroinflammation through key metabolic intermediate alpha-ketoglutarate
    1953. Glutaminase C overexpression in the brain induces learning deficits, synaptic dysfunctions, and neuroinflammation in mice
    1954. Glutaminyl cyclases: enzyme targets to treat Alzheimer’s disease and neuroinflammation
    1955. Glutathione depletion: Starting point of brain metabolic stress, neuroinflammation and cognitive impairment in rats
    1956. Glycine inhibits ethanol-induced oxidative stress, neuroinflammation and apoptotic neurodegeneration in postnatal rat brain
    1957. Glycyrrhizic acid attenuates neuroinflammation and oxidative stress in rotenone model of Parkinson’s disease
    1958. Glycyrrhizin alleviates neuroinflammation and memory deficit induced by systemic lipopolysaccharide treatment in mice
    1959. GM-CSF in neuroinflammation: licensing myeloid cells for tissue damage
    1960. GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts
    1961. GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early-onset Tay-Sachs disease.
    1962. Going with the flow: neuroinflammation
    1963. Gold drug auranofin could reduce neuroinflammation by inhibiting microglia cytotoxic secretions and primed respiratory burst
    1964. Gonadal hormone modulation of chronic neuroinflammation
    1965. GPER agonist G1 attenuates neuroinflammation and dopaminergic neurodegeneration in Parkinson disease
    1966. Gracilin A Derivatives Target Early Events in Alzheimer’s Disease: in Vitro Effects on neuroinflammation and Oxidative Stress
    1967. Granulocyte colony-stimulating factor attenuates chronic neuroinflammation in the brain of amyloid precursor protein transgenic mice: an Alzheimer’s disease mouse …
    1968. Graphene Oxide Nanosheets and Neural System: From Synaptic Modulation to neuroinflammation
    1969. Graphene quantum dots inhibit T cell-mediated neuroinflammation in rats
    1970. Green Tea Polyphenol (−)-Epigallocatechin Gallate (EGCG) Attenuates neuroinflammation in Palmitic Acid-Stimulated BV-2 Microglia and High-Fat Diet-Induced …
    1971. GSK-3β inhibitors suppressed neuroinflammation in rat cortex by activating autophagy in ischemic brain injury
    1972. Guanabenz Reverses a Key Behavioral Change Caused by Latent Toxoplasmosis in Mice by Reducing neuroinflammation
    1973. Gut microbiota and neuroinflammation in pathogenesis of hypertension: A potential role for hydrogen sulfide
    1974. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease
    1975. Gut microbiota to counteract metabolic disorders and neuroinflammation
    1976. Gut microbiota to counteract metabolic disorders and neuroinflammation: Impact of dietary factors and their potential to prevent Alzheimer’s disease
    1977. Gut microbiota–brain axis in depression: The role of neuroinflammation
    1978. Gx-50 inhibits neuroinflammation via α7 nAChR activation of the JAK2/STAT3 and PI3K/AKT pathways
    1979. Gypenosides attenuate lipopolysaccharide-induced neuroinflammation and anxiety-like behaviors in rats
    1980. Gypenosides attenuate lipopolysaccharide-induced neuroinflammation and memory impairment in rats
    1981. Gypenosides reverses depressive behavior via inhibiting hippocampal neuroinflammation
    1982. Hashimoto’s thyroiditis induces neuroinflammation and emotional alterations in euthyroid mice
    1983. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1640-z”>HDAC2 hyperexpression alters hippocampal neuronal transcription and microglial activity in neuroinflammation-induced cognitive dysfunction
    1984. HDAC8 inhibitor WK2-16 therapeutically targets lipopolysaccharide-induced mouse model of neuroinflammation and microglial activation
    1985. HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation
    1986. Heat shock protein 70 suppresses neuroinflammation induced by α-synuclein in astrocytes
    1987. Heat Shock Proteins in neuroinflammation
    1988. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-015-0324-6″>Heat stress-induced memory impairment is associated with neuroinflammation in mice
    1989. Heat stress-induced neuroinflammation and aberration in monoamine levels in hypothalamus are associated with temperature dysregulation
    1990. Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammation
    1991. Helminth products potently modulate experimental autoimmune encephalomyelitis by downregulating neuroinflammation and promoting a suppressive …
    1992. Heme oxygenase-1 induction by carbon monoxide releasing molecule-3 suppresses interleukin-1β-mediated neuroinflammation
    1993. Heme oxygenase–1 and carbon monoxide suppress autoimmune neuroinflammation
    1994. Hemorrhage Associated Mechanisms of neuroinflammation in Experimental Traumatic Brain Injury
    1995. Heparan sulfate proteoglycans as relays of neuroinflammation
    1996. Heparin reduces neuroinflammation and transsynaptic neuronal apoptosis in a model of subarachnoid hemorrhage
    1997. Hepatocyte growth factor limits autoimmune neuroinflammation via glucocorticoid-induced leucine zipper expression in dendritic cells
    1998. Herbal Complement inhibitors in the treatment of neuroinflammation
    1999. Herbal compounds with special reference to gastrodin as potential therapeutic agents for microglia mediated neuroinflammation
    2000. Herbicide paraquat induces sex-specific variation of neuroinflammation and neurodegeneration in Drosophila melanogaster
    2001. neuroinflammation&ots=ayGh5CnMqE&sig=pgRuz2LA2s4VRe1YMpCM3px8gPo”>Herpes simplex virus type 1 neuronal infection elicits cellular and molecular mechanisms of neuroinflammation and neurodegeneration in in vitro and in vivo mice …
    2002. Herpes viruses and neuroinflammation
    2003. Herpesvirus trigger accelerates neuroinflammation in a nonhuman primate model of multiple sclerosis
    2004. HERV-W envelope is significantly expressed in Multiple Sclerosis and causes neuroinflammation in animal models with specific antibody inhibition
    2005. Hesperetin inhibits neuroinflammation on microglia by suppressing inflammatory cytokines and MAPK pathways
    2006. Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats
    2007. Hesperetin, a citrus flavonoid, attenuates LPS-induced neuroinflammation, apoptosis and memory impairments by modulating TLR4/NF-κB signaling
    2008. Hesperidin alleviates lipopolysaccharide-induced neuroinflammation in mice by promoting the miRNA-132 pathway
    2009. Hesperidin ameliorates functional and histological outcome and reduces neuroinflammation in experimental stroke
    2010. Hesperidin ameliorates immunological outcome and reduces neuroinflammation in the mouse model of multiple sclerosis
    2011. High and Low Molecular Weight Hyaluronic Acid Differentially Influences Oxylipins Synthesis in Course of neuroinflammation
    2012. High Ca2+ Influx During Traumatic Brain Injury Leads to Caspase-1-Dependent neuroinflammation and Cell Death
    2013. High cholesterol‐induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice
    2014. High CRMP2 expression in peripheral T lymphocytes is associated with recruitment to the brain during virus-induced neuroinflammation
    2015. High Dietary Salt Aggravates Experimental neuroinflammation in Mice Via Induction of Th17 Cells (S50. 003)
    2016. High dimensional cytometry of central nervous system leukocytes during neuroinflammation
    2017. High fat diet exacerbates neuroinflammation in an animal model of multiple sclerosis by activation of the renin angiotensin system
    2018. High fat diet increases cognitive decline and neuroinflammation in a model of orexin loss
    2019. High fat diet increases cognitive decline and neuroinflammation in a model of orexin loss
    2020. High fat diet increases neuroinflammation and alters behavior in mice latently-infected with HSV-1
    2021. HIGH GLUCOSE CONCENTRATIONS INCREASE LEUKOCYTE ADHESION TO ASTROCYTES IN A POST-TRAUMATIC neuroinflammation MODEL.: 144
    2022. High levels of cerebrospinal fluid chemokines point to the presence of neuroinflammation in peripheral neuropathic pain: a cross-sectional study of 2 cohorts …
    2023. High levels of serum soluble TWEAK are associated with neuroinflammation during multiple sclerosis
    2024. High Pulsatile Pressure Promotes Cerebrovascular Damage and Endothelial Cell Death, Leading to Hypoperfusion, neuroinflammation and Cognitive Decline in Mice
    2025. High Sensitivity C-Reactive Protein as a Potential Biomarker of neuroinflammation in Major Psychiatric Disorders
    2026. High-energy diet consumption predisposes rats to cognitive impairments, neuroinflammation, and neurovascular damage
    2027. High-fat diet and aging interact to produce neuroinflammation and impair hippocampal-and amygdalar-dependent memory
    2028. High-Fat Diet Causes Increased neuroinflammation and Decreased Motor Function in a Rodent Model of Parkinson’s Disease
    2029. High-Fat Diet Induces neuroinflammation and Mitochondrial Impairment in Mice Cerebral Cortex and Synaptic Fraction
    2030. High-fat diet–induced dysbiosis as a cause of neuroinflammation
    2031. High-fructose diet during adolescent development increases neuroinflammation and depressive-like behavior without exacerbating outcomes after stroke
    2032. High-mobility group box1 protein promotes neuroinflammation after intracerebral hemorrhage in rats
    2033. High-refined carbohydrate diet consumption induces neuroinflammation and anxiety-like behavior in mice
    2034. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-020-1714-y”>High-salt diet does not boost neuroinflammation and neurodegeneration in a model of α-synucleinopathy
    2035. High-throughput automated image analysis of neuroinflammation and neurodegeneration enables quantitative assessment of virus neurovirulence
    2036. Higher-Resolution MR Elastography Reveals Early Mechanical Signatures of neuroinflammation in Patients with Clinically Isolated Syndrome
    2037. Higher‐resolution MR elastography reveals early mechanical signatures of neuroinflammation in patients with clinically isolated syndrome
    2038. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration
    2039. Highly selective activation of heat shock protein 70 by allosteric regulation provides an insight into efficient neuroinflammation inhibition
    2040. Highly selective cyclooxygenase-1 inhibitors P6 and Mofezolac counteract inflammatory state both in vitro and in vivo models of neuroinflammation
    2041. Hippo Signaling Pathway has a critical role in Zika Virus Replication and in the Pathogenesis of neuroinflammation
    2042. Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures
    2043. Hippocampal metabolomics using ultrahigh-resolution mass spectrometry reveals neuroinflammation from Alzheimer’s disease in CRND8 mice
    2044. Hippocampal Neurogenesis and neuroinflammation after Cranial Irradiation with 56Fe Particles
    2045. Hippocampal neurogenesis dysfunction linked to depressive-like behaviors in a neuroinflammation induced model of depression
    2046. Hippocampal neuroinflammation and depression: Relevance to multiple sclerosis and other neuropsychiatric illnesses
    2047. Hippocampal neuroinflammation, functional connectivity, and depressive symptoms in multiple sclerosis
    2048. Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy
    2049. Histamine and neuroinflammation: insights from murine experimental autoimmune encephalomyelitis
    2050. Histamine H4 receptor agonist‐induced relief from painful peripheral neuropathy is mediated by inhibition of spinal neuroinflammation and oxidative stress
    2051. Histological and direct evidence for the role of complement in the neuroinflammation of AD
    2052. Histone deacetylase 2 inhibitor CAY10683 alleviates lipopolysaccharide induced neuroinflammation through attenuating TLR4/NF-κB signaling pathway
    2053. Histone Deacetylase Inhibitor MS-275 Alleviates Postoperative Cognitive Dysfunction in Rats by Inhibiting Hippocampal neuroinflammation
    2054. Histone deacetylase inhibitor trichostatin a ameliorated endotoxin-induced neuroinflammation and cognitive dysfunction
    2055. HIV gp120‐induced neuroinflammation potentiates NMDA receptors to overcome basal suppression of inhibitory synapses by p38 MAPK
    2056. HIV-1 associated neuroinflammation: effects of two complimentary medicines illustrated in an in vitro model of the blood-brain barrier
    2057. HIV-1 Envelope Glycoprotein 120 Induced neuroinflammation Does Not Result in Neurocognitive Impairment in An in vivo Rat Model
    2058. HIV-1 gp120-induced neuroinflammation: relationship to neuron loss and protection by rSV40-delivered antioxidant enzymes
    2059. HIV-1 Tat primes and activates microglial NLRP3 inflammasome-mediated neuroinflammation
    2060. HIV-1 viral protein R activates NLRP3 inflammasome in microglia: implications for HIV-1 associated neuroinflammation
    2061. HIV-1, HCV and alcohol in the CNS: potential interactions and effects on neuroinflammation
    2062. HIV-induced neuroinflammation: impact of PAR1 and PAR2 processing by Furin
    2063. HMGB-1 AND ANNEXIN A1: IMPORTANT MEDIATORS OF neuroinflammation IN THE SYNDROME OF ALZHEIMER’S DEMENTIA WITH CONCOMITANT …
    2064. HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration
    2065. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0670-z”>HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in …
    2066. HMGB1 gene silencing inhibits neuroinflammation via down-regulation of NF-κB signaling in primary hippocampal neurons induced by Aβ25–35
    2067. HMGB1-mediated differential response on hippocampal neurotransmitter disorder and neuroinflammation in adolescent male and female mice following cold …
    2068. HMGB1-RAGE signaling plays a role in organic dust-induced microglial activation and neuroinflammation
    2069. HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain
    2070. HMGB1: a common biomarker and potential target for TBI, neuroinflammation, epilepsy, and cognitive dysfunction
    2071. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1673-3″>HMGB1/RAGE axis mediates stress-induced RVLM neuroinflammation in mice via impairing mitophagy flux in microglia
    2072. Homocysteine exaggerates microglia activation and neuroinflammation through microglia localized STAT3 overactivation following ischemic stroke
    2073. Honokiol abrogates lipopolysaccharide-induced depressive like behavior by impeding neuroinflammation and oxido-nitrosative stress in mice
    2074. Honokiol ameliorates amyloidosis and neuroinflammation and improves cognitive impairment in Alzheimer’s disease transgenic mice
    2075. Honokiol ameliorates cognitive impairment by attenuating amyloidosis and neuroinflammation in a transgenic mouse model of Alzheimer’s disease
    2076. Honokiol Attenuates the Memory Impairments, Oxidative Stress, neuroinflammation, and GSK-3 β Activation in Vascular Dementia Rats
    2077. Hormesis, cellular stress response and neuroinflammation in schizophrenia: early onset versus late onset state
    2078. How air pollution alters brain development: the role of neuroinflammation
    2079. How can viruses influence the neuroinflammation and neurodegeneration in the aged human brain
    2080. How do statins control neuroinflammation?
    2081. How neuroinflammation contributes to neurodegeneration
    2082. HSPA12B regulates SSeCKS-mediated astrocyte inflammatory activation in neuroinflammation
    2083. Human amyloid β‐induced neuroinflammation is an early event in neurodegeneration
    2084. Human and mouse neuroinflammation markers in Niemann-Pick disease, type C1
    2085. Human antimicrobial peptide LL-37 induces glial-mediated neuroinflammation
    2086. Human bone marrow mesenchymal stem cell-derived extracellular vesicles attenuate neuroinflammation evoked by focal brain injury in rats
    2087. Human brain pericytes as mediators of neuroinflammation: Implications for disease and therapeutics
    2088. Human endogenous retrovirus and neuroinflammation in chronic inflammatory demyelinating polyradiculoneuropathy
    2089. neuroinflammation_in_Chronic_Inflammatory_Demyelinating_Polyradiculoneuropathy/links/56e9360008ae9bcb3e1e5571/Human-Endogenous-Retrovirus-and-neuroinflammation-in-Chronic-Inflammatory-Demyelinating-Polyradiculoneuropathy.pdf”>Human Endogenous Retrovirus and neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
    2090. Human herpesvirus 6 and neuroinflammation
    2091. Human immunodeficiency virus type 1 (HIV-1)-mediated neuroinflammation dysregulates neurogranin and induces synaptodendritic injury
    2092. Human iPSC-derived neurons and astrocytes as models of neurodegeneration, neuroinflammation and vesicular trafficking in Alzheimer’s disease
    2093. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic …
    2094. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson’s disease
    2095. Human TBK1: a gatekeeper of neuroinflammation
    2096. Human Umbilical Cord Mesenchymal Stem Cells Attenuate Ocular Hypertension-Induced Retinal neuroinflammation via Toll-Like Receptor 4 Pathway
    2097. Human Urinary Kallidinogenase Reduces Lipopolysaccharide-Induced neuroinflammation and Oxidative Stress in BV-2 Cells
    2098. Human whole-body biodistribution and dosimetry of a new PET tracer,[{sup 11} C] ketoprofen methyl ester, for imagings of neuroinflammation
    2099. Human whole-body biodistribution and dosimetry of a new PET tracer,[11C] ketoprofen methyl ester, for imagings of neuroinflammation
    2100. Huperzine A alleviates neuroinflammation, oxidative stress and improves cognitive function after repetitive traumatic brain injury
    2101. Huperzine A ameliorates cognitive dysfunction and neuroinflammation in kainic acid‐induced epileptic rats by antioxidant activity and NLRP 3/caspase‐1 pathway …
    2102. Hydrogen sulfide and neuroinflammation
    2103. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-9-202″>Hydrogen sulfide attenuates spatial memory impairment and hippocampal neuroinflammation in beta-amyloid rat model of Alzheimer’s disease
    2104. Hydrogen sulfide inhibits ATP-induced neuroinflammation and Aβ1–42 synthesis by suppressing the activation of STAT3 and cathepsin S
    2105. Hydrogen sulfide protects against cognitive impairment induced by hepatic ischemia and reperfusion via attenuating neuroinflammation
    2106. Hydrogen sulfide protects hippocampal neurons against methamphetamine neurotoxicity via inhibition of apoptosis and neuroinflammation
    2107. Hydrogen sulfide‐releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation
    2108. Hydroxy-safflor yellow A inhibits neuroinflammation mediated by Aβ1–42 in BV-2 cells
    2109. Hydroxysafflor yellow A attenuates lipopolysaccharide-induced neurotoxicity and neuroinflammation in primary mesencephalic cultures
    2110. Hyperammonemia induces glial activation, neuroinflammation and alters neurotransmitter receptors in hippocampus, impairing spatial learning: reversal by …
    2111. Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy
    2112. Hyperbaric oxygen effects on depression-like behavior and neuroinflammation in traumatic brain injury rats
    2113. Hyperbaric oxygen preconditioning attenuates neuroinflammation after intracerebral hemorrhage in rats by regulating microglia characteristics
    2114. Hyperbaric oxygen therapy ameliorates pathophysiology of 3xTg-AD mouse model by attenuating neuroinflammation
    2115. Hyperbaric oxygen therapy reduces neuroinflammation and expression of matrix metalloproteinase-9 in the rat model of traumatic brain injury.
    2116. Hyperbaric oxygen therapy reduces neuroinflammation and expression of matrix metalloproteinase‐9 in the rat model of traumatic brain injury
    2117. Hyperglycemia-driven neuroinflammation compromises BBB leading to memory loss in both diabetes mellitus (DM) type 1 and type 2 mouse models
    2118. Hyperpolarized 13C magnetic resonance spectroscopy detects toxin‐induced neuroinflammation in mice
    2119. Hyperpolarized 13C MR metabolic imaging can detect neuroinflammation in vivo in a multiple sclerosis murine model
    2120. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-015-0455-9″>Hypoestoxide reduces neuroinflammation and α-synuclein accumulation in a mouse model of Parkinson’s disease
    2121. Hypothermia Attenuates Neuro-Glial Injury and neuroinflammation in Prolonged Status Epilepticus (S56. 004)
    2122. neuroinflammation&ots=IbFgxNnme9&sig=aLLdVUx5F7tXwBY2xBF8zTP_Ua8″>Hypoxia and neuroinflammation: Connections with Toll-Like Receptor Signaling in Brain Microglia
    2123. Hypoxia as an initiator of neuroinflammation: microglial connections
    2124. Hypoxia-induced neuroinflammation and learning–memory impairments in adult zebrafish are suppressed by glucosamine
    2125. Hypoxic preconditioning suppresses glial activation and neuroinflammation in neonatal brain insults
    2126. Hypoxic-conditioned medium from adipose tissue mesenchymal stem cells improved neuroinflammation through alternation of toll like receptor (TLR) 2 and TLR4 …
    2127. Ibuprofen inhibits neuroinflammation and attenuates white matter damage following hypoxia–ischemia in the immature rodent brain
    2128. Icariin and icaritin ameliorated hippocampus neuroinflammation via inhibiting HMGB1-related pro-inflammatory signals in lipopolysaccharide-induced inflammation …
    2129. Icariin and icaritin ameliorated hippocampus neuroinflammation via mediating HMGB1 expression in social defeat model in mice
    2130. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1472-x”>Icariin attenuates neuroinflammation and exerts dopamine neuroprotection via an Nrf2-dependent manner
    2131. Icariin targets Nrf2 signaling to inhibit microglia-mediated neuroinflammation
    2132. Icariside II attenuates lipopolysaccharide-induced neuroinflammation through inhibiting TLR4/MyD88/NF-κB pathway in rats
    2133. Idebenone alleviates neuroinflammation and modulates microglial polarization in LPS-stimulated BV2 cells and MPTP-induced Parkinson’s disease mice
    2134. Identification of a fatty acid binding protein4-UCP2 axis regulating microglial mediated neuroinflammation
    2135. Identification of ADAM proteinase substrates in neurodegeneration and neuroinflammation
    2136. Identification of brain regions predicting epileptogenesis by serial [18F] GE-180 positron emission tomography imaging of neuroinflammation in a rat model of …
    2137. Identification of naturally occurring fatty acids of the myelin sheath that resolve neuroinflammation
    2138. Identification of novel candidate protein biomarkers for the post-polio syndrome—implications for diagnosis, neurodegeneration and neuroinflammation
    2139. Identification of target genes in neuroinflammation and neurodegeneration after traumatic brain injury in rats
    2140. Identifying the role of complement in triggering neuroinflammation after traumatic brain injury
    2141. Identifying the role of IL-1 in neuroinflammation of MPSIIIA
    2142. IFN-β induces IL-6 production by B cells to promote TH17-mediated neuroinflammation
    2143. IL-1-induced Bhlhe40 identifies pathogenic TH cells in a model of autoimmune neuroinflammation
    2144. IL-1–induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation
    2145. IL-11 antagonist suppresses Th17 cell-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis
    2146. IL-11 antagonist suppresses Th17 cells-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis (P2. 406)
    2147. IL-12p35 inhibits neuroinflammation and ameliorates autoimmune encephalomyelitis
    2148. IL-13 ameliorates neuroinflammation and promotes functional recovery after traumatic brain injury
    2149. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson’s disease
    2150. IL-17A induces autophagy and promotes microglial neuroinflammation through ATG5 and ATG7 in intracerebral hemorrhage
    2151. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-015-0394-5″>IL-17A is implicated in lipopolysaccharide-induced neuroinflammation and cognitive impairment in aged rats via microglial activation
    2152. IL-17A promotes microglial activation and neuroinflammation in mouse models of intracerebral haemorrhage
    2153. IL-17A promotes the neuroinflammation and cognitive function in sevoflurane anesthetized aged rats via activation of NF-κB signaling pathway
    2154. IL-18 is differently regulated in specific areas of rat brain during neuroinflammation: relevance for neurodegenerative disease
    2155. IL-18: a key player in neuroinflammation and neurodegeneration?
    2156. IL-1β-mediated changes in cerebral perfusion and neural activity in a rat model of neuroinflammation and excitotoxicity
    2157. IL-22RA2 associates with multiple sclerosis and macrophage effector mechanisms in experimental neuroinflammation
    2158. IL-27 and IL-35 as gene therapy of neuroinflammation
    2159. IL-27, but not IL-35, inhibits neuroinflammation through modulating GM-CSF expression
    2160. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1169-6″>IL-33/ST2 plays a critical role in endothelial cell activation and microglia-mediated neuroinflammation modulation
    2161. neuroinflammation_AFTER.282.aspx”>IL-8 IS A KEY MEDIATOR OF neuroinflammation AFTER TRAUMATIC BRAIN INJURY: 363
    2162. IL‐4 attenuates the neuroinflammation induced by amyloid‐β in vivo and in vitro
    2163. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0596-5″>IL4 induces IL6-producing M2 macrophages associated to inhibition of neuroinflammation in vitro and in vivo
    2164. Imaging Amnestic Mild Cognitive Impairment: neuroinflammation, Beta-Amyloid and Glutathione
    2165. Imaging biomarkers and the role of neuroinflammation in neuropathic pain
    2166. Imaging cellular markers of neuroinflammation in the brain of the rat model of amyotrophic lateral sclerosis
    2167. IMAGING MARKER OF neuroinflammation PREDICTS DISEASE PROGRESSION IN ALZHEIMER DISEASE
    2168. Imaging marker of neuroinflammation predicts progression in Alzheimer’s disease
    2169. Imaging microglial activation during neuroinflammation and Alzheimer’s disease
    2170. Imaging neuroinflammation after brain injuries by ultrasensitive MRI and two-photon laser-scanning microscopy
    2171. Imaging neuroinflammation after stroke: current status of cellular and molecular MRI strategies
    2172. Imaging neuroinflammation in Alzheimer disease with [1–11C] arachidonic acid and positron emission tomography
    2173. Imaging neuroinflammation in Alzheimer’s disease and other dementias: recent advances and future directions
    2174. Imaging neuroinflammation in Alzheimer’s disease with radiolabeled arachidonic acid and PET
    2175. IMAGING neuroinflammation IN AMNESTIC MILD COGNITIVE IMPAIRMENT (AMCI) USING A NOVEL PET RADIOLIGAND:[18F]-FEPPA
    2176. Imaging neuroinflammation in Gray and White Matter in Schizophrenia: An In-Vivo PET Study With [ 18 F]-FEPPA
    2177. Imaging neuroinflammation in ischemic stroke and in the atherosclerotic vascular disease
    2178. Imaging neuroinflammation in multiple sclerosis using TSPO-PET
    2179. Imaging neuroinflammation in neurodegenerative diseases (INMIND): Concepts and future directions
    2180. Imaging neuroinflammation in Post Traumatic Stress Disorder
    2181. Imaging neuroinflammation in Progressive Multiple Sclerosis
    2182. Imaging neuroinflammation in vivo in a neuropathic pain rat model with near-infrared fluorescence and 19F magnetic resonance
    2183. Imaging neuroinflammation using 18F-DPA-714 microPET after low intensity pulsed focused ultrasound treatment with microbubbles.
    2184. Imaging neuroinflammation using18F-DPA-714 PET after disrupting the blood brain barrier with pulsed focused ultrasound.
    2185. Imaging neuroinflammation–from bench to bedside
    2186. Imaging neuroinflammation: quantification of astrocytosis in a multitracer PET approach
    2187. Imaging neuroinflammation? A perspective from MR spectroscopy
    2188. Imaging of neuroinflammation
    2189. Imaging of neuroinflammation in Alzheimer’s disease, multiple sclerosis and stroke: Recent developments in positron emission tomography
    2190. Imaging of neuroinflammation in dementia: a review
    2191. Imaging of neuroinflammation in migraine with aura: A [11C] PBR28 PET/MRI study
    2192. Imaging of neuroinflammation in parkinsonian syndromes with positron emission tomography
    2193. Imaging of neuroinflammation with an ICAM-1 Specific Paramagnetic and Fluorescent Nanoparticle
    2194. Imaging of neuroinflammation: TSPO and beyond
    2195. Imaging Tau, neuroinflammation, and Aβ in Dementia With Lewy Bodies: A Deep‐Phenotyping Case Report
    2196. Imaging the Breakdown of the BBB and neuroinflammation in Models of Neurodegeneration
    2197. Imaging toxin-induced neuroinflammation in mice using hyperpolarized 13C magnetic resonance spectroscopy
    2198. Imaging translocator protein as a biomarker of neuroinflammation in dementia
    2199. Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune …
    2200. Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood–brain barrier integrity and by modulating the peripheral immune …
    2201. Immune activation and neuroinflammation in alcohol use and HIV infection: evidence for shared mechanisms
    2202. Immune dysfunction and neuroinflammation in autism spectrum disorder.
    2203. Immune heterogeneity in neuroinflammation: dendritic cells in the brain
    2204. IMMUNE MECHANISMS ASSOCIATED TO neuroinflammation IN ALZHEIMER¿ S DISEASE
    2205. Immune privilege as an intrinsic CNS property: astrocytes protect the CNS against T-cell-mediated neuroinflammation
    2206. Immune System in Acute and Chronic neuroinflammation
    2207. Immune System in Acute and Chronic neuroinflammation
    2208. Immune system markers of neuroinflammation in patients with clinical diagnose of neuromyelitis optica
    2209. Immunity, neuroglia and neuroinflammation in autism
    2210. Immunization with Bacillus Calmette-Guérin (BCG) alleviates neuroinflammation and cognitive deficits in APP/PS1 mice via the recruitment of inflammation-resolving …
    2211. Immunobiology of WNV-induced neuroinflammation
    2212. Immunoglobulin G (IgG) attenuates neuroinflammation and improves neurobehavioral recovery after cervical spinal cord injury
    2213. Immunoglobulin G: a potential treatment to attenuate neuroinflammation following spinal cord injury
    2214. Immunological Approaches to Prevent Neuronal Apoptosis During neuroinflammation
    2215. Immunomodulatory influence of bone marrow-derived mesenchymal stem cells on neuroinflammation in astrocyte cultures
    2216. Immunomodulatory properties of bone marrow-derived mesenchymal stem cells: influence on neuroinflammation
    2217. Immunomodulatory role of the extracellular matrix protein tenascin-C in neuroinflammation
    2218. Immunotherapy against APP β-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on …
    2219. Immunotherapy in Autoimmune and neuroinflammation-Related Epilepsies
    2220. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0954-y”>Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation
    2221. Impact of indomethacin on neuroinflammation and hippocampal neurogenesis in aged mice
    2222. Impact of long-term RF-EMF on oxidative stress and neuroinflammation in aging brains of C57BL/6 mice
    2223. Impact of metabolic syndrome on neuroinflammation and the blood–brain barrier
    2224. Impact of neuroinflammation on hippocampal neurogenesis: relevance to aging and Alzheimer’s disease
    2225. Impact of novel N-aryl piperamide NO donors on NF-κB translocation in neuroinflammation: rational drug-designing synthesis and biological evaluation
    2226. Impact of opiate addiction on neuroinflammation in HIV
    2227. neuroinflammation_and_disease/links/5c42205ba6fdccd6b5b6e83e/Impact-of-the-paracaspase-MALT1-on-rabies-virus-induced-neuroinflammation-and-disease.pdf”>Impact of the paracaspase MALT1 on rabies virus-induced neuroinflammation and disease
    2228. Impact of Titanium Dioxide Nanoparticles on neuroinflammation in a Mouse Model of Asthma
    2229. Impaired lipid metabolism markers to assess the risk of neuroinflammation in autism spectrum disorder
    2230. Impaired remission from autoimmune neuroinflammation upon T cell-specific knockout of the stress kinase GCN2
    2231. Impairment of blood brain barrier is related with the neuroinflammation induced peripheral immune status in intracerebroventricular colchicine injected rats: An …
    2232. Implications of heparan sulfate and heparanase in neuroinflammation
    2233. Improved 3D hydrogel cultures of primary glial cells for in vitro modelling of neuroinflammation
    2234. Improved brain insulin/IGF signaling and reduced neuroinflammation with T3D-959 in an experimental model of sporadic Alzheimer’s disease
    2235. In a Model of neuroinflammation Designed to Mimic Delirium, Quetiapine Reduces Cortisol Secretion and Preserves Reversal Learning in the Attentional Set Shifting …
    2236. In silico design of novel gold-phosphate containing compounds as selective inhibitors of cathepsin B in neuroinflammation
    2237. In vitro assessment of neurotoxicity and neuroinflammation of homemade MWCNTs
    2238. In Vitro Model of neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid
    2239. In vitro models to study insulin and glucocorticoids modulation of trimethyltin (TMT)-induced neuroinflammation and neurodegeneration, and in vivo validation in db/db …
    2240. In vivo analysis of neuroinflammation in the late chronic phase after experimental stroke
    2241. In vivo assessment of amyloid deposition, neuroinflammation, and metabolic changes in neurodegenerations of different origin
    2242. In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [18F]DPA714 PET
    2243. In vivo detection of age-and disease-related increases in neuroinflammation by 18F-GE180 TSPO microPET imaging in wild-type and Alzheimer’s transgenic mice
    2244. In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer’s disease
    2245. In vivo evaluation of” Meriva” curcumin, and apigenin as anti-inflammatory drugs in a mouse model of chronic neuroinflammation
    2246. In vivo evidence for pre‐symptomatic neuroinflammation in a MAPT mutation carrier
    2247. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-1038-8″>In vivo evidence for the contribution of peripheral circulating inflammatory exosomes to neuroinflammation
    2248. In vivo expression of cyclooxygenase-1 in activated microglia and macrophages during neuroinflammation visualized by PET with 11C-ketoprofen methyl ester
    2249. In vivo imaging biomarkers of neuroinflammation in the development and assessment of stroke therapies-towards clinical translation
    2250. In vivo imaging detects a transient increase in brain arachidonic acid metabolism: a potential marker of neuroinflammation
    2251. In vivo imaging of human neuroinflammation
    2252. In vivo imaging of neuroinflammation
    2253. In Vivo Imaging of neuroinflammation in Acute Brain Injury
    2254. In vivo imaging of neuroinflammation in Alzheimer’s disease
    2255. In vivo imaging of neuroinflammation in neurodegenerative diseases
    2256. In vivo imaging of neuroinflammation in schizophrenia
    2257. In vivo imaging of neuroinflammation in the rodent brain with [11C]SSR180575, a novel indoleacetamide radioligand of the translocator protein (18 kDa)
    2258. In vivo imaging of neuroinflammation: a comparative study between [18F]PBR111, [11C]CLINME and [11C]PK11195 in an acute rodent model
    2259. In vivo imaging of Α7 nicotinic receptors as a novel method to monitor neuroinflammation after cerebral ischemia
    2260. In vivo imaging of”neuroinflammation”. Principles and applications
    2261. In vivo imaging of”neuroinflammation”. Principles and applications; In-vivo-Darstellung”neuroinflammatorischer”Veraenderungen mit [{sup 11} C] PK11195-PET …
    2262. In vivo molecular imaging of neuroinflammation in Alzheimer’s disease
    2263. In vivo nanoneurotoxicity screening using oxidative stress and neuroinflammation paradigms
    2264. In vivo peptide biomarker screening for molecular imaging in eae neuroinflammation
    2265. In vivo PET imaging of neuroinflammation in Alzheimer’s disease
    2266. In Vivo Retinal Imaging of neuroinflammation in a Mouse Model of Traumatic Brain Injury
    2267. In vivo study of a PET radiotracer for imaging P2X7 receptors for neuroinflammation in animal model
    2268. In vivo targeting of Abeta and tau amyloidogeneses, neuroinflammation, calcium-mediated neurotoxicity and their interplays
    2269. In vivo TSPO and cannabinoid receptor type 2 availability early in post-stroke neuroinflammation in rats: a positron emission tomography study
    2270. neuroinflammation/links/55f6d2cc08aec948c462f6b8/In-Vitro-Ly6Chi-monocytes-and-their-role-in-neuroinflammation.pdf”>IN-VITRO Ly6C hi MONOCYTES AND THEIR ROLE IN neuroinflammation
    2271. In-vivo imaging of grey and white matter neuroinflammation in Alzheimer’s disease: a positron emission tomography study with a novel radioligand,[18 F]-FEPPA
    2272. In-vivo imaging of neuroinflammation in Veterans with Gulf War Illness
    2273. Incipient melanoma brain metastases instigate astrogliosis and neuroinflammation
    2274. Increase in core body temperature of Alzheimer’s disease patients as a possible indicator of chronic neuroinflammation: a meta-analysis
    2275. Increased brain docosahexaenoic acid has no effect on the resolution of neuroinflammation following intracerebroventricular lipopolysaccharide injection
    2276. Increased cerebral Tff1 expression in two murine models of neuroinflammation
    2277. Increased cortical infarction and neuroinflammation in ischemic stroke mice with experimental periodontitis
    2278. Increased expression of astrocyte markers in schizophrenia: association with neuroinflammation
    2279. Increased neuroinflammation in Asymptomatic LRRK2 Mutation Carriers: A Pilot PET Imaging Study (P4. 321)
    2280. Increased neuronal PreP activity reduces Aβ accumulation, attenuates neuroinflammation and improves mitochondrial and synaptic function in Alzheimer …
    2281. Increased neuronal PreP activity reduces Aβ accumulation, attenuates neuroinflammation and improves mitochondrial and synaptic function in Alzheimer disease’s …
    2282. Increased olfactory bulb volume due to treatment of chronic rhinosinusitis: neuroinflammation and adult neurogenesis
    2283. Increased P2X7 receptor binding is associated with neuroinflammation in acute but not chronic rodent models for Parkinson’s disease
    2284. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-5-10″>Increased systemic and brain cytokine production and neuroinflammation by endotoxin following ethanol treatment
    2285. Increases in neuroinflammation and Astrocyte Activation in a Murine Model of Mixed Dementia
    2286. Increasing extracellular cGMP in cerebellum in vivo reduces neuroinflammation, GABAergic tone and motor in-coordination in hyperammonemic rats
    2287. Indirect effects of radiation induce apoptosis and neuroinflammation in neuronal SH-SY5Y cells
    2288. Indispensable role of CX3CR1+ dendritic cells in regulation of virus-induced neuroinflammation through rapid development of antiviral immunity in peripheral …
    2289. Indoxyl sulfate affects glial function increasing oxidative stress and neuroinflammation in chronic kidney disease: interaction between astrocytes and microglia
    2290. Inducible ablation of Cxcr2 in oligodendroglia attenuates autoimmune, but not viral, mediated neuroinflammation and demyelination
    2291. INDUCTION AND RESOLUTION OF neuroinflammation AND NEUROTOXICITY
    2292. Induction of hyperhomocysteinemia models vascular dementia by induction of cerebral microhemorrhages and neuroinflammation
    2293. Induction of neuroinflammation and Neurotoxicity by Synthetic Hemozoin
    2294. Induction of Nrf2/HO-1 pathway suppresses neuroinflammation in ischemic stroke
    2295. Induction of suppressor of cytokine signaling 3 via HSF-1-HSP70-TLR4 axis attenuates neuroinflammation and ameliorates postoperative pain
    2296. Infection with mosquito-borne alphavirus induces selective loss of dopaminergic neurons, neuroinflammation and widespread protein aggregation
    2297. Infiltrating macrophages contribute to age-related neuroinflammation in C57/BL6 mice
    2298. Infiltrating regulatory B cells control neuroinflammation following viral brain infection
    2299. neuroinflammation_and.2.aspx”>Inflamed in the Membrane: neuroinflammation and Perioperative Neurocognitive Disorders
    2300. Inflamed in vitro retina: cytotoxic neuroinflammation and galectin-3 expression
    2301. Inflammasomes in neuroinflammation and changes in brain function: a focused review
    2302. Inflammasomes link vascular disease with neuroinflammation and brain disorders
    2303. Inflammasomes, hormesis, and antioxidants in neuroinflammation: role of NRLP3 in Alzheimer disease
    2304. Inflammasomes: An emerging mechanism translating environmental toxicant exposure into neuroinflammation in Parkinson’s disease
    2305. Inflammatory cell populations in early neuroinflammation in the core and peri-ischemic lesions of rat brain after transient focal cerebral ischemia: A …
    2306. Inflammatory cells and cytokines in the olfactory bulb of a rat model of neuroinflammation; insights into neurodegeneration?
    2307. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0710-8″>Infliximab reduces peripheral inflammation, neuroinflammation, and extracellular GABA in the cerebellum and improves learning and motor coordination in …
    2308. Influence of caffeine on 3, 4‐methylenedioxymethamphetamine‐induced dopaminergic neuron degeneration and neuroinflammation is age‐dependent
    2309. Influence of chronic Helicobacter pylori infection on systemic and neuroinflammation and its impact on cognition
    2310. Influence of HAART on HIV-related CNS disease and neuroinflammation
    2311. Influence of LPS-induced neuroinflammation on acetylcholinesterase activity in rat brain
    2312. Influence of neuroinflammation on Neuronal Function in Neurodegenerative Diseases: An 11C-(R)-PK11195 and 18F-FDG PET Study (IN9-1.001)
    2313. Influence of neuroinflammation on Neuronal Function in Neurodegenerative Diseases: An 11C-(R)-PK11195 and 18F-FDG PET Study (S44. 003)
    2314. Influence of neuroinflammation on the regulation of glutamate handling in astrocytes, link with neuropathies
    2315. Influence of post-traumatic stress disorder on neuroinflammation and cell proliferation in a rat model of traumatic brain injury
    2316. Influenza infection induces neuroinflammation and impacts hippocampal structure and function
    2317. Influenza infection induces neuroinflammation, alters hippocampal neuron morphology, and impairs cognition in adult mice
    2318. Inhalation of hydrogen gas attenuates brain injury in mice with cecal ligation and puncture via inhibiting neuroinflammation, oxidative stress and neuronal apoptosis
    2319. Inhaled budesonide protects against chronic asthma-induced neuroinflammation in mouse brain
    2320. Inheritance of autoimmune neuroinflammation
    2321. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1271-9″>Inhibiting aberrant p53-PUMA feedback loop activation attenuates ischaemia reperfusion-induced neuroapoptosis and neuroinflammation in rats by …
    2322. Inhibiting neuroinflammation: the role and therapeutic potential of GABA in neuro-immune interactions
    2323. Inhibiting RIPK1 limits neuroinflammation and alleviates postoperative cognitive impairments in D-galactose-induced aged mice
    2324. Inhibition of 26S protease regulatory subunit 7 (MSS1) suppresses neuroinflammation
    2325. Inhibition of 5-lipoxygenase activity in mice during cuprizone-induced demyelination attenuates neuroinflammation, motor dysfunction and axonal damage
    2326. Inhibition of activator protein 1 attenuates neuroinflammation and brain injury after experimental intracerebral hemorrhage
    2327. Inhibition of AGEs/RAGE/Rho/ROCK pathway suppresses non-specific neuroinflammation by regulating BV2 microglial M1/M2 polarization through the NF-κB …
    2328. Inhibition of Amyloid-Beta Production, Associated neuroinflammation, and Histone Deacetylase 2-Mediated Epigenetic Modifications Prevent Neuropathology …
    2329. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1476-6″>Inhibition of apoptosis signal-regulating kinase by paeoniflorin attenuates neuroinflammation and ameliorates neuropathic pain
    2330. Inhibition of Aβ production, associated neuroinflammation, and HDAC2-mediated epigenetic modifications prevent neuropathology in Alzheimer’s disease in vitro …
    2331. Inhibition of cathepsin X reduces the strength of microglial-mediated neuroinflammation
    2332. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0875-9″>Inhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation
    2333. Inhibition of DNA methylation with zebularine alters lipopolysaccharide-induced neuroinflammation in mice
    2334. Inhibition of DNA methylation with zebularine alters lipopolysaccharide-induced sickness behavior and neuroinflammation in mice
    2335. Inhibition of Endocannabinoid Degradation Improves Recovery of Neurobehavioral Function and Resolution of neuroinflammation and Synaptic Hyperexcitability in a …
    2336. Inhibition of fibrin formation reduces neuroinflammation and improves long-term outcome after intracerebral hemorrhage
    2337. Inhibition of HDAC6 alleviating lipopolysaccharide-induced p38MAPK phosphorylation and neuroinflammation in mice
    2338. Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke
    2339. Inhibition of MALT1 decreases neuroinflammation and pathogenicity of virulent rabies virus in mice
    2340. Inhibition of microRNA-155 Alleviates Cognitive Impairment in Alzheimer’s Disease and Involvement of neuroinflammation
    2341. Inhibition of microRNA-155 Alleviates Neurological Dysfunction Following Transient Global Ischemia and Contribution of neuroinflammation and Oxidative Stress in …
    2342. Inhibition of miR-155 limits neuroinflammation and improves functional recovery after experimental traumatic brain injury in mice
    2343. Inhibition of miR-429 improves neurological recovery of traumatic brain injury mice and attenuates microglial neuroinflammation
    2344. Inhibition of NADPH oxidase promotes alternative and anti‐inflammatory microglial activation during neuroinflammation
    2345. Inhibition of neuroinflammation and mitochondrial dysfunctions by carbenoxolone in the rotenone model of Parkinson’s disease
    2346. Inhibition of neuroinflammation by AIBP: spinal effects upon facilitated pain states
    2347. Inhibition of neuroinflammation by artemisinin and its derivatives
    2348. Inhibition of neuroinflammation by cinnamon and its main components
    2349. Inhibition of neuroinflammation by Synthetic Androstene Derivatives Incorporating Amino Acid Methyl Esters on Activated BV‐2 Microglia
    2350. Inhibition of neuroinflammation by thymoquinone requires activation of Nrf2/ARE signalling
    2351. Inhibition of neuroinflammation in BV2 microglia by the biflavonoid kolaviron is dependent on the Nrf2/ARE antioxidant protective mechanism
    2352. Inhibition of neuroinflammation in LPS-activated microglia by cryptolepine
    2353. Inhibition of neuroinflammation prevents injury to the serotonergic network after hypoxia-ischemia in the immature rat brain
    2354. INHIBITION OF neuroinflammation REDUCES DEGENERATION OF DOPAMINERGIC NEURONS IN THE SUBSTANTIANIGRA INDUCED BY …
    2355. Inhibition of NF-κB activity by aminoguanidine alleviates neuroinflammation induced by hyperglycemia
    2356. Inhibition of P2X7 receptor ameliorates nuclear factor-kappa B mediated neuroinflammation induced by status epilepticus in rat hippocampus
    2357. neuroinflammation.97515.aspx”>Inhibition of PAR-2 Attenuates neuroinflammation and Improves Short-Term Neurocognitive Functions via ERK1/2 Signaling Following Asphyxia-Induced Cardiac …
    2358. Inhibition of PDE5 attenuates streptozotocin-induced neuroinflammation and tau hyperphosphorylation in a streptozotocin-treated rat model
    2359. Inhibition of RAGE-Related Pathway Prevents Subarachnoid Hemorrhage (sah)-Associated neuroinflammation and Neurologic Dysfunction in Rats
    2360. Inhibition of semicarbazide‐sensitive amine oxidase/vascular adhesion protein‐1 reduces lipopolysaccharide‐induced neuroinflammation
    2361. Inhibition of SERPINA3N‐dependent neuroinflammation is essential for melatonin to ameliorate trimethyltin chloride–induced neurotoxicity
    2362. Inhibition of sPLA2-IIA Prevents LPS-Induced neuroinflammation by Suppressing ERK1/2-cPLA2α Pathway in Mice Cerebral Cortex
    2363. Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson’s disease models
    2364. Inhibition of the JAK/STAT pathway protects against α-synuclein-induced neuroinflammation and dopaminergic neurodegeneration
    2365. Inhibition of the P2X7–PANX1 complex suppresses spreading depolarization and neuroinflammation
    2366. Inhibition of the receptor for advanced glycation end-products (RAGE) attenuates neuroinflammation while sensitizing cortical neurons towards death in experimental …
    2367. Inhibition of the Sur1-Trpm4 channel reduces neuroinflammation and cognitive impairment in subarachnoid hemorrhage
    2368. Inhibition of TNF-alpha protein synthesis restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation
    2369. Inhibitor of phosphodiestearse-4 improves memory deficits, oxidative stress, neuroinflammation and neuropathological alterations in mouse models of dementia of …
    2370. Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer’s disease
    2371. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-9-35″>Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear …
    2372. Inhibitory effect of ethanol extract of Nannochloropsis oceanica on lipopolysaccharide-induced neuroinflammation, oxidative stress, amyloidogenesis and …
    2373. Inhibitory effect of ferulic acid on neuroinflammation in LPS-activated microglia
    2374. Inhibitory effect of INT-777 on lipopolysaccharide-induced cognitive impairment, neuroinflammation, apoptosis, and synaptic dysfunction in mice
    2375. Inhibitory effect of memantine on streptozotocin-induced insulin receptor dysfunction, neuroinflammation, amyloidogenesis, and neurotrophic factor decline in …
    2376. Inhibitory effect of Petalonia binghamiae on neuroinflammation in LPS-stimulated microglial cells
    2377. Inhibitory effect of punicalagin on lipopolysaccharide-induced neuroinflammation, oxidative stress and memory impairment via inhibition of nuclear factor-kappaB
    2378. Inhibitory effects of betulinic acid on LPS-induced neuroinflammation involve M2 microglial polarization via CaMKKβ-dependent AMPK activation
    2379. Inhibitory effects of ginsenoside Rb1 on neuroinflammation following systemic lipopolysaccharide treatment in mice
    2380. Inhibitory Effects of Myricetin on Lipopolysaccharide-Induced neuroinflammation
    2381. Inhibitory effects of walnut (Juglans regia) peptides on neuroinflammation and oxidative stress in lipopolysaccharide-induced cognitive impairment mice
    2382. Initial evaluation in healthy humans of [18F] DPA-714, a potential PET biomarker for neuroinflammation
    2383. Initial Parkinson’s and healthy control studies of 123-I CLINDE, a SPECT marker of the peripheral benzodiazepine receptor and neuroinflammation
    2384. Injecting mitochondria into mouse hippocampi induces neuroinflammation and raises app expression
    2385. INMiND: getting to the bottom of neuroinflammation
    2386. Innate and adaptive immune-mediated neuroinflammation and neurodegeneration in Parkinson’s disease
    2387. Innate immunity and neuroinflammation
    2388. Innate immunity and neuroinflammation
    2389. neuroinflammation-in-neuropsychiatric-conditions-including-autism-spectrum-disor?fbclid=IwAR3JgpmxalljKo8WI8Aa5iMW_xTEWKULZ7aeZtda6bqsG0iSYGCJ2_OLu6o”>Innate Immunity and neuroinflammation in Neuropsychiatric Conditions Including Autism Spectrum Disorders: Role of Innate Immune Memory
    2390. Innate immunity and neuroinflammation in the CNS: The role of microglia in Toll‐like receptor‐mediated neuronal injury
    2391. Innate immunity and protective neuroinflammation: new emphasis on the role of neuroimmune regulatory proteins
    2392. Innate lymphotoxin receptor mediated signaling promotes HSV-1 associated neuroinflammation and viral replication
    2393. Inosine improves cognitive function and decreases aging-induced oxidative stress and neuroinflammation in aged female rats
    2394. INSIGHTS FROM FLUID BIOMARKERS OF neuroinflammation
    2395. Insights into macrophage heterogeneity and cytokine-induced neuroinflammation in major depressive disorder
    2396. Insights into neuroinflammation in Parkinson’s disease: from biomarkers to anti-inflammatory based therapies
    2397. Insights into the Role of neuroinflammation in the Pathogenesis of Multiple Sclerosis
    2398. Insights on the pathophysiology of Alzheimer’s disease: the crosstalk between amyloid pathology, neuroinflammation and the peripheral immune system
    2399. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-015-0282-z”>Insulin improves memory and reduces chronic neuroinflammation in the hippocampus of young but not aged brains
    2400. Insulin resistance, neuroinflammation, and Alzheimer’s disease
    2401. Insulin sensitizers improve learning and attenuate tau hyperphosphorylation and neuroinflammation in 3xTg-AD mice
    2402. Insulin Signaling Suppresses Virus Replication and neuroinflammation in HIV/AIDS (S53. 005)
    2403. Insulin treatment normalizes retinal neuroinflammation but not markers of synapse loss in diabetic rats
    2404. Insulin treatment prevents neuroinflammation and neuronal injury with restored neurobehavioral function in models of HIV/AIDS neurodegeneration
    2405. Insulin treatment protects the brain against neuroinflammation by reducing cerebral cytokines and modulating mitochondrial function
    2406. Insulin-like growth factor-1 and neuroinflammation
    2407. Integration of Th17-and lymphotoxin-derived signals initiates meningeal-resident stromal cell remodeling to propagate neuroinflammation
    2408. Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration
    2409. Integrin α5β1 inhibition by ATN-161 reduces neuroinflammation and is neuroprotective in ischemic stroke
    2410. Intensive Combination Immunotherapy and neuroinflammation Resolution in a Child With Anti-PCA-1 (Yo) Paraneoplastic Syndrome and 2 Malignancies
    2411. Interaction between CNS-resident cells and gut dysbiosis in multiple sclerosis: consequences on neuroinflammation
    2412. Interactions Between Neurons and Microglia During neuroinflammation
    2413. Interactions between the canonical WNT/beta-catenin pathway and PPAR gamma on neuroinflammation, demyelination, and remyelination in multiple sclerosis
    2414. Interactions of Aβ with endogenous anti-inflammatory agents: a basis for chronic neuroinflammation in Alzheimer’s disease
    2415. Interfering with the CCL2–glycosaminoglycan axis as a potential approach to modulate neuroinflammation
    2416. Interferon mediated neuroinflammation in polyglutamine disease is not caused by RNA toxicity
    2417. Interferon-β plays a detrimental role in experimental traumatic brain injury by enhancing neuroinflammation that drives chronic neurodegeneration
    2418. neuroinflammation&ots=hOgZ6fNPTZ&sig=6Z4oj6aRgr9HIlCQrN-Vvfs5bts”>Interleukin 1 Receptor and Alzheimer’s Disease-Related neuroinflammation
    2419. Interleukin 6 mediates neuroinflammation and motor coordination deficits after mild traumatic brain injury and brief hypoxia in mice
    2420. Interleukin-1, neuroinflammation, and Alzheimer’s disease
    2421. Interleukin-10 inhibits neuroinflammation-mediated apoptosis of ventral mesencephalic neurons via JAK-STAT3 pathway
    2422. Interleukin-17 contributes to neuroinflammation and neuropathic pain following peripheral nerve injury in mice
    2423. Interleukin-18, from neuroinflammation to Alzheimer’s disease
    2424. INTERLEUKIN-1α AS PLEIOTROPIC BIOMARKER FOR neuroinflammation IN ALZHEIMER’S DISEASE
    2425. Interleukin-1β in neuroinflammation associated to Alzheimer disease
    2426. neuroinflammation_in_Autism/links/5a00c366aca2725286dfb2e0/Interleukin-1b-Interleukin10-Ratio-Produced-by-Monocytes-as-a-Biomarker-of-neuroinflammation-in-Autism.pdf”>Interleukin-1β/interleukin10 ratio produced by monocytes as a biomarker of neuroinflammation in autism
    2427. Interleukin-6 trans-signaling: implications for neuroinflammation and cognitive deficits in the aged
    2428. Interleukin-6: A Marker of neuroinflammation in Glaucoma
    2429. Interleukin-7 is required for CD4+ T cell activation and autoimmune neuroinflammation
    2430. neuroinflammation,_and_secondary.54.aspx”>Interleukin-8, neuroinflammation, and secondary brain injury
    2431. Interleukin‐1: A master regulator of neuroinflammation
    2432. Intermittent fasting attenuates lipopolysaccharide-induced neuroinflammation and memory impairment
    2433. Intermittent low-level lead exposure provokes anxiety, hypertension, autonomic dysfunction and neuroinflammation
    2434. Internalization of particulate delivery systems by activated microglia influenced the therapeutic efficacy of simvastatin repurposing for neuroinflammation
    2435. Interplay between age and neuroinflammation in multiple sclerosis: effects on motor and cognitive functions
    2436. INTERPLAY OF CELLULAR ADAPTIVE IMMUNITY AND INNATE neuroinflammation IN ALZHEIMER’S DISEASE
    2437. Intra-amniotic LPS causes acute neuroinflammation in preterm rhesus macaques
    2438. Intra-and intercellular functions of redoxins during neuroinflammation
    2439. Intracellular delivery of dendrimer-based nanoconjugates for cancer and neuroinflammation
    2440. Intracellular Effectors of Synaptic Dysfunction and neuroinflammation in Alzheimer’s and other Neurodegenerative Diseases
    2441. Intracerebral delivery of brain-derived neurotrophic factor using HyStem®-C hydrogel implants improves functional recovery and reduces neuroinflammation in a rat …
    2442. Intracerebral interleukin-10 injection modulates post-ischemic neuroinflammation: an experimental microarray study
    2443. Intracerebroventricular Aβ-Induced neuroinflammation Alters Peripheral Immune Responses in Rats
    2444. Intracerebroventricular streptozotocin impairs adult neurogenesis and cognitive functions via regulating neuroinflammation and insulin signaling in adult rats
    2445. Intracisternal delivery of NFκB-inducible scAAV2/9 reveals locoregional neuroinflammation induced by systemic kainic acid treatment
    2446. Intracranial delivery of interleukin-17A via adeno-associated virus fails to induce physical and learning disabilities and neuroinflammation in mice but improves …
    2447. Intracranial electrode implantation produces regional neuroinflammation and memory deficits in rats
    2448. Intracranial injection of LPS in rat as animal model of neuroinflammation
    2449. Intranasal brain delivery of cationic nanoemulsion-encapsulated TNFα siRNA in prevention of experimental neuroinflammation
    2450. Intranasal delivery for peptide and siRNA to the brain using lipid-based nanocarriers for the treatment of neuroinflammation
    2451. Intranasal delivery of dexamethasone efficiently controls LPS‐induced murine neuroinflammation
    2452. Intranasal delivery of nerve growth factor attenuates neuroinflammation following traumatic brain injury in rats
    2453. Intranasal Exosomes for Treatment of neuroinflammation?: Prospects and Limitations
    2454. Intranasal insulin administration ameliorates streptozotocin (ICV)-induced insulin receptor dysfunction, neuroinflammation, amyloidogenesis, and memory impairment …
    2455. Intranasal insulin treatment alleviates methamphetamine induced anxiety-like behavior and neuroinflammation
    2456. Intranasal Methylprednisolone Effectively Reduces neuroinflammation in Mice With Experimental Autoimmune Encephalitis
    2457. Intranasal MMI-0100 attenuates Aβ1-42-and LPS-induced neuroinflammation and memory impairments via the MK2 signaling pathway
    2458. Intranasal post-cardiac arrest treatment with orexin-A facilitates arousal from coma and ameliorates neuroinflammation
    2459. Intranasally administered pitavastatin ameliorates pentylenetetrazol-induced neuroinflammation, oxidative stress and cognitive dysfunction
    2460. Intraperitoneal inoculation of Sandhoff mouse neonates with an HIV-1 based lentiviral vector exacerbates the attendant neuroinflammation and disease phenotype
    2461. Intrathecal application of the antimicrobial peptide CRAMP reduced mortality and neuroinflammation in an experimental model of pneumococcal meningitis
    2462. Intrathecal BCR transcriptome in multiple sclerosis versus other neuroinflammation: equally diverse and compartmentalized, but more mutated, biased and …
    2463. Intrathecal curcumin attenuates pain hypersensitivity and decreases spinal neuroinflammation in rat model of monoarthritis
    2464. Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation
    2465. Intrauterine inflammation induces sex-specific effects on neuroinflammation, white matter, and behavior
    2466. Intravenously infusing the secretome of adipose-derived mesenchymal stem cells ameliorates neuroinflammation and neurological functioning after traumatic brain …
    2467. Intravital correlated microscopy reveals differential macrophage and microglial dynamics during resolution of neuroinflammation
    2468. Intravitreal injection of adenosine A 2A receptor antagonist reduces neuroinflammation, vascular leakage and cell death in the retina of diabetic mice
    2469. Introduction to a special issue on cytokines in neuroinflammation and immunity
    2470. INVESTIGATE THE RELATIONSHIP BETWEEN TAU AND neuroinflammation IN ALZHEIMER’S DISEASE USING PET AND REACTION RATE MODELLING
    2471. Investigating Imaging Biomarkers of neuroinflammation and Neurodegeneration in Rodent Models of Alzheimer’s Disease
    2472. Investigating neuroinflammation and demyelination in the nervous system of Twitcher mice by the use of immunohistochemistry
    2473. Investigating the contribution of astrocytes and neuroinflammation to pathological tau changes in Alzheimer’s disease
    2474. INVESTIGATING THE LINK BETWEEN PATHOLOGICAL TAU ACCUMULATION, neuroinflammation AND BRAIN ATROPHY IN A MODEL OF TAUOPATHY
    2475. Investigating the mechanistic link between neuroinflammation and biometal homeostasis in neurodegenerative diseases
    2476. Investigating the role of the locus coeruleus-noradrenergic system during social stress on neuroinflammation and resulting changes in serotonin
    2477. Investigation into RAGE as a biomarker of the LPS-induced murine model of neuroinflammation
    2478. investigation into the effects of tenilsetam on markers of neuroinflammation in GFAP-IL6 mice
    2479. Investigation of consequences of chronic neuroinflammation in the cerebellum and brainstem regions of young rats
    2480. Investigation of how endoplasmic reticulum stress causes insulin resistance and neuroinflammation
    2481. Investigation of the Effects of Image Signal-to-noise Ratio on TSPO PET Quantification of neuroinflammation
    2482. Investigation of the Nrf2-Mediated inhibition of neuroinflammation by diosgenin
    2483. INVESTIGATION OF THE RELATIONSHIP BETWEEN TAU AND neuroinflammation IN ALZHEIMER’S DISEASE USING PET AND REACTION MODELLING
    2484. Investigations into the role of 26S proteasome non-ATPase regulatory subunit 13 in neuroinflammation
    2485. Involvement of acute neuroinflammation in postoperative delirium-like cognitive deficits in rats
    2486. Involvement of AMP-activated protein kinase in neuroinflammation and neurodegeneration in the adult and developing brain
    2487. Involvement of bone marrow cells and neuroinflammation in hypertension
    2488. Involvement of early growth response-2 (Egr-2) in lipopolysaccharide-induced neuroinflammation
    2489. INVOLVEMENT OF ELEVATED neuroinflammation IN KEY REGIONS OF THE PAIN PATHWAY IN NOCICEPTIVE PROCESSING IN ALZHEIMER’S DISEASE
    2490. Involvement of neuroinflammation during brain development in social cognitive deficits in autism spectrum disorder and schizophrenia
    2491. Involvement of neuroinflammation in models of neurodegeneration
    2492. Involvement of neuroinflammation in the pathogenesis of monocrotaline-induced pulmonary hypertension
    2493. Involvement of NLRC4 inflammasome through caspase-1 and IL-1β augments neuroinflammation and contributes to memory impairment in an experimental model of …
    2494. Involvement of NMDA receptors in both MPTP-induced neuroinflammation and deficits in episodic-like memory in Wistar rats
    2495. Involvement of NMDA receptors in both MPTP-induced neuroinflammation and deficits in episodic-like memory in Wistar rats
    2496. Involvement of rat hippocampal astrocytes in β-amyloid-induced angiogenesis and neuroinflammation
    2497. Ion Transporters in Microglial Function: New Therapeutic Targets for neuroinflammation in Ischemic Stroke?
    2498. Iptakalim alleviates rotenone-induced degeneration of dopaminergic neurons through inhibiting microglia-mediated neuroinflammation
    2499. Irisin attenuates neuroinflammation and prevents the memory and cognitive deterioration in streptozotocin-induced diabetic mice
    2500. Iron, neuroinflammation, and Alzheimer’s disease
    2501. Irradiation of Mouse Brain Leads to neuroinflammation and Delayed Infiltration of Immune Cells: Role of Interleukin-1 and CCR2 Signaling
    2502. Is calprotectin a novel biomarker of neuroinflammation in diabetic periferal neuropathy?
    2503. Is neuroinflammation in the injured spinal cord different than in the brain? Examining intrinsic differences between the brain and spinal cord
    2504. Is neuroinflammation involved in the development of dementia in patients with Parkinson’s disease?
    2505. Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation?
    2506. Ischemia-induced neuroinflammation is associated with disrupted development of oligodendrocyte progenitors in a model of periventricular leukomalacia
    2507. Ischemia-reperfusion injury as a model of activation and resolution of retinal neuroinflammation and vascular permeability
    2508. Isoflurane‑induced postoperative cognitive dysfunction is mediated by hypoxia‑inducible factor‑1α‑dependent neuroinflammation in aged rats
    2509. Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer’s disease
    2510. Isolated spinal cord contusion in rats induces chronic brain neuroinflammation, neurodegeneration, and cognitive impairment: Involvement of cell cycle activation
    2511. Isoliquiritigenin attenuates neuroinflammation in traumatic brain injury in young rats
    2512. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic …
    2513. Isorhynchophylline exerts antidepressant-like effects in mice via modulating neuroinflammation and neurotrophins: involvement of the PI3K/Akt/GSK-3β signaling …
    2514. Isothiocyanates are promising compounds against oxidative stress, neuroinflammation and cell death that may benefit neurodegeneration in Parkinson’s disease
    2515. Isovitexin regulates microglia M1/M2 polarization in LPS-induced neuroinflammation via activation of CaMKKβ/AMPK-PGC-1α signaling axis
    2516. Isovitexin-Mediated Regulation of Microglial Polarization in Lipopolysaccharide-Induced neuroinflammation via Activation of the CaMKKβ/AMPK-PGC-1α …
    2517. Itk signals promote neuroinflammation by regulating CD4+ T-cell activation and trafficking
    2518. IκBα deficiency in brain leads to elevated basal neuroinflammation and attenuated response following traumatic brain injury: implications for functional …
    2519. Janus faces of amyloid proteins in neuroinflammation
    2520. Involvement of rat hippocampal astrocytes in β-amyloid-induced angiogenesis and neuroinflammation
    2521. Ion Transporters in Microglial Function: New Therapeutic Targets for neuroinflammation in Ischemic Stroke?
    2522. Iptakalim alleviates rotenone-induced degeneration of dopaminergic neurons through inhibiting microglia-mediated neuroinflammation
    2523. Irisin attenuates neuroinflammation and prevents the memory and cognitive deterioration in streptozotocin-induced diabetic mice
    2524. Iron, neuroinflammation, and Alzheimer’s disease
    2525. Irradiation of Mouse Brain Leads to neuroinflammation and Delayed Infiltration of Immune Cells: Role of Interleukin-1 and CCR2 Signaling
    2526. Is calprotectin a novel biomarker of neuroinflammation in diabetic periferal neuropathy?
    2527. Is neuroinflammation in the injured spinal cord different than in the brain? Examining intrinsic differences between the brain and spinal cord
    2528. Is neuroinflammation involved in the development of dementia in patients with Parkinson’s disease?
    2529. Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation?
    2530. Ischemia-induced neuroinflammation is associated with disrupted development of oligodendrocyte progenitors in a model of periventricular leukomalacia
    2531. Ischemia-reperfusion injury as a model of activation and resolution of retinal neuroinflammation and vascular permeability
    2532. Isoflurane‑induced postoperative cognitive dysfunction is mediated by hypoxia‑inducible factor‑1α‑dependent neuroinflammation in aged rats
    2533. Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer’s disease
    2534. Isolated spinal cord contusion in rats induces chronic brain neuroinflammation, neurodegeneration, and cognitive impairment: Involvement of cell cycle activation
    2535. Isoliquiritigenin attenuates neuroinflammation in traumatic brain injury in young rats
    2536. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic …
    2537. Isorhynchophylline exerts antidepressant-like effects in mice via modulating neuroinflammation and neurotrophins: involvement of the PI3K/Akt/GSK-3β signaling …
    2538. Isothiocyanates are promising compounds against oxidative stress, neuroinflammation and cell death that may benefit neurodegeneration in Parkinson’s disease
    2539. Isovitexin regulates microglia M1/M2 polarization in LPS-induced neuroinflammation via activation of CaMKKβ/AMPK-PGC-1α signaling axis
    2540. Isovitexin-Mediated Regulation of Microglial Polarization in Lipopolysaccharide-Induced neuroinflammation via Activation of the CaMKKβ/AMPK-PGC-1α …
    2541. Itk signals promote neuroinflammation by regulating CD4+ T-cell activation and trafficking
    2542. IκBα deficiency in brain leads to elevated basal neuroinflammation and attenuated response following traumatic brain injury: implications for functional …
    2543. Janus faces of amyloid proteins in neuroinflammation
    2544. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-9-175″>JNK signaling is the shared pathway linking neuroinflammation, blood–brain barrier disruption, and oligodendroglial apoptosis in the white matter injury of the …
    2545. JNK signaling pathway regulates the process of neuroinflammation and apoptosis of nigral cells in the MPTP mouse model of subacute Parkinson′ s disease [J]
    2546. JNK-IN-8, a c-Jun N-terminal kinase inhibitor, improves functional recovery through suppressing neuroinflammation in ischemic stroke
    2547. JNK‐IN‐8, ac‐Jun N‐terminal kinase inhibitor, improves functional recovery through suppressing neuroinflammation in ischemic stroke
    2548. JSH‐23 targets nuclear factor‐kappa B and reverses various deficits in experimental diabetic neuropathy: effect on neuroinflammation and antioxidant defence
    2549. Juglanin ameliorates LPS-induced neuroinflammation in animal models of Parkinson’s disease and cell culture via inactivating TLR4/NF-κB pathway
    2550. Juglone prevents metabolic endotoxemia-induced hepatitis and neuroinflammation via suppressing TLR4/NF-κB signaling pathway in high-fat diet rats
    2551. Junctional complexes of the blood–brain barrier: permeability changes in neuroinflammation
    2552. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1269-3″>K284-6111 prevents the amyloid beta-induced neuroinflammation and impairment of recognition memory through inhibition of NF-κB-mediated CHI3L1 …
    2553. Kaempferol acts through mitogen‐activated protein kinases and protein kinase B/AKT to elicit protection in a model of neuroinflammation in BV2 microglial cells
    2554. Kaempferol alleviates LPS-induced neuroinflammation and BBB dysfunction in mice via inhibiting HMGB1 release and down-regulating TLR4/MyD88 pathway
    2555. Kaempferol attenuates cognitive deficit via regulating oxidative stress and neuroinflammation in an ovariectomized rat model of sporadic dementia
    2556. Kaempferol attenuates LPS-induced striatum injury in mice involving anti-neuroinflammation, maintaining BBB integrity, and down-regulating the HMGB1 …
    2557. Kaempferol attenuates neuroinflammation and blood brain barrier dysfunction to improve neurological deficits in cerebral ischemia/reperfusion rats
    2558. KCa3. 1 deficiency attenuates neuroinflammation by regulating an astrocyte phenotype switch involving the PI3K/AKT/GSK3β pathway
    2559. Ketamine-mediated alleviation of electroconvulsive shock-induced memory impairment is associated with the regulation of neuroinflammation and soluble amyloid …
    2560. Ketogenic diet-induced peroxisome proliferator-activated receptor-γ activation decreases neuroinflammation in the mouse hippocampus after kainic acid-induced …
    2561. Kinetics of the neuroinflammation-oxidative stress correlation in rat brain following the injection of fibrillar amyloid-β onto the hippocampus in vivo
    2562. Kinin B1 Receptor Blockade Prevents Angiotensin II-induced neuroinflammation and Oxidative Stress in Primary Hypothalamic Neurons
    2563. Kinins and microglial responses in bipolar disorder: a neuroinflammation hypothesis
    2564. Kinins and neuroinflammation: dual effect on prostaglandin synthesis
    2565. Knockdown of cathepsin D protects dopaminergic neurons against neuroinflammation‐mediated neurotoxicity through inhibition of NF‐κB signalling pathway in …
    2566. Knockdown of circulating C1 inhibitor induces neurovascular impairment, glial cell activation, neuroinflammation, and behavioral deficits
    2567. Knockdown of endogenous circulating C1 inhibitor induces neurovascular impairment, neuroinflammation and cognitive decline
    2568. Knockdown of hippocampal cysteinyl leukotriene receptor 1 prevents depressive behavior and neuroinflammation induced by chronic mild stress in mice
    2569. Knockdown of interleukin-1 receptor type-1 on endothelial cells attenuated stress-induced neuroinflammation and prevented anxiety-like behavior
    2570. Korean Red Ginseng alleviates neuroinflammation and promotes cell survival in the intermittent heat stress-induced rat brain by suppressing oxidative stress …
    2571. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0876-8″>Kososan, a Kampo medicine, prevents a social avoidance behavior and attenuates neuroinflammation in socially defeated mice
    2572. Koumine decreases astrocyte-mediated neuroinflammation and enhances autophagy, contributing to neuropathic pain from chronic constriction injury in rats
    2573. Krabbe disease: cytototicity and neuroinflammation
    2574. KRICT-9 inhibits neuroinflammation, amyloidogenesis and memory loss in Alzheimer’s disease models
    2575. Krüppel-like factor 4 regulates amyloid-β (Aβ)-induced neuroinflammation in Alzheimer’s disease
    2576. Krüppel-like factor 4, a novel transcription factor regulates microglial activation and subsequent neuroinflammation
    2577. Kukoamine A prevents radiation-induced neuroinflammation and preserves hippocampal neurogenesis in rats by inhibiting activation of NF-κB and AP-1
    2578. Kynurenine pathway metabolic balance influences microglia activity: targeting kynurenine monooxygenase to dampen neuroinflammation
    2579. Kynurenines, gender and neuroinflammation; showcase schizophrenia
    2580. L-8 is a key mediator of neuroinflammation in severe traumatic brain injuries
    2581. L-F001, a novel multifunctional ROCK inhibitor, suppresses neuroinflammation in vitro and in vivo: involvement of NF-κB inhibition and Nrf2 pathway activation
    2582. l‐DOPA‐induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?
    2583. l‐DOPA‐induced dyskinesia in Parkinson’s disease: Are neuroinflammation and astrocytes key elements?
    2584. Lack of chronic neuroinflammation in the absence of focal hemorrhage in a rat model of low-energy blast-induced TBI
    2585. Lack of Galectin-3 attenuates neuroinflammation and protects the retina and optic nerve of diabetic mice
    2586. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-015-0390-9″>Lack of neuroinflammation in the HIV-1 transgenic rat: an [18 F]-DPA714 PET imaging study
    2587. Lack of Rhes increases MDMA-induced neuroinflammation and dopamine neuron degeneration: Role of gender and age
    2588. neuroinflammation-and-memory-impairment-in-vitro-and-in-vivo/28B25A5C3FE4186AC8F34EAED7C68458″>Lactobacilli-fermented cow’s milk attenuated lipopolysaccharide-induced neuroinflammation and memory impairment in vitro and in vivo
    2589. Lanthionine ketimine ester promotes locomotor recovery after spinal cord injury by reducing neuroinflammation and promoting axon growth
    2590. Laser Moxibustion Alleviates Knee Osteoarthritis Pain by Inhibiting Spinal Microglial Activation-Mediated neuroinflammation in Rats
    2591. Late aging–associated increases in L-DOPA–induced dyskinesia are accompanied by heightened neuroinflammation in the hemi-parkinsonian rat
    2592. Late anxiety-like behavior and neuroinflammation in mice subjected to sublethal polymicrobial sepsis
    2593. Late exercise reduces neuroinflammation and cognitive dysfunction after traumatic brain injury
    2594. Lateral cerebellar nucleus stimulation promotes motor recovery and suppresses neuroinflammation in a fluid percussion injury rodent model
    2595. Lateral fluid percussion brain injury in the mouse: regional and temporal characterization of neuroinflammation
    2596. Leishmania infection and neuroinflammation: Specific chemokine profile and absence of parasites in the brain of naturally-infected dogs
    2597. Lentivirus infection causes neuroinflammation and neuronal injury in dorsal root ganglia: pathogenic effects of STAT-1 and inducible nitric oxide synthase
    2598. Lentivirus-mediated downregulation of α-synuclein reduces neuroinflammation and promotes functional recovery in rats with spinal cord injury
    2599. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1117-5″>Lentivirus-mediated overexpression of OTULIN ameliorates microglia activation and neuroinflammation by depressing the activation of the NF-κB signaling …
    2600. Leonurine exerts antidepressant-like effects in the chronic mild stress-induced depression model in mice by inhibiting neuroinflammation
    2601. Leonurine suppresses neuroinflammation through promoting oligodendrocyte maturation
    2602. Leptin, neuroinflammation and obesity
    2603. Less estrogen, more neuroinflammation
    2604. Letter to the Editor. Impaired glymphatic pathway as potential contributing factor in amyloid beta accumulation and enhanced neuroinflammation after IVH
    2605. Leucine rich repeats and calponin homology domain containing 1 inhibits microglia-mediated neuroinflammation in a rat traumatic spinal cord injury model
    2606. Leucine-rich repeat kinase 2 modulates neuroinflammation and neurotoxicity in models of human immunodeficiency virus 1-associated neurocognitive disorders
    2607. Leukotriene-mediated neuroinflammation, toxic brain damage, and neurodegeneration in acute methanol poisoning
    2608. neuroinflammation_in_Disease_Development/links/5e30390a92851c7f7f05efb9/Lichen-Planus-Sparing-the-Extremity-Affected-by-Poliomyelitis-The-Profound-Role-of-neuroinflammation-in-Disease-Development.pdf”>Lichen Planus Sparing the Extremity Affected by Poliomyelitis: The Profound Role of neuroinflammation in Disease Development
    2609. Licofelone modulates neuroinflammation and attenuates mechanical hypersensitivity in the chronic phase of spinal cord injury
    2610. Lidocaine alleviates morphine tolerance via AMPK-SOCS3-dependent neuroinflammation suppression in the spinal cord
    2611. Lidocaine injection into the rat dorsal root ganglion causes neuroinflammation
    2612. Ligustilide ameliorates neuroinflammation and brain injury in focal cerebral ischemia/reperfusion rats: involvement of inhibition of TLR4/peroxiredoxin 6 signaling
    2613. Limiting Autoimmune neuroinflammation using Novel T Cell Suppressants & Investigating Overlapping Lysosomal Reductase Function in Macrophages and …
    2614. LIMITING FACTORS IN SELF-PACED EXERCISE TOLERANCE-THE ROLE OF neuroinflammation AND CENTRAL SENSITISATION
    2615. lincRNA-Cox2 regulates NLRP3 inflammasome and autophagy mediated neuroinflammation
    2616. Linking Gut Dysbiosis and neuroinflammation Observed in Individuals with Autism Spectrum Disorder and Possible Treatment with Bacteroides Fragilis
    2617. Linking neuroinflammation and Glial Phenotypic Changes in Neurological Diseases
    2618. Linking neuroinflammation and neurodegeneration in Parkinson’s disease
    2619. Lipid dynamics in LPS-induced neuroinflammation by DESI-MS imaging
    2620. Lipid metabolism and neuroinflammation in Alzheimer’s disease: a role for liver X receptors
    2621. Lipid rafts in glial cells: Role in neuroinflammation and pain processing
    2622. Lipid-core nanocapsules improve the effects of resveratrol against Aβ-induced neuroinflammation
    2623. Lipocalin-2 deficiency attenuates neuroinflammation and brain injury after transient middle cerebral artery occlusion in mice
    2624. Lipocalin-2: a new regulator of nonpathogen-associated neuroinflammation
    2625. Lipolysaccharide-induced neuroinflammation is associated with Alzheimer-like amyloidogenic axonal pathology and dendritic degeneration in rats
    2626. Lipopolysaccharide induces neuroinflammation in microglia by activating the MTOR pathway and downregulating Vps34 to inhibit autophagosome formation
    2627. Lipopolysaccharide preconditioning reduces neuroinflammation against hypoxic ischemia and provides long-term outcome of neuroprotection in neonatal rat
    2628. Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular …
    2629. neuroinflammation_leads_to_the_accumulation_of_ubiquitinated_proteins_and_increases_susceptibility_to_neurodegeneration_induced_by_proteasome_inhibition_in_rat_hippocampus/links/09e41506554324c6f5000000.pdf”>Lipopolysaccharide-induced neuroinflammation
    2630. Lipopolysaccharide-induced neuroinflammation as a bridge to understand neurodegeneration
    2631. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1490-8″>Lipopolysaccharide-induced neuroinflammation induces presynaptic disruption through a direct action on brain tissue involving microglia-derived interleukin …
    2632. Lipopolysaccharide-induced neuroinflammation leads to the accumulation of ubiquitinated proteins and increases susceptibility to neurodegeneration …
    2633. Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid β peptide in APPswe transgenic mice
    2634. Lipopolysacharide-induced neuroinflammation leads to the accumulation of ubiquitinated proteins and increases susceptibility to neurodegeneration induced …
    2635. Lipotoxicity, neuroinflammation, glial cells and oestrogenic compounds
    2636. Lipotoxicity, neuroinflammation, glial cells and oestrogenic compounds
    2637. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0540-8″>Lipoxin A4 inhibits microglial activation and reduces neuroinflammation and neuropathic pain after spinal cord hemisection
    2638. Lithium ameliorates neurodegeneration, suppresses neuroinflammation, and improves behavioral performance in a mouse model of traumatic brain injury
    2639. Lithium and memantine improve spatial memory impairment and neuroinflammation induced by β-amyloid 1-42 oligomers in rats
    2640. Lithium modifies brain arachidonic and docosahexaenoic metabolism in rat lipopolysaccharide model of neuroinflammation
    2641. Live imaging of neuroinflammation reveals sex and estrogen effects on astrocyte response to ischemic injury
    2642. Liver X receptor activation enhances cholesterol loss from the brain, decreases neuroinflammation, and increases survival of the NPC1 mouse
    2643. Liver X Receptor α Is Involved in Counteracting Mechanical Allodynia by Inhibiting neuroinflammation in the Spinal Dorsal Horn
    2644. Liver X receptors activation decreases neuroinflammation in Parkinson’s disease (846.5)
    2645. Liver X receptors activation, through TO901317 binding, reduces neuroinflammation in Parkinson’s disease
    2646. Lixisenatide reduces amyloid plaques, neurofibrillary tangles and neuroinflammation in an APP/PS1/tau mouse model of Alzheimer’s disease
    2647. Lnhibitory effects of hua feng dan on microglia-mediated neuroinflammation
    2648. Loading into nanoparticles improves quercetin’s efficacy in preventing neuroinflammation induced by oxysterols
    2649. Local glutamate level dictates adenosine A2A receptor regulation of neuroinflammation and traumatic brain injury
    2650. Local neuroinflammation and the progression of Alzheimer’s disease
    2651. Localized calcium accumulations prime synapses for phagocyte removal in cortical neuroinflammation
    2652. Locus coeruleus neurons are most sensitive to chronic neuroinflammation-induced neurodegeneration
    2653. Long Non-coding RNA MALAT1 Inhibits Neuron Apoptosis and neuroinflammation While Stimulates Neurite Outgrowth and Its Correlation With MiR-125b Mediates …
    2654. Long noncoding RNA H19 promotes neuroinflammation in ischemic stroke by driving histone deacetylase 1–dependent M1 microglial polarization
    2655. Long noncoding RNA SNHG1 promotes neuroinflammation in Parkinson’s disease via regulating miR-7/NLRP3 pathway
    2656. Long-term administration of melatonin attenuates neuroinflammation in the aged mouse brain
    2657. Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate …
    2658. Long-term dietary supplementation of pomegranates, figs and dates alleviate neuroinflammation in a transgenic mouse model of Alzheimer’s disease
    2659. Long-term impact of intrauterine neuroinflammation and treatment with magnesium sulphate and betamethasone: Sex-specific differences in a preterm labor …
    2660. Long-term neuroinflammation induced by influenza A virus infection and the impact on hippocampal neuron morphology and function
    2661. Long-term pain, neuroinflammation and glial activation
    2662. Long-term voluntary wheel running does not alter vascular amyloid burden but reduces neuroinflammation in the Tg-SwDI mouse model of cerebral amyloid …
    2663. Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6‐hydroxydopamine rat model of Parkinson’s disease
    2664. Longitudinal investigation of neuroinflammation and metabolite profiles in the APPswe×PS1Δe9 transgenic mouse model of Alzheimer’s disease
    2665. Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer’s disease enabled by positron …
    2666. Loss of brain norepinephrine elicits neuroinflammation-mediated oxidative injury and selective caudo-rostral neurodegeneration
    2667. Loss of function due to neuroinflammation: A role for oxygen therapy?
    2668. Loss of G as6 and A xl signaling results in extensive axonal damage, motor deficits, prolonged neuroinflammation, and less remyelination following cuprizone …
    2669. Loss of IGF1R from oligodendrocytes ameliorates neuroinflammation without affecting cell survival
    2670. Loss of microglial parkin inhibits necroptosis and contributes to neuroinflammation
    2671. Loss of PAFR prevents neuroinflammation and brain dysfunction after traumatic brain injury
    2672. Loss of tissue-nonspecific alkaline phosphatase (TNAP) enzyme activity in cerebral microvessels is coupled to persistent neuroinflammation and behavioral deficits in …
    2673. Low avidity CD8+ T cells in viral infection: From neuroinflammation to adoptive T cell therapy
    2674. Low cerebral blood flow is a non-invasive biomarker of neuroinflammation after repetitive mild traumatic brain injury
    2675. Low sucrose, omega-3 enriched diet has region-specific effects on neuroinflammation and synaptic function markers in a mouse model of doxorubicin-based …
    2676. Low-density lipoprotein receptor deficiency attenuates neuroinflammation through the induction of apolipoprotein E
    2677. Low-dose NSAIDs reduce pain via macrophage targeted nanoemulsion delivery to neuroinflammation of the sciatic nerve in rat
    2678. Low-Dose Subcutaneous Anti-CD20 Treatment Depletes Disease Relevant B Cell Subsets and Attenuates neuroinflammation
    2679. Low-grade neuroinflammation due to chronic sleep deprivation results in anxiety and learning and memory impairments
    2680. Low-intensity pulsed ultrasound attenuates LPS-induced neuroinflammation and memory impairment by modulation of TLR4/NF-κB signaling and CREB/BDNF …
    2681. Low-level primary blast induces neuroinflammation and neurodegeneration in rats
    2682. Low-Molecular Weight Metabolites from Polyphenols as Effectors for Attenuating neuroinflammation
    2683. Low, but not high, dose triptolide controls neuroinflammation and improves behavioral deficits in toxic model of multiple sclerosis by dampening of NF-κB activation …
    2684. LPS and neuroinflammation: a matter of timing
    2685. LPS induces mediators of neuroinflammation, cell proliferation, and GFAP expression in human astrocytoma cells U373MG: the anti-inflammatory and anti-proliferative …
    2686. LPS-induced murine neuroinflammation model: main features and suitability for pre-clinical assessment of nutraceuticals
    2687. LPS-induced proNGF synthesis and release in the N9 and BV2 microglial cells: a new pathway underling microglial toxicity in neuroinflammation
    2688. LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
    2689. LRRK2 kinase activity induces mitochondrial fission in microglia via Drp1 and modulates neuroinflammation
    2690. LRRK2 regulates innate immune responses and neuroinflammation during Mycobacterium tuberculosis infection
    2691. Lumbar nerve root injury induces central nervous system neuroimmune activation and neuroinflammation in the rat: relationship to painful radiculopathy
    2692. Lupeol inhibits LPS-induced neuroinflammation in cerebellar cultures and induces neuroprotection associated to the modulation of astrocyte response and expression …
    2693. Luteolin could improve cognitive dysfunction by inhibiting neuroinflammation
    2694. Luteolin reduces primary hippocampal neurons death induced by neuroinflammation
    2695. Luteoloside attenuates neuroinflammation in focal cerebral ischemia in rats via regulation of the PPARγ/Nrf2/NF-κB signaling pathway
    2696. LW-AFC Attenuates LPS-Induced neuroinflammation via Inhibiting Nuclear Factor-Kappa B Signaling
    2697. Lychee seed fraction inhibits Aβ (1-42)-induced neuroinflammation in BV-2 cells via NF-κB signaling pathway
    2698. Lycopene attenuates insulin signaling deficits, oxidative stress, neuroinflammation, and cognitive impairment in fructose-drinking insulin resistant rats
    2699. Lycopene supplementation attenuates oxidative stress, neuroinflammation, and cognitive impairment in aged CD-1 mice
    2700. Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and neuroinflammation in a Rat Model of Parkinson’s Disease
    2701. Lymphatic Drainage of the CNS and Its Role in neuroinflammation and Neurodegenerative Disease
    2702. Lymphoid chemokines in chronic neuroinflammation
    2703. Lysosomal Dysfunction in Brain Aging and Neurodegeneration: Roles in Trophic Signaling and neuroinflammation
    2704. Macranthol attenuates lipopolysaccharide-induced depressive-like behaviors by inhibiting neuroinflammation in prefrontal cortex
    2705. Macrophage galactose-type lectin (MGL) is induced on M2 microglia and participates in the resolution phase of autoimmune neuroinflammation
    2706. Macrophage migration inhibitory factor (MIF) decreases neuroinflammation in the solitary tract nucleus (NTS) of spontaneously hypertensive rats (SHR).
    2707. Macrophage migration inhibitory factor potentiates autoimmune-mediated neuroinflammation
    2708. Macrophage migration inhibitory factor promotes central nervous system pathology in a model of neuroinflammation (35.8)
    2709. Macrophage-derived extracellular succinate licenses neural stem cells to suppress chronic neuroinflammation
    2710. Macrophage-inducible C-type lectin/spleen tyrosine kinase signaling pathway contributes to neuroinflammation after subarachnoid hemorrhage in rats
    2711. Macrophages in neuroinflammation: role of the renin-angiotensin-system
    2712. Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation
    2713. Magnesium ion influx reduces neuroinflammation in Aβ precursor protein/Presenilin 1 transgenic mice by suppressing the expression of interleukin-1β
    2714. Magnesium lithospermate B suppresses lipopolysaccharide-induced neuroinflammation in BV2 microglial cells and attenuates neurodegeneration in …
    2715. Magnesium sulfate attenuates brain edema by lowering AQP4 expression and inhibits glia-mediated neuroinflammation in a rodent model of eclampsia
    2716. Magnesium sulfate provides neuroprotection in eclampsia-like seizure model by ameliorating neuroinflammation and brain edema
    2717. Magnesium sulfate treatment reverses seizure susceptibility and decreases neuroinflammation in a rat model of severe preeclampsia
    2718. Magnetic resonance imaging as a tool to image neuroinflammation in a rat model of P arkinson’s disease–phagocyte influx to the brain is promoted by bilberry …
    2719. Magnetic resonance imaging of glutamate in neuroinflammation
    2720. neuroinflammation_in.98491.aspx”>Magnetic resonance imaging of neuroinflammation in chronic pain: a role for astrogliosis?
    2721. Magnetic resonance molecular imaging of post‐stroke neuroinflammation with a P‐selectin targeted iron oxide nanoparticle
    2722. Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain
    2723. Magnolol abrogates chronic mild stress-induced depressive-like behaviors by inhibiting neuroinflammation and oxidative stress in the prefrontal cortex of mice
    2724. Mammary tumor and mastectomy synergistically promote neuroinflammation in a breast cancer survivor model
    2725. Mammary tumors induce neuroinflammation, but not behavioral deficits in Balb/C mice
    2726. Management of glia-mediated neuroinflammation and related patents
    2727. Manganese Exposure Induces neuroinflammation by Impairing Mitochondrial Dynamics in Astrocytes
    2728. Manganese exposure induces neuroinflammation by impairing mitochondrial dynamics in astrocytes
    2729. Manganese induces neuroinflammation via NF-κB/ROS NLRP3 pathway in rat brain striatum and HAPI cells
    2730. Manganese-induced neurotoxicity: new insights into protein misfolding, mitochondrial impairment and neuroinflammation
    2731. Manipulation of the Gut Microbiome: Influencing alcohol-induced neuroinflammation
    2732. neuroinflammation&ots=Nt1EPelELO&sig=3Pzjub43OxKfSGyj7YK64lYrFXc”>Many causes of delirium have been proposed, including neuroinflammation, neuronal aging, oxidative stress, neurotransmitter deficiency, neuroendocrinopathy …
    2733. MAPK-activated protein kinase 2 (MK2) in neuroinflammation, Hsp27 phosphorylation and cell cycle: Role and Targeting
    2734. MAPKAP kinase 2‐deficiency prevents neurons from cell death by reducing neuroinflammation–relevance in a mouse model of Parkinson’s disease
    2735. Mapping neuroinflammation in frontotemporal dementia with molecular PET imaging
    2736. Mapping neuroinflammation in vivo in healthy aging and Alzheimer’s disease: A PET study using a novel translocator protein 18kDA (TSPO) radioligand,[18F]-FEPPA
    2737. Maresin 1 attenuates neuroinflammation in a mouse model of perioperative neurocognitive disorders
    2738. Marine pharmacology: therapeutic targeting of matrix metalloproteinases in neuroinflammation
    2739. Markers of neuroinflammation and neuronal injury in bipolar disorder: Relation to prospective clinical outcomes
    2740. Markers of neuroinflammation associated with Alzheimer’s disease pathology in older adults
    2741. Markers of neuroinflammation influence measures of cortical thickness in bipolar depression
    2742. Mast cell–glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide
    2743. Mast cells and neuroinflammation
    2744. Mast Cells Augment neuroinflammation and Neurodegeneration
    2745. Mast cells in neuroinflammation and brain disorders
    2746. neuroinflammation&ots=nzdAElKJQb&sig=JGZ2QVVHUwTbKK_yo7hv77dQ3OM”>Mast Cells in Stress, Pain, Blood-Brain Barrier, neuroinflammation and Alzheimer’s
    2747. Mast cells in stress, pain, blood-brain barrier, neuroinflammation and Alzheimer’s disease
    2748. Mast cells, glia and neuroinflammation: partners in crime?
    2749. Mast Cells, neuroinflammation and Pain in Fibromyalgia Syndrome
    2750. Matairesinol suppresses neuroinflammation and migration associated with Src and ERK1/2-NF-κB pathway in activating BV2 microglia
    2751. Maternal alcohol binge drinking induces persistent neuroinflammation associated with myelin damage and behavioural dysfunctions in offspring mice
    2752. Maternal immune activation in late gestation increases neuroinflammation and aggravates experimental autoimmune encephalomyelitis in the offspring
    2753. Maternal immune activation increases neuroinflammation and aggravates EAE in adult offspring
    2754. Maternal separation induces neuroinflammation and long-lasting emotional alterations in mice
    2755. Matrine ameliorates anxiety and depression-like behaviour by targeting hyperammonemia-induced neuroinflammation and oxidative stress in CCl4 model of liver …
    2756. Matrix metalloprotease-9 release from monocytes increases as a function of differentiation: implications for neuroinflammation and neurodegeneration
    2757. Matrix metalloproteinase 9 in epilepsy: the role of neuroinflammation in seizure development
    2758. Matrix metalloproteinase inhibitors attenuate neuroinflammation following focal cerebral ischemia in mice
    2759. MATRIX METALLOPROTEINASE-12 ACTIVITY IN A NEUROPATHIC PAIN RODENT MODEL: IMPACT ON neuroinflammation RESPONSE: 29
    2760. Matrix metalloproteinase-12 contributes to neuroinflammation in the aged brain
    2761. Matrix metalloproteinase-8 plays a pivotal role in neuroinflammation by modulating TNF-α activation
    2762. Matrix metalloproteinase-mediated neuroinflammation in vascular cognitive impairment of the Binswanger type
    2763. Matrix metalloproteinases and neuroinflammation in multiple sclerosis
    2764. Matrix metalloproteinases and proteolytic opening of the blood-brain barrier in neuroinflammation
    2765. Matrix metalloproteinases in neuroinflammation
    2766. Matrix metalloproteinases in neuroinflammation and cerebral ischemia
    2767. MATRIX METALOPROTEINASE INHIBITOR PROTECTS FROM neuroinflammation AND PAIN.
    2768. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1589-y”>MCP1-CCR2 and neuroinflammation in the ALS motor cortex with TDP-43 pathology
    2769. MDA5-Associated neuroinflammation and the Singleton–Merten Syndrome: Two Faces of the Same Type I Interferonopathy Spectrum
    2770. MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex
    2771. Measuring neuroinflammation in hemiparkinsonian rhesus treated with iPSC-derived dopaminergic neuronal grafts using [18F] FEPPA PET
    2772. Mechanism of antrocytic connexin-43 autophagy degradation in oxygen-glucose deprivation and its effect on neuroinflammation
    2773. Mechanism of neuroinflammation: enhanced cytotoxicity and IL-17 production via CD46 binding
    2774. Mechanism of Non-receptor Tyrosine Kinase Src Regulating neuroinflammation Through Phosphatase and Tensin Homology Protein in Microglia.
    2775. Mechanisms and implications of regional sensitivity to neuroinflammation: in vivo and in vitro studies
    2776. Mechanisms behind T cell-mediated neuroinflammation
    2777. Mechanisms of dietary flavonoid action in neuronal function and neuroinflammation
    2778. Mechanisms of glucocorticoids in the control of neuroinflammation
    2779. neuroinflammation&ots=hOgZ6fNOSU&sig=tGJiamClvtlXoR8-6YkxDiivlFM”>Mechanisms of neuroinflammation
    2780. Mechanisms of neuroinflammation and inflammatory mediators involved in brain injury following subarachnoid hemorrhage.
    2781. Mechanisms of neuroinflammation and inflammatory neurodegeneration in acute brain injury
    2782. Mechanisms of stress-dependent neuroinflammation and their implications for understanding consequences of alcohol exposure
    2783. Mechanisms of Synaptic Alterations in a neuroinflammation Model of Autism
    2784. Mechanisms to prevent the toxicity of chronic neuroinflammation on forebrain cholinergic neurons
    2785. Mechanisms underlying select chemotherapeutic-agent-induced neuroinflammation and subsequent neurodegeneration
    2786. Mediators of neuroinflammation
    2787. Mediators of neuroinflammation
    2788. Mediators of neuroinflammation
    2789. Medicinal Chemistry: ARTICLE; Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation
    2790. Melanoma-secreted Amyloid Beta Supresses neuroinflammation and Promotes Brain Metastasis
    2791. Melastatin-related transient receptor potential 2 channel in Aβ42-induced neuroinflammation: implications to Alzheimer’s disease mechanism and …
    2792. Melatonin and oestrogen treatments were able to improve neuroinflammation and apoptotic processes in dentate gyrus of old ovariectomized female rats
    2793. Melatonin and Rapamycin Attenuate Isoflurane-Induced Cognitive Impairment Through Inhibition of neuroinflammation by Suppressing the mTOR Signaling …
    2794. Melatonin attenuated mediators of neuroinflammation and alpha-7 nicotinic acetylcholine receptor mRNA expression in lipopolysaccharide (LPS) stimulated rat …
    2795. Melatonin attenuates D‐galactose‐induced memory impairment, neuroinflammation and neurodegeneration via RAGE/NF‐KB/JNK signaling pathway in aging …
    2796. Melatonin attenuates methamphetamine-induced neuroinflammation through the melatonin receptor in the SH-SY5Y cell line
    2797. Melatonin attenuates pain hypersensitivity and decreases astrocyte-mediated spinal neuroinflammation in a rat model of oxaliplatin-induced pain
    2798. Melatonin inhibits neuronal dysfunction‐associated with neuroinflammation by atopic psychological stress in NC/Nga atopic‐like mouse models
    2799. Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF‐κB and Nrf2 cascades
    2800. Melatonin protects methamphetamine-induced neuroinflammation through NF-κB and Nrf2 pathways in glioma cell line
    2801. Melatonin reduced microglial activation and alleviated neuroinflammation induced neuron degeneration in experimental traumatic brain injury: possible involvement …
    2802. Melatonin regulates neuroinflammation ischemic stroke damage through interactions with microglia in reperfusion phase
    2803. Melatonin rescue oxidative stress-mediated neuroinflammation/neurodegeneration and memory impairment in scopolamine-induced amnesia mice model
    2804. Meloxicam blocks neuroinflammation, but not depressive-like behaviors, in HIV-1 transgenic female rats
    2805. Memantine protects against LPS-induced neuroinflammation, restores behaviorally-induced gene expression and spatial learning in the rat
    2806. Membrane damage induced by amyloid beta and a potential link with neuroinflammation
    2807. Menin deficiency leads to depressive-like behaviors in mice by modulating astrocyte-mediated neuroinflammation
    2808. Meningeal Lymphatic Network: the Middleman of neuroinflammation
    2809. Meningeal lymphatics, immunity and neuroinflammation
    2810. Mesenchymal Stem Cell Derived Exosomes as a Mediator of neuroinflammation and Neuronal Damage Following Cortical Injury
    2811. Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the …
    2812. Mesenchymal stem cell transplantation modulates neuroinflammation in focal cerebral ischemia: contribution of fractalkine and IL-5
    2813. Mesenchymal stem cell-conditioned medium triggers neuroinflammation and reactive species generation in organotypic cultures of rat hippocampus
    2814. Mesenchymal stem cells alleviate Japanese encephalitis virus-induced neuroinflammation and mortality
    2815. Mesenchymal stem cells enhance microglia M2 polarization and attenuate neuroinflammation through TSG-6
    2816. Mesenchymal stem cells transplantation delays functional deterioration by inhibiting neuroinflammation response in aged mice.
    2817. Mesenchymal stem cells transplantation delays functional deteriorationby inhibiting neuroinflammation response in aged mice
    2818. Mesuagenin C mitigated LPS-induced neuroinflammation in BV-2 and NG108-15 cells through pMTOR-PI3K-Akt and ccl21 downregulation
    2819. Metabolic control of glia-mediated neuroinflammation
    2820. Metabolic endotoxemia promotes neuroinflammation after focal cerebral ischemia
    2821. Metabolomic signatures in peripheral blood associated with Alzheimer’s disease amyloid-β-induced neuroinflammation
    2822. Metabotropic glutamate receptor 5 ablation accelerates age-related neurodegeneration and neuroinflammation
    2823. Metabotropic glutamate receptor subtype 5 is altered in LPS-induced murine neuroinflammation model and in the brains of AD and ALS patients
    2824. Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation
    2825. Metal toxicity links to alzheimer’s disease and neuroinflammation
    2826. Metalloprotease Adam10 suppresses epilepsy through repression of hippocampal neuroinflammation
    2827. Metalloproteinases in neuroinflammation
    2828. Metallothionein and neuroinflammation
    2829. Metals and neuroinflammation
    2830. Metformin ameliorates sepsis-induced brain injury by inhibiting apoptosis, oxidative stress and neuroinflammation via the PI3K/Akt signaling pathway
    2831. Metformin attenuates neurological deficit after intracerebral hemorrhage by inhibiting apoptosis, oxidative stress and neuroinflammation in rats
    2832. Metformin reduces morphine tolerance by inhibiting microglial-mediated neuroinflammation
    2833. METH-induced neurotoxicity is alleviated by lactulose pretreatment through suppressing oxidative stress and neuroinflammation in rat striatum
    2834. Methadone diminishes neuroinflammation and disease severity in EAE through modulating T cell function
    2835. Methamphetamine induces neuroinflammation and neuronal dysfunction in the mice hippocampus
    2836. Methamphetamine neurotoxicity, microglia, and neuroinflammation
    2837. Methamphetamine-induced neuroinflammation and Neurotoxicity: a Role for Interleukin-1β
    2838. Methamphetamine‐induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin
    2839. Methionine Sulfoxide Reductase A Negatively Controls Microglia-Mediated neuroinflammation via Inhibiting ROS/MAPKs/NF-κB Signaling Pathways Through a …
    2840. Method of Passsive Immunization Against Disease or Disorder Charcterized by Amyloid Aggregation with Diminished Risk of neuroinflammation
    2841. Methods to assess neuroinflammation
    2842. Methyl jasmonate attenuates memory dysfunction and decreases brain levels of biomarkers of neuroinflammation induced by lipopolysaccharide in mice
    2843. Methylene blue attenuates neuroinflammation after subarachnoid hemorrhage in rats through the Akt/GSK-3β/MEF2D signaling pathway
    2844. Methylene blue attenuates traumatic brain injury-associated neuroinflammation and acute depressive-like behavior in mice
    2845. Methylene Blue Infusion for Treatment of Traumatic Brain Injury-associated neuroinflammation
    2846. Methylene blue inhibits Caspase-6 activity, and reverses Caspase-6-induced cognitive impairment and neuroinflammation in aged mice
    2847. Methylene blue mitigates acute neuroinflammation after spinal cord injury through inhibiting NLRP3 inflammasome activation in microglia
    2848. Methylene Blue Reduced Brain Edema, neuroinflammation, and Behavioral Deficits associated with a Moderate Traumatic Brain Injury
    2849. Methylene Blue: A Novel Disease-modifying Drug for neuroinflammation in Parkinson’s Disease
    2850. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-9-135″>Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors?
    2851. Mevalonate kinase deficiency and neuroinflammation: balance between apoptosis and pyroptosis
    2852. MFG-E8 mediates primary phagocytosis of viable neurons during neuroinflammation
    2853. MG17, A Novel Triazole Derivative Abrogated neuroinflammation and Related Neurodegenerative Symptoms in Rodents
    2854. MG53 attenuates lipopolysaccharide-induced neurotoxicity and neuroinflammation via inhibiting TLR4/NF-κB pathway in vitro and in vivo
    2855. Microarray analysis identifies the potential role of long non-coding RNA in regulating neuroinflammation during Japanese encephalitis virus infection
    2856. Microbial Translocation is associated with neuroinflammation in HIV-infected subjects on ART
    2857. Microdose Lithium NP03 Diminishes Pre-Plaque Oxidative Damage and neuroinflammation in a Rat Model of Alzheimer’s-Like Amyloidosis
    2858. Microglia Activated by Excess Cortisol Induce HMGB1 Acetylation and neuroinflammation in the Hippocampal DG Region of Mice Following Cold Exposure
    2859. Microglia and astroglia: the role of neuroinflammation in lead toxicity and neuronal injury in the brain
    2860. Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia
    2861. Microglia and calcium dysregulation during chronic neuroinflammation and aging: causes and consequences
    2862. Microglia and mast cells: two tracks on the road to neuroinflammation
    2863. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-1-14″>Microglia and neuroinflammation: a pathological perspective
    2864. Microglia contribute to the glia limitans around arteries, capillaries and veins under physiological conditions, in a model of neuroinflammation and in human brain …
    2865. Microglia in neurodegenerative disorders and neuroinflammation
    2866. Microglia Mediated neuroinflammation: Focus on PI3K Modulation
    2867. Microglia modulate Ang II induced neuronal activity and neuroinflammation
    2868. Microglia morphological categorization in a rat model of neuroinflammation by hierarchical cluster and principal components analysis
    2869. Microglia pre-activation and neurodegeneration precipitate neuroinflammation without exacerbating tissue injury in experimental autoimmune …
    2870. Microglia TREM2 is required for electroacupuncture to attenuate neuroinflammation in focal cerebral ischemia/reperfusion rats
    2871. Microglia-Based Phenotypic Screening Identifies a Novel Inhibitor of neuroinflammation Effective in Alzheimer’s Disease Models
    2872. Microglia-dependent presynaptic disruption in an organotypic hippocampal slice culture model of neuroinflammation
    2873. Microglia-mediated neuroinflammation and neurotrophic factor-induced protection in the MPTP mouse model of Parkinson’s disease-lessons from transgenic mice
    2874. Microglia-mediated neuroinflammation in neurodegenerative diseases
    2875. Microglia-mediated neuroinflammation is an amplifier of virus-induced neuropathology
    2876. neuroinflammation_and_Ab_in_Alzheimer’s_disease/links/567f699d08ae051f9ae6761d.pdf”>Microglia, neuroinflammation, and Aβ in Alzheimer’s disease
    2877. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease
    2878. Microglial activation and neuroinflammation in Alzheimer’s disease: a critical examination of recent history
    2879. Microglial activation in neuroinflammation: Implications for the etiology of neurodegeneration
    2880. Microglial activation is not equivalent to neuroinflammation in alcohol-induced neurodegeneration: The importance of microglia phenotype
    2881. Microglial CD14 activated by iNOS contributes to neuroinflammation in cerebral ischemia
    2882. Microglial genes regulating neuroinflammation in the progression of Alzheimer’s disease
    2883. Microglial immunoreceptor tyrosine-based activation and inhibition motif signaling in neuroinflammation
    2884. Microglial inhibitory effect of ginseng ameliorates cognitive deficits and neuroinflammation following traumatic head injury in rats
    2885. Microglial IRF5-IRF4 regulatory axis regulates neuroinflammation after cerebral ischemia and impacts stroke outcomes
    2886. Microglial Kv1. 3, a voltage-gated potassium channel, mediates neuroinflammation and neurodegeneration in cell culture and animal models of Parkinson’s disease
    2887. Microglial LOX-1 reacts with extracellular HSP60 to bridge neuroinflammation and neurotoxicity
    2888. Microglial LOX-1/MAPKs/NF-κB positive loop promotes the vicious cycle of neuroinflammation and neural injury
    2889. Microglial migration and interactions with dendrimer nanoparticles are altered in the presence of neuroinflammation
    2890. Microglial mitophagy mitigates neuroinflammation in Alzheimer’s disease
    2891. Microglial neuroinflammation contributes to tau accumulation in chronic traumatic encephalopathy
    2892. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0819-4″>Microglial-derived microparticles mediate neuroinflammation after traumatic brain injury
    2893. Microinjection of l-arginine into corpus callosum cause reduction in myelin concentration and neuroinflammation
    2894. MicroRNA 155 and viral-induced neuroinflammation
    2895. MicroRNA let-7c-5p improves neurological outcomes in a murine model of traumatic brain injury by suppressing neuroinflammation and regulating microglial …
    2896. MicroRNA-125b mimic inhibits ischemia reperfusion-induced neuroinflammation and aberrant p53 apoptotic signalling activation through targeting TP53INP1
    2897. MicroRNA-146a protects against cognitive decline induced by surgical trauma by suppressing hippocampal neuroinflammation in mice
    2898. MicroRNA-152 attenuates neuroinflammation in intracerebral hemorrhage by inhibiting thioredoxin interacting protein (TXNIP)-mediated NLRP3 inflammasome …
    2899. MicroRNA-155 negatively affects blood–brain barrier function during neuroinflammation
    2900. MicroRNA-181 variants regulate T cell phenotype in the context of autoimmune neuroinflammation
    2901. MicroRNA-181b-5p attenuates early postoperative cognitive dysfunction by suppressing hippocampal neuroinflammation in mice
    2902. MicroRNA-23b alleviates neuroinflammation and brain injury in intracerebral hemorrhage by targeting inositol polyphosphate multikinase
    2903. MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3
    2904. MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson’s disease
    2905. MicroRNA‐190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP‐induced Parkinson’s disease mouse model
    2906. MicroRNA‑195 triggers neuroinflammation in Parkinson’s disease in a Rho‑associated kinase 1‑dependent manner
    2907. microRNA‐200b modulates microglia‐mediated neuroinflammation via the cJun/MAPK pathway
    2908. microRNA‐9‐5p alleviates blood‐brain barrier damage and neuroinflammation after traumatic brain injury
    2909. MicroRNAs and the genetic nexus of brain aging, neuroinflammation, neurodegeneration, and brain trauma
    2910. MicroRNAs as novel regulators of neuroinflammation
    2911. MicroRNAs in neuroinflammation: implications in disease pathogenesis, biomarker discovery and therapeutic applications
    2912. MicroRNAs in the brain: it’s regulatory role in neuroinflammation
    2913. MicroRNAs: roles in regulating neuroinflammation
    2914. MICROVESICLES: MESSENGERS AND MEDIATORS OF neuroinflammation
    2915. Midkine is a novel regulator of amphetamine-induced striatal gliosis and cognitive impairment: evidence for a stimulus-dependent regulation of neuroinflammation by …
    2916. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-1002-7″>Mild endoplasmic reticulum stress ameliorates lipopolysaccharide-induced neuroinflammation and cognitive impairment via regulation of microglial …
    2917. Mild Neurocognitive Impairment in HIV Infection Is Associated with neuroinflammation on Positron Emission Tomography (IN3-1.008)
    2918. Mild Neurocognitive Impairment in HIV Infection Is Associated with neuroinflammation on Positron Emission Tomography (S37. 003)
    2919. Mildronate and its neuroregulatory mechanisms: targeting the mitochondria, neuroinflammation, and protein expression
    2920. Mincle/Syk Signaling Pathway Contributes to neuroinflammation after Subarachnoid Hemorrhage in Rats
    2921. Mineralocorticoid receptors, neuroinflammation and hypertensive encephalopathy
    2922. Minocycline alleviates beta-amyloid protein and tau pathology via restraining neuroinflammation induced by diabetic metabolic disorder
    2923. Minocycline ameliorates anxiety-related self-grooming behaviors and alters hippocampal neuroinflammation, GABA and serum cholesterol levels in female Sprague …
    2924. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-5-15″>Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia
    2925. Minocycline attenuates neonatal germinal-matrix-hemorrhage-induced neuroinflammation and brain edema by activating cannabinoid receptor 2
    2926. Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE in a transgenic model of Alzheimer’s-like amyloid pathology
    2927. Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer’s disease-like amyloid pathology
    2928. MINOCYCLINE IMPROVES MEMORY AND REDUCES THE neuroinflammation OF MICE SUBJECT TO AMYLOID B (1-42) PEPTIDE ADMINISTRATION
    2929. neuroinflammation_and_enhances_vascular_endothelial_growth_factor_expression_in_a_cerebral_ischemiareperfusion_rat_model/links/567f6d1708aebccc4e05f9e9/Minocycline-inhibits-neuroinflammation-and-enhances-vascular-endothelial-growth-factor-expression-in-a-cerebral-ischemia-reperfusion-rat-model.pdf”>Minocycline inhibits neuroinflammation and enhances vascular endothelial growth factor expression in a cerebral ischemia/reperfusion rat model
    2930. Minocycline modulates neuroinflammation independently of its antimicrobial activity in staphylococcus aureus-induced brain abscess
    2931. Minocycline plus N-acteylcysteine induces remyelination, synergistically protects oligodendrocytes and modifies neuroinflammation in a rat model of mild traumatic …
    2932. Minocycline reduces astrocytic reactivation and neuroinflammation in the hippocampus of a vascular cognitive impairment rat model
    2933. Minocycline reduces neuroinflammation but does not ameliorate neuron loss in a mouse model of neurodegeneration
    2934. miR-140-5p Attenuates neuroinflammation and Brain Injury in Rats Following Intracerebral Hemorrhage by Targeting TLR4
    2935. miR-142-3p is a key regulator of IL-1β-dependent synaptopathy in neuroinflammation
    2936. miR‐194 relieve neuropathic pain and prevent neuroinflammation via targeting FOXA1
    2937. neuroinflammation_AND_APOPTOSIS_ASSOCIATED_WITH_ALZHEIMER’S_DISEASE_IN_EXPERIMENTAL_MODEL/links/544fa8ea0cf26dda08920a14.pdf”>Miracle enzymes serrapeptase and nattokinase mitigate neuroinflammation and apoptosis associated with Alzheimer’s disease in experimental model
    2938. MiRNA-210 induces microglial activation and regulates microglia-mediated neuroinflammation in neonatal hypoxic-ischemic encephalopathy
    2939. miRNA-3473b contributes to neuroinflammation following cerebral ischemia
    2940. Mitigating Role Of Chrysin Loaded Solid Lipid Nanoparticles Against Cognitive Decline neuroinflammation And Impaired Brain Aand# 946; Clearance In …
    2941. Mitigation effects of a novel herbal medicine, hepad, on neuroinflammation, neuroapoptosis, and neuro-oxidation
    2942. Mitigation of postnatal ethanol-induced neuroinflammation ameliorates trace fear memory deficits in juvenile rats
    2943. Mitoapocynin treatment protects against neuroinflammation and dopaminergic neurodegeneration in a preclinical animal model of Parkinson’s disease
    2944. Mitochondria and the link between neuroinflammation and neurodegeneration
    2945. Mitochondria as the core of neuroinflammation and neurodegeneration in models of neuronal and astrocytic dysfunction
    2946. Mitochondria at the interface between neurodegeneration and neuroinflammation
    2947. Mitochondria in neuroinflammation–Multiple sclerosis (MS), Leber hereditary optic neuropathy (LHON) and LHON-MS
    2948. Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer’s disease
    2949. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1094-8″>Mitochondrial damage and “plugging” of transport selectively in myelinated, small-diameter axons are major early events in peripheral neuroinflammation
    2950. Mitochondrial damage and axon degeneration in chronic neuroinflammation
    2951. Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: novel therapeutic strategies for neurodegenerative disorders
    2952. Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration?
    2953. Mitochondrial dysfunctioning and neuroinflammation: Recent highlights on the possible mechanisms involved in Traumatic Brain Injury
    2954. Mitochondrial JNK phosphorylation as a novel therapeutic target to inhibit neuroinflammation and apoptosis after neonatal ischemic brain damage
    2955. Mitochondrial metabolism: a common link between neuroinflammation and neurodegeneration
    2956. Mitochondrial transcription factor A (TFAM) as a novel intercellular signaling molecule of the brain: its role in glial cell activation and neuroinflammation
    2957. Mitochondrial translocator protein (TSPO), astrocytes and neuroinflammation
    2958. Mitogen-activated protein kinase–activated protein kinase 2 in neuroinflammation, heat shock protein 27 phosphorylation, and cell cycle: role and targeting
    2959. MKP1 reduces neuroinflammation via inhibiting endoplasmic reticulum stress and mitochondrial dysfunction
    2960. MLKL mediated necroptosis accelerates JEV-induced neuroinflammation in mice
    2961. MMP-3 contributes to nigrostriatal dopaminergic neuronal loss, BBB damage, and neuroinflammation in an MPTP mouse model of Parkinson’s disease
    2962. MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation …
    2963. Modafinil abrogates methamphetamine-induced neuroinflammation and apoptotic effects in the mouse striatum
    2964. MODELING AMYLOID-β INDUCED neuroinflammation IN ZEBRAFISH
    2965. Modeling cytokine regulatory network dynamics driving neuroinflammation in central nervous system disorders
    2966. Modeling HIV-1 induced neuroinflammation in mice: role of platelets in mediating blood-brain barrier dysfunction
    2967. Modeling neuroinflammation in Individuals with Parkinson’s
    2968. Modeling of TREX1-dependent autoimmune disease using human stem cells highlights L1 accumulation as a source of neuroinflammation
    2969. Modeling the Effect of HIV-1 Induced neuroinflammation on the Cerebral Vasculature: Acute Intracranial Exposure to HIV-1 Tat Leads to Dysregulation of …
    2970. Modelling neuroinflammation In Vitro: A Tool to Test the Potential
    2971. Modelling neuroinflammation in vitro: a tool to test the potential neuroprotective effect of anti-inflammatory agents
    2972. Modest reductions in BACE1 activity significantly reduce beta-amyloid plaque load and neuroinflammation in a mouse model of Alzheimer’s disease
    2973. Modifiable risk factors of Alzheimer’s disease and neuroinflammation: what are the links?
    2974. Modulating acute neuroinflammation in intracerebral hemorrhage: the potential promise of currently approved medications for multiple sclerosis
    2975. Modulating neuroinflammation and oxidative stress to prevent epilepsy and improve outcomes after traumatic brain injury
    2976. Modulating neuroinflammation to treat neuropsychiatric disorders
    2977. Modulating neuroinflammation with Porous Templated Scaffolds
    2978. Modulation by astrocytes of microglial cell-mediated neuroinflammation: effect on the activation of microglial signaling pathways
    2979. Modulation of adult hippocampal neurogenesis during myelin‐directed autoimmune neuroinflammation
    2980. Modulation of dendritic cell function by PGE2 and DHA: a framework for understanding the role of dendritic cells in neuroinflammation
    2981. Modulation of glutamate transmission during amyotrophic lateral sclerosis: regulation of glutamate transporters and implication of neuroinflammation
    2982. Modulation of ischemic brain injury and neuroinflammation by adenosine A2A receptors
    2983. Modulation of lipopolysaccharide-induced memory insult, γ-secretase, and neuroinflammation in triple transgenic mice by 5-lipoxygenase
    2984. Modulation of LPS-induced memory insult, γ-secretase and neuroinflammation in 3xTg mice by 5-Lipoxygenase
    2985. Modulation of LPS-stimulated neuroinflammation in BV-2 microglia by Gastrodia elata: 4-hydroxybenzyl alcohol is the bioactive candidate
    2986. Modulation of neuroimmune responses on glia in the central nervous system: implication in therapeutic intervention against neuroinflammation
    2987. Modulation of neuroinflammation and memory dysfunction using percutaneous vagus nerve stimulation in mice
    2988. Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer’s disease using a biased and selective beta-1 adrenergic receptor partial …
    2989. Modulation of neuroinflammation by cysteinyl leukotriene 1 and 2 receptors: Implications for cerebral ischemia and neurodegenerative diseases
    2990. Modulation of neuroinflammation by dietary flavonoids
    2991. neuroinflammation&ots=5kTGIOIBpw&sig=ub7C6qLj1OZlElnzmEHE1dXc1Ao”>MODULATION OF neuroinflammation BY MEDICINAL HERBS AND FLAVONOIDS
    2992. Modulation of neuroinflammation by Taklisodok-um in a Spinal Cord Injury Model
    2993. Modulation of neuroinflammation in Experimental Subarachnoid Hemorrhage
    2994. Modulation of neuroinflammation in the central nervous system: role of chemokines and sphingolipids
    2995. Modulation of neuroinflammation with the phytoestrogen, formononetin
    2996. Modulation of neuroinflammation: role and therapeutic potential of TRPV1 in the neuro-immune axis
    2997. Modulation of post-traumatic epilepsy by MIS416, a novel innate immune modulator for the treatment of neuroinflammation (P6. 232)
    2998. Modulation of pro-inflammatory response of retina by adenosinergic systems: neuroinflammation/neuroprotection
    2999. Modulation of the endocannabinoid system and PanX1-mediated neuroinflammation in an in vitro model of Alzheimer’s disease
    3000. Modulation of thrombin-induced neuroinflammation in BV-2 microglia by carbon monoxide-releasing molecule 3
    3001. Modulatory Effect of a Standardised Andrographis Paniculata Aqueous Extract on Urine Metabolomics in a Rat Model of neuroinflammation
    3002. Modulatory effects of neuropeptides on pentylenetetrazol-induced epileptic seizures and neuroinflammation in rats
    3003. Modulatory role of ketogenic diet on neuroinflammation; a possible drug naïve strategy to treatment of Parkinson’s disease
    3004. Molecular and cellular insights: neuroinflammation and amyotrophic lateral sclerosis
    3005. Molecular and Cellular Mechanisms of neuroinflammation
    3006. Molecular and Cellular Mechanisms of neuroinflammation
    3007. Molecular and Cellular Substrates of neuroinflammation in Alzheimer Disease and Depression
    3008. Molecular basis of etiological implications in Alzheimer’s disease: focus on neuroinflammation
    3009. Molecular chaperone α-crystallin prevents detrimental effects of neuroinflammation
    3010. Molecular cross-talk between Lrrk2 and NF-κ/INS; B in neuroinflammation in an/INS; animal model of Parkinson’s disease (PD)
    3011. Molecular hydrogen attenuates sepsis-induced neuroinflammation through regulation of microglia polarization through an mTOR-autophagy-dependent pathway
    3012. Molecular hydrogen reduces LPS-induced neuroinflammation and promotes recovery from sickness behaviour in mice
    3013. Molecular imaging of neuroinflammation in Alzheimer’s disease
    3014. Molecular imaging of neuroinflammation in Alzheimer’s disease and mild cognitive impairment
    3015. Molecular imaging of neuroinflammation in HIV
    3016. Molecular Imaging of neuroinflammation in Idiopathic Parkinson’s Disease
    3017. Molecular imaging of neuroinflammation in neurodegenerative dementias: the role of in vivo PET imaging
    3018. Molecular imaging of neuroinflammation in patients after mild traumatic brain injury: a longitudinal 123I‐CLINDE single photon emission computed tomography study
    3019. Molecular imaging of neuroinflammation in preclinical rodent models using positron emission tomography.
    3020. Molecular indicators of stress-induced neuroinflammation in a mouse model simulating features of post-traumatic stress disorder
    3021. Molecular Indicators of Stress-Induced neuroinflammation in a Mouse Model Simulating Features of Post-Traumatic Stress Disorder (Open Access)
    3022. Molecular insights into NR4A2 (Nurr1): an emerging target for neuroprotective therapy against neuroinflammation and neuronal cell death
    3023. Molecular mechanism of aluminum induced neuroinflammation
    3024. MOLECULAR MECHANISMS IN P25/CDK5-MEDIATED neuroinflammation AND SUBSEQUENT NEURODEGENERATION: THERAPEUTIC …
    3025. Molecular mechanisms linking neuroinflammation and neurodegeneration in MS
    3026. Molecular mechanisms of neuroinflammation and injury during acute viral encephalitis
    3027. Molecular Mechanisms Of neuroinflammation Following Global Cerebral Ischemia: The Role Of Hypothermia Therapy
    3028. Molecular mechanisms of synaptotoxicity and neuroinflammation in Alzheimer’s disease
    3029. Molecular mechanisms responsible for neuroinflammation and neurological impairments in mevalonate kinase deficiency
    3030. Molecular pathogenesis of neuroinflammation
    3031. Molecular Tipping Points in neuroinflammation
    3032. Molecular triggers of neuroinflammation in mouse models of demyelinating diseases
    3033. Momordica charantia (bitter melon) attenuates high-fat diet-associated oxidative stress and neuroinflammation
    3034. neuroinflammation_in_vivo_with_CEST_imaging/links/545d28ca0cf27487b44d4b1e.pdf”>Monitoring neuroinflammation in vivo with CEST imaging
    3035. monitoring the immune cell infiltration in the LPS-induced neuroinflammation region with simultaneous small animal PET/MR imaging using a TSPO-targeting probe
    3036. Monoacylglycerol lipase blockade impairs fine motor coordination and triggers cerebellar neuroinflammation through cyclooxygenase-2
    3037. Morin attenuates ifosfamide-induced neurotoxicity in rats via suppression of oxidative stress, neuroinflammation and neuronal apoptosis
    3038. Morin decreases cortical pyramidal neuron degeneration via inhibition of neuroinflammation in mouse model of schizophrenia
    3039. Morin exerts neuroprotection via attenuation of ROS induced oxidative damage and neuroinflammation in experimental diabetic neuropathy
    3040. Morin mitigates chronic constriction injury (CCI)-induced peripheral neuropathy by inhibiting oxidative stress induced PARP over-activation and neuroinflammation
    3041. Moringa oleifera inhibit neuroinflammation in LPS activated BV2 microglia
    3042. Morphine activates neuroinflammation in a manner parallel to endotoxin
    3043. Morphine preconditioning protects against LPS-induced neuroinflammation and memory deficit
    3044. Motor neuron loss and neuroinflammation in a model of α-synuclein-induced neurodegeneration
    3045. MP47-04 CYCLOPHOSPHAMIDE-INDUCED CYSTITIS TRIGGERS NLRP3–DEPENDENT neuroinflammation IN THE HIPPOCAMPUS AND DEPRESSION IN …
    3046. MPTP lesion causes neuroinflammation and deficits in object recognition in Wistar rats.
    3047. MPTP-induced dopaminergic degeneration and deficits in object recognition in rats are accompanied by neuroinflammation in the hippocampus
    3048. MPTP-induced neuroinflammation increases the expression of pro-inflammatory cytokines and their receptors in mouse brain
    3049. neuroinflammation&ots=2C2HCDj5nS&sig=j6aV5d8hErsur7qEKrYaI-nLSnc”>MRI Assessment of Post-Ischemic neuroinflammation in Stroke: Experimental and Clinical Studies
    3050. MRI coupled with clinically-applicable iron oxide nanoparticles reveals choroid plexus involvement in a murine model of neuroinflammation
    3051. MRI monitoring of neuroinflammation in mouse focal ischemia
    3052. MRI of monocyte infiltration in an animal model of neuroinflammation using SPIO-labeled monocytes or free USPIO
    3053. MRI visualization of neuroinflammation using VCAM-1 targeted paramagnetic micelles
    3054. MRI/MRS in neuroinflammation: methodology and applications
    3055. MSCs-derived exosomes and neuroinflammation, neurogenesis and therapy of traumatic brain injury
    3056. MSP-dependent activation of CNS Ron Receptor Tyrosine Kinase signaling attenuates neuroinflammation through the physiological regulation of IL1B and NLRP3 …
    3057. mTOR and neuroinflammation
    3058. mTOR pathway inhibition prevents neuroinflammation and neuronal death in a mouse model of cerebral palsy
    3059. mTOR Pathway Inhibition Prevents neuroinflammation and Neuronal Death in a Mouse Model of Spinal Cord Injury
    3060. mTOR signaling inhibition modulates macrophage/microglia-mediated neuroinflammation and secondary injury via regulatory T cells after focal ischemia
    3061. mTORC1 pathway disruption abrogates the effects of the ciliary neurotrophic factor on energy balance and hypothalamic neuroinflammation
    3062. Mucopolysaccharide diseases: a complex interplay between neuroinflammation, microglial activation and adaptive immunity
    3063. Mucuna pruriens protects against MPTP Intoxicated neuroinflammation in Parkinson’s disease through NF-κB/pAKT signaling pathways
    3064. Müller Cell–Microglia Cross Talk Drives neuroinflammation in Diabetic Retinopathy
    3065. Multi-functional diarylurea small molecule inhibitors of TRPV1 with therapeutic potential for neuroinflammation
    3066. Multi-scale analyses of molecular network dynamics underlying neuronal excitability, neuroinflammation, and organismal homeostasis
    3067. Multifaces of neuropeptide Y in the brain–neuroprotection, neurogenesis and neuroinflammation
    3068. Multimodal approach to the evaluation of diffuse neuroinflammation in multiple sclerosis using positron emission tomography and diffusion tensor imaging
    3069. Multimodal evaluation of neuroinflammation-associated changes during epileptogenesis using small animal PET and MRI.
    3070. Multimodal molecular imaging demonstrates myeloperoxidase regulation of matrix metalloproteinase activity in neuroinflammation
    3071. Multiple loci comprising immune-related genes regulate experimental neuroinflammation
    3072. Multiple sclerosis and neuroinflammation: the overview of current and prospective therapies
    3073. Multiple Sclerosis is a Primary System of Neurodegeneration Permissive for neuroinflammation and Demyelination
    3074. Multiple sclerosis: Coagulation factors could mediate neuroinflammation in multiple sclerosis
    3075. Multiple sclerosis: implications of obesity in neuroinflammation
    3076. Multitarget Profiling of a Strigolactone Analog for Early Events of Alzheimer’s Disease: in Vitro Therapeutic Activities against neuroinflammation
    3077. Mumefural Ameliorates Cognitive Impairment in Chronic Cerebral Hypoperfusion via Regulating the Septohippocampal Cholinergic System and neuroinflammation
    3078. Murine K2P5. 1 deficiency has no impact on autoimmune neuroinflammation due to compensatory K2P3. 1-and KV1. 3-dependent mechanisms
    3079. Mutant huntingtin gene-dose impacts on aggregate deposition, DARPP32 expression and neuroinflammation in HdhQ150 mice
    3080. Mutated tau, amyloid and neuroinflammation in Alzheimer disease—A brief review
    3081. Mutations of complement factor I and potential mechanisms of neuroinflammation in acute hemorrhagic leukoencephalitis
    3082. Mycobacterium vaccae immunization protects aged rats from surgery-elicited neuroinflammation and cognitive dysfunction
    3083. MyD88 is dispensable for cerebral amyloid pathology and neuroinflammation in PSAPP transgenic mice
    3084. MyD88 is dispensable for cerebral amyloidosis and neuroinflammation in APP/PS1 transgenic mice
    3085. Myelin loss associated with neuroinflammation in hypertensive rats
    3086. Myeloid cell transmigration across the CNS vasculature triggers IL-1β–driven neuroinflammation during autoimmune encephalomyelitis in mice
    3087. Myeloid cells as therapeutic targets in neuroinflammation after stroke: Specific roles of neutrophils and neutrophil–platelet interactions
    3088. Myeloid Kruppel-like factor 2 deficiency exacerbates neurological dysfunction and neuroinflammation in a murine model of multiple sclerosis
    3089. Myeloid microvesicles are a marker and therapeutic target for neuroinflammation
    3090. Myeloid sphingosine-1-phosphate receptor 1 is important for CNS autoimmunity and neuroinflammation
    3091. Myeloid-derived suppressor cells infiltrate the brain and suppress neuroinflammation in a mouse model of focal traumatic brain injury
    3092. Myeloperoxidase Molecular MRI Reveals Synergistic Combination Therapy in Murine Experimental Autoimmune neuroinflammation
    3093. Myocardial infarction is associated with neuroinflammation-a systemic analysis using TSPO-targeted molecular imaging.
    3094. Myocardial inflammation predicts remodeling and neuroinflammation after myocardial infarction
    3095. Myosin1f-mediated neutrophil migration contributes to acute neuroinflammation and brain injury after stroke in mice
    3096. Myricetin prevents dopaminergic neurons from undergoing neuroinflammation-mediated degeneration in a lipopolysaccharide-induced Parkinson’s disease model
    3097. n-3 Docosapentaenoic acid-derived protectin D1 promotes resolution of neuroinflammation and arrests epileptogenesis
    3098. n-3 Fatty Acid-Derived Lipid Mediators against Neurological Oxidative Stress and neuroinflammation
    3099. N-3 polyunsaturated fatty acid and neuroinflammation in aging and Alzheimer’s disease
    3100. N-3 Polyunsaturated Fatty Acid and neuroinflammation in Aging: Role in Cognition
    3101. N-3 Polyunsaturated Fatty Acids and neuroinflammation in Alzheimer’s Disease
    3102. N-3 polyunsaturated fatty acids and the resolution of neuroinflammation
    3103. n-3 Polyunsaturated fatty acids in animal models with neuroinflammation
    3104. N-3 polyunsaturated fatty acids in animal models with neuroinflammation: An update
    3105. N-acetyl-L-leucine treatment attenuates neuronal cell death and suppresses neuroinflammation after traumatic brain injury in mice
    3106. N-acetylcysteine attenuates neuroinflammation associated depressive behavior induced by chronic unpredictable mild stress in rat
    3107. N-acetylcysteine Prevents Alcohol Related neuroinflammation in Rats
    3108. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0751-z”>N-Docosahexaenoylethanolamine ameliorates LPS-induced neuroinflammation via cAMP/PKA-dependent signaling
    3109. N-Palmitoylethanolamine and neuroinflammation: a Novel Therapeutic Strategy of Resolution
    3110. N-Palmitoylethanolamine-oxazoline (PEA-OXA): a new therapeutic strategy to reduce neuroinflammation and oxidative stress associated to vascular dementia
    3111. N-Palmitoylethanolamine-oxazoline (PEA-OXA): a new therapeutic strategy to reduce neuroinflammation, oxidative stress associated to vascular dementia in an …
    3112. N-Palmitoylethanolamine-Oxazoline as a New Therapeutic Strategy to Control neuroinflammation: Neuroprotective Effects in Experimental Models of Spinal Cord …
    3113. N, N-disubstituted azines attenuate LPS-mediated neuroinflammation in microglia and neuronal apoptosis via inhibiting MAPK signaling pathways
    3114. Nafamostat mesilate improves function recovery after stroke by inhibiting neuroinflammation in rats
    3115. NAFLD induces neuroinflammation and accelerates Alzheimer’s disease
    3116. Naja sputatrix venom preconditioning attenuates neuroinflammation in a rat model of surgical brain injury via PLA2/5-LOX/LTB4 cascade activation
    3117. Nalmefene prevents alcohol‐induced neuroinflammation and alcohol drinking preference in adolescent female mice: role of TLR4
    3118. NAMPT inhibitor protects ischemic neuronal injury in rat brain via anti-neuroinflammation
    3119. Nano-size Particles Of Probiotics For Preventing And Treating neuroinflammation
    3120. Nanoliposome containing cyclosporine A reduced neuroinflammation responses and improved neurological activities in cerebral ischemia/reperfusion in rat
    3121. Nanomedicine and its application in treatment of microglia-mediated neuroinflammation
    3122. Nanoscale effects in dendrimer-mediated targeting of neuroinflammation
    3123. NanoString analysis of neuroinflammation in multiple system atrophy
    3124. Nanotherapeutics for gene modulation that prevents apoptosis in the brain and fatal neuroinflammation
    3125. Naringenin decreases α-synuclein expression and neuroinflammation in MPTP-induced Parkinson’s disease model in mice
    3126. Naringenin protects against 1-methyl-4-phenylpyridinium-induced neuroinflammation and resulting reactive oxygen species production in SH-SY5Y cell line …
    3127. Naringin attenuates autophagic stress and neuroinflammation in kainic acid-treated hippocampus in vivo
    3128. Narrative Review Article: neuroinflammation and Perioperative Neurocognitive Disorders
    3129. Natural AD-Like neuropathology in Octodon degus: impaired burrowing and neuroinflammation
    3130. Natural compound 2 provides neuroprotection and anti-neuroinflammation via Nrf2/AREdependent HO-1 expression through activation of the PI3K/AKT …
    3131. Natural compounds isolated from wild Alaska bog blueberries intervene with molecular targets of neuroinflammation
    3132. Natural flavone jaceosidin is a neuroinflammation inhibitor
    3133. Naturally occurring beta-secretase inhibitors mitigate behavioral impairment, cerebral amyloidosis and neuroinflammation in transgenic mice
    3134. NCX1 and NCX3 as potential factors contributing to neurodegeneration and neuroinflammation in the A53T transgenic mouse model of Parkinson’s Disease
    3135. NDP-MSH binding melanocortin-1 receptor ameliorates neuroinflammation and BBB disruption through CREB/Nr4a1/NF-κB pathway after intracerebral …
    3136. Near-infrared photobiomodulation combined with coenzyme Q10 for depression in a mouse model of restraint stress: reduction in oxidative stress, neuroinflammation …
    3137. Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases
    3138. Necroptosis in microglia contributes to neuroinflammation and retinal degeneration through TLR4 activation
    3139. NEIL1 stimulates neurogenesis and suppresses neuroinflammation after stress
    3140. NEK7 regulates NLRP3 inflammasome activation and neuroinflammation post-TBI
    3141. Neonatal Bacillus Calmette-Guerin vaccination alleviates lipopolysaccharide-induced neurobehavioral impairments and neuroinflammation in adult mice
    3142. Neonatal hydrocephalus leads to white matter neuroinflammation and injury in the corpus callosum of Ccdc39 hydrocephalic mice
    3143. Neonatal lipopolysaccharide treatment alters hippocampal neuroinflammation, microglia morphology and anxiety-like behavior in rats selectively bred for an infantile …
    3144. Nerolidol ameliorates cyclophosphamide-induced oxidative stress, neuroinflammation and cognitive dysfunction: Plausible role of Nrf2 and NF-κB
    3145. Nesfatin-1 Ameliorate Learning and Memory Deficit via Inhibiting Apoptosis and neuroinflammation Following Ethanol-Induced Neurotoxicity in Early Postnatal Rats
    3146. Netrin 1 regulates blood–brain barrier function and neuroinflammation
    3147. Netrin‐1 and multiple sclerosis: a new biomarker for neuroinflammation?
    3148. Network medicine in drug design: implications for neuroinflammation
    3149. Neural stem cell small extracellular vesicle-based delivery of 14-3-3t reduces apoptosis and neuroinflammation following traumatic spinal cord injury by …
    3150. Neural stem cell transplantation decreases neuroinflammation in a transgenic mouse model of Alzheimer’s disease
    3151. Neural Stem Cell Treatment Prevents neuroinflammation and Increases Hippocampal BDNF Levels in Genetic Absence Epileptic WAG/Rij Rats
    3152. Neural stem cell-derived small extracellular vesicles attenuate apoptosis and neuroinflammation after traumatic spinal cord injury by activating autophagy
    3153. Neural stem cells respond to extracellular succinate via SUCNR1/GPR91 to ameliorate chronic neuroinflammation
    3154. Neuraminidase-induced neuroinflammation is largely dependent on microglial TLR4 receptor
    3155. Neuregulin upregulates microglial α7 nicotinic acetylcholine receptor expression in immortalized cell lines: implications for regulating neuroinflammation
    3156. Neuregulin-1 protects mouse cerebellum against oxidative stress and neuroinflammation
    3157. Neuroactive Steroids and neuroinflammation
    3158. Neuroactive steroids, their metabolites, and neuroinflammation
    3159. Neurobehavioral performance in feline immunodeficiency virus infection: integrated analysis of viral burden, neuroinflammation, and neuronal injury in cortex
    3160. Neurocysticercosis and hippocampal damage: a causal link favored by epileptogenesis or neuroinflammation?
    3161. Neurodegeneration and neuroinflammation in a Mouse Model of Sarin Exposure
    3162. Neurodegeneration and neuroinflammation in cdk5/p25-inducible mice: a model for hippocampal sclerosis and neocortical degeneration
    3163. Neurodegeneration and neuroinflammation in diabetic retinopathy: potential approaches to delay neuronal loss
    3164. Neurodegeneration and neuroinflammation in Parkinson’s disease: reasearch of blood circulating biomarkers.
    3165. Neurodegeneration and neuroinflammation: two processes, one target
    3166. Neurodegeneration in Chronic Kidney Disease: role of neuroinflammation and uremic toxins
    3167. Neurofilaments and tau proteins in cerebrospinal fluid and serum in dementias and neuroinflammation.
    3168. Neurogenesis and neuroinflammation: the role of Wnt proteins
    3169. Neurogenic neuroinflammation in fibromyalgia and complex regional pain syndrome
    3170. Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity
    3171. Neuroglial activation and neuroinflammation in the brain of patients with autism
    3172. Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease
    3173. Neuroimaging in Autoimmune and neuroinflammation-Related Epilepsies
    3174. Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia
    3175. Neuroimmune and Systemic Manifestations of neuroinflammation in the Temporomandibular Joint and Related Disorders
    3176. Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases
    3177. Neuroimmunity and neuroinflammation
    3178. Neuroimmunologic and neurotrophic interactions in autism spectrum disorders: relationship to neuroinflammation
    3179. Neuroimmunology and neuroinflammation in autoimmune, neurodegenerative and psychiatric disease
    3180. Neuroimmunology: What Role for Autoimmunity, neuroinflammation, and Small Fiber Neuropathy in Fibromyalgia, Chronic Fatigue Syndrome, and Adverse Events …
    3181. neuroinflammation&ots=-KoBSjGwXH&sig=fjjvr2jagzCoEcv7IEP9zwCo3VI”>neuroinflammation
    3182. neuroinflammation
    3183. neuroinflammation
    3184. neuroinflammation
    3185. neuroinflammation
    3186. neuroinflammation
    3187. neuroinflammation/links/5cdc0b7092851c4eaba0ac0c/Pentraxin-3-regulates-neutrophil-infiltration-to-the-brain-during-neuroinflammation.pdf”>neuroinflammation [version 1; peer review: awaiting peer review]
    3188. neuroinflammation & pre-mature aging in the context of chronic HIV infection and drug abuse: Role of dysregulated autophagy
    3189. neuroinflammation a Common Link in Neurodegenerative Neurological and Psychiatric Disorders
    3190. neuroinflammation activates Mdr1b efflux transport through NFκB: promoter analysis in BBB endothelia
    3191. neuroinflammation after acute brain injury: the role of interleukin-1 actions on non-neuronal cells
    3192. neuroinflammation after intracerebral hemorrhage
    3193. neuroinflammation after Intracerebral Hemorrhage and Potential Therapeutic Targets
    3194. neuroinflammation after neonatal hypoxia–ischemia is associated with alterations in the purinergic system: adenosine deaminase 1 isoenzyme is the most …
    3195. neuroinflammation after Subarachnoid Hemorrhage: The Role of Microglia
    3196. neuroinflammation after traumatic brain injury is enhanced in activating transcription factor 3 mutant mice
    3197. neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention
    3198. neuroinflammation after traumatic injury to the developing brain
    3199. neuroinflammation alters cellular proteostasis by producing endoplasmic reticulum stress, autophagy activation and disrupting ERAD activation
    3200. neuroinflammation alters integrative properties of rat hippocampal pyramidal cells
    3201. neuroinflammation alters the hippocampal pattern of behaviorally induced Arc expression
    3202. neuroinflammation alters voltage-dependent conductance in striatal astrocytes
    3203. neuroinflammation AND 18F-AV-1451 PET FINDINGS IN SEMANTIC DEMENTIA
    3204. neuroinflammation and aberrant hippocampal plasticity in a mouse model of emotional stress evoked by exposure to ultrasound of alternating frequencies
    3205. neuroinflammation and activation of Zif-268 in dyskinetic 6-OHDA-lesioned rats is counteracted by association of a 5-HT1A/1B receptor agonist and an A2A receptor …
    3206. neuroinflammation and adult hippocampal neurogenesis in neuropathic pain and alkyl glycerol ethers treatment in aged mice
    3207. neuroinflammation and ageing: current theories and an overview of the data
    3208. neuroinflammation and aging: influence of dietary n-3 polyunsaturated fatty acid
    3209. neuroinflammation and aging: significance of declining circadian functions and melatonin
    3210. neuroinflammation and ALS: transcriptomic insights into molecular disease mechanisms and therapeutic targets
    3211. neuroinflammation&ots=LIP7KlYssk&sig=42pD9K5jqIRRd0t3Fj9CZyDMbso”>neuroinflammation and alteration of the blood-brain barrier in Alzheimers disease
    3212. neuroinflammation_and_Alzheimer_Disease__Clinical.9.aspx”>neuroinflammation and Alzheimer disease: clinical and therapeutic implications
    3213. neuroinflammation&ots=0X3DK28gT7&sig=dG0aSCnRosIxkjSKtogLGjlHVM4″>neuroinflammation AND ALZHEIMER’S
    3214. neuroinflammation and Alzheimer’s Disease
    3215. neuroinflammation and Alzheimer’s disease: implications for microglial activation
    3216. neuroinflammation and Alzheimer’s disease: implications of Abeta immunotherapy
    3217. neuroinflammation and Alzheimer’s disease: lessons learned from 5-lipoxygenase
    3218. neuroinflammation and amyloid deposition: Concurrent [11C] PBR28 and [11C] PIB PET imaging in patients with Alzheimer’s disease, mild cognitive impairment, and …
    3219. neuroinflammation AND AMYLOID PATHOLOGY AFTER TBI
    3220. neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer’s …
    3221. neuroinflammation and anti-inflammatory therapy for Alzheimer’s disease
    3222. neuroinflammation and astrocytic reaction in the course of Phoneutria nigriventer (armed-spider) blood–brain barrier (BBB) opening
    3223. neuroinflammation and autism spectrum disorder: a review
    3224. neuroinflammation and autism: toward mechanisms and treatments
    3225. neuroinflammation and Aβ accumulation linked to systemic inflammation are decreased by genetic PKR down-regulation
    3226. neuroinflammation and B-Cell Phenotypes in Cervical and Lumbosacral Regions of the Spinal Cord in Experimental Autoimmune Encephalomyelitis in the Absence …
    3227. neuroinflammation and behavior
    3228. neuroinflammation and behavior in HIV-1 transgenic rats exposed to chronic adolescent stress
    3229. neuroinflammation and behavioral abnormalities after neonatal terbutaline treatment in rats: implications for autism
    3230. neuroinflammation and blood-brain barrier changes in capillary amyloid angiopathy
    3231. neuroinflammation and blood–brain barrier disruption following traumatic brain injury: Pathophysiology and potential therapeutic targets
    3232. neuroinflammation and both cytotoxic and vasogenic edema are reduced in interleukin-1 type 1 receptor-deficient mice conferring neuroprotection
    3233. neuroinflammation and brain antioxidant levels in ethanol leaf extract of Nauclea latifolia and Artemisinin-combination therapy in Swiss mice infected with …
    3234. neuroinflammation and brain atrophy in former NFL players: an in vivo multimodal imaging pilot study
    3235. neuroinflammation and brain functional disconnection in Alzheimer’s disease
    3236. neuroinflammation and brain infections: historical context and current perspectives
    3237. neuroinflammation and Cannabinoid CB2 Receptor Expression in the Human Huntington’s Disease Brain and R6/1 Transgenic Mouse Model
    3238. neuroinflammation and cell therapy for Parkinson’s disease
    3239. neuroinflammation and central nervous system regeneration in vertebrates
    3240. neuroinflammation and central PI3K/Akt/mTOR signal pathway contribute to bone cancer pain
    3241. neuroinflammation and central sensitization in chronic and widespread pain
    3242. neuroinflammation and cerebrovascular disease in old age: a translational medicine perspective
    3243. neuroinflammation and Circuitry Changes in the Dorsal Raphe Nucleus with Depressive Phenotype after Spinal Cord Injury
    3244. neuroinflammation and CNS disorders
    3245. neuroinflammation AND COGNITION
    3246. neuroinflammation and Cognition
    3247. neuroinflammation-and-cognition-across-psychiatric-conditions/3F71B7A20C855994E45166E06561C0AB”>neuroinflammation and cognition across psychiatric conditions
    3248. neuroinflammation and cognitive aging
    3249. neuroinflammation and cognitive dysfunction in chronic disease and aging
    3250. neuroinflammation and cognitive function in aged mice following minor surgery
    3251. neuroinflammation and cognitive impairment in the aged: implications for nutritional intervention
    3252. neuroinflammation and cognitive plasticity following experimental stroke
    3253. neuroinflammation and common mechanism in Alzheimer’s disease and prion amyloidosis: amyloid-associated proteins, neuroinflammation and neurofibrillary …
    3254. neuroinflammation and comorbid depression: a role for interleukin-1 beta converting enzyme and indoleamine 2, 3-dioxygenase
    3255. neuroinflammation and comorbidities are frequently ignored factors in CNS pathology
    3256. neuroinflammation and comorbidity of pain and depression
    3257. neuroinflammation and Complexes of 17β-Hydroxysteroid Dehydrogenase type 10-Amyloid β in Alzheimer’s Disease
    3258. neuroinflammation and copper in Alzheimer’s disease
    3259. neuroinflammation and cytokine abnormality in major depression: cause or consequence in that illness?
    3260. neuroinflammation and cytokines in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a critical review of research methods
    3261. neuroinflammation AND DEFECTIVE MYELINATION IN POLYMICROGYRIA
    3262. neuroinflammation and defining gene therapy approaches for ovine CLN6 Batten disease
    3263. neuroinflammation and demyelination from the point of nitrosative stress as a new target for neuroprotection
    3264. neuroinflammation and demyelination in multiple sclerosis after allogeneic hematopoietic stem cell transplantation
    3265. neuroinflammation and depression: microglia activation, extracellular microvesicles and microRNA dysregulation
    3266. neuroinflammation_and_Depression___The_Role_of.2.aspx”>neuroinflammation and depression: the role of indoleamine 2, 3-dioxygenase (IDO) as a molecular pathway
    3267. neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system
    3268. neuroinflammation and EIF2 signaling persist in an HiPSC tri-culture model of HIV infection despite antiretroviral treatment
    3269. neuroinflammation and endoplasmic reticulum stress are coregulated by crocin to prevent demyelination and neurodegeneration
    3270. neuroinflammation and endoplasmic reticulum stress are coregulated by cyclo (His-Pro) to prevent LPS neurotoxicity
    3271. neuroinflammation and ER-stress are key mechanisms of acute bilirubin toxicity and hearing loss in a mouse model
    3272. neuroinflammation and excitatory symptoms in bipolar disorder
    3273. neuroinflammation and excitotoxicity in neurobiology of HIV-1 infection and AIDS: targets for neuroprotection
    3274. neuroinflammation and fatty acids
    3275. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1412-9″>neuroinflammation and fractalkine signaling in Alzheimer’s disease
    3276. neuroinflammation and Fragile X syndrome: regulation by glycogen synthase kinase-3
    3277. neuroinflammation and functional connectivity in Alzheimer’s disease: interactive influences on cognitive performance
    3278. neuroinflammation And Glial Cell Activation In Mental Disorders
    3279. neuroinflammation and glial cell activation in pathogenesis of chronic pain
    3280. neuroinflammation and glial phenotypic changes in alpha-synucleinopathies
    3281. neuroinflammation and Immune Regulation in Ischemic Stroke: Identification of New Pharmacological Targets
    3282. neuroinflammation and immunity: a new pharmacological target in depression
    3283. neuroinflammation and impairment of hippocampal neurogenesis underlies depressive-like behaviors of obese rats: Role of TNF-alpha inhibition
    3284. neuroinflammation_and_infection.6.aspx”>neuroinflammation and infection
    3285. neuroinflammation and infection: molecular mechanisms associated with dysfunction of neurovascular unit
    3286. neuroinflammation and inhibitory synaptic control of cultured premotor circuits
    3287. neuroinflammation and iron handling in animal models with brain iron overload
    3288. neuroinflammation and its modulation by flavonoids
    3289. neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis
    3290. neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration
    3291. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-11-98″>neuroinflammation and M2 microglia: the good, the bad, and the inflamed
    3292. neuroinflammation and mechanisms of neuropathic pain development
    3293. neuroinflammation and memory: the role of prostaglandins
    3294. neuroinflammation and microglia in glaucoma: time for a paradigm shift
    3295. neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment
    3296. neuroinflammation and Microvascular Dysfunction After Experimental Subarachnoid Hemorrhage: Emerging Components of Early Brain Injury Related to Outcome
    3297. neuroinflammation and mitochondrial dysfunction in Alzheimer’s and prion’s diseases
    3298. neuroinflammation and mitochondrial dysfunction in the pathogenesis of Alzheimer’s disease: modulation by Coriolus Versicolor (Yun-Zhi) nutritional …
    3299. neuroinflammation and MMPs: potential therapeutic targets in neonatal hypoxic-ischemic injury
    3300. neuroinflammation and myelin status in Alzheimer’s disease, Parkinson’s disease, and normal aging brains: A small sample study
    3301. neuroinflammation and neuroaxonal damage in multiple sclerosis: a cross-sectional cerebrospinal fluid-based proteomic study
    3302. neuroinflammation and neurodegeneration
    3303. neuroinflammation&ots=2HceOwx6ua&sig=GaEDXSrarKdo3HfEpB571nVgJeI”>neuroinflammation and neurodegeneration
    3304. neuroinflammation and neurodegeneration as mechanisms for worsened outcomes in elderly traumatic brain injury
    3305. neuroinflammation and neurodegeneration in adult rat brain from binge ethanol exposure: abrogation by docosahexaenoic acid
    3306. neuroinflammation and neurodegeneration in human brain at single-cell resolution
    3307. neuroinflammation and neurodegeneration in overnutrition-induced diseases
    3308. neuroinflammation and neurodegeneration: pinpointing pathological and pharmacological targets
    3309. neuroinflammation and Neurodegeneration: Pinpointing Pathological and Pharmacological Targets
    3310. neuroinflammation&ots=QyIFUBqwja&sig=3wkI8_bj8XEWNCkA13OyrH3J5ek”>neuroinflammation and Neurodegenerative Diseases
    3311. neuroinflammation and neurodegenerative diseases: a single subject analysis
    3312. neuroinflammation and Neurogenesis in Alzheimer’s Disease and Potential Therapeutic Approaches
    3313. neuroinflammation and neurogenesis in the choroid plexus
    3314. neuroinflammation and neurohormesis in the pathogenesis of Alzheimer’s disease and Alzheimer-linked pathologies: modulation by nutritional mushrooms
    3315. neuroinflammation and neuroimmune dysregulation after acute hypoxic-ischemic injury of developing brain
    3316. neuroinflammation and Neuroimmunomodulation in Alzheimer’s Disease
    3317. neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin
    3318. neuroinflammation and neurological alterations in chronic liver diseases
    3319. neuroinflammation and Neuromodulation in Neurological Diseases
    3320. neuroinflammation and neuronal autophagic death were suppressed via Rosiglitazone treatment: New evidence on neuroprotection in a rat model of global cerebral …
    3321. neuroinflammation and neuronal loss precede Aβ plaque deposition in the hAPP-J20 mouse model of Alzheimer’s disease
    3322. neuroinflammation and neuroplasticity in pain
    3323. neuroinflammation and neuroprotection in schizophrenia and autism spectrum disorder
    3324. neuroinflammation and neuroprotection: an update on (future) neurotrophin-related strategies in multiple sclerosis treatment
    3325. neuroinflammation and neuroprotective strategies in acute ischaemic stroke-from bench to bedside
    3326. neuroinflammation and neurosteroidogenesis: Reciprocal modulation during injury to the adult zebra finch brain
    3327. neuroinflammation and neurotoxicity contribute to neuroprogression in neurological and psychiatric disorders
    3328. neuroinflammation&ots=hOgZ6fNTNW&sig=NGRzjWIWFCmPOt3OptgV0YIqGTk”>neuroinflammation and Neurotransmission Mechanisms Involved in Neuropsychiatric Disorders
    3329. neuroinflammation and neurotrophic actions of chemokines during a cerebral ischemic process
    3330. neuroinflammation AND NEUROVASCULAR DYSFUNCTION IN CVN MICE AFTER ORTHOPEDIC SURGERY
    3331. neuroinflammation and non-motor symptoms: the dark passenger of Parkinson’s disease?
    3332. neuroinflammation and not tauopathy is a predominant pathological signature of nodding syndrome
    3333. neuroinflammation and optic nerve regeneration: where do we stand in elucidating underlying cellular and molecular players?
    3334. neuroinflammation and optic nerve regeneration: where do we stand in elucidating underlying cellular and molecular players?
    3335. neuroinflammation and oxidation/nitration of α-synuclein linked to dopaminergic neurodegeneration
    3336. neuroinflammation and oxidative injury in developmental neurotoxicity
    3337. neuroinflammation and oxidative stress act in concert to promote neurodegeneration in the diabetic retina and optic nerve: galectin-3 participation
    3338. neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets
    3339. neuroinflammation and oxidative stress in psychosis and psychosis risk
    3340. neuroinflammation and oxidative stress in rostral ventrolateral medulla contribute to neurogenic hypertension induced by systemic inflammation
    3341. neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson’s disease
    3342. neuroinflammation and pain
    3343. neuroinflammation and Parkinson disease: the silent battleground
    3344. neuroinflammation and Parkinson’s disease
    3345. neuroinflammation and Parkinson’s Disease: Understanding the Inflammatory Process Induced by Chronic Peripheral Injection of LPS in LRRK2 G2019S KI Mice in …
    3346. neuroinflammation and Pediatric Lupus
    3347. neuroinflammation and peripheral immune infiltration in Parkinson’s disease: an autoimmune hypothesis
    3348. neuroinflammation and physical exercise as modulators of adult hippocampal neural precursor cell behavior
    3349. neuroinflammation_and_postoperative_cognitive.2.aspx”>neuroinflammation and postoperative cognitive dysfunction: can anaesthesia be therapeutic?
    3350. neuroinflammation and postoperative cognitive dysfunction: what do we know?
    3351. neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum.
    3352. neuroinflammation and proteostasis are modulated by endogenously biosynthesized neuroprotectin D1
    3353. neuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-10-43″>neuroinflammation and psychiatric illness
    3354. neuroinflammation and Psychiatric Illness
    3355. neuroinflammation and psychosis; antipsychotic medication.
    3356. neuroinflammation and regeneration in the early stages of Alzheimer’s disease pathology
    3357. neuroinflammation and regulation of glial glutamate uptake in neurological disorders
    3358. neuroinflammation and related neuropathologies in APPSL mice: further value of this in vivomodel of Alzheimer’s disease
    3359. neuroinflammation and schizophrenia
    3360. neuroinflammation and Schizophrenia
    3361. neuroinflammation and Seizures After Pediatric Brain Injury: What a Headache!
    3362. neuroinflammation and sickness induced by lipopolysaccharide in adult and aged mice are not mitigated by dietary broccoli (134.4)
    3363. neuroinflammation and Sjogren’s Syndrome
    3364. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0492-z”>neuroinflammation and structural injury of the fetal ovine brain following intra-amniotic Candida albicans exposure
    3365. neuroinflammation and sympathetic overactivity: mechanisms and implications in hypertension
    3366. neuroinflammation and synaptic loss
    3367. neuroinflammation and synaptic plasticity: theoretical basis for a novel, immune-centred, therapeutic approach to neurological disorders
    3368. neuroinflammation and tau interact with amyloid in predicting sleep problems in aging independently of atrophy
    3369. neuroinflammation and the APOε genotype: Implications for Alzheimer’s disease and modulation by dietary flavonoids and n-3 polyunsaturated fatty acids
    3370. neuroinflammation and the Behavioral Consequences of Air Pollution Over the Life Course
    3371. neuroinflammation and the blood‐brain‐interface: new findings in brain pathology
    3372. neuroinflammation and the blood–brain interface: New findings in brain pathology
    3373. neuroinflammation and the cGAS-STING pathway
    3374. neuroinflammation and the dynamic lesion in traumatic brain injury
    3375. neuroinflammation and the generation of neuropathic pain
    3376. neuroinflammation and the genetics of Alzheimer’s disease: the search for a pro-inflammatory phenotype
    3377. neuroinflammation and the glial endocannabinoid system
    3378. neuroinflammation and the Glial Response Contribute to Both Beneficial and Pathological Outcomes in Multiple Disease Models
    3379. neuroinflammation and the gut microbiota: possible alternative therapeutic targets to counteract Alzheimer’s disease?
    3380. neuroinflammation and the immune-kynurenine pathway in anxiety disorders
    3381. neuroinflammation and the plasticity-related immediate-early gene Arc
    3382. neuroinflammation and the prospects for anti-inflammatory treatment of Parkinson’s disease.
    3383. neuroinflammation and the role of glia: relevance for neurodegenerative and neurosupportive roles
    3384. neuroinflammation_and_Therapeutic_Potential_of.14.aspx”>neuroinflammation and Therapeutic Potential of Neuromediation in Pruritus and Inflammation
    3385. neuroinflammation and Toll-Like Receptors in the Skin
    3386. neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer’s disease
    3387. neuroinflammation and Virus Replication in the Spinal Cord of Simian Immunodeficiency Virus–Infected Macaques
    3388. neuroinflammation and White Matter Alterations in Obesity Assessed by Diffusion Basis Spectrum Imaging
    3389. neuroinflammation and white matter pathology in schizophrenia: systematic review
    3390. neuroinflammation and α-synuclein accumulation in response to glucocerebrosidase deficiency are accompanied by synaptic dysfunction
    3391. neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other Driving Chronic Progression of Parkinson’s Disease
    3392. neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson’s disease
    3393. neuroinflammation and β amyloid deposition in Alzheimer’s disease: in vivo quantification with molecular imaging
    3394. neuroinflammation appears early on PET imaging and then plateaus in a mouse model of Alzheimer disease
    3395. neuroinflammation Appears Early on PET Imaging and Then Plateaus in a Mouse Model of Alzheimer Disease
    3396. neuroinflammation as a cause of chronic pain
    3397. neuroinflammation as a common feature of neurodegenerative disorders
    3398. neuroinflammation as a common mechanism associated with the modifiable risk factors for Alzheimer’s and Parkinson’s diseases
    3399. neuroinflammation as a factor of neurodegenerative disease: Thalidomide analogs as treatments
    3400. neuroinflammation as a mechanism for cardiovascular diseases
    3401. neuroinflammation as a neurotoxic mechanism in alcoholism: commentary on” Increased MCP-1 and microglia in various regions of human alcoholic brain”.
    3402. neuroinflammation-as-a-possible-link-between-cannabinoids-and-addiction/6983C95DD34F3DCDF29E4CC9796083AC”>neuroinflammation as a possible link between cannabinoids and addiction
    3403. neuroinflammation as a Potential Mechanism Underlying Parkinsons Disease
    3404. neuroinflammation as a potential therapeutic target in dementia with Lewy bodies
    3405. neuroinflammation as a risk factor for attention deficit hyperactivity disorder
    3406. neuroinflammation as a target for glaucoma therapy
    3407. neuroinflammation as a target for intervention in subarachnoid hemorrhage
    3408. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1571-8″>neuroinflammation as a target for treatment of stroke using mesenchymal stem cells and extracellular vesicles
    3409. neuroinflammation as a therapeutic target in neurodegenerative diseases
    3410. neuroinflammation as an Early Event and Prime Mover in Alzheimer’s Pathobiology
    3411. neuroinflammation&ots=RMtS0vhQRl&sig=xazZeTqBhRhBVaf6W8Sn_zL2bQM”>neuroinflammation as an Important Pathogenic
    3412. neuroinflammation as an important pathogenic mechanism in spinal cord injury
    3413. neuroinflammation as fuel for axonal regeneration in the injured vertebrate central nervous system
    3414. neuroinflammation as fuel for axonal regeneration: unravelling the underlying players
    3415. neuroinflammation as modifier of genetically caused neurological disorders of the central nervous system: understanding pathogenesis and chances for treatment
    3416. neuroinflammation as the proximate cause of signature pathogenic pattern progression in amyotrophic lateral sclerosis, AIDS, and multiple sclerosis
    3417. neuroinflammation assessment of a mouse model of multiple sclerosis
    3418. neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress
    3419. neuroinflammation at the interface of depression and cardiovascular disease: Evidence from rodent models of social stress
    3420. neuroinflammation biomarkers
    3421. neuroinflammation by cytotoxic T-lymphocytes impairs retrograde axonal transport in an oligodendrocyte mutant mouse
    3422. neuroinflammation caused by mental stress: the effect of chronic restraint stress and acute repeated social defeat stress in mice
    3423. neuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0942-2″>neuroinflammation contributes to autophagy flux blockage in the neurons of rostral ventrolateral medulla in stress-induced hypertension rats
    3424. neuroinflammation contributes to high salt intake-augmented neuronal activation and active coping responses to acute stress
    3425. neuroinflammation contributes to hypokinesia in rats with hepatic encephalopathy: ibuprofen restores its motor activity
    3426. neuroinflammation disorders exacerbated by environmental stressors
    3427. neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis
    3428. neuroinflammation during Parkinson’s disease: key cells and molecules involved in it
    3429. neuroinflammation during RNA viral infections
    3430. neuroinflammation explains aspects of chronic pain and opens new avenues for therapeutic interventions
    3431. neuroinflammation Extends Brain Tissue at Risk to Vital Peri-Infarct Tissue: A Double Tracer [11C]PK11195- and [18F]FDG-PET Study
    3432. neuroinflammation facilitates LIF entry into brain: role of TNF
    3433. neuroinflammation follow-up in a quinolinic acid rat model of excitotoxicity by translocator protein (18 kDa) mapping with CLINDE
    3434. neuroinflammation following disease modifying therapy in multiple sclerosis: a pilot positron emission tomography study
    3435. neuroinflammation Following Sleep Fragmentation In A Pediatric Model
    3436. neuroinflammation functionally regulates CNS lymphatic vasculature and drainage
    3437. neuroinflammation imaging markers for epileptogenesis
    3438. neuroinflammation_impact_in_epileptogenesis_and.6.aspx”>neuroinflammation impact in epileptogenesis and new treatment strategy
    3439. neuroinflammation impairs adaptive structural plasticity of dendritic spines in a preclinical model of Alzheimer’s disease
    3440. neuroinflammation in a Forceps Compression Model of Spinal Cord Injury
    3441. neuroinflammation_in_a_mouse_model_of_colitis_cross-talk_between_the_gut_and_the_brain/links/5620c48408ae93a5c9244ec7.pdf”>neuroinflammation in a mouse model of colitis: cross-talk between the gut and the brain.
    3442. neuroinflammation IN A T-CELL TGF-β RECEPTOR DISRUPTED P301S MOUSE
    3443. neuroinflammation in acute hepatic encephalopathy rats: imaging and therapeutic effectiveness evaluation using 11C-PK11195 and 18F-DPA-714 micro-positron …
    3444. neuroinflammation in acute liver failure: mechanisms and novel therapeutic targets
    3445. neuroinflammation in addiction: A review of neuroimaging studies and potential immunotherapies
    3446. neuroinflammation in advanced canine glaucoma
    3447. neuroinflammation in Age-Related Neurodegenerative Diseases
    3448. neuroinflammation in Aging
    3449. neuroinflammation in alcoholism using [11C] PBR28: from rat to human
    3450. neuroinflammation in Alzheimer’s
    3451. neuroinflammation in Alzheimer’s disease
    3452. neuroinflammation in Alzheimer’s disease
    3453. neuroinflammation in Alzheimer’s disease
    3454. neuroinflammation in Alzheimer’s disease and Down syndrome
    3455. neuroinflammation in Alzheimer’s disease and involvement of interleukin-1: a mechanistic view
    3456. neuroinflammation_in_Alzheimers_Disease20160416-27284-1tmcp5n.pdf”>neuroinflammation in Alzheimer’s disease and major depression
    3457. neuroinflammation in Alzheimer’s disease and mild cognitive impairment: a field in its infancy
    3458. neuroinflammation in Alzheimer’s disease and obesity
    3459. neuroinflammation in Alzheimer’s disease and Parkinson’s disease: are microglia pathogenic in either disorder?
    3460. neuroinflammation in Alzheimer’s disease and prion disease
    3461. neuroinflammation in Alzheimer’s Disease and Prion Disease
    3462. neuroinflammation in Alzheimer’s Disease and Vascular Cognitive Impairment
    3463. neuroinflammation IN ALZHEIMER’S DISEASE PATHOLOGY DECREASES WITH AGE
    3464. neuroinflammation in Alzheimer’s disease wanes with age
    3465. neuroinflammation-in-alzheimer-disease-a-review-manju-bhaskar.pdf”>neuroinflammation in Alzheimer’s disease-A review
    3466. neuroinflammation in Alzheimer’s disease; a source of heterogeneity and target for personalized therapy
    3467. neuroinflammation in Alzheimer’s disease: an understanding of physiology and pathology
    3468. neuroinflammation in Alzheimer’s disease: are NSAIDs and selective COX-2 inhibitors the next line of therapy?
    3469. neuroinflammation in Alzheimer’s disease: Characterization and modification of the response of transgenic mice to intrahippocampal lipopolysaccharide …
    3470. neuroinflammation in Alzheimer’s disease: chemokines produced by astrocytes and chemokine receptors
    3471. neuroinflammation in Alzheimer’s disease: current evidence and future directions
    3472. neuroinflammation in Alzheimer’s disease: different molecular targets and potential therapeutic agents including curcumin
    3473. neuroinflammation in Alzheimer’s disease: focus on NF-κB and C/EBP transcription factors
    3474. neuroinflammation in Alzheimer’s disease: from pathogenesis to a therapeutic target
    3475. neuroinflammation in Alzheimer’s disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation
    3476. neuroinflammation in Alzheimer’s Disease: Microglia, Molecular Participants and Therapeutic Choices
    3477. neuroinflammation in Alzheimer’s disease: pleiotropic roles for cytokines and neuronal pentraxins
    3478. neuroinflammation in Alzheimer’s Disease: Potential Targets for Disease-Modifying Drugs
    3479. neuroinflammation in Alzheimer’s disease: protector or promoter?
    3480. neuroinflammation in Alzheimer’s disease: the preventive and therapeutic potential of polyphenolic nutraceuticals
    3481. neuroinflammation in Alzheimer’s, Parkinson’s and Huntington’s Diseases
    3482. neuroinflammation in amyotrophic lateral sclerosis
    3483. neuroinflammation in amyotrophic lateral sclerosis: new targets for the treatment?
    3484. neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease
    3485. neuroinflammation in amyotrophic lateral sclerosis: role of redox (dys) regulation
    3486. neuroinflammation in an Alzheimer’s disease animal model andthe effectiveness of selective suppression of glial activation
    3487. neuroinflammation in animal models of autism
    3488. neuroinflammation in animal models of fatigue
    3489. neuroinflammation in animal models of traumatic brain injury
    3490. neuroinflammation in autism spectrum disorders
    3491. neuroinflammation in autism spectrum disorders: Role of high mobility group box 1 protein
    3492. neuroinflammation in autism: plausible role of maternal inflammation, dietary omega 3, and microbiota
    3493. neuroinflammation in Bacterial Meningitis
    3494. neuroinflammation in bipolar disorder–A [11C]-(R)-PK11195 positron emission tomography study
    3495. neuroinflammation in bipolar disorders
    3496. neuroinflammation in CNS diseases: molecular mechanisms and the therapeutic potential of plant derived bioactive molecules
    3497. neuroinflammation in delirium: a postmortem case-control study
    3498. neuroinflammation in Demyelinating Diseases: Oxidative Stress as a Modulator of Glial Cross-Talk
    3499. neuroinflammation in depression
    3500. neuroinflammation in early and late onset Alzheimer´ s disease: a multimodal analysis
    3501. neuroinflammation in Early Stages of Alzheimer’s Disease and Parkinson’s Disease
    3502. neuroinflammation in epilepsy: an analysis of patients’ sera and its effect on microglia-like cells (S55. 007)
    3503. neuroinflammation in epileptogenesis: insights and translational perspectives from new models of epilepsy
    3504. neuroinflammation in fibromyalgia and CRPS is multifactorial
    3505. neuroinflammation in fibromyalgia and CRPS: top-down or bottom-up?
    3506. neuroinflammation in first episodes of psychosis
    3507. neuroinflammation in frontotemporal dementia
    3508. neuroinflammation in frontotemporal lobar degeneration revealed by 11C‐PBR28 PET
    3509. neuroinflammation in glaucoma and optic nerve damage
    3510. neuroinflammation in glaucoma: a new opportunity
    3511. neuroinflammation in glaucoma: soluble tumor necrosis factor alpha and the connection with excitotoxic damage
    3512. neuroinflammation in Gulf War Illness is linked with HMGB1 and complement activation, which can be discerned from brain-derived extracellular vesicles in the blood
    3513. neuroinflammation in hAPPSL transgenic mice
    3514. neuroinflammation in HCV-infection–Peril or protection?
    3515. neuroinflammation in healthy aging: A PET study using a novel Translocator Protein 18 kDa (TSPO) radioligand,[18F]-FEPPA
    3516. neuroinflammation in heart failure: new insights for an old disease
    3517. neuroinflammation in hepatic encephalopathy: mechanistic aspects
    3518. neuroinflammation in Huntington’s & Related Neurodegenerative Disorders
    3519. neuroinflammation in Huntington’s disease
    3520. neuroinflammation in Huntington’s disease
    3521. neuroinflammation in Huntington’s disease-effects of fractalkine on microglia in a mouse model R6/2 of Huntington’s disease
    3522. neuroinflammation in Huntington’s Disease: New Insights with 11C-PBR28 PET/MRI
    3523. neuroinflammation in hypertension: the renin-angiotensin system versus pro-resolution pathways
    3524. neuroinflammation in inflammatory bowel disease
    3525. neuroinflammation in intrauterine growth restriction
    3526. neuroinflammation in Ischaemic Stroke: Utilizing the Biphasic Niche of Neuroprotection and Neurotoxicity for Clinic
    3527. neuroinflammation in ischemic brain injury as an adaptive process
    3528. neuroinflammation in ischemic pediatric stroke
    3529. neuroinflammation in l-DOPA-induced dyskinesia: beyond the immune function
    3530. neuroinflammation in Lewy body dementia
    3531. neuroinflammation in liver disease: sessional talks from ISHEN
    3532. neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism
    3533. neuroinflammation in Major Depressive Disorder and Schizophrenia: A PET Study
    3534. neuroinflammation in manganese neurotoxicity
    3535. neuroinflammation in mild cognitive impairment and Alzheimer’s disease: A meta-analysis
    3536. neuroinflammation in mood disorders: Mechanisms and drug targets
    3537. neuroinflammation in motor neuron disease
    3538. neuroinflammation in motor neuron disease
    3539. neuroinflammation in mouse models of Alzheimer’s disease
    3540. neuroinflammation in Movement Disorders
    3541. neuroinflammation in multiple sclerosis: evidence for autoimmune dysregulation, not simple autoimmune reaction
    3542. neuroinflammation in multiple system atrophy: response to and cause of α-synuclein aggregation
    3543. neuroinflammation in murine cirrhosis is dependent on the gut microbiome and is attenuated by fecal transplant
    3544. neuroinflammation in neocortical epilepsy measured by PET imaging of translocator protein
    3545. neuroinflammation in neurodegeneration: role in pathophysiology, therapeutic opportunities and clinical perspectives
    3546. neuroinflammation in neurodegenerative diseases: Current multi-modal imaging studies and future opportunities for hybrid PET/MRI
    3547. neuroinflammation in neurodegenerative disorders—a review
    3548. neuroinflammation in Neurodegenerative Disorders: Harmful or Helpful?
    3549. neuroinflammation in neurological disorders
    3550. neuroinflammation in Neurological Dysfunction and Degeneration
    3551. neuroinflammation in neuronal degeneration and repair
    3552. neuroinflammation in obesity: circulating lipopolysaccharide-binding protein associates with brain structure and cognitive performance
    3553. neuroinflammation in organophosphate-induced neurotoxicity
    3554. neuroinflammation in overnutrition-induced diseases
    3555. neuroinflammation in Parkinson’s disease
    3556. neuroinflammation in Parkinson’s disease
    3557. neuroinflammation in Parkinson’s disease and its potential as therapeutic target
    3558. neuroinflammation in Parkinson’s disease and related disorders: a lesson from genetically manipulated mouse models of-synucleinopathies
    3559. neuroinflammation in Parkinson’s disease animal models: a cell stress response or a step in neurodegeneration?
    3560. neuroinflammation in Parkinson’s disease: a target for neuroprotection?
    3561. neuroinflammation_in_Parkinson’s_disease_is_there_sufficient_evidence_for_mechanism-based_interventional_therapy/links/00463521f6198e15e3000000/neuroinflammation-in-Parkinsons-disease-is-there-sufficient-evidence-for-mechanism-based-interventional-therapy.pdf”>neuroinflammation in Parkinson’s disease: is there sufficient evidence for mechanism-based interventional therapy
    3562. neuroinflammation in Parkinson’s disease: its role in neuronal death and implications for therapeutic intervention
    3563. neuroinflammation in Parkinson’s disease: role in neurodegeneration and tissue repair
    3564. neuroinflammation in Parkinson’s patients and MPTP-treated mice is not restricted to the nigrostriatal system: microgliosis and differential expression of interleukin-1 …
    3565. neuroinflammation in patients with chronic fatigue syndrome/myalgic encephalomyelitis: an 11C-(R)-PK11195 PET study
    3566. neuroinflammation in plaque and vascular β-amyloid disorders: clinical and therapeutic implications
    3567. neuroinflammation in Post-Traumatic Epilepsy: Pathophysiology and Tractable Therapeutic Targets
    3568. neuroinflammation in preclinical Alzheimer’s disease is associated with parahippocampal pathology and memory deficits
    3569. neuroinflammation in preclinical Alzheimer’s disease: a review of current evidence
    3570. neuroinflammation in preterm babies and autism spectrum disorders
    3571. neuroinflammation in primary blast neurotrauma: Time course and prevention by torso shielding
    3572. neuroinflammation in prion diseases: concepts and targets for therapeutic intervention
    3573. neuroinflammation in pulmonary hypertension: concept, facts, and relevance
    3574. neuroinflammation in response to intracereb